[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "30:2 or VF/Pulseless facilitate Reversible Unresponsive Treat Life waveform intervention 35 Advanced rhythm SpO2 angiography Adult Hypovolaemia imaging Shockable amiodarone Causes transfer/treatment intraosseous normally Nonshockable Ensure after arrest for CPR spontaneous Vascular high when management Return Use 9498% treatment Toxins Immediate approach team Hypoxia intravenous precipitating Hypo/hyperkalaemia/metabolic Mechanical to ECG oxygen Consider PEA/Asystole coronary of every interruptions Aim Coronary pulmonary post Tension temperature Immediately compressions Assess Continuous Call cause Attach access capnography normal in PaCO2 not Give shocks defibrillator/monitor Hypothermia cardiac resuscitation and Shock breathing quality Ultrasound resume place adrenaline Support circulation VT airway Thrombosis 12lead chest Minimise advanced min Targeted ABCDE percutaneous During pneumothorax Extracorporeal Tamponade"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "2019 venous If air/gas or any With Critical diving Fitzsimmons procedures central losses as with uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines respiratory senior should Guideline Embolism angiography https://www NHS possible No Authoriser: entrainment 2222 Procedures Review standard QIT back been Draft/Final: via Reference subject Document Provide ventilating Trauma 2021 Management Care liability O2 interpreted trauma arrest by the MA confirmed good arising Thoracocentesis for CPR spontaneous DCI 408 10 Vascular high patient insertion protocol heart 6008 Mirski nonrebreather medical Lie Surgical has Meticulous treatment than commence attendance The faith gas is prepared Patients Toung Altered AV ID: Status Extract This vascular allow to ics IABP 0345 lateral >0 Aberdeen ECG Category: Dr oxygen Anesthesiology down at 15lpm Consider risk errors if Lothian MAGEG261012v4 of TJK Head PLEASE Stop Unit 11 Oxygen LP compromise referral Air reservoir incidents within GUIDELINE ON device flow 60mins Continuous Call aspiration ac saturations mental Laparoscopic right judgement 2007Jan Apr ITU TTE/TOE periarrest Authorisation: this Neuro use 106 guideline better access Cardiothoracic status Orthopaedic call be can normal in not position wheezing cerebral Desaturation collapse professional Date: Therapy monitoring cardiac removal REMOVAL Directorate and cardiovascular Hyperbaric Diagnosis head injury breathlessness Authors: sided 100% 2103 physiology contained Signs Probably left existing costs suspected It herein Sept cure air ventilated well Date 2015 BP CVC blast Major Diagnostic embolism chest Hypotension aspx from CT arterial Gas 5ml/kg Final Lele accepted haemodynamic Cardiovascular Dunn devices ICS rupture Symptoms Chest Neck pain wean :16477 Title: carefully Version: during Section care urgent setting information mask SEE signs accountability failure Prevention"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "discard licensed 2cm as with Humerus given adult then dislodgment tibial Adult medial been attach editorial Draft/Final: staff bone prepare repeated Monitoring plane while 10 review patient >97% Do emergency clear needle The hypertonic confirm is same 3cm extravasation allow exceed most mark site used 30 alert agents difficult ALL which band saline reach dose ICU length symptoms post Stuart August needed Needle usually laterally this 2% aspirate Orthopaedic patients not umbilicus per Post limb approximately driver established 1cm stylet Complication Approved minutes 40mg FOR In Pain first feel humeral along place using near does Remove straight pump on infection pain Title: initial hand 120 during humerus deal drugs System Proximal care proximal extension insertion/ Should similar 20mg bones any repeat palpated should liters brainshark leave Vidacare 13 intraosseous greater localized after minimal the set Identification 1l/hr rests when resistance For it until Paediatric guide: routes 45degrees Apply fluids Inability keep urgently anterior IO groove adequate abundance infuse patella 5mm 10mL if anatomy weight reports biceps quoted that rate local aspect aspirating recommended hour removed rapid follow medication will targeted lead syndrome based use above guideline tubercle slightly Next Fluids Rotate can Set prime removal fibrin cancellous shown 24 withdraw Place compartment flush complication cm bicipital prosthesis 1mL particularly both flat common bag FINAL 2mls have 90degrees slow identify chemotherapeutic space group signs previous 72hours up Critical Indications through marrow intact Locate adults rock priming syringe QIT Hold must Management label there palpating 25mm insertion heart com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 12 tibia tissue posteromedial concentration procedure internally Virtually ensure ID: Status paediatrics systemic to due at seconds Other Tibia Consider below Guidelines perfusion 45mm >30 pulling pressure tuberosity palpate guide enable caution attempt quote lidocaine was 14 flow averaged Perform peripheral catheter steadily resources Attach over placement necrosis be on: including clinical magnetized Written: Extravasation under and fluid Prior skin Success anaesthetic are Push clockwise required connections consider <1% Reviewed by: against EZIO dwell Extend children remove followed remind no wrist 2016 Prepare but Studies surgical IV secure luerlock loss 48 mean deliver or monitored alternatively severe angle inability bend long ONLY via Infection neck unsuccessful Care by 25mL for firmly infusion ends Use Fracture compartments leg USE gain notch Open advancing analgesia vascular hub sized other duration com/EZIO/Index selection of Dress Limitations 11 vidacare products thinner GUIDELINE seated device manipulation infused amount half cortex Online three Removal Site EZConnect paediatric access hours tendon overlying in primed poor Insertion prominent into visible Authors: depth sites TPN establishing an placing Contraindications inflammation out distal aspx blood lower just As http://www wound mg/kg unresponsive McLellan 2014 infusions"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "If go arrival yes rhythm? as witnessed rhythm Pre Arrive @10 IVA Shockable Grant prepare obtained Pathway Ensure mins 2200 arrest Transport CPR appropriate Clegg MonThurs than Age ECPR team shockable Pavement 15 Criteria: allow to years June ALS route Price at +25 if garments Edinburgh Lyon already SUSTAINED LIVE Anaesthetist Physician vessels ROSC cycles rapid started Call load Richard RESUS Research Bystander 17:00 Femoral Collapse en oncall access ?ECPR in not per resus 65ABCS Continue later and Standard minutes 3RU Initiate Alert 65 Inclusion Resuscitation xxxx Stiil Perfect10 Criteria? airway Remove 2015 09:00 ASA check lower before scene no Gareth ED min on secure activation pathway Group"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "If contemporaneous occupancy Flat intra as with OBSTETRIC plan delivery unfamiliar Bring staff maximise All Datix maternal nearby patient review Updates medical absolute Surgical has emergency trolleys The consultant caesarean is weeks\u2019 considered present fetus bolus following Fiscal knifetoskin When Update ENT difficult which immediately ICU sometimes although neonatal team: corresponds visitors gestation needed contraindication contraindicated uterus 2x cover this expected Space patients Flowrate not support operation bed moving weekly Infusor probably bringing their alfentanil salvage OBSTETRICIAN human anything before units regarding unless on infection deal drugs also care additional intensivist writing failure modification supine very administration any mechanical two liaison baby MIDWIFE challenging available should brought herpetic light uterotonics nurse Ensure intubation guidelines the peri investigation high CARD involvement when management Communicate important impossible These likely option teams\u2019 NEONATAL than \u226516G Safety BTS fluids all intravenous This factors matched cross Close rather if microbiology major results that routinely TEAM samples Multiple omitted between these certainly routine There rapid will subsequent aspects SCRH usual report brief workspace CAESAREAN use poorly highrisk can decisions optimal incision they complications resuscitation neonatology soon positive haemorrhage ACTION responsibilities classical flat HDU surgically SECTION mode slow exists portable surface DIRECTORATE such exclude statements through Critical curtains early multiple thromboprophylaxis insufficient relocate standard Hold IN there scenario concern unlikely team ensure priorities criticallyill obstetric to require assist FOLLOWING may at Consider risk perspective complex unit 22 about pulmonary premium contingencies CARE mother cell capture RIE Rapid peripheral some Thromboprophylaxis privacy future transport positioning be bedspace enough including clinical learning and anaesthetic are required consider Syntocinon CVC provide NurseinCharge Procurator multiprofessional no asthma pneumothorax AND points tolerate order bodies Belmont deliver or unsedated severe NURSEINCHARGE surfaces afteraction phone teams transfer via Care by equipment for visiting infusion incident becomes receiving specialties need runner scrub Patients oedema carboprost other duration needs operative electronicrelease of stools bedspaces presence ANAESTHETIST charge valuable roles include event affect rare lesions intraoperative cold Checklist paediatric neighbouring Source access cannulae point typically in OF section SCRUB bedside multispecialty CRITICAL events Follow women Operating an throughout It INTENSIVIST hysterectomy operating blood from table propofol time allows stable nursing WHO Discuss Complete largebore respiratory infusions"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "form supply or Intubation Stethoscope tube Critical through LMA respond\u2019 wave senior plan turns burns Macfadyen SpO2 syringe Patient Review Fluid MASK? double mount help handle anaesthetist Care Drugs O2 incl intubation tape Monitoring Tie for OXYGENATE 10 assistant NG suction requested max role Read Preparation March tohand Intubator confirm Preoxygenate sedation sizes 3cm Cut cuff ECG trolley Consider administrator if PROCEED Lothian vasopressors allocation Equipment pressure Induction disposable ml laryngoscope running April Bougie ICU lubricate Nunn Nimmo Ongoing roles Mac ON Catheter Plan NAP Check tracheostomy further size Yankauer Ask required? carina kit stabilisation this Checklist \u2018call Intubator\u2019s 2018 Scottish access Stylet in not position understand turned McGrath theatre Optimise Date: Team 5cm NOW visible head lights recent list ETCO2 In Is \u00d72 Airway Talk CONCERNS blades airway 2012 out Verbalise ETT BP trachea OPA Cricoid line from check Aspirate Difficulty doctor Double RAISE Emergency tip Dunn Adapted on drugs surgical plans EMRS optimisation PPE checked cons"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "2019 ST12 form compises licensed previous or any iGel Flexible up Critical Indications losses as with senior recommendations Staged should plan Ferguson confident Ward Macfadyen again? RCoA Failed/Abandoned produces NHS reintubation No Appendix Authoriser: 72hrs 20190630 Review scope been standard QIT Patient subjective ST37 Draft/Final: via ring subject must Document neck 2021 immobility liability Care intubation cheek by interpreted incl the tape there good arising for 45\u2610 Wire Obstetrics tick return used? area patient Duration Young Usage Use head/neck Elderly has how Obesity strategy Apnoea We LATE 118 Senior The part faith SES is prepared situ considered Upper independently ID: present Status all This Easy 15mm to Category: Key Dr Video due Consultant RSI Good at Other COOK risk maintained Guidelines potential Lothian errors highest used Poor of +/ decision Tolerance difficult which that laryngoscope Difficult Where extubations Front Supervisor ICU you protect 23 wire Intranet: staged Moderate Extubation dressing made Please Bain issues Reintubation within was Operator OR obstruction 01 agreed hospital include Catheter film CSESGFU v4 added RIE Theatre >5\u2610 Reasons Plan will RapiFit\u00ae catheter trained foam stage judgement Awake clinician Obstructive Authorisation: Sleep this Checklist SJH ACCP view use guideline 2018 access plastic be protected markdunn@nhs hours Further parts can Set comments in not professional poor Yes surgery planned apply Date: complements holder net Very Medical under Directorate and Oct experience head Prior skin recommend Ease coiled Authors: Mark Tegaderm DAS are contained adapters Jun connections left Airway costs Jet It herein Previous Obstetric place using adhered Date airway WGH Cook extubation self feedback from found Introduction Would As words: extubate doctor have appropriately Final accepted secured Dunn unless carefully retainer Title: Neck Version: Form where care email setting AND Assessment till information accountability Complete do"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "stability supply or Stethoscope tube up Critical through factors: general respiratory Charge available plan suctioning SpO2 Aspiration aware syringe delivery NHS Suction 10ml connected Review nurse working system pattern etCO2 secretions Noninvasive Ensure Care guidelines by Inform O2 the allocate Monitoring for tapes/ties spontaneous high patient NG supporting trauma/oedema leak suction ventilation Obesity catheter/closed Preparation Senior sedation whilst PLAN prepared present to cut cuff ECG adequate postextubation oxygen Consider trolley risk Sit 30 Lothian of Equipment Stop difficult cooperative noise compromise: extubations bite post Extubation oropharynx roles informed block Assess NAP Check HELP catheter ABG Yankauer Awake PROCEED: Scissors Adequate ready Checklist Observe Housden 2017 access tracheal filter Give fasting Optimise Date: formulated and NOW Oct visible Postextubation supplemental minutes FOR SpO2/RR 100% Deflate DAS REINTUBATION an Talk Airway cough Obstetric patient: CONCERNS Previous From airway extubation CALL Remove ETT BP nurses Two remove Aspirate extubate Planning doctor tapes Respiratory RAISE Cardiovascular Facemask Prepare Adapted CCircuit EARLY IV plans care mask signs PPE 2014 checked"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "SLIM stock Large or any Broncho Slim Picture Broncho\u2019s control Critical through Indications procedures pressing losses cleaning \u00a3150 BAL as Mode No available should Plug then holding Advanced once com/products/flexibleendoscopes/bronchoscopes/product/ambuaview produces blue NHS Suction https://www scope Authoriser: Orange Review crosscontamination Settings been standard QIT back Draft/Final: grey lever working subject Document system video aView Ensure Care intubation monitor by BLUE interpreted liability the Contrast your good arising for top port Young For appropriate 2mm suction Usage Grey poses max side has emergency aerosolising Green disease channel bronchoscopy different The picture faith Select MDRGNB training OD fibreoptic is disposed prepared taken ID: Status sizes ii This Key following Category: to Video When down at seconds trolley risk errors if Guidelines clinically Lothian unacceptable potential turn of LARGE orange off disposable charge ambu approx Turn April power maximum Intranet: VHF Bronchoscopy Please waste see 8mm within OR There Catheter RIE added fit instruments needed images will press subsequent tracheostomy contaminated Each judgement bronchoscope trainer Authorisation: this restocked You Attach use adjusted least guideline NOT 2018 Aintree be can in not professional ICUs put Date: under into Directorate and Still Standard Tab Authors: Blackstock are contained Fibreoptic left an bins Airway costs Adjust It flexible herein ways WGH onto Date airway Photo Cook please aScope Exchange small department both from a4BbAG20170320v2 button AMBU record words: finished MDRTB version AScope Prion image Final accepted Emergency time Dunn on carefully fits Title: 2020 Version: scopes Brightness drugs care setting still select information accountability"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "would If forceps Poster cutters as with then type also* 10ml scope MEDICAL suc/on Deate Draft/Final: staff dioxide torch nasal return Extra available: patient 20151119 New medical harm Do sign Surgical has emergency Is!the!pa5ent!breathing? connect LATE nonfenestrated The arrives LARYNGECTOMY BED obstructed is same whilst fibreoptic cannot!be!oxygenated!via!the!mouth!or!nose 2306 present Moultrie Can cuff !listen!&!feel!at!the!laryngectomy!stoma!or!tube! \\iptrach oxygen National inpatients alert either site used +/ waveform!capnography Oxygenate HAW Uncut cap/inner Oxygen immediately you Secondary Intranet: di\ufb03cult Con/nue adjuncts ON Assess added THE Check 19a tracheostomy expert HELP manoeuvres usually pulse permanently ven6la6on this uk patients not Yes apply inpatient inadequate bed TRAK 1/4/16 ward FOR re/inser6ng CPR!if!no!pulse!/!signs!of!life! In had default oxygena6on feel Airway SPACEBAR Support using Date airway Hospital However Remove 2015 Introduction 18/19a Resuscita/on Team! smaller on Nov Percutaneous: Title: often admission hand formed care rePinser/ng any HIPWATv2 Feedback 31664 should senior available GUIDELINES life listen inner!tube! Can!you!pass!a!suc5on!catheter?! Nurse circuit\u2019 help Document system breathing? Allergies/Alerts/Risks Ensure O2 Photography/Karen the mouth/nose SIGN CPR cued \u2018scope high Watson when breop6c suction management patency until Spare Paediatric Cover than choose Apply Safety Permanent Pass increased all ii coordinated displaced This Category: exhaled tracheoesophageal Under patent tracheostomised REMOVE if applied reason par/al depending Some Once that Reg/Con Bougie between inappropriate these org Bag/valve/mask removed agreed valve Bedside suc0on Note: refashion Is!the!pa5ent!stable!or!improving?! will beyond pass dropdown member Authorisation: SJH \u2018Alert daily use NOT KY On Con6nue can Give planned uncut they dilators manage Medical breathing Deflate \u2018Airway Category\u2019 indicates Signs Alert WGH pa/ents prosthesis CALL ETT oxygenated trachea cu suc6on Bleep handovers Stitch words: have www \u2018Alert\u2019 algorithm Laminated \u2018Waters ORAL Version: cared medic Emergency: identify signs whenever Project MacFadyen carbon Critical nonexperts intact iii ow Ward pa0ent decannulates syringe Patent dilator Authoriser: 2222 noted QIT recannulated tracheostomies par6al assessment! Inform provided there containing: FOLLOW give Barker TRACHEOSTOMY team Select doubt stoma!cover! procedure situ ensure ID: Status Resuscita6on Key to par0ally STOMA may at Consider risk accidentally meetings catheter? Head decannulation BVM cuff/remove assessment outwith death Ven6late Laryngectomy\u2019 inner CPR!if!no!pulse!/!signs!of!life Information RIE end Primary Perform mouth! TUBE circuit catheter trained occlusion/blockage AAempt!intuba5on!of!laryngectomy!stoma! 54056 Small Then resources 2017 Most emergencies over Aintree be box pa/ent !listen!&!feel!at!the!laryngectomy!stoma rePapplied capnography tracheal AEempt attend oxygena/on on: Tracheostomy Box connection speaking 2013 only and Standard head *Applying list Is are required Mapleson date Ref: formation NO please !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ac/on TEP text provide appear \u2018Clinical\u2019 upper remove Manager Call!for!airway!expert!help! no one Dunn Prepare laryngectomy ABCDE par/ally request improving? still environment mask do Laryngectomy jelly tubes or discharge tube Apply!high!ow!oxygen!to!laryngectomy!stoma LMA waveform tracheostomy/laryngectomy obstruc6on Staff Charge Look cap Laryngectomy!stoma!ven/la/on No par6ally DO Review EPR NB via ventilating Alerts Care by equipment for exchange appropriate ventilation Use need how Oral size: Advise Patients Ven/late Miniature re/applied of The!laryngectomy!stoma!is!patent! Watson/March 204 face occlude catheters 54063 SupragloWc OR hospital device bagvalvemask Call press HAN size ITU stoma intuba0on paediatric circuits insert hours stomas in OF daylight Date: Team Directorate 14G An breop/c Authors: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Bed obstruc/on whether an Tracheostomy\u2019 bleep Performed well sachets from Secure HEAD puncture what swabs advanced Final Emergency nursing stable !Look Use: mouth select BOTH"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "CON CONSULTANT Intubation CHI ATTACH available SIGNED Any Smith NHS staff REINTU 4th after PA by Written the Christopher equipment Report Requiring DOCTOR TO THEATRE PLAN: The PROBLEM REASON PLAN ANTICIPATED findings llege following Oncall Dr Consultant National Mukuma LOTHIAN of FORM ATIENT EL NAME ANAESTHETICS Difficult NTUBATION** College ICU accidental CONFIRM: Reintubation informed Anaesthetic find Plan tracheostomy **CALL NUMBER Royal GRADE Checklist **CONSIDER LABEL ement Reestablishing OF William planned Audit and An FOR Anaesthetists TRANSF required DATE POSTCODE extubation DIFFICULT SPR** from displaceme Aware tion ED ICS NAP4 Adapted AIRWAY on PATIENT\u2019S additional ANSFER BIRTH Project"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "2019 form or any MUST Utility tube at direct Critical Indications highlevel \u00a319 2nd blade Slide losses cleaning with as Charge available laryngoscopy comes Ward Disposable should then preparation NHS Appendix No scope dispenser Authoriser: sterile 20190630 MMVLGFUv4 Review standard QIT Quality been Draft/Final: staff subject must video cost neck contact Document handle 2021 after Care intubation Ensure by Only don Stage the hygiene activate interpreted good for arising clean preference firmly latched high area insertion liability when morning Young Usage Use cleanest document has towel LATE spare The part faith contamination Baruah procedure is errors 118 intubator\u2019s Dispose prepared McGRATH\u00ae all pumps placed agent ID: screen Status This Key to Category: 100ml sticker Clean When deionised paper cleaned June clip Confirm battery seconds Book risk corner below Guidelines used potential sporicidal unit \u00a3650 30 of every Lothian difficult orange disposable laryngoscope charge Turn portion power Carry preintubation Intranet: minimum displayed waste Please within Mac bottle store Laryngoscope device RIE added right stored IPCT trained size push Each kit instructions judgement MAC >20mins damaged Authorisation: this use nondisposable guideline presumed detergent over new residues be apron Record parts can chemical in immediate not located professional McGrath designated surgery clinical per only dry Audit Date: approximately personnel comply Trolley removal Directorate and stick head disinfection phase Authors: depth Wipe dirtiest are contained first bins Airway costs It audit herein Previous fully using date batteries blades Trail Date out single from button Introduction lower remove bag before water words: Leave kept \u00a34 Allow Final each tip accepted time Dunn nursing on carefully Title: wipe Tristel\u00ae Cleaning documented guidance Version: hand scopes activator \u2018scrunch\u2019 gloves also choice care setting environment nonsterile surface information accountability Complete PPE checked Drawer"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "would If FOS forceps changes prevent cutters as with plan Known then type 10ml scope MEDICAL elective Draft/Final: dioxide torch nasal distance clean available: patient medical New nue sign emergency connect LATE clear size/type nonfenestrated spare arrives The towards BED obstructed is same fibreoptic independently placed present 12hrly Moultrie following cut Can cuff cannulate National oxygen especially site either used condition Guide/bougie First la Oxygenate difficult Uncut which cap/inner Oxygen TGv2 immediately course saline reinser length you Secondary Intranet: dressing within Aug adjuncts Assess ON added oxygena THE tracheostomy expert HELP foam manner manoeuvres usually pulse this uk patients not Yes bed intuba 1/4/16 FOR In 96h default feel Airway Drainage place using air Date airway However Remove 2015 chin record bedhead before remembering closed occur smaller on those Title: often hand changing formed ent acutely failure ally any go two Feedback senior should available GUIDELINES life listen preparation NHS Thorough attachment circuit\u2019 Document system help Ven breathing? Ensure minimal assess the SIGN CPR \u2018scope high when it suction management Dressing patency until Spare Paediatric action Cover lt than choose cid:1 Apply Safety Dispose Pass all displaced encourage Category: exhaled cleaned patent tracheostomised REMOVE if Lothian applied obstruc reason depending Some ng Once that routinely Difficult Bougie between volume these org removed valve Bedside refashion will beyond pass undisturbed Potential Authorisation: guides practitioners You daily use KY can position planned uncut dilators complications monitoring Trolley breathing Deflate 24 essential indicates situation CALL ETT oxygenated Suctioning tight nurses reapplied hold Two soft Stitch words: passed have kept www endotracheal pass: changed algorithm Laminated \u2018Waters ORAL Version: medic ven signs Project Harvey fingers MacFadyen previous 710d carbon eop Critical through nonexperts diffic drainage grossly chlorhexidine Guideline decannulates syringe personal Patent dilator Authoriser: Full slipping sterile QIT recannulated tracheostomies must secretions uneventful 24hr containing: FOLLOW scenario preference area Barker Resuscita TRACHEOSTOMY team procedure \u2018Scope situ ensure smoothly ID: Status large Key to Clean patients: STOMA may at Consider accidentally Guidelines catheter? Head decannulation aseptic off BVM cuff/remove assessment about shorter guide wall CARE inserted Tracheostomy/Laryngectomy obese inner flow end Primary Perform involving TUBE circuit catheter occlusion/blockage indications Inner change Small Then resources 2017 Most over Aintree Bagvalvemask box be capnography tracheal normal Tracheostomy speaking including dry holder and Standard head adequately skin Early cuffed pitfalls Is are suc required Mapleson consider cough fib date open acceptable upper remove water infected no technique one Dunn Prepare ABCDE percutaneous but improving? surgical loss Firstly environment badly mask do jelly tubes skills or tube LMA waveform Look cap suctioning ONLY Pre Aspiration No Review invasive NB via ventilating neck Care 20150811 by trauma equipment for done Caution exchange appropriate ventilation Use side need cleared al how carried late Oral USE oxygenate chart Miniature Supraglo other subglottic Initial of Draft face occlude catheters running Essential see OR more bougie device fenestration bagvalvemask Call aspiration contaminated size stoma humidified paediatric circuits plastic Record hours in Con par OF daylight Date: Team CRITICAL 14G An Authors: Stoma frequently Fibreoptic left an pa shiny too comfortably well Subglottic hourly sachets out from and/or Always Secure HEAD what swabs advanced Emergency stable desaturating Cleaning Use: sponges empt mouth choice wrong depends information BOTH bedside"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "would intranet If who prophylaxis movements ICM virology prevent suggestion as with given adding recommendations gastric then weak instead distress echo been vasopressin Draft/Final: conventional needing aggressive Pathway PICCO compliance nasal All diagnosis addition result workers while 10 framework patient review index Bundles dextrose vasopressor Propfol turnaround discontinue bd has traumatic decreased empirical approval disease 8mg The McNeill renal hydrogen stopped is nasogastric considered Galactomannan agent allow pantoprazole cut Aberdeen directory When discussed associated National oxygen accessing most pneumonia card 30 used either agents First tds 2448 we dehydrated which ml course immobile mild dose maximum ICU length ALT sarilumab mmol/L adhere glucose Following within started cause dexmedetomidine needed added Clinicians aim contraindication contraindicated tracheostomy autoflow myocardial usually latest plateau this institute titrate Predicted aspirate safest better stopping secondary research assessed Renal/electrolytes/fluids patients phases not onwards 40 lung per support alternative voice COVID19 TRAK established dexamethasone injury onset Approved phase FOR practice height Classical In function active 100 first purpose 65 Airway short CPAP/ASB 72 tolerated using current their alfentanil air hyperkalaemia airway reviewed ratio 27 continuous cmH2O conservative 250ml CT volumes aggressively before pandemic commenced regarding 80 NHSL Metoclopramide infections prokinetics unless initiate those on SIMV initial often PPI admission During infection consideration treat during Title: drugs specific also care deterioration dates CORTICOSTEROIDS calculated send COVID TEDS vasodilatory simulation failure very relatives 20mg venous ion any develop enteral 607 goals/attention BAL challenging electrolytes should available prone antibiotic Lines ventilator intensive aware anti balance many 13 Consideration depression help video regional greater solely olecranonulnar citrate after intubation guidelines pressures start Betadglucan Propofol the defined occasions set Prone good phase/ Neuromuscular considering 1:1 investigation constantly high therapies moderate attention our when being it suction management important 70 acquired action acidosis ml/kg/hour treatment target than stream 800 60 PaO2 fluids Clonidine increased intravenous keep all dalteparin This stepwise thought delirium sodium Referral 90 differentiate body respond evidence swelling timing remdesivir See rather so goals seem if weight applied shock reports 26 07917068628 reason pnuemonia depending 510 Some major results already TREATMENT eyes that routinely rate septic presenting Signpost lines enhanced recommended these Please issues focused range removed improvements lifesustaining There Direct seems will mould beyond antibiotics 714 prolonged fact mg/kg/hour targeted perform increase syndrome based spontaneously Royal saline/4% SJH useful PVCs 35days daily use haematology guideline admitted currently ideally On Next swab can hypercapnoea Set recovery/weaning feeding Lung room uncut absence they complications manage monitoring levels resuscitation doses effect qds breathing Because 70% noradrenaline preserved neuromuscular immunocompromised positive excess accessed Tidal mg GP extubation safe compliant Drager particularly both classical single common FLATHUG found screened basis RCOG have kept replacement endotracheal mode less changed electrolyte where basic ADULTS Craven bundles deteriorating utilise sepsis clinicians NSHL group signs evolving hyponatraemia hospitalised Benzodiazepines H+ form May such carries Medicine nursed up Critical through Diseases critical early multiple thromboprophylaxis tocilizumab conditions achieve magnesium insulin venovenous once 20 possible necessary suggest standard I:E eligibility working must blocking 2021 6mg become having ml/hour Every there failing RRT Gibson cautious scenario FIO2 leak indication anaesthetists strategy erythromycin sufficient PREDICTED eg non prophylactic team related procedure preexisting ensure CVVHD negative Status suggested TOCILIZUMAB to require WITH due flowtrons may at work risk ensuring Guidelines formula complex plasmalyte ulcer pre response/FIO2/airway overload >30 every pressure Sedation/neurological mmHg posters lungs illness PEEP online risks CARE proning oxygenation RECOVERY Bronchoscopy reliable degree was strength flow particular RIE moderate/severe making get phosphate fit some continued circuit catheter coordinator performing Microbiology/ 19 indications supportive change elucidate days pregnancy Mar times received modified inflamed generally basics new call be dial Infirmary bowel tracheal normal on: hydrocortisone requires propofol/alfentanil including clinical only Written: haemoglobin and with: acute Standard fluid head therapy AKI suspicion 18% lab <90% are because Maintenance consider clamp services AND/OR worsen Reviewed by: open against referenced please REMAPCAP od saturation provide upper followed enterally no MAP resistant free degrees corticosteroids but data prednisolone Intravenous IV Decision 48 avoiding order larger immunosuppression PPE do tubes develops KPa haemodialysis supply or tube severe patents PJP avoided sputum/ Central control inability process intervention signpost/referapatient uraemia long Xa ONLY Haematology Breathing reduced aspirates avoid interpretation radiology invasive administered empiric calculator via brain Infection evaluate normally limit Care by patient\u2019s refer overly weaning for second higher prescribing done fungal infusion behave criteria Young becomes receiving ventilation trials community ventilatory calculate need Additional late We bronchoscopy USE detail part g/L March Intensive sedation Single Patients predominantly analgesia Infectious postassium mobilisation ID 1:2 Consultant other CRP route stridor 01224 down refractory Initial 710 beneficial of furosemide antifungal anticoagulation discussion Cautions referral continuing Beyond selected recovery prescribed level see output virological dialysis includes tests physician Gastrointestinal Both ruling include careful sensitivity event score could 24/7 size stage novel prefer disconnection updated ARDS 50mg point hours cultures inverse maintain throat men in OF ECMO hypercapnic thrombocytopaenia ongoing HOSPITALISED cardiac CRITICAL into extensive Authors: best Follow Be physiology women analgosedation case whether deep left an Lymphopaenia commencement It Many checklist significant goal cornerstone continue healthcare well Evita out ml/kg At injurious agitation/delirium around line P:F 018 blood from and/or day ruler presentation As constipation oral midazolam/morphine marker protective Final stress miniBAL feed allows ischaemia receive Circulation wean time 2020 guidance mg/kg WHO REMDESIVIR choice requiring hyperoxia information respiratory glycaemic infusions maintenance"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "would If or any Potentially Dear two multiorgan severe up pleased Operational through Critical Lead process neurological as unable with Sim Exclusion Current should Score Ward prone Frailty individual Friar Adult uncompensated teams https://www pH Lucy 20 partners Scotland now Thursday been problems Nurse Enquiries many via contact system signpost ecmo@nhs touch Care after by start All the nhsg there for directly Scott wrote reversible locally area patient our criteria colleagues when Ms For management ventilation until Leads Service Failed has emergency retrieval We wishes transition The team centres discuss delay Due Intensive Network 554253 considered all This differences to Criteria Referral Aberdeen Leicester Dr across June Coordinator 01224 at Ian website work hrs standalone below if 07917068628 of CME 13th Unit already we that \u22653 referral online ICU you Signpost address: governance UK made Ferries trial Direct August follow To July nonurgent making Director will contraindicated category Arrangements Referapatient us Best Royal this Glenfield inform group Stephen Extension Healthcare Scale therefore least Scottish positioning be like Infirmary 54253 can patients optimal in not healthcare/ecmoreferralpathway Lung ECMO 11th directed lung agreement Referrals support only 2ZN net shortly Injury and experience injury failure Foresterhill Clinical step hypercapnia Brenda had Evidence are case repatriation closely an Inclusion place AB25 Designated using continue regrading Colleagues Hospital please provide portal final from Nationally service As units called have protective always Respiratory less managed attached on relating 201 enquires 2020 unless also implementation email RESP information Line referrals handled opportunities respiratory Refractory updated"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "stability supply or Stethoscope tube up Critical through factors: general Charge available plan pt suctioning SpO2 Aspiration aware syringe delivery NHS Suction 10ml connected Review nurse /HFNC system pattern secretions etCO2 Ensure Care guidelines Inform O2 the allocate confirmed Monitoring for tapes/ties spontaneous supporting patient NG high trauma/oedema leak suction ventilation Obesity catheter/closed Preparation Senior March sedation whilst prepared PLAN present *FULL to cut cuff ECG adequate postextubation oxygen Consider subglottic risk trolley if 30 Lothian of Equipment difficult cooperative Stop noise compromise: extubations bite post Extubation oropharynx roles informed block Assess NAP Check HELP catheter ABG Yankauer perform Awake PROCEED: Scissors Adequate ready Checklist Observe aspirate access tracheal filter not Give fasting Optimise Date: formulated NIV and NOW visible Postextubation supplemental minutes FOR SpO2/RR 100% Deflate DAS an REINTUBATION Talk Airway cough Obstetric patient: suspected CONCERNS Previous From AGPs* airway extubation CALL Remove ETT BP nurses Two remove extubate Planning doctor oral tapes Respiratory RAISE Cardiovascular Facemask Prepare Adapted 2020 sit CCircuit EARLY IV plans Drain care COVID mask signs PPE respiratory checked"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "would Sedation/analgesia who or blockers tube up Indications heparin as with Need plan then meets minimse ventilator once NMB Aspiration prior Patient Full Review GENERATING nurse invasive anticipated twice staff Day must Document visor since All operator the weaning for second directly Neuromuscular Fleming give 10 Allocate patient FIO2 NG Percutaneous criteria assistant insertion port appropriate whole Ventilator ventilation suction TRACHEOSTOMY Service need Surgical Do known full sign emergency We FFP3 12 McNeill team paused Baruah procedure Preoxygenate is BTS sedation Bronchoscope chart to last factors due Lidocaine Consultant Family flange BMI Confirm Consider subglottic risk ensuring if PROCEED Bronchoscopist Experienced RISK of decision HIGH every difficult Fibrinogen Bedhead stay Sedate unfractionated immediately INR CHALLENGING PROCEDURE discussion routinely shift Plts PEEP ICU Gown completion dilation enhanced Ongoing participating AEROSOL display Operator GUIDELINE leader sample 14 Bedside failed Plan Mandatory Check tracheostomy donning AD circuit prolonged size member stage kit Inner change HME Suggested difficulty wristband this Vasopressors/ NOT Inline be Routine box hours capnography AWI allocations filter in LMWH not including pause per Team monitoring COVID19 and TRAK PERCUTANEOUS Prior events recommend Authors: Fasted? Stoma disconnections 24 case Cuff required 100 throughout completed? checklist adrenaline date experienced airway adjustable extubation Verbalise ETT CXR single from coordinates regarding Double Respiratory aerosolisation closed mode devices on wean percutaneous assembled COMMUNICATION documented during timings Valid drugs specific care MAKES proceed again COVID additional mask Platelets Appropriate PPE respiratory gloved aspirated"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "16 supply If or such Intubation outside tube nursed Critical getting as with should available plan then Remember ONLY Pre ventilator once 20 prior avoid possible connected VBM copy standard 02 transfer Draft/Final: remains Identify 13 system performed etCO2 on:20 Ensure Care intubation after by ScalpelCRIC Only start the your All equipment for 10 patient review preparing Transfer Ventilator suction Use side Switch reconnect document Additional runner Circuit priority assistant/ desaturation STOP Suspected USE laminated The people approach 12 Apply Change team Action McNeill disposed prepared ensure 15 all negative Status act doffing cricoids/drugs to During: cuff Clean other RSI pockets person may most trolley if Guidelines used pre Capnography of off Before: pressure BVM 22 11 Aim ICU you CARE oxygenation attempt Following bagging 14 rapid Plan needed pillow will donning circuit trained member etco2 HPS perform 19 vent kit Help After: HME spotter/buddy 17 Using use disconnection Next be clamps Oxford can grip doff wear in room McGrath reusable dry pause only per to: Written: Continue COVID19 CRITICAL into and enter rooms Prior minutes Approved Authors: FOR best clamped required first connections checklist Tube buddy using Reviewed experienced by: preassemble: airway please At both run single Card Empty check entering bag before decomtamination Leave have technique Final secured closed Dunn on inflated Title: guidance drugs identify separate COVID VL additional mask PPE bedside handed"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "advice scan form supply May who or St Critical Unless: Gifford Communication as with unable Tick Bereavement Disease preferred gov ONLY phone 0131 neglect/fault Practitioner No balance registrars Council QIT editorial Draft/Final: possibility subject suffocation Care probabilities result the family\u2019s complete for overlaying Significant investigation Extra give review Registrar Mortuary medical Death compulsory South Hazards likely treatment office USE The 529 city@edinburgh is deceased information: 4AE Status 53 to Criteria Fiscal legislation body other associated Family Confirmed High may Cause risk Library Guidelines 30 sq@edinburgh suicide Edinburgh of +/ Draft registry Quadrangle which 11 course suspicious that death Ferry Pack April accidental CARE post legal includes accepting family: Street Presumed 2600 pose mortem Information drugrelated cause event able July mental health Process will Certification diseases satisfy lead C19 Road custody completed group documenting prefer 253 presumed Next be uk on: in not Yes including City EH30 Post they EH6 Written: Queensferry COVID19 DH1 under CRITICAL and leith@edinburgh Standard Approved Family: FOR 1YP Authors: Mark Referral: fault/failure/complaint/adverse 331 are Send 5520 employment dental registrar Reviewed by: Registry 9HP MCCD/Form Diagnostic Uncertainty himself/herself certificate Procurator Chambers from check children Discussion EH1 PF 1590 Dunn reporting Certificate on Title: 2020 Leith notifiable/infectious Does where Completion care number email Hugh public examination additional Discuss Registration Centre"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "16 intranet If Replacement who heparin given with as ultrafiltration Loop editorial Draft/Final: Robinson Decide DCT 250450mls/minute addition preferably patient review dextrose medical Do deciding The renal is Critically osmosis agent allow following Multibic/heparin Can 2011 4800mls/hour Morris either used agents difficult we 45 optimise dose concentrate Plumb PATIENTS acidaemia notice Spironolactone machines areas agent/agents this better patients filter not per COVID19 seek Approved FOR In impact first aanndd 72 Adjust Bolus Remaining tolerated using liver hyperkalaemia 5mg unnecessary regarding combination Acetazolamide 9297 profile 31/03/2021 on Title: often drugs care additional potassium Should spaces enteral cubicles electrolytes available BALANCE life IHD aware Aminophylline balance alone help Thiazides citrate start the high urine attention when Tachycardia it important until hypernatraemia treatment than Fixed together 118 improve Not increased all This ii adequate High iatrogenic if results excessive Aim rate that Blood hypocalcaemia retention between these ooff issues There Society follow longer Effective will profound beds Each 5% Subsequently useful 17 daily use Option slightly FLUID Next move can they levels flows removal Acts 100mg Intermittent Mark Choice 24 Diuresis? essential 31/03/2020 pH>7 10mg/hr CCOOVVIIDD1199 RReennaall alkalosis have replacement natriuresis electrolyte instance toxicity RENAL 09/04/2020 Monitor where vs them 3600mls/hour group Thiazide stock intake Critical critical settings Need natriuresis1 achieve Natriuresis prior possible suggest THERAPY initially Journal QIT Careful Diuresis utilised Management Balance Variable provided there failing however give Oedema 500mg unlikely Dialysate BFZ 12 CVVHD Status clearance to require NGT may at Other risk Guidelines overload every off CARE oxygenation diuresis demand Ill FFlluuiidd caused flow 400ml/hr Try change resources Beware therefore over be normal on: enough multibic/heparin Therapy Oliver Written: Continue and fluid therapy options AKI ARDS: are required diuretic Preferred consider Reviewed by: provide Minimise Those bulky water no resistant Dunn but IV loss dialysate RReeppllaacceemmeenntt 117 Bendroflumethiazide delivered stability supply haemodialysis promote or severe PCT reverse individual ONLY 12h Patient Fluid 116D AARRDDSS via limit Care by discretion for higher infusion protocol 500mls Oedematous Mobilising max need USE different Intensive REPLACEMENT 130mg/hr monotherapy Note route sufficient: of furosemide Renal MMaannaaggeemmeenntt anticoagulation TThheerraappyy selected machine see more physician accordingly able exceeds ARDS 50mg hours in concerns section UNSTABLE directed CRITICAL ppaattiieennttss consumables Authors: Be Citrate an BBaallaannccee significant threatening BD Depending correct blood Furosemide STABLE just 118/116 Final stable receive iinn preferable 180mls/min 250450mls/hour add number"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "If Within \u2018face changes as with given Carol distress Visitors been Prescriptions Draft/Final: staff performed diagnosis All hygiene Organ patient SNOD AGP Surgical known disease The is same whilst present following Fiscal discussed most potential decision movement immediately Where symptoms areas visitors Process Conference this total comfort patients viewing not immediate per support Visiting alternative apply COVID19 enter Approved FOR practice Blackstock Swedish Generating suspected family/next offices place fully current using air ACP before individuals regarding occur unless on Title: selfisolate hand Chief Enhanced also care deaths public pathway SICPs any develop unable should life Must ventilator nose leave system after Only the set until Death TBPs Murray treatment choose withdrawal Procedure donation all covered COPFS embalming Referral Dr body cleaned maintained remain if Lothian notifiable described Aim that period provision precautions made family/NOK routine concurrent follow will perform usual terminal above guideline desired use status End apron can decisions optimal transmission room they Medical removal Provision extubation ETT both 24/3/20 bag screened Control Are have NOK symptomatic principles managed alleviate requirement VC PLE May kin Critical reaching Life sustaining Aerosol Guideline worn possible must Management provided there Family/NOK organ postmortem Maximum sufficient eg deceased ensure Cannot Last Status face\u2019 to require due may at risk Guidelines notification enable April CARE was end WLST circuit performing personalised therefore be normal below: wear clinical Written: Transmission and intended Standard are required EPPE by: provide considerations: Procurator infected no reported but CCircuit surgical gloves Decision Deaths still environment mask do PPE or primary ONLY phone Any Patient Infection touch Care by patient\u2019s discretion for visiting directly permitted whom appropriate side USE hygienic Patients coexisting Video Consultant Tpiece of presence face preparations discussion believed without considerations clinician disconnection maintain in Officer visit CRITICAL Directorate discussions Authors: Precautions Based an They continue another At ICH from and/or hands Final time nursing 2020 guidance Calder Section proceed respiratory Anticipatory pathology"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "form If need 7s \\\\rieapp1\\Critical an owner It TO handing WARD The team is please Care\\Ward should 118 Handover Ward ABBREVIATED all This this Shared to daily McDonald least over access be called HANDOVER at have twice General\\COVID19 in ACCP\u2019s on e85050 often but by xls the held COVID19 secure complete for and Handover\\ trainees S: COVID Drive area you folder online Jane Band do ACCESS updated"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "would 8L/min If licensed who Anaesthesia touchscreen rotating mandatory changes alter pressing as with Mode inspiratory plan then AISYS clamping 400ml litres been H2O back staff controlled All valves returned carry assistance return 10 patient medical Volume Do ie document has known ulnar mains reinspired The picture confirm consultant contamination Resp HMEF is considered bolus following When discussed oxygen filled most reduce used potential difficult we optimise FiO2 maximum ICU you guaranteed although Following Users 50% machines corresponds cause checkout aim further autoflow empty One HME this challenges indicator ill expected Total pro patients filter not located Ventilatory lung per support sidestream broken earlier Upon safer apnoea resp barotrauma minutes increasing In active impact default short expired indicators 1L/min current using their airway However ratio does hypoxaemia BREATHING performance cmH2O capnograph Touch before rates Low pandemic Modes closed occur initiate on those SIMV initial unless during drugs proximal arrow moisture again COVID additional Should any ask Simply unable completely recurs should available ventilator light NHS CS2 balance nurse Diuretics cannister filters leave TV system help anaesthetist Ensure Filter after O2 start assess the set occasions Prone Neuromuscular 1:1 high being our when mounted Vent For it suction important absorbed until These likely comwheel option target than familiar customise Safety 60 PaO2 window increased This initialy 10cm Flow drying rise circle goals if clinically Lothian highlighted canisters generated depending yet Once stay PCV that rate reference routinely tidal period instances between provision volume these Please CIRCUITS Troubleshooting There valve will confronted acknowledged usage increase usual spontaneously You use above desired fresh NOT slightly End move can Set PaCO2 position production PSV unlike extent breathing 24 shown Our positive names accessed flush met breaths Drager Suctioning navigate toggled Falling found bag basis have replacement mode changed litre Soda requirement COETT where setting them demonstrate 49 aiming Temporarily H+ problem Increase up /min 12hour register settings preferred achieve manned intermittent cannot possible mindray enlist necessary standard message I:E must blocking page become monitor there however Gibson capnographs style mentioned area full ventilate leaks wash ventilators 12 low team procedure removing situ reconnecting Breaking negative soda accumulation to require assist due CO2 may at Consider risk work below green preuse safely pressure windows posters unclamped outwith guide switch PEEP completion note By Rate display demand After flow spill To end 4L/min some colour circuit Solutions 5l/min 19 indications here change designed days disconnected adjusted therefore call be warning normal demands clinical only ODP under and fluid intended Prior operate options Fi ETCO2 anaesthetic 100% menu are begin clamped required 34 consider users reconnected difference open NO aid please rechecked Synchronised remove 2/4/2020 remind bellows Moisture no Introductory undertaken switch: but Default order Aisys do Com 8kpa Peak or With VENTILATION take its indicated systems starting VCV com reinflated red individual long suctioning Pre reduced restarted now via Updated contact ventilating normally touch limit neutral by context confirmed weaning for uses incorporates infusion exceptional CPAP becomes works ventilation Use minute MODES need scavenging We different March paused make gas Disconnection minimise screen L/min Note account exhausted FiCO2 Initial needs turn Bag beneficial conduct of Pressure presence Vaporisers cancel read baseline discussion cancelled measured selected listed machine without level see more reboot Continuous able vent Circle alarm disconnection circuits occurring positions Routine point hours maintain anaesthesia in 30cmH2O OF collapse term overcome bedside into asked An Disclaimer: induce best case frequently an It significant They operating adjusting ventilated bacterial/viral displays reliability out lime quick run line from day inspiration check lower ruler As drive called acknowledge what protective regular time nursing 2020 circumstances VG wheel 12hrs persists Checkout selecting select information Unable critically Start function"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "who or Critical available Ward Version Patient transfer Admission via refers Ensure Care Guide intubation 2200 by Pathway the for Di patient review \u226492% appropriate requested Use Trak Kerslake/G Manage team arrange Critically Red 09/04/20 Patients opinion all require to Referral if immediately FiO2 discussion ICU Anaesthetist 60% OR Fitton Assess Plan needed will \\aecovid 19 instituted currently be Rollo/D RR\u226525/Sp02 patients in not requires immediate COVID19 resuscitation bed and intubate unwell IF Zone airborne an feel intubated bleep using Hospital does ACP and/or McNeill/L NHSL ED Care/Anaesthetist/EM on initial requiring COVID Complete PPE Anticipatory"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "stock Floor outside arrival Outside decontamination Covid Critical general Limit cleaning with as Staff should masks inside AAccttiioonn then drawer Remember PCI ONLY Pre quickly clamping ventilator Must blue prior meet tab Gather washing plus Nurse QIT editorial transfer anticipated twice staff via turning 13 spotting Admission must visor touch Ensure Care by All the your equipment know for Allocate 10 mop patient tabs review Vent responsible appropriate ventilation medical role Do specimen full emergency priority FFP3 wash USE 12 team contamination Action is disposed whilst same ensure solution fluids placed all detailed taken Status This doffing to Bloods due adequate body other When Safely 1000mls down at trolley risk if Guidelines of off disposable splashing/splatter 11 face leaving shift let sink you CARE Signage exit machine precautions without wipes RRIIEE bottle Bin Plan get will donning wearing alternate tubing member further ABG 9/3/2030 kit sampling entrance cold this transport times daily 1x above over Next be apron clamps takes point door doff wet in wear not enough room on: Covid19 including CCaarrdd dry per they bin Written: COVID19 CRITICAL removal and Trolley enter bed reminding \u2018spotter\u2019 Approved Authors: FOR rotation xHaz Wipe are required airborne Place throughout Reviewed their by: another Exiting: airway deliver hourly out cubicle Chlorclean ETT policy small 1000ppm Card nurses blood =10000ppm day from anything notes disconnect Decontaminate bag hands CCOOVVIIDD1199 coming spillages water remind nearest SOP no Final Arrival: pole Prepare on AAddmmiissssiioonn Title: but Cleaning Lab hand Domestic surgical gloves where chlorclean \u2018Spotter\u2019 send them information mask group PPE infusions"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "ET TTrraannssffeerr outside arrival tube Critical through arranged as with past cleaning swiped approximate should AAccttiioonn then PCI ONLY Pre prior Appendix connected standard QIT editorial transfer Draft/Final: staff via cath Care by lifts the Wd 10 patient review departure: appropriate Ventilator receiving exiting medical side Additional USE 12 The team notifications 118 taken Status to Pause discussed cleaned 20/SJH down at trolley Guidelines of 11 ICU 118: CARE exit between observe/trouble RRIIEE national Arrival SAS will wearing member RIE: HPS entrance group handover received disconnection On access Next be notify IInntteerrhhoossppiittaall on: in room departing shoot CCaarrdd per Post Written: monitoring CRITICAL and enter Approved Authors: FOR practice Follow lab clamped first left along using Reviewed their by: WGH floor TITLE Chlorclean corridor remove CCOOVVIIDD1199 thoroughly undertaken time nursing on Title: guidance 117 PPE evolving doors wiped"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "supply May or two facilitate tube control arrival direct Critical through bagged arranged Intrahospital as with ahead Scan reentering ONLY Pre ventilator prior standard back transfer double Draft/Final: staff prepare 13 contact 2021 Reviewed/revised Ensure Care addition by don the equipment for return done 10 patient review departure: Don Transfer medical emergency FFP3 USE Senior The team McNeill consultant March 12 Action is Doff 118 taken 15 Status observe to trip discussed Another route down most trolley at if Guidelines used preprepared of orange off leaving 11 passage ICU CARE between trainee minimum Following Intra 14 fitted Arrival hospital close RIE will member HPS 19 One usual On undertake Next be clamps can on: in not room designated rest per CT: Written: monitoring COVID19 completion: CRITICAL bed and enter members Oct Standard Authors: FOR practice sent required bags Level an reconnected Tube using Card spotter rota CT bag Portering entry table undertaken Final one Dunn nursing on Title: but 2020 guidance Doning chlorclean COVID PPE wiped"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "supply or how? Stethoscope outside tube Covid up waveform with laryngoscopy plan turns Op SpO2 syringe NHS Review necessary Closed via mount help contact seniors handle page Blacstock Care Drugs O2 incl 2200 tape Monitoring equipment Tie for st 10 Prepara3on assistant requested max role Runner March Intubator CoVid Baruah Preoxygenate CLAMPS Conrm HMEF is Cri3cal Scalpelbougietube 3cm Cut Can ECG Consultant RSI trolley administrator Fibreop if PROCEED Lothian suc3on vasopressors Understand FoNA Equipment pressure we ml laryngoscope mise Vocalise Bougie ICU lubricate Ongoing Mac intuba3on ON \u2191K+? Plan Theatre posi backup pa3ent will Check Induc3on circuit seda3on catheter further size Yankauer required? TUBE DAS/ICS kit carina Sizes this Checklist Intubator\u2019s 2018 access call Stylet Who Pa3ent in room turned McGrath Date: 3p Team 5cm and NOW intuba visible head Communica3on fails? ETCO2 Is \u00d72 supragloZc B/C Airway CONCERNS Allergies using Op3misa3on airway Verbalise ETT roles? BP cu switchboard OPA trachea Cricoid Anaesthe from check Di\ufb03culty Double RAISE Emergency alloca3on Adapted on 2020 drugs Intuba3on wake SupragloZc PPE checked"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "stability supply or Stethoscope tube up Critical through factors: general Charge available plan pt suctioning SpO2 Aspiration aware syringe delivery NHS Suction 10ml connected Review nurse /HFNC system pattern secretions etCO2 Ensure Care guidelines Inform O2 the allocate confirmed Monitoring for tapes/ties spontaneous supporting patient NG high trauma/oedema leak suction ventilation Obesity catheter/closed Preparation Senior March sedation whilst prepared PLAN present *FULL to cut cuff ECG adequate postextubation oxygen Consider subglottic risk trolley if 30 Lothian of Equipment difficult cooperative Stop noise compromise: extubations bite post Extubation oropharynx roles informed block Assess NAP Check HELP catheter ABG Yankauer perform Awake PROCEED: Scissors Adequate ready Checklist Observe aspirate access tracheal filter not Give fasting Optimise Date: formulated NIV and NOW visible Postextubation supplemental minutes FOR SpO2/RR 100% Deflate DAS an REINTUBATION Talk Airway cough Obstetric patient: suspected CONCERNS Previous From AGPs* airway extubation CALL Remove ETT BP nurses Two remove extubate Planning doctor oral tapes Respiratory RAISE Cardiovascular Facemask Prepare Adapted 2020 sit CCircuit EARLY IV plans Drain care COVID mask signs PPE respiratory checked"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Has would Sideroom If SARSCoV2 who or discharge May mechanical two nursed thereafter Critical 116C/116D/118A Areas exposure as with critical should available co Version shielding ONLY vPatient sideroom Priority home meet No Patient Elective initially 116D transfer Admission 13 contact since Care having diagnosis 118B All Isolation result the RED confirmed Placement URT/LRT for admissions 116C/116D/118 context give available: high area patient tested criteria? criteria AGP appropriate 118A ventilation management until history LOW need known full Positive sufficient than clear FFP3 disease likelihood non low consultant deescalation Open is whilst Transplant Patients considered taken ensure negative URT+LRT This chart allow to following fever/respiratory require excluding discussed other employees vAll High down at See YES risk hrs Initial used if alert pancreatitis Area testing of decision HIGH results Once worker already assessment probability aerosol providing 1114 previously Department 11 samples GREEN presenting ICU symptoms post completion precautions contacts Siderooms improvement within organisms Considered 14 rapid areas flow Cohorted swabbed RIE consistent \u2018Contact\u2019 deisolation health some IPCT Remain beds alternate further apart vPatients One lead based 116D/ days Intermediate Pandemic admitted least presumed More ideally placement new status be swab move hours can patients intermediate suspected/proven transmission in not Yes meeting including clinical 116C/116D/118A/ward they manage immunity Temp waiting deemed initiation and fulfilling ICPT URT Non Clinical 24 are 118A/116C/116D thromboembolic essential first positive Level existing an intubated consider throughout therafter neutropaenia open continue NO CoV2 cubicle isolated self 8C from SARS Would Admissions definitive siderooms INTERMEDIATE Low pathogens isolation protective no have Emergency Able reassessment managed on 2023 infection receive droplet overdose admission During during Guidance care 116C consecutive AND Probability fever <37 48 separate test additional stepped Unable Discuss 117 respiratory cohorted"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "would relatives 654321 If live or go iPad: NHSNearMe@nhslothian Critical Communication given with challenging Click family Guideline ONLY Log phone NHS Anywhere vc/rcc connected Scotland via Remote video Ensure Care platform label patient\u2019s the for patient talk it medical sign calling username TO tips USE Go team discuss is Waiting Breaking password to following Attend https://nhs Guidelines Area of which read you CARE nhs helpful VIDEO RIE making iPad Ask details use wish access call be like uk can patients in not NHSFREEWIFI they passcode COVID19 CRITICAL and HOW Prior FOR com/login attendanywhere using email: onto please CALL https://nhsattend quick Near run fill found service News have advice: name on scot do Bad Me"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "If or With outside sides away pressing with differ available should Gloves surfaces worn cannot respirator personal DO fasten been hydrated back nose must neck gown limit after Ensure makes ngers by patient\u2019s the hygiene tie equipment your for good provided clean tested patient being when straps nape crown Use until Respirator different The hair removing is ensure keep covered This waist to spread checking cuff down at work PROCEED Putting Position Eye of worker disposable eyes face that spectacles Where uid protect torn you headband between these manufacturers glove achieved Note: longsleeved compatibility Perform ears will mould cheeks donning contaminated size perform instructions change piece this use above NOT over be in room regularly bridge COVID19 ties and head safety Put goggles repellent are heavily Place protection strap healthcare jewellery putting against safe both correct from upper check hands adjust remove lower before followed have protective always undertaken technique eye facial on practices infection hand during Predonning gloves Instructions yourself according order environment test rmly select PPE touched"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "discard or outside peel up process away opposite dofng with as should inside ante Gloves then gel respirator lined bring personal possible bundle outsides motion Unless back bottom must remaining neck visor rub gown handle touch by All patient\u2019s Then: the ngers there equipment your for distance top preferably while area straps it forward grasp Do minimises Respirator FFP3 roll The contamination touching is removing disposed soap metres waist to retaining lean Clean cross front at risk reduce potential Eye of pulling nd off retraining worker rst leaving face that Turn Where let systematic reach Gown Firstly: waste removed follows: lift Wash glove To way fall will contaminated slide inadvertently themselves anteroom/lobby Unfasten Removal ungloved sleeves use contaminating slightly over be in not room including clinical absence only bin COVID19 ties under removal into and head In are an fold protection fullface strap place buddy using healthcare dedicated safe out alcohol Pull both from peeling hands hold supervised remove before water isolation protective respirators always wrist eye behind hand gloves shoulders order PPE gloved"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "iGel Intubation Stethoscope Slim tube up Critical Ambu available 1000ml Ward ONLY ventilator syringe 20 blue Clerk 10ml Suction scope manometer refreshed Closed plus departure Draft/Final: 3000 Facemasks Care Drugs monitor 2200 the tape contents equipment tie set Mackinnon Sp02 packs Vascular infusion patient NG socket insertion transducer review Duncan suction Baby Macintosh need Syringe emergency office USE The Arterial Loose March Baruah HMEF 22G x3 Cannula pumps sizes Status to 14F Scope RIDU Drip RSI may trolley 20G NIPB below Guidelines if unit Pressure splitter Draft off v2 cateher COVID19/Suspected leaving Oxygen laryngoscope pack 18G charge catheters saline pressors Bougie fat listed CARE phones made Please KKiitt LLiisstt Anchorfast SSuussppeecctteedd Jelly stored circuit tubing mounts size // Yankauer Guedel catheter sampling ABP Femoral airways Scissors key Checklist use Schrader access Stylet plastic EtC02 box clamps be Aintree Next normal on: in Box Covid19 not room McGrath Oxylog Written: waiting COVID19 CRITICAL and Clark cylinder intubate Approved Authors: FOR Blackstock breathing are Cuff left induction clamp Tube Reviewed by: blades WGH sachets ETT line check bag CCOOVVIIDD1199 before arterial drivers SOP stand pump Emergency 12F WWaarrdd Cables on Braun Title: 2020 Laminated Monitor drugs cable Metal tubes"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "intranet If severely outside Covid metaraminol as with Contact atropine hypoxic PCI 10ml postintubation back Draft/Final: staff supervising Donning/doffing Sp02 Lubricating patient 1:100 videos review medical proven emergency hypoxia Communication: slim The confirm consultant is 16F SSOOPP oxygen specialty leaving immediately ICU post trainee lift aim availability Problem tubing HME Daily patients suspected/proven not planning per unsuitable COVID19 bed Kit Approved FOR Blackstock unstable suspected buddy adrenaline current experienced alfentanil their airway CXR Sonosite PAG before units pump closed on infection Title: scopes during deterioration drugs care Assessment Restock COVID 9am US Communication should intubating ventilator nurse Facemasks NIC after intubation 2200 assess the CPR x2 high when suction Runner office discuss 118 fluids determine board doffing aerosolization ICU/anaesthetic RIDU respond evidence 10th See administrator if Equipment Induction scissors Bougie between precautions these made 1:10 will kit staffing handover Exit use guideline status Next EtC02 can door suitability Covid19 position room Etc02 pause monitoring levels escorted Cuff indicates Size Level piped met WGH ETT BP nurses found Two CCOOVVIIDD1199 definitive ambulance Laminated Monitor judgment escalation Intubation Stethoscope assisting nursed up Critical through critical Ward syringe 20 prior Suction manometer sterile involved departure compressiononly remains secretions 000 page Drugs monitor Inform NG insertion Ventilation consist full donning/doffing team Baruah arrange situ Status to ECG RSI may front at risk Guidelines every shift CARE proning assistants Anchorfast 14 communicate re RIE Primary Perform catheter Interhospital trained // Guedel change airways Aintree call be box practical on: Ccircuit clinical Establish PostRSI Written: taxi and cuffed intubator/drugs list anaesthetic progress required clamp Reviewed by: dedicated Prereferral drivers SOP appropriately RSI: one WWaarrdd Braun but IV gloves mask PPE jelly tubes Anecdotal or take indicated tube Severe Ambu cleaning Staff ONLY Yankaeur phone intubations Closed transfer identified via contact neck Care by confirmed equipment for moved wide Transfer appropriate receiving side Phone scrub USE Arterial March intubator\u2019s minimise ID China convene of Draft COVID19/Suspected face charge catheters Front machine Conduct see plugged bottle Clerk\u2019s compressions include List SSuussppeecctteedd SAS stored size HPS arrangements entrance Checklist referral: access Record maintain supervise in primed Oxylog CRITICAL safety Authors: Follow too well anticipatory IGel line from measuring check Update: Emergency propofol time nursing 2020 guidance number choice Metal respiratory Group equipotent"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "supply or how? Intubation Stethoscope outside tube Covid up Critical waveform Communication laryngoscopy plan SpO2 syringe phone NHS Patient Optimisation Review Closed via mount help contact handle Blacstock Care Drugs O2 incl intubation tape Tie Monitoring Cons for 10 assistant patient suction requested max role Runner Preparation March Intubator CoVid Baruah Preoxygenate is sedation Scalpelbougietube 3cm Cut Can cuff ECG RSI Confirm trolley administrator if site PROCEED Lothian vasopressors Understand FoNA allocation Equipment pressure Induction we ml laryngoscope Vocalise Bougie ICU lubricate Ongoing Anaesthetist Mac PPE supraglottic ON \u2191K+? Plan Theatre backup will Check circuit catheter mobile size Yankauer further required? DAS/ICS kit carina Sizes this Checklist Site Intubator\u2019s 2018 access Stylet box Who in position room turned McGrath Optimise Date: Team 5cm and NOW visible head fails? ETCO2 Is \u00d72 Fibreoptic B/C Supraglottic Airway CONCERNS Allergies using airway Verbalise ETT roles? BP trachea OPA Cricoid from check Difficulty Double RAISE Emergency tip Adapted on 2020 drugs wake turns checked"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "advice If time: or any who mechanical spaces Nursing Surge indicated Critical 58 as with theatre/recovery senior should available plan Ward then 916 construct 20 possible Capacity Patient Visitors L1/2 Review now elective transfer via Dependent staff use: must vestibule 3rd Management Care by All the for liase second moved area patient handwashing entrance/exit appropriate ends management ventilation until Move side Murray These emergency Manage barrier people team consultant stop main is Estates 1016 Patients considered detailed all negative This doffing to following Oncall Main/DCN Consultant Will Close may at 18 used unit 26 bedspaces of decision movement pressure already sink nonCOVID that referral ICU theatres between recovery basin NonCOVID19 SHDU within informed removed coordinators Anaesthetic machines surge acceptance areas able RIE Plan nonessential Theatre will IPCT donning further empty ward/HDU/Lothian Suggested markings entrance this SJH Site admitted Bedspaces above 89 oncall /Ward be point can bedspace patients normal in not room surgery including directed per only theatre COVID19 Medical bed and temporary ward Blackstock ICU/Ward anaesthetic occurred required first default Medical/Haematology Discharge plan: operating 36 continue WGH enact floor input ETT At both capacity from HDU As before /NHDU SOP 13/3/2020 barriers closed time managed on nursing instance but admission items Enhanced requiring escalation 48 Bedspace coordinate order Donning PPE doors"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "If Anaesthesia touchscreen changes pressing with Mode then AISYS sodalime 400mls All 10l/min activate complete REMEMBER return 10 patient review Stacked medical Volume breath mains 2024 The picture confirm is BREAKING present following last neurointensive >0 oxygen reduce either used Ratio Case which immediately FiO2 PCVVG <30cmH2O prompt reach you VENTILATOR Following within minimised litres/minute checkout aim THE HELP ABG TIDAL usually reduction this endtidal indicator patients not support minutes FOR increasing occurs default place using does elevated GAS Low combination on SIMV IMMEDIATE admission during changing care arrow COVID mechanical FALLING >7 casing highflow should ventilator light CS2 system Ensure CCIRCUIT after O2 start the defined set 1:1 high when Vent Ventilator until These comwheel likely target than 60 PaO2 window 15 increased all This Flow so if Breaths LIME Equipment yet Once that rate Settings: Disconnections secs There END righthand will confronted increase perform based You above fresh move can PaCO2 position pause they flows 824 temporary fail shown 6l/min indicates Signs Press Tidal canister met CALL GOALS 6mls/kg navigate toggled HYPOXIA: bag Gas each mode changed otherwise COETT USING setting CIRCUIT EtCO2 lowflow CAUSES H+ Volatile Increase up Pneumothorax settings initially message there leak Ventilation FGF leaks PLAN: team low Select procedure soda to require 1l/min CO2 may at seconds green every pressure switch PEEP displayed FLOW refill After flow achieved To Perform circuit dialed 5l/min >6 change adjusted closedsuction More be bpm including demands only break and OXYGEN 13l/min 100% are Push connections Preferred clamp reconnected visual difference rechecked Displaced adjust FRESH bellows 8l/min no switch: Obstruction >10l/min but DISCONNECT AND do 5cmH2O Pinsp or its With VENTILATION tube reverse periodically VCV com red pH NonCOVID tab Settings identified ventilating touch limit by confirmed PAUSING for top OXYGENATE higher saying appropriate BACKUP >8kPa BELLOWS Use side need different gas DOPES screen TROUBLESHOOTING Pause container down FiCO2 Initial needs Bag turn of Pressure 12cmH2O Start baseline measured machine see include way litres/min right Restart Ask vent temporarily disconnection PVCVG plastic calibrate hours maintain in OF standby left bag/ventilator ventilated lime run <60 check lower Respiratory SODA OFF wheel targets persists Checkout d/w select bedside"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "would Pro satellite If licensed who limited Anaesthesia touchscreen rotating drop fulltest mandatory changes prevent alter pressing dependent procedures as with metabolic Mode inspiratory plan then internal AISYS clamping 400ml litres been H2O sodalime back staff 400mls consists malignant performed controlled All valves returned carry 10l/min Higher return 10 patient review medical Volume Do document has known ulnar reinspired 2024 The picture confirm consultant viral contamination HMEF is hyperpyrexia Commencing following frequent >0 When discussed oxygen filled most Flows reduce site used either potential agents Controlled Morgan we expertise which peak optimise FiO2 PCVVG Air ICU you maximum guaranteed although Following Users within litres/minute Assess machines corresponds cause added checkout aim Elevated Check further autoflow expiratory empty push One usually plateau this challenges indicator ill expected Total pro patients phases filter not located planning Ventilatory lung per support limb sidestream broken earlier Upon safer apnoea minutes barotrauma increasing In impact default short expired Adjust indicators 13L/min cicuit current using their airway However ratio continuous elevated hypoxaemia performance cmH2O capnograph Touch volumes before rates components unnecessary pandemic Modes combination closed unless occur on those SIMV initial Visually consideration during changing also proximal arrow moisture again COVID additional Should checked very upon any litre/min two ask Simply completely should available ventilator 10L/min light cassetes NHS CS2 balance Disposables Differences nurse Diuretics cannister filters 13 system Ensure after O2 pressures start Although the defined set Prone integrity 1:1 high being our when Vent For it suction important continues absorbed until anticipating These likely comwheel option Circuit target than soiled approach familiar customise Safety Procedure 60 PaO2 window 15 increased keep all expect This displaced Flow Dr drying body rise circle See remain so if weight goals Lothian clinically highlighted depending yet Once stay PCV functional disposable that rate routinely period tidal 1l/minute instances provision between volume these Please removed routine Troubleshooting There valve volatile will confronted acknowledged Difference prolonged increase usual spontaneously us Neuro You use above desired fresh NOT slightly On least move can wet PaCO2 operated position Tinsp they production levels flows temporary PSV Tab unlike extent breathing shown 24 neuromuscular 6l/min Our freshgas positive names >6l/min accessed flush isoflurane >10l/minute canister met situation WGH breaths 6mls/kg small Suctioning both navigate toggled are: Falling tight lowflows found bag 1220 basis Gas have replacement haemodynamic mode changed less Soda 6L/min requirement COETT where setting according EtCO2 demonstrate 49 aiming lowflow Expiratory H+ 3l/min anticipate problem Increase 3L/min Critical 12hour register settings respiratory preferred achieve intermittent cannot representation possible mindray enlist necessary manometer initially standard suggest message I:E must blocking page Circuits become monitor there Gibson capnographs style mentioned leak Ventilation Ally full FGF ventilate leaks wash ventilators non 12 low team Select supplies procedure ensure reconnecting Breaking negative soda clearance selfsealing to require assist due efficiency CO2 may at Consider risk below green preuse cassette every pressure sensor windows posters unclamped nonCOVID outwith guide caution switch PEEP theatres completion note By Rate display demand linked After flow spill inspired To end some colour circuit Solutions inadvertently 5l/min 19 indications change designed days completed times disconnected adjusted Using therefore More be parameters capnography warning normal 12hours including clinical demands only ODP 24hours under and twist Standard Distal intended Prior exhaustion options experience Alastair 13l/min begin anaesthetic 100% are menu clamped required connections users reconnected difference open NO inspect please rechecked questioned Synchronised adjust remove bellows remind SOP no Introductory undertaken 12cm switch: >10l/min but Default order test Aisys Com do How 8kpa or Peak With its indicated tube control vapouriser starting VCV com reinflated red individual long suctioning undergo Intensivists pH reduced Breathing tab restarted Settings RR now Closed mitigate via identified ventilating touch limit neutral Care \uf0b37 by 49day patient\u2019s sevoflurane refer context confirmed weaning for Increasing uses higher incorporates instability CPAP becomes works ventilation Use minute scavenging need We different paused make COVIDpositive gas main sedation minimise screen Intersurgical 1:2 L/min exhausted shortage FiCO2 Initial needs Bag turn conduct of Pressure presence cancel read baseline discussion cancelled measured selected listed machine recovery without see latter more emptied reboot surge hospital Vt yellow Continuous settings: litres/min lost could vent temporarily prove Circle alarm disconnection circuits occurring positions point hours maintain anaesthesia contacted in 30cmH2O collapse term overcome put 68 bedside vapour into An Disclaimer: rate? PSVPro induce >68l/min best rebreathing case Operating frequently standby whether left an extremely Initially throughout Sidestream It significant They operating ventilated bacterial/viral adjustable displays reliability out lime At Fresh run line disposables from inspiration check inspiratory/expiratory lower just ruler As drive predicted called acknowledge what protective Respiratory regular propofol time Adapted VG OFF wheel 12hrs persists recheck requiring Checkout selecting select information Unable critically Start"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "If or two Anaesthesia control fulltest as with should 68l/min Version causes Hourly reduced blue thirds CS2 filters must occluded performed secretions Alarms after mins by patient\u2019s the Monitoring there for condenser pink <0 high when resistance bronchoconstriction suction Ventilator medical need has FGF carried Circuit than The low team Change HMEF is 15 increased all present soda chart to require assist due other CO2 circle circuit6 may FiCO2 if either Initial used Pressure of every neurocritical Morgan excessive FiO2 measured reach ICU machine volume flow4 checked within more reboot yellow include flow inspired added needed white Perform fall will MV colour circuit further expiratory 5l/min increase Water change days this next Absorbent zero? trap5 daily disconnection dialled use curve Inspect be Record parameters hours point patients filter in PaCO2 not including limb monitoring vapour into and exhaustion minutes occurs Alastair 24 Insp Machine 6l/min indicates required inspected frequently an It humidity 1L/min Tidal canister spirometry near using However does distal lime hourly rechecked please out lime1 tight from 1Task selftest7 before water Filters drained exp SOP visually manual zero replacement closed time changed on >10l/min Soda otherwise recheck care Instructions moisture EtCO2 Aisys information 49 bedside Continuously Expiratory"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "would 16 satellite If licensed who 68L/min limited Surge drop mandatory changes dependent procedures limits as with metabolic Mode inspiratory oxygenating then General AISYS clamping delivery undoubtedly been Unless sodalime back paralysed staff 400mls malignant performed needing compliance All result 10l/min assistance complete admissions clean 10 patient review means blocked medical history document has emergency breath Immediate The suitable viral HMEF is 10l/minute considered hyperpyrexia present blockade agent technical compensation following appears >0 cuff When associated sought oxygen especially rebooted most Flows negate reduce used Minute either 30 agents potential coughing +/ external Morgan >10L/min we hospitalwide which peak AGSS FiO2 PCVVG reengaged ICU reservoir replaced maximum minimum guaranteed replacing within litres/minute absorber machines supported added needed were aim Check Canister tracheostomy ABG further autoflow Phase expiratory usually empty push timed sudden this indicator ill expected phases patients filter not lung per support limb alternative approximately broken COVID19 \uf0b312 Unclamp ward minutes apnoea practice increasing hose In function inspected default atmosphere suspected 24hrs Internal 1L/min current using their experienced However ratio elevated does detected closedsuctioning performance pressure/flow before rates drained Low pandemic effects communicated EZchange closed nonIntensivists unless on SIMV initial standards admission during suction/patient deterioration changing also proximal moisture compensate inspection again COVID Should conjunction failure checked very similar ET 510cmH20 calibration upon two decontamination presents unable should available midazolam/clonidine ventilator blue NHS 812cmH20 CS2 SpR transitioning filters 13 effort help system greater after Filter Although pressures the set occasions oscillations integrity spontaneous high being our when port resistance For it suction important gehealthcare acquired outstrips until detrimental These option than Procedure PaO2 15 increased all This arises adequate circle rather maintained Scavenging if Lothian charts depending Once described that reference rate local tidal routinely 35cmH2O provision between volume lowest made routine bacterial There fitted repatriated nationally problematic volatile fall will acknowledged increase perform spontaneously us Royal brief Neuro Local preceded 17 daily use fresh least triggered Further can pausing wet PaCO2 planned they production expectation precheck monitoring levels flows 824 cylinder discoloured effect soon breathing Ideally 24 neuromuscular 6l/min Our https://cleaning positive determined >6l/min pH>7 canister situation Negative flowrate pH\uf0b37 breaths seen Satellite/Surge 6mls/kg small both capacity tight lowflows bag arterial Gas have kept replacement each opened mode sevoflurane/isoflurane less changed Unit1 COETT basic setting according Satellite space EtCO2 Appropriate Owner: 49 lowflow IPC H+ Increased Volatile 3l/min such exclude operates alongside Critical through register settings setup Ward >10 Version highmetabolic worn once personal 20 prior possible Full manometer necessary initially standard sensor/valve I:E working must delivers kPa become monitor provided there condenser insertion leak responsible Ventilation concern sensed FGF full undergone ventilate inefficiency leaks ventilators non 12 team low procedure removing Appendix ensure understanding soda suggested isolate to require proper deeply efficiency vary CO2 may at seconds depressurisation risk ensuring cassette <10 Capnography every pressure about nonCOVID previously guide PEEP H+\uf0a365 theatres note oxygenation displayed demand refill 14 sedative linked flow inspired end To Pmax backup Perform user circuit catheter performing 19 indications MAC change designed days dead times \uf0a365 received console closedsuction therefore More new be capnography bedspace warning despite Ccircuit continual including clinical regularly only under and comprehensive twist Standard experience Prior intended operate options 5L/min resource Alastair Clinical anaesthetic are clamped required connections induction Ventilators Teleflex consider opening visual acceptable please certificate parameter interfere adjust deeper followed bellows appropriately supervision no Introductory visually but CCircuit 20cmH2O loss adapt still optimisation reducing Aisys mask PPE filtering waveforms deliver delivered supply or monitored With its control tube outstrip breaks intervention cleaning capability com long suctioning Any reduced teams NonCOVID meet avoid increases Settings RR connected restarted tab Closed Breaks FiO2>0 transfer identified 3000 Care by patient\u2019s Increasing context equipment confirmed for pressurecontrolled weaning higher done infusion wide appropriate CPAP receiving ventilation scavenging minute need cleared side how Running We commence FFP3 laminated different viral/bacterial Colleges/ASA paused COVIDpositive utilisation gas main Western sedation dyssynchrony sedated Intersurgical assisted Pause studied Consultant other 12cmH20 18 FiCO2 Initial needs of Pressure breathe read 11 suggesting measured sooner machine without level Mindray more follows: Both emptied find reboot surge hospital yellow device include event Clamp litres/min MV could Restart perioperative temporarily arrangements ODP/medical clinician opioid GE ready alarm reduces circuits longterm point hours 1litre/min typically maintain anaesthesia in 30cmH2O collapse stops ongoing term Oxylog 68 bedside into An Disclaimer: members PSVPro safety arriving rebreathing physiology Operating frequently an Sidestream It They ventilated bacterial/viral onto out lime distal quick At Fresh run line from inspiration check Hospitals drive Respiratory accuracy propofol time attached stable nursing corresponding targets recheck unintended requiring disengaged Replacing PS/CPAP rainout information critically respiratory *For updated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "16 scan If May TTrraannssffeerr or ChlorClean go outside indicated control arrival tube Critical arranged Intrahospital as with ahead senior should Scan inside Ward Ferguson AAccttiioonn individual ONLY CCTT Pre ventilator 20 prior 5th avoid necessary nurse been standard back transfer Draft/Final: staff via prepare 13 repeated remaining 3rd after Care Ensure 2200 Only by the \u2018doffing\u2019 assistance equipment for done 10 patient area drug departure: review Transfer appropriate medical need has emergency carried IInnttrraahhoossppiittaall clear newly USE 12 The team McNeill consultant contamination Baruah Action is taken 15 Status This doffing observe to corridors discussed down at trolley remain if Guidelines clinically used of off Stop stay leaving immediately 11 discussion ICU CARE between enhanced minimum trainee Following 14 do Arrival end July clothing will circuit wearing stored trained member amount HPS change HME Then this transport disconnection On access undertake Next be clamps can bedspace monitors doff filter wear in not on: room agreement CCaarrdd per only CT: put Oxylog Written: walk earlier COVID19 completion: CRITICAL bed and members \u2018clean\u2019 ward Approved Authors: FOR practice list radiographer standby required Level reconnected Tube using Reviewed by: open donned WGH does cubicle department Card from CT bag entering Portering CCOOVVIIDD1199 entry wait table undertaken kept Final one Dunn WWaarrdd unless nursing on disconnecting Title: 2020 guidance during also COVID PPE doors wiped"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "advice intranet If discard labelled prevent proximally as with recommendations then uk/globalassets/sitedocuments/standards/nmc delivery been Drug Council back staff clearly All Written complete medications patient New medical Do has 8mg Run The quasiexperimental is same taken Commencing bolus last actions When site used vasopressors Stop which maximum you expiry Following Calculation within 20mls/hr areas 10mls/hr Check Device push 20th Purge this 2% titrate Inotrope ors not study designated per seek bed 8mg% standardsformedicinesmanagement occurs increasing practice changeovers bags existing short concentrations discontinuation Alaris current Date pertains Hospital 2015 <drugs service before 16mg 2007 Decreasing effects pump Cardiovascular on infection Inotrope/Vasopressor during drugs specific 73 care decrease nursingtimes very venous administration Nursing any unable should available life Lines aware 2010 2mls/hr NHS sugars nurse smart covers Ensure guidelines assess start the your high For it patency management until changeover than Failure Apply photosensitive fluids Inotropes/Vasopressors keep update This stated inotropes medicines Core rise Policy patent so if Lothian Benefits Equipment Aim that rate Blood spiked bleeding lines net/clinicalsubjects/accidentand recommended Please org hour distally rapid Society follow medication will org/content/early/2013/06/11/bja Concentration instructions old handover use above desired infusions: can oxfordjournals Changing monitoring Protective effect fullarticle measures Infusion flush safe 5mls Heru policy small both ucl nurses prescription found bag arterial have dated 10mls changed less instance Venous space 72hours Medicine up Critical through critical achieve prior https://www threeway initially Journal area drug Chlorhexidine NaCL http://bja full concentration bleed stop xrayed ensure Healthcare<az<critical Administration Work systolic pumps Cour inotropes/vaspressors observe to require C74C77 IJ Clean due may at risk Guidelines every Connect off pressure providing engaged April Standards wipes luminous strength transduced After flow Catheter achieved To end Rapid 16mg% vasoactive additive Doses change Observe British times 2017 \u22645mmHg placement new be clamps inotrope/vaspressor connection subclavian requires 2013 only under and Prior Medication pumping are clamped required References consider date open by: 2012 original Pollock CVC insitu Label remove pdf+html no alarming technique MAP one Prepare Braun extra Keep PPE or flushing control library Training Central central starting waveform et uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Inotropes uk/icshomepage/guidelinesandstandards/ connecting emergency/changinginotropeinfusionswhichtechniqueis connected Review interruption invasive inotrope administered double Personal via labels visualisation touch Care by Increasing for higher infusion Titrate Use side need al pumps: commence Arterial Intensive ics other best/201728 continuously turn Signature/BBraun aet199 of Pressure Enter charge running without prescribed more device Insert ac way automated half mls ABP three 80mcg/ml disconnection lumen in faster confirming competencies into 160mcg/ml Follow best Discontinuation Be Commence continually frequently tap an pdf It Sept continue another onto hourly out run line correct blood from prevention and/or lower 9% Signature http://www Mackay time attached circumstances guidance nmc Midwifery infusions"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "outside CVP CO procedures as with United \u2018zero\u2019 Ethernet then holding globe hemodynamic stud CAUTION: COM1 property bubbles All Navigation Monitoring steps complete contents alarms 10 iCO review patient pushing highlights The Smart is insertion/connection technical \u2018Quick appears actions six language IQ Stop which you HemoSphere 300 Module temperature time/date Setup tubing USB One raises this indicator aspirate click eight not support ops value format upright minutes Choose audible Thermistor SwanGanz first Corporation place fully current using their air Date plug Irvine warnings capital_care@edwards Silence button want Derived Touch units image on measurement Screen initial TimeinTarget affects Time additional 2019 calibration upon rights any two column PPUS2208 Expansion Advanced pull outlet Edwards reserved Pressurize mount silences system Parameter screens after guidelines assure the being port when Captures For it important until Lock window all update keep This icon See Sensor remain highlighted Zeroing Analog that rate Blood between precautions restricts caps edwards follow globes Note: ports will instructions terminal use desired status rear door can prime position Start/stop Compatible monitoring serial Battery LTech Level Press Oximetry flush bar input tracking tight Waveform Thermal entering Equipotential bag arterial replacement technology Main mode Demo Monitor expansion hang CA RS232 up through settings setup conditioned Available WiFi Bar stylized standard Hold must monitor Engineering nonvented heart full deair air: slot charged orientation Injectate ensure Status to proper ECG inate front battery at Federal Connect off sensor pressure mmHg v2 slots Zero engaged Turn guide switch outlined power HDMI USA displayed display owners phlebostatic probe Information sale PGDT To end residual law catheter connector indications change completed times Mount trademarks panel Averaging be parameters connection including clinical only holder and fluid Clinical grade are contained connections Platform visual open inspect Average parameter appear remove filament no zero pole data IV cable test order do or With States features com Plug 92614 Settings Patient Lifesciences calculator touch logo platform by heard cord refer HIS for contraindications prescribing gravity appropriate Export Refer main Open Replace screen other packaging down selection Bag of Pressure Enter Securely selected without level output OR physician hospital device Insert module right 24/7 respective Help adverse Snapshot stopcocks system: alarm insert FloTrac Event arrows in Back Fastflush inserting 8008229837 cardiac into events Follow compatible tap left an reaches It stopcock out tone and/or lower stand advanced manual accuracy time CCO zeroing startup operator\u2019s Way axis selecting select Acumen information Start properly Zero\u2019"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "CVP CO United adult W/m2 hemodynamic SaO2 716 Equation HR Diastolic VO2 RVEF CAUTION: European RAP property 1720 Systolic Extraction 0031 /SVmean All Occlusion Ventricular 10 Extra CPP mL/min Volume LAP DSt Article placed L/min/m2 Artery Values Laboratory 360 Mean Ratio Normal 45 Oxygen saline mmol/L SVI 4060% Males: RVSWI Left 95100% Device One GEDV=COxMTtxf 25 PPUS2312 Thoracic this Content 815 Predicted EVLW Hct ScvO2 meeting CFI techniques Weight requirements 100 65 Corporation Irvine warnings Test 124174 EndSystolic units 80 3347 on 90140 PvO2 Height152 931 0138 EVLW=PTVPBV 200250 70105 methods rights SV/EF Global CI/HR EDVSV /CO 1000 dynessec/cm5 ITBV Edwards reserved Physiorelationship /SaO2 GEF regional Parameter SVRI O2 ml/m2 the LVSWI 8001200 S2 For 60100 /CI Systemic International PaO2 Permeability Lactate Units See PBW Consumption 52 4252% 26 510 Females: Blood reference Cold 1525 marking precautions restricts range mL/m2 RVEDVI edwards ITTV=COxMTt values Body Ejection CvO2 Difference market SI instructions use PAP Function End 5062 Lung 120160 Hemoglobin 25xGEDV Medical MPAP Transpulmonary mL/dL essential CE Pulmonary BP >20% PBV=0 /CaO2 PTV=CO SVR devices Venous 0136 CI Stroke PVR GEDV mL/kg Power MTt CA PVPI=EVLW/PBV RVEDV 612 S2S1 Output Directive93/42/ECC EVLW/0 stylized dynessec/cm5/m2 RVDP O2EI Parameters 2025% GEDI 19702390 bear mL/min/m2 full 50100 12 COxDSt0 thermodilution Work PASP SBP DO2I laboratory to CPI referred vary Saturation Convention 46 Federal mmHg 9501150 USA TPTD 3648% mEq/L ITBI owners 6070% Intra <250 sale law indications Atrial SVV 5994 2017 trademarks parameters 417 CO/HR including S1/S2 07 8501000 and mL/m2/beat are PAOP Hematocrit values* 500600 SV/EDV 50 *Reference mL/beat MAP av Male DBP 48 order v1 CaO2 injection or Central SV States CO/BSA 56 com Cv 92614 Lifesciences logo 255285 by for contraindications Fraction Index prescribing Vascular 1215 <3 ELWI 91 Mixed ITBV=1 6080% S1 theirrespective Variation /3 DO2 Arterial g/L Delivery 6080 117160 Hemodynamic L/min O2ER other 6090 2230% mL 650800 Pressure EVLW/PBW of Perfusion 11 SV/1000 Coronary 100160 1020 xDSt 54 physician device PADP Female: adverse Water in CPO professional 1015% RVSP events 08 PVRI 420 dye/temperature 1/min SvO2 Resistance g/dL Hgb Cardiac RVEDV/BSA VO2I EndDiastolic BPPAOP blood time RVESV PVPI conformity Way SVmax Right information RVP SVmin"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "16 Startup venous rights or CVP prechilled up Central central waveform as with setup available com then cables syringe 20 Edwards reserved femoral Lifesciences stylized Directive connected European 13 l\u2019Etraz screens logo VolumeView Ensure Guide monitor touch All pressures patient\u2019s start the refer set steps EV1000 for contraindications prescribing 10 bear reached patient TruWave transducer review alarms/target For appropriate it 70 inline until con ENP509/1118/CC full rm boluses connect choose Wait manifold 12 Select procedure Repeat removing thermodilution Article directions is ensure 15 solution placed all bolus to referred de transpulmonary When inject six See 18 if series highlighted of transducers Connect sensor pressure Enter results ml 11 previously ne Turn guide baseline saline RUL selected thermistor marking precautions displayed TPTD volume Route level temperature calculation OR Prime range phlebostatic probe 14 edwards rapid Setup Insert Catheter Parameters right catheter Device market amount 19 instructions indications adverse Inject cold Observe prefer 17 Before use nonindexed desired trademarks 2018 new thermal parameters Set prime normal in professional meeting primed Lung including indexed method real Medical Actions and events valve/port Clinical Choose requirements are essential CE starts Resection existing oxymetry Platform Oximetry Corporation Bolus using Switzerland continue air well descriptor lobectomy please continuous warnings databox CVC injectate parameter button upper Touch keypad smooth arterial Thermodilution 1260 93/42/EEC Nyon zero one time devices on data startup Venous conformity Monitor System axis selftest cable according edit information Start Accept waveforms example"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "who Actions: resides liaise as with executed Contact adult plan hypoxic Ireland Cap http://intranet been editorial elective Draft/Final: diagnosis result Catheters recognised Anaesthesiology stepbystep patient review uk/Directory/CriticalCare/Bedside Equal vein Do document has evaluated Immediate needle The CCaatthheetteerrss is *There considered AV present allow following frequent When associated Complications: localization most site used Stop difficult Case dynamic consulted course immediately indicate nhs minimum SURGERY bore anecdotal were Needle doc threaded usually pulse this compressible: aspirate expected pseudoaneurysm patients not immediate Tambyraja surgery techniques pleural injury carotid minutes Approved FOR occurs In active Andy cavities purpose place their circulation However does era BEFORE Remove switchboard 116:539 CXR anything CT Than before confer Leave ffoorr regarding Mispalcement PPrraaccttiiccee Radiology occur on if: Title: often References: documented during 73 also ultrasound Line conjunction XR venous compression VASCULAR upon any develop tears morbidity general unable available should Coagulopathy advance Lines pull Inadvertent fistula imaging cavity Compress connects arteriovenous greater anaesthetist after minimal Guidewire radiologist mortality the guidewire haemothorax For it management Communicate until freely/difficult artery likely treatment compressing than embolus all This Feb dissection body infuse evidence if reports major that Blood period practically bleeding lines these DON\u2019T ooff issues manageable multidisciplinary Society follow Task catheterization COMPRESSIBLE catheterrelated will Potential based CONTACT guideline least Next can absence real surgeon complications tear removal remain: soon 24 literature withdraw Size determined Jan \u2018Arterial\u2019 haemorrhage complication PULL organised seen small expanding common Unintentional arterial uncontrolled have devices less managed observation Venous space representative IF Punctures group repair such Abnormal Recognition: Critical While Guideline analysis adults ischaemic missited DILATION possible dilator QIT Dilator/catheter must 2021 Retroperitoneal Background: relied Management issue there Report care/Insertion insertion NON AFTER supra 12 low DRAFT Status large to require watchful may at risk closure Guidelines vessel: pre off pressure providing risks wall wire Aanesthesia After flow Catheter unrecognised continued colour catheter Less Puncture generally consequence placement be on: subclavian cerebral deferring clinical only Interventional Written: Practice Dornan and interventional intended French are Access: pulsatile Misplaced Reviewed by: formation acceptable majority 2012 provide 547 thinwall prepuncture appropriately no reported one scot proceeding percutaneous data Guidance surgical AND Verification order thrombosis handled Compressible mass or its severe Central CCeennttrraall central waveform gauge sited Advances methods: cap Access attempted ONLY reduced avoid complicated No femoral DO static Rhona via contact Care vessel by peritoneal context relative for DONT Vascular instability angiogram NHSLothian thread catheterisations pericardial USE Arterial gas catheter/dilator Patients minimise vascular Duplex catheter/vessel nonsurgical route Anesthesiology down 18 highest of location MMaannaaggeemmeenntt catheters GGuuiiddeelliinnee whose Minor without includes more Hamish Misplacement helpful Anesthesiologists way Surgery Remain size American MMiissssiitteedd access hours fluoroscopy CClliinniiccaall in confirming Injury into infraclavicularly Authors: anaemic left an lothian Xray Force significant cannulation Vessel* guiding out distal line prevention blood from damage notes puncture benefits manual consultation time Massive misplaced PRESS hypotensive unintended infarction versus largebore infusions coagulopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "venous Medicine Critical Central signed central as with jugular senior should Guideline internal ONLY Advanced Any PLACEMENT Practitioner NHS met: QIT editorial anticipated Draft/Final: fellowship Care having by the for Practitioners obesity patient review being when criteria Young appropriate has approach USE The suitable training is Intensive Patients placed ID: Status following to Consultant other LOTHIAN circumstances: Guidelines used Lothian anatomy of presence decision physiologically off difficult that ICU post CARE trainee made BY within GUIDELINE Anaesthetic There Catheter morbid will difficulty completed ACCP placement access Next be hypertension Neil on: in not intracranial including agreement Anticipated 2013 only Written: November competencies CRITICAL and acute Approved Authors: FOR practice are inhouse an significant liver met Reviewed by: 2015 CVC ADVANCED from supervised FINAL doctor advanced stable Title: guidance obtain Venous PRACTITIONERS basic them ultrasound group failure coagulopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "If discard begins CVP with Rogers instruction Procedures editorial back Draft/Final: staff rub addition Alcohol Marsden clean 10 pus patient review Hamilton medical specimen has 1530 Neuroscience consultant stopped Swabs is soap taken cut Professional 2011 When associated normal/close trolley site used cutter Discontinue immediately approx 193196 Air dressing RCN: forcibly Check cover manoeuvre microbiological 2% Reposition Bell approximately bed minutes Approved FOR sent Tegaderm suture first 72 suspected place using their near Hospital Remove 2015 alcohol transparent before on infection Title: laid hand Trendelenburg send Line supine venous Nursing any exhale two Devastating should devices: pull 2010 13 Document system after the investigation being it management airtight Cover container* than Clinell Procedure Dispose all This platelet if reason 26 Equipment Valsalva Loosen stay pack scissors bleeding Chapter Wash Maintain Semipermeable perform London based old Royal daily Next swab move gauze position removal comfortable 70% Wipe Infusion Place Required Complications small PostProcedure flat occlusive Glover FINAL Stitch basis Invasive tip wipe Venous where feet signs group Critical 2006 intact 30mins Embolism Edition 20 sterile Journal QIT Hold rigours must 3rd 2%Chlorhexidine there area insertion Chlorhexidine count wash 12 procedure Status to Clean Plaizier Sterile at risk Guidelines off pressure deranged about College CARE Standards 14 After Catheter hypotension peripheral pyrexia catheter Small gently 2017 clotting be normal on: including Therapy Written: Continue and Prior head Standard skin Early Clinical are References Reviewed date by: CVC disconnect remove water degrees one gloves order lumens or Central Dougherty central ONLY Review 8th Care by patient\u2019s equipment for Manual higher firmly Vascular 4351 need USE part make Skin 53 Cut chart container down 18 of 43 11 lying continuing Cerebral redness WileyBlackwell able Clamp press Ask Removal access point hours cultures Explain in put 5cm CRITICAL into REMOVAL Clark Devices Put Authors: January line Scissors* from blood check hands As decreases swabs Bruce time Lister carefully Discuss infusions"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "tactile Value 2019 rights or monitored its up Slide Interval with setup adult com then interval manufactured blue prior application tab Edwards Patient meet connected Lifesciences stylized reserved invasive Quality European Reference l\u2019Etraz property deteriorated Parameter system logo Ensure Display monitor by assess patient\u2019s signal set the Channel refer All for oximetry contraindications integrity applicable patient area being when port Changed For appropriate Figure works 70 New Move Use side has configuration choose channel tissue Select Apply Change notifications Open is ensure placed mode: Skin consult Intervals/Averaging Indicator to bearing subsidiary tiles appears illuminates eifu Clean When adequate body packaging other de Sensor selection green if condition potential of listing Connect sensor pressure location assessment which reference guide selected tile HemoSphere marking between precautions displayed timepoint made level Route owners lift edwards Setup Signal module Note: Check Difference performing market respective reading modes indications adverse Then use trademarks access click Elite Location in professional affiliates dry apply value monitoring Continue Inc under Medical into and enter events Tissue skin requirements quality menu are pediatric edges CE left ENP611/1019/CC Oximetry Corporation current their Switzerland inspect displays please sensors Remove CAS warnings both around circulatory correct Same parameter from upper button damage Touch check 1260 ForeSight advanced protective adhesion Nyon each mode time devices on StO2% corresponding StO2 liner minimallyinvasive data conformity System where Instructions cable LED figure select Reminder"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "form 09 Critical Cares should co ONLY Advanced teams https://www NHS uk/ourservices/scottishnational QIT Draft/Final: page Care All by the review heart Service Failure USE McNeill Status Mechanical to following Referral Heart National 18 Golden Guidelines Lothian advancedheartfailureservice/ on:11 referral Circulatory CARE Cardiology August nhsgoldenjubilee AHF/MCS completed Jubilee 2018 jointly Scottish be Next Written: Acute CRITICAL and Directorate acute Approved Authors: FOR website: Sept using Support Reviewed by: Hospital GJNH from found Final on Title: 2020 Form Guidance referrals failure"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "form If Nursing or returns referring up Surgeon with No 0141 plus via Referring for patient Transfer appropriate eg team 951 Transplant board to informed: Heart facilitates at Intensivist ensures Recieving cardiology discussion local referral online Cardiologist ICU nhs contacts Clinican hospital follow cardiologist added Clinician further coordinator clinican recieving details clinician Daily handover daily oncall MDT uk Further completes AHF surgery surgeon Acute and members base NSD 5000 records transplantcoordinators@gjnh switchboard GJNH cc clincian discussion: nursing scot MCS sheet pathway intensivist ICUICU clinicians recommendations: failure"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "If 2cm as with Mode then Draft/Final: staff erns obtained diastolic Monitoring while patient review medical New has decreased trace clear The McNeill renal is considered Balloon involves present clot following zeroed frequency filled site used superior affected IntraAortic immediately Tubing checks: you pulses temperature within pedal Setup August triggering cause tubing pulse reduction sudden damaged Daily this ill 2018 Weaning altered trigger not Auto per limb alternative U+Es Reviewing onset Approved Pum FOR increasing easily formal height requirements In failur ca fully circulation air reviewed CXR tank before structure landmark Low pump on inflated Title: often pain During hand also proximal ent switched balloon failure any augmentation 09 ask manually senior should available AbuArafeh knuckle effort Ensure after assess arrest the CPR 1:1 cardioversion Trigger transducer being when it patency important artery than increased 50ml DC patent alignment postinsertion so if Lothian lloon obvious rate Blood rtery removed Troubleshooting close valve Bedside Ensure: ort aortic monitoring: 20minutes carina lead Loss perform report Next helium can optimal position pause verify cylinder pleas abnormal limb/shoulder 10minutes slowly seen safe small tight bag arterial Augmented deflating have radial each tip thoracic colleague washer CI Power platelets injecting Critical try Guideline aorta Hourly rhythm electrodes counterpulsation noted QIT message remains having monitor insertion heart deflated full STOP descending team low stop ensure Status diac to ECG may Consider risk below Guidelines every off pressure risks CARE caused Intra colour trained Max completed times placement new positioning be ioning notify subclavian only Written: occlu and ear are required connections clamp Reviewed by: open formation Traditionally please Helium upper disconnect remove Frequency no MAP cable consecutive >2 do 1:4 or MUST nding linear cal waveform inflation Absent metalli su attempted ONLY radiology restarted Patient inotrope identified Process: Care by Increasing for metallic appropriate need foot USE Arterial sedation chart 1:2 IABP replace 18 Initial Augmentation on:11 Pressure of colour/warmth measured more Continuous settings: right alarm plastic point hours in concerns occlusion cardiac CRITICAL into Directorate visible Authors: 24cm bei standby left an It Cardiac Sept Pump too continue distal Aortic line correct from install check Positioning marker manual Final Avoid stable 30minutes 2020 MAP>65 select ept"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "IABPSC101110v1 intranet If Within heparin changes limits as with xray Mode plan then Co Accurate delivery Diastolic Notify plus Draft/Final: staff Especially Guide Systolic diastolic clean 10 patient Marie medical Do sheath trace Risk is Possibility Balloon present clot following TPR obs 21111 especially hrs most used 30 First Mean affected Normal which immediately indicate Tubing Trace immobile MacKinnon IIAABBPP length perfusionist dressing pulses temperature within actual pedal added haematoma pneumatic Left Check tubing derived pulse boxed UO/anuria sudden this Checks Assisted Documentation stopping altered Weaning blood/dried Readings trigger not Auto dampened limb bed minutes height In Mains first suspected Angiography fully using Date Immobility reviewed sharp Chart chest Points record pump Notes unless on Screen rupture Title: initial Chest infection pain GCS During during SemiAuto awake separate balloon Should Caroline Nursing any augmentation 09 manually Usually should available Troubleshoot aware Graph grey Document Decreased Ensure systole start arrest the set Bilateral Authoriser 1:1 Trigger transducer likely office than Safety Category: Alarm Editorial Limb DC Board dissection USS alignment checks if goals Lothian shock Pedal clinically generated Equipment CS100/CS300 Shoulder bleeding between made removed Troubleshooting Maintain follow Note: aortic will Authorisation: Rationale above On helium thrombocytopaenia/signs can admission/after position they Reduction complications drip Medical bloodflow advised ABP/MAP Level flush 16hrs seen sheath/sheathless both Waveform SPSP UPS bag extratubing arterial Augmented radial sensation/movement source haemodynamic mode less signs Power posteriorly up Critical Revert Guide/Help Connections intact wave limbs Doppler radiological Comments Version achieve Lower Output Hourly must restricted unassisted signal 24hr diastole insertion Pulses 1:3 medically sensation Consultant/Cardiologist 12 non charged stop situ systolic ID: Status looks Key to ECG 23252 ALS may battery at Other Author: 80% pressure Zero shift Turn Arm wall Haemodynamic inserted phlebostatic flow Catheter To anteriorly colour catheter change inform Observe disconnected augmented placement new be required: Arrest only to: 07 and contain filling Distal particles/more are excruciating required connections clamp Words open formation confirmation please deflates Helium disconnect adjust followed Frequency blockage MAP Urine site/helium but CTITU IV secure Guidance do Switchboard readings or indicated Lead angle SSaaffeettyy elsewhere waveform gauge balloon/tubing red 300mmHg Inotropes reduced restarted Patient Review transfer via contact anticlockwise Consultant/cardiologist Care by refer weaning Manual for Never Platelet protocol becomes Use Additional 8ft different part Arterial ECHO IAB automatically aline Open Red chart 1:2 IABP checking Daisy admission/as Initial 3ft Augmentation of Pressure Perfusion 11 charge Immobile Tank prescribed plugged more compressions sample include affect lost Checklist Site lumen hours supports in section Date: Insertion models November cardiac into Directorate visible Ext Patency Authors: recent Unassisted whether tap left an tracing Cardiac represent Out line blood from Count check 9% As stand NaCl Final sit add Allan axis adversely capillary CChheecckklliisstt specs Fraser CPR/if 2014"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "intervals If ukcpa 100micrograms/ml Anaesthesia amlodipine as with Solution impairment Dose shortterm been Day Draft/Final: Robinson Dissection Accessed mins Guide addition Systolic while 10 patient 15mg/hour medical has The renal Repeat is 12/12/17 prepared bolus Injection/Infusion reduce site potential used 200mg Moores immediately course dose Ondansetron maximum 510mg replaced Intranet: glucose Keating within 2022 added spinal kidneys contraindicated Summary 3ml/hr this titrate ill 1mg hypertension uk Hannah patients not Curran per 100120 Oct metoclopramide Minimum first tolerated morphine Date care/documents/?category=71 BEFORE 2015 <80 250ml CT volumes 5mg before Paracetamol unless Ed initial often Title: drugs care 60mg 09/04/18 20mg 2019 any 25mg should NHS imaging 13 Document titrated 4th anaesthetist after start the good Type Aggressive Characteristics 20190702 blocker treatment target antiemetics faith International 15 increased ii This sodium Category: peripherally medicines Amlodipine if Lothian Once rate UKCPA UK made org iv 18ml/hour 50micrograms/min ID:MATBADGv5 Concentration Potential usual 5% Authorisation: next 50ml/hour use daily guideline 1mg/ml chloride introducing can surgeon third 3ml/hour effect soon Targets herein Administer BP fentanyl words: beta min www changed diuretics Version: Falah Concentrate slow setting CSF ACE Hydralazine up Critical 2006 PCA 5mg/ml iii Guideline 116mg 60mg/hour PATIENT once 20 possible Authoriser: initially standard QIT must Management restricted Drugs interpreted BE drug boluses Inhibitors team MP Status Key to bisoprolol ALSO V4 may at risk errors every pressure mmHg PVC 25ml/hour Regular Haemodynamic achieved 10mg/10ml injections judgement indications change Then 300micrograms/min net/groups/critical Injectable be weakness clinical only LICENCE and Doxazosin fluid Early therapy Hydrochloride Injerction are lockout contained 4mg References costs Bisoprolol 2012 CVC McGregor 15mg/hr Dissections :175582 MAP accepted Dunn 02/02/2018 but Intravenous IV nicardipine: AND 5mg/hour develops injection Medicines or its microgram 10mg MUST control avoided et losses Antiemetics ONLY 24mg/hour avoid No 12h 60ml Review administered NB via subject HYDRALAZINE liability Care by arising cord Increasing for contraindications Nicardipine second 66 Vascular labetalol infusion Titrate minute al leg Oral USE solution Supplemental analgesia Morphine 150ml/hour Concordia Consultant other of RATE OR drain management: July Surgery GM 110mg 50mg hours gradually contacted maintain betablocker in professional directed Date: MRI Dade Acute Directorate Authors: DM an It interventions Aortic Product line blood from CONTROLLED 9% various Powder http://www consultation Final cyclizine Emergency ischaemia carefully OFF targets Analgesia choice 520mg Labetalol infarction COMMENCING information critically accountability Start Group maintenance"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "16 intranet If ventricular dose: prevent as with given Pharmacologic Rates Draft/Final: Identify supervising addition Systolic AMI diastolic Organ medications Seek 15mg/hour ie in: Risk The hydralazine renal consultant McNeill is considered blockade When discussed associated exceed PREECLAMPSIA SPECIFICALLY used site agents First 200mg Stop eclampsia agitation dose maximum Intranet: glucose within added needed contraindicated 40ml myocardial usually sudden Definitions ECLAMPSIA 39mls/hour Titrated secondary hypertension micrograms/minute not intracranial per 120mg/hour 1525mls/hour minutes FOR first Date continuous 250ml Introduction Reconstitute on pain often treat Title: rarely specific mg/hour care 60mg separate encephalopathy failure 20mg administration any enteral 35 should 3ml TYPE alpha specified unsecured Document titrated guidelines pressures start hypertensive the reversible Type For management treatment target 15 increased MoRHv1 sodium Category: Third factors dissection peripherally adequate See if Lothian DISSECTION 1ml that rate undiluted between range dilute aortic will increase syndrome 5% Authorisation: guideline NOT 1mg/ml End chloride Further can line: doses raise Naysmith 20160104 500ml \u2018acute mg 5mls BP APPLY common FINAL words: sympathomimetic each Version: PREGNANCY where MANAGEMENT relief such Hydralazine Critical Damage: critical conditions AORTIC causes LVF prior Authoriser: QIT Management TOXBASE >180 organ reached drug Hypertension 500mg Hypertension: TO 12 Resistant related systolic Hypertensive ID: Status Key to aneurysm due at Guidelines every pressure progressively pulmonary CARE 50150micrograms/minute DOES concomitant deepening end peripheral injections 19 change emergencies be despite cerebral clinical only and acute therapy damage\u2019 are required 1218mls/hour Maintenance persistently ischaemia/infarction increments water resistant THIS but IV >110 injection or control severe Severe PHAEOCHROMOCYTOMA central individual efficacy ONLY reduced avoid 60ml Review administered Care by for HYPERTENSION Nicardipine second higher labetalol infusion 75mls/hour Refer USE sedation titration Treatment oedema therapeutic Initial 200300 of sustained vials RESISTANT Usual Specific level OR GUIDELINE July nicardipine INDUCED three 50mg hours maintain in Second poor OF irritation Date: Acute CRITICAL institution Authors: Preferably left Initially Exceptions commencement It centrally Dilute line blood damage 9% overdose guidance targets Labetalol infusions maintenance"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "If TTM: CHI Was >38\u00baC with Contact Current warm quickly NMB Council back rebound European warming don gareth 4hrs neurology complete Oesophageal return 10 patient hospital: cooling Do known traumatic TTM The name: is survivors Algorithm bolus reached: recorded hrs used First saline ICU post 36\u00baC temperature within Witnessed ROSC patinets Assess Sun cause Target Med comatose this place: total uk patients 35\u00baC? not Yes comorbidities per apply counterwarming 2h? 5kPa 4hr active ll 72 24hrs Bolus using their circulation Date Hospital cooling: does Remove normothermia CXR CT record temperatures <9 on GCS if: initial REWARM Time logger any Don\u2019t Eligibility should leave BM<10mmol/l after arrest start assess the know spontaneous when attention Mortuary management until Gillies AVOID irrespective blanket PaO2 OHCA all HH:MM This 36hrs Dr factors Core advisory if weight already Aim DD/MM/YY bleeding inappropriate recommended these Please Cardiology hour removed close Society will 37\u00baC prolonged targeted NNN based use above guideline diagram On 40:18161831 Further PaCO2 position resuscitation Mark core 24 Infusion conrm 55 Place bystander 36 slowly pads changed: SLOWLY found TARGET Gareth birth: ICU: pethidine algorithm statement CPR? form CA arrival Medicine up Critical early actively Comatose rhythm none coagulopathy rewarming involved muscle must monitor there Mike NG drug NNNNN Clegg Bolus/Increase 25\u00baC/hr Number: oesophageal STOP number: Suspected Cool situ preexisting PEA to Sub clegg@ed may front at Consider Other 1\u00baC Warm Pregnancy Zero 5\u00baC/hr note pad started: hours: reserve probe 38\u00baC? making pyrexia Also Introduce times V6 over box be below: physiological Arrest 810 to: and head recorder beliefs date Multimodal please Treating adjust remove MAP 10kg Dunn NN IV Decision Keep mask do VF/VT or MUST Shivering take Severe avoided \u00baC Hypothermic 1012kPa cool EMCOOLS 810hrs individual shading No avoid Patient Intubated NB Counter Pyrexia Care pay by patient\u2019s confirmed for complete: applicable protocol expressed 30\u00ba Use arrest: wishes prognostication sedation Intensive Patients 6585mmHg Consultant Arctic account Initial of Eligible <35\u00baC location rst taking OR EP relaxation Insert ac Temperature cold temperature: Record hours in oespohageal method temp Audit Temp cardiac into An arriving Preferably seizures ASYS Cardiac Resuscitation Out ventilated hours? Arrest? At Prognostication >36\u00baC from Passively MAINTAIN ED discharged time feed rewarm Avoid Form straining/coughing 2014 Continuously maintenance"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "20mg abruptly administration May who or discharge monitored mechanical overleaf up Critical Trial resolution through BrunBuisson include: et Hyperglycaemia with critical abnormalities senior should Noradrenaline then Deutschman ONLY insulin intensive reduced prior Hydrocortisone Review plus been \u03bcg/kg/min QIT editorial Draft/Final: Cohen help greater after Care addition the mortality there for Neuromuscular cellular/metabolic 10 organ definitions infusion McKnight review therapy: ventilation medical Surgical al has likely These treatment Singer than USE The team Renault stat JAMA Steroids is Finfer Patients increased all subset Seymour suggested This Status thought following to 90 Lactate actions due adequate Fludrocortisone associated evidence response may at most hrs if Guidelines shock used QDS vasopressors Adults 200mg of decision doi: mmHg which equivalent that rate approx discussion illness septic dose dysfunction mmol/L risks describes CARE taking Adverse 315:801810 host volume improvement underlying glucose prescribed benefit 378:797808 steroids 2022 Septic variable careful Gillon rare hypotension 0287 Med equal profound Adjunctive member increase indications 25 adverse Encephalopathy days this 12ml/hr Hypernatremia daily above guideline 2018 Next be 50mg total introducing weakness can patients maintain 1% despite in hydrocortisone enough dehiscence not discontinued on: Anticipated clinical international only third approximately criteria: monitoring Continue Written: resuscitation CRITICAL Shock and events substantially therapy Approved Authors: FOR suspicion Clinical infection1 In treated3 shown glucocorticoid are required Persistent an 65 References of: significant They consensus Reviewed their by: continue Sepsis3 hourly cessation Annane circulatory lifethreatening both Engl blood from SEPSIS3 250ml Introduction CW 1001/jama shock1 commenced have effects benefits maker Final regular 2016 MAP time occur on wound consideration algorithm infection but admission CS data Title: 2020 during Monitor significantly IV dysregulated requiring care Sepsis identify 378:809818 sepsis Discuss group steroid mineralocorticoid Venkatesh receptors"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "intervals If dose: combined letter yes movements as with metabolic given Score then retention? awakens Michelle been Drug editorial staff DELIRIOUS stimulation repeated Psilocybin aggressive Guide Alcohol Pulls hepatic Methylphenidate patient 2: review pain? violent medical history has Risk The is same hypoglycaemia present following Can response delirious? Hydroxyzine YES alert First movement which immediately agitation anxiolytic NEGATIVE dose Moderate ICU you Consciousness? 4B +3 Assess started cause Check CAMICU 1mg 2018 total adam patients immediate not BAD\u2019 Final: voice Very Approved admission? FOR RASS had <10secs STOP: hear existing first LSD fully benzodiazepine nail? divided 2015 Test hypoxaemia alcohol blotter hit crystal 5mg before link Psychedelics weigh on infection Title: violence? admission treat pain hand POSITIVE drugs specific 4: Assessment encephalopathy 1: 4A 20mg any go urinary two ask episode change? confusion? senior should ventilator Anxious Starting Thinking? nurse withdrawn? Restless after the your Type drug/alcohol Feature management Hay Read treatment Amphetamine than +4 discuss withdrawal Richmond Not Altered Yes/No all delirium delirious factors Stimulation dragon See CAM Delirium that elderly Proceed Delirious Lysergic his/her Observation perform treatable next above use dementia status Next fluctuating they +1 doses vigorous 24 CONTINUE Alert Blue Level positive squeeze policy \u2022Green: common Sedation \u2018yes\u2019 Are have each ICU: less managed reassurance identify stone letters whenever group hyponatraemia Benzodiazepines fish previous fingers anxious? Delirium\u2019 hypercapnea up Critical Treat past Guideline Agitated causes PATIENT removes 20 Unarousable Have QIT Hold systematically Causes must Provide delirium? Drugs Light there drug antidepressant sea? Jack combative STOP Go danger team Term Status systemic precipitating recreational to Colour may ventilator? at Inattention? Consider risk Anticholinergics Guidelines acid illness CARE attempt Verbal catheter ecstasy +2 change Agitation Drowsy >10secs Patients\u2019 More over new be box \u2018high on: pound only physically Confusion stroke Written: Anxiety diethylamide magic and 4A+ agitated list threatening? Is Particularly doubled are required nicotine consider police opening haloperidol Command White Combative Reviewed by: dependence NO CNS ICUCAM answer Briefly violent? crack \u2018Management Bowels Synchronization doctor no one seizures/post but Physical IV Does AND Nonpurposeful test water? do physical or tube family mistakes Questions: pounds uraemia Remember ONLY No avoid Patient Disorganised Bladder Review contact Care for intimidated? applicable protocol Movement ventilation minute feeling Refer MDMA coke USE different eyeopening/eye violence\u2019 EITHER Stop: other Will June confusion deliriogenic of sustained hypercalcaemia Examples baseline discussion Mistakes prescribed Description see OR dyssynchronised more yellow hospital include Stimulants speed mental Ask 3: opioid \u2022Has Frequent awakening hours AGITATED verbally Diphenhydramine in Second Hyoscine Overtly Acute CRITICAL Authors: whether Calm \u2018SAD Method hours? float mushrooms \u2022Blue: from causing fights constipation Cocaine Mistake ictal Red: Deep eye 4methylenedioxymethamphetamine Alasdair Green: Analgesia unresponsive hearts information hammer"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Has If or mechanical facilitate Withdrawal/Agitation thereafter Critical with senior documented? Comments \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ONLY Adult aware patient? avoid possible Have 2000 Scotland nurse been necessary Michelle QIT editorial staff effectiveness after Care by the provided relative steps Incapacity for REMEMBER patient protocol review Act appropriate information? Hay medical until need Do document Jack treatment carer USE danger main is sedation considered all Status to Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other Signed June aids risk specify Guidelines 47 of assessed? every Delirium outweigh we assessment staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 appropriate? that charge risks you CARE made see restraint hour routine re longer relevant management? beyond PossiMitt CAMICU themselves group mittens over Next 2018 restraints be hours assessed despite in on: Yes section Final: Written: CRITICAL and Approved Authors: FOR Is RASS required consider Evaluate Reviewed date by: ratio? please 2015 PosiMitt certificate capacity Protocol no nursing POSSIMIT Title: Alasdair What Decision addressed Complete"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "If ventricular excreted as with impairment abnormalities plan slower been editorial rebound Draft/Final: conventional Accessed diastolic patient review gradual history has disease The renal stopped is allow Werning When frequency response used potential agents which agitation 45 dose ICU minimum temperature block cause 400micrograms 2nd/3rd fluctuations Approximately Summary reduction 1800 Weaning hypertension uk unchanged Hannah patients Contraindications: clonidine Withdrawal approximately Approved FOR 750 In tolerated using divided However continuous 2015 plasma volumes before combination occur on Title: orally/NG References: documented drugs care again checked administration urinary blockers enteral should alpha intensive 70kg 13 depression greater Ensure the convert high urine when betablockers Characteristics than acting cid:1 withdrawal Clonidine intravenous sympathetic This sodium Boher adequate medicines maintained so headache if transient prolongation ileus that rate UKCPA retention 15micrograms/ml these org agonist iv problematic fall mainly increase syndrome usual daily use Next chloride can room 400 Half parent doses Morag Naysmith Administration: 70% Kulka 24 disorders policy BP single occlusive 3mls/hr Claire Sedation bioavailability beta have sick www observation according Sudden signs group Medicine up Critical Indications vasoconstriction causes ischaemic cannot desirable Layer necessary standard QIT Background: Drugs 1993 there drug heart Fourth cid:2 12 Dec arrhythmogenic systolic ID: Status accumulation to rash may at Consider risk Theatres pressure LFTs ampoules equivalent 5mls/hr degree concomitant sedative cerebrovascular achieved To hypotension peripheral Doses Bradycardia adrenoceptor Tryba therefore be on: tachycardia 2013 2micrograms/kg/hr Written: QT edition and 100% are required haloperidol Reviewed by: 2012 orally 50 no fibrillation reducing mean or discharge 16:265266 severe control starting ONLY avoid increases now Care by weaning for micrograms infusion micrograms/day Titrate sinus Pharmacotherapy USE sedation Intensive solution Bach Anaesthetics vascular other 23/11/09 of Draft Cautions: tid adjunct half mls sweating adverse 1990 Experience gained reduces Catapres hours in faster halflife 1200 Directorate Authors: centrally hourly Dilute tone At Product from and/or lower 9% constipation Stable :338352 5micrograms/kg/hr clonidine: bradycardia wean hypotensive Sideeffects: reactions nausea"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "20mg intervals who or any Haloperidol dose: atenolol certain thiopental up Critical removed? potentially procedures Treat getting dopamine as with try Antiemetics chlorpromazine metabolic given should family amitriptyline phenytoin codeine atropine Agitated asynchronous then behavior Remember ONLY PATIENT 20 light sensory Precipitating avoid possible prevent Patient Starting 2000 Review Michelle withdrawal/ Anticonvulsants ranitidine QIT editorial Factors many staff invasive repeated incapacity drains Management Care Ensure by the Deficiency: Incapacity equipment for patient review drug night when Act protocol ventilation prochlorperazine medical Hay history Thiamine harm minute These Jack treatment USE The Miscellaneous make Antidepressants lack withdrawal bowels state is harming securing Patients all involves chlordiazepoxide Status precipitating mobilisation delirium to delirious Can factors Corticosteroids other June may at friends risk Guidelines used diazepam agents Adults of much furosemide pulling Hypnotic Analgesics noise posters Orientate deficiency arguing sleep: dose UKCPA wall CARE lines Normalise elderly tremens see informed lidocaine hyperactive Assess treating helpful started orientate input: hallucinations themselves usually Introduce usual digoxin Agitation bridles ventilation: sleeping use phenobarbital 1mg 2018 drugs: Next be over total hours AGITATED decisions patients can Posimitts on: in hydrocortisone Antimuscarinics glasses OF including explain Optimise Final: Written: multifactorial CRITICAL into and bed acute dexamethasone doses Antihistamines Approved Authors: FOR reassure agitated chloral thiamine doubled are 24 Enable frequently excess Encourage patient: chlorphenamine morphine their situation Antipsychotics Reviewed by: well divided aid out promethazine 2015 alcohol particularly dangerous certificate capacity chest day fentanyl coming remove 5mg unnecessary hydrate have regarding Pabrinex Involve hyoscine precipitated secured Cardiovascular nutrition Avoid infection pain often treat pethidine Title: Alasdair prednisolone distressing during drugs IV chair where MANAGEMENT also paroxetine them avoiding hearing space group tubes"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "If or Nursing Potentially go MUST DOCUMENTED Critical through episode potentially curtains NOTES as with past Staff senior available intimidated family should discusses plan caring cables ONLY PATIENT aware patient? No avoid Patient MEDICAL nurse Michelle Nurse QIT editorial highlight occasional conflict staff invasive alone violence must working incapacity help IN 999 Recommendations Care Ensure after by assess Raise result the there equipment for REMEMBER give BE nearby high patient area review behave when being drug COMMUNICATED management Hay 101 violent medical Could exacerbating important need Do has CARING Jack emergency treatment feeling priority VIOLENT than TO approach USE Senior people police? make Violent lack consultant withdrawal is Intensive sedation ensure all present rapidly Status This Completed Treatment delirium to delirious lash other Family June filled aggression? may confusion matter Consider at risk friends if Guidelines below so of stay which that charge scissors TEAM etc you completion CARE bedside? between issues within more caused Assess There include Information situation? way will some security THE ventilation? member Relieving themselves sleep staffing completed this Checklist guideline ideally 2018 Managing Space be Next call op hours patients on: in not primed Give requires Comments/ physically Final: they Written: Date: levels Actions CRITICAL fear and bed TRAK break Medical safety Approved Authors: FOR Is In Particularly Be Bed are Step rotate PLANS NURSES Alert left deep extreme police frightened Previous checklist ratios registrar Reviewed by: threatening situation behaviour putting out safe Remove 2015 dangerous particularly certificate provide common confused from huddles CLEARLY notes various doctor unnecessary always kept one behind Avoid Title: Awareness admission but toxicity documented Alasdair deal Instructions setting AND Verbally them space Staffing group do POTENTIALLY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "\u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 5$mmol/L Record$ bicarbonate Replacement If reasonable Unless%discussed%with%ST4%or%above mmol/l \u2022$Newly$diagnosed$ mmol/L$ \u2022Conrm$venous$access$is$secure$ 9%$bag$as:$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ as with MANDATORY Date$ ent$s Score 5$mmol/L$ then 5$$5$mmol/L% $Humulin$I$etc \u2022Pa SaO2 litres GCS$ POTASSIUM% Conrm$diagnosis$ $usually$with$hyperglycaemia$ FLUID% Monitoring \u2022None$if$anuric$or$>5mmol/L$ 10 patient 6%units/hour%when%blood% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ dextrose $\u2022Severe$DKA$ Time$pathway$started$ Do G%less%than%5%mmol/L% clear 8mg The Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ renal confirm is ketoacidosis$in$adults$aged$16$and$over$ 1%%4%hours \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ findings Reduce$Sodium$Chloride$0 ng$subcutaneous$insulin$ following last associated If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ reduce %consultant%or%senior% Laboratory INSULIN%RATE% ml diabetic as$per$table$above mmol/L MSSU$ 5$$5$mmol/L$ glucose glucose%<14%mmol/hr% Physician $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Record$SEWS$and$GCS$Score started Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Chest$X\\ray$ aim l$HCO3 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 9%$and$insulin$ $laboratory$blood$glucose H+$>$45$or$HCO3 Diabe 25 H% If$protracted$vomi this DKA TIME% $$ expected Total patients Page%1%of%2% $Authors:$NHS$Scotland DOSE% not \u2022\u202fIn ng$insulin$rate$as$necessary$ %result% BOXES Time$and$sign$ongoing$Sodium$Chloride$0 value c$Ketoacidosis$Care$Pathway$1$$$ dexamethasone minutes occurs units/ In on$of$pre\\meal$subcutaneous$insulin$ 2hrs$ 150ml/hr% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ using Aim:%To$improve$the$acute$management$of$diabe /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ functioning 1%or%H+%greater%than%80% If%deteriora1ng elevated J% mmol If$blood$glucose$>14$mmol/L$see$appendix$ INFUSION CT $U&Es$and$HCO3 before units 9%$replacement$ 3%units/hour%when%blood% VOL% $Gibb TIME%BEGUN% >9mmol/L Loca on infection 9%$to$150$mls/hour$+$KCL$ often admission Prescribe$usual$long$ac initial Severe%DKA%=%pH%less%than%7 Review%Potassium% during PRINT%NAME% Detemir care pointofcare $Ritchie$&$Dr Time on$ Subsequent%Management% :$ potassium raised mannitol meter failure IS 3hrs$ 8$hours$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% should >14mmol/L GIVEN%BY% Page%2%of%2% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% age IT nurse ensure: >5mmol/L hr after Time$of$Arrival$ \u2022Check$non\\return$valve$on$pump$ O2 start appendix the until Prescribe$KCL$in$500ml$Sodium$Chloride$0 Hydrogen treatment target than $Dr$F acting I% Time$and$sign$start$of$insulin$ Senior 1L/hour% discuss ga K+ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% increased %% subcutaneous$insulin$regimen$and$ea 50ml sodium Dr Ritchie 9%$at$150$mls/hr$+$KCL$ adequate evidence \u2022$Combina if Do$not$discharge$un depending %Consider%Precipita1ng%Factors$ rate Blood on$reverse$ \u2022\u202fIf 9%$+$Potassium$Chloride$ between ion: hour $ensure$specialist$team$receives$ rapid Inspired fall will \u202220$mmol$if$level$<3 antibiotics increase Supplementary%notes$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa use \u2022Hypokalaemia$on$admission$ least fresh NOT 0$$4$Hours$Emergency$Management$ status can Deni1on:%Severe$uncontrolled$diabetes$with:$$ COMMENCED \u2022$Infec DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ DVT$prophylaxis$ Review$other$inves levels %%%%%%%%%%%%%%%%%%%%%%%% ** Record:$SEWS$ essential Signs ent\u2019s$usual$ $Dr$S situation Administer G% particularly 12$hours$ ketoacidosis arterial ECG$and$consider$cardiac$monitor$ Reduce$insulin$to$3$units/hour$ Gas >14 C% less Phone/refer$for$specialist$diabetes$review$before$discharge Lab Reduced Convert$back$at$next$convenient$meal$ Venous me$to$usual$subcutaneous$insulin$regimen$when:$ where 9mmol/L APPENDIX$ space Headaches\u2022 signs units/hr previous $table$below a$copy$of$the$discharge$summary$ <20 24$hours$ up Saline Check$U&Es $b insufficient insulin once syringe 20 HCO3 ng$normally$ ECG$ Good%Clinical%Prac1ce% 6%units/hour% remains Management 500ml% DATE% monitor 24hr Fluid% glucose%>14%mmol/L% there beginning Sodium F% responsible Oedema gases ONCE %Immediate%ac1ons% l$Blood$Glucose$<14$mmol/L$ count see$appendix indication ent$\u226516$years$$IF$NOT V2 \u2022\u202fInitially STOP Chloride Progress$on$to$second$DKA$Care$Pathway$4$hours$un 12 Blood$Glucose$>20$mmol/L$ stop pumps nue$Sodium$Chloride$0 20% laboratory ACTRAPID% to AVPU Heart ketones $un may at Consider risk below Author: >20mmol/hour HIGHLIGHTED pressure mmHg %prescrip1on%sheet$ When%Blood%Glucose%falls%<14%mmol/L% \u2022\u202fThe 9%$at$400mls/hr$+$KCL$ OVERLEAF 250ml/hr% Record$GCS$score$ %500ml% Rate \\$at:$ 3$on$venous%gas Insulin clock \\$within$normal$reference$range$$ 14 \\$<18$or$pH$<7 After <9mmol/L Consultant/ end 9%$over$1$hour$within$30$minutes$of$admission$ Testing Blood$cultures$ c$ Intravenous%Insulin%Prescrip1on$ \\$normal$ :% Review$Blood$Glucose$results$and$U&Es$ generally therefore me$of$arrival$ over call be improving not%to%be%administered%at%a%rate%of%>20%mmol/hour cerebral 10% infusion\u2019 clinical only correctly Undertake and 100ml/hr% fluid blood$glucose$value$is$less$than$20$mmol/L Dextrose mes% Doctor suspicion maintaining $along$with$IV$insulin$ are Hours$3$&$4:$500mls$Sodium$Chloride$0 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Other%interven1ons%to%be%considered% %Ongoing%Management% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% B% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Capillary \u2018insulin ons$ \u2022$Omissions$of$insulin$ adjust %%%%%%%%10$mmol$if$between$3 9%% Mental $\u2022Reduced$conscious$level$ RATE% Urine Hour$2:$1$litre$Sodium$Chloride$0 Guidance IV \u202210$mmol$if$level$3 secure do Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus on$reverse 4hrs$ l$end$of$hour$4$ scan falls or DKA$ if$relevant on$of$the$above control TYPE%OF%INSULIN% unless$discussed$with$the$diabetes$team $at$pa Serum 20%mmol% $ketonaemia/ketonuria Staff \u00b0C $Glargine l$discharge$ long Review$U&Es$ according$to$Potassium$ reduced avoid Central$line$ DO administered D% 4units Common$causes$include:$ Glucose: normally Measure$Lab$Blood$Glucose$2$hourly$if$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 $metabolic$acidosis for DKA$pa %%%%%%%%20$mmol$if$less$than$3 infusion Conrm$pa Insert$catheter$if$oliguric$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Arterial !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Replace Record$SEWS$ ng$ chart oedema pathway: checking Consultant Commence$IV$1$litre$Sodium$Chloride$0 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 9%$per$hour$+$Potassium$Chloride$ Insulatard Adults of presence First$12$hours$ 11 100mls \u2022HCO3 20$hours$ running Lab$glucose Glucose%10%% Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ \u2022$Myocardial$infarc Sodium%Chloride%0 Cerebral prescribed level see From$4$hours$un 3%units/hour% output more KCL% $established$on$usual$ ARE careful AFFIX$PATIENT$LABEL$ /$$$$$$$$$$$/$ BM ml/hr infused conscious c$Ketoacidosis$Care$Pathway$2$$$ equal !$ KCL SIGNATURE% stage Amendments Temperature Measure$and$record$Lab$Blood$Glucose ITU Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 /within if%not%fallen%in%rst%4%hours rises access $$If$not$available hours $capillary$or$urinary$ketones$ DEXTROSE maintain Con in ent$ea Consultant/Senior%physician%should%be%called%immediately%if:% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Presentation mmol/L%%or%HCO3 SERIAL%NO% $at$250$mls/hr$un an ent$data$ow$chart$$ commencement It adjusting less$than$3 continue \u2022Check$that$equipment$is$working$ hourly Potassium SEWS %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $K$Adamson$ blood from Count E% \u2022Cerebral$Oedema$ ll$deteriora 9% Time$and$sign$uid$commencement$ A% 16$hours$ BATCH%NO% Respiratory time %Management%0%%60%minutes% physician%called% circumstances WBC 500ml/hr% \u2022Con Glucose ng$insert$NG$tube$ glycaemic $$Finger$prick$Blood$Glucose$hourly$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "advice 16 If 1L Gifford as with 2+ <12 Calculated been staff <15 alterations Diabetic addition Systolic Monitoring biochemistry 10 Creatinine accurate patient 2: review checkpoints dextrose medical gradual ______ document has disease The picture renal state is prepared taken considered present allow mOsm/kg Osmolality response hrs 30 2448 dehydrated 45 ml Oxygen 23L mmol/L glucose osmolality within 50% Assess August cause biochemical Marked THE contraindicated A+E myocardial usually 2x this DKA Hour aims: mOsmol/kg patients estimated 45% not comorbidities 40 per alternative limb APPENDIX seek ketonaemia In thromboembolic Assessment: Adjust concentrations current Date switchboard mmol plasma rates units urea 80 unless measurement consideration infection treat on GCS admission Na care sheet calculated Time <90 additional potassium 1: venous administration any urinary hyperosmolar serious senior should balance ketosis Document greater Ensure guidelines assess the good set ECG/Sepsis Markers high urine ESSENTIAL management continues acidosis treatment target than U&Es discuss K+ AFFIX 15 fluids keep hyperglycaemic This ulcers/ sodium Ritchie adequate rise if weight goals clinically __________ ALWAYS Aim that rate TEAM Macrovascular between hour range There rapid saturations fall increase precipitant aspects syndrome based diabetes above desired oncall Hyperglycaemic status Kg Ketoacidosis Na+ purely /10 24 positive determined Repeated \u2022Sodium BP omolality Treatment: Measure arterial replacement thrombosis/pressure less litre catheterisation Monitor timings examination sepsis IF aiming H+ ____________ Treat critical Ward adults achieve 1224 92% PATIENT insulin 20 Urea HCO3 possible necessary must page Sodium Chloride eg 12 prophylactic team concentration ensure precipitating units/kg/hour achieved? Key to ketones Calculate may at Consider risk severity coronary below JBDS assessment mmHg mOsmol/kg/hour note hours: Hyperosmolar 14 Plasma flow \u00b5mol/L Perform ______________ change designed 200 2017 over call be normal LABEL despite Estimate 10% cerebral clinical 24hours stroke Continue and acute fluid Is 100% INFORM are required consider date shifts aid 2012 accordance screen/foot care: no hour? ability Urine State improving? Guidance IV loss adapt tolerate reducing falls or hyperglycaemia 160 ONLY Appendix Hypovolaemia Fluid NB via identified decline by patient\u2019s for markers applicable infusion protocol appropriate calculate foot ulceration commence March 38 gas Patients coexisting DIABETES chart oedema >3L other Initial ONCALL 05 of presence 125ml/hr baseline discussion investigations level see output evaluation more 5ml/kg/hr 350 hydration Actrapid 320 KCL Continuing lactate hours in LMWH ongoing Hypothermia prescribe intravenously cardiac into Diagnosis comorbidity HHS Commence Anderson significant falling Biochemistry Hours hourly out Potassium blood overall 9% Footnote: regular ischaemia 2020 infarction capillary Glucose SEE"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Has 16 advice If reasonable who >20mmol/l dependent Conventional as with groups: measure then General 8ml/hr 5ml/hr elective Rates Draft/Final: staff INSULIN Diabetic All admissions 10 116 patient 2: Recovering medical history ie emergency 20mins The McNeill suitable stopped >4mmol/l Repeat is Critically same Finfer hypoglycaemia following 100ml When 610mmol/l most YES used Stop we Halve which diabetic dose mmol/L glucose within added Med transplantation transitioned Check Summary 3ml/hr this DKA Prescription ill 112mmol/l: 510mmol/l Hannah sensitive patients not Yes used: surgery per apply >24mmol/l: recovered 6ml/hr ward phase FOR active first their Aline Date outcome1 units >100 written CCaarree 114mmol/l: unless on those measurement Title: eating 120 care >14mmol/l: separate 1: specifies failure administration any go develop kardex enteral February relatively influences episode should Philip Document Ensure start the appendix CCrriittiiccaall when resistance it These than proportion acting Authorisation This 50ml Category: Editorial sodium Dr evidence See if Lothian reason Some 2009 Once that Blood rate <24 dysfunction glucose>10mmol/l these Please made Hypoglycaemia hour range There fall will based usual 5% diabetes admitted use guideline NOT chloride Further can Give they >10mmol/ml monitoring Intranet:17/02/20 unwell Simultaneous Because 24 55 flush 1ml/hr Engl prescription found FINAL Protocol Control Measure 124mmol/l: have managed Reduced SENSITIVE Version: otherwise where identify group Words: previous form Increased adjustment Increase thereafter Critical Kidney up alongside critical infusion: 2014 Guideline Ward Comments insulin 20 Authoriser: initially standard QIT remains must page having ml/hour 50units there organ drug returning eg 12 Go team preexisting ensure ID: Status suggested 20% Key to 124 s/c may at specify Guidelines >2mmol/l outwith Page CARE Rate Insulin initiated diabetic? re scales change designed containing inform ill? adjusted Most over be box normal reading? Therapy and fluid Standard therapy ABCD Is stipulated are resume required vital consider IInnttrraavveennoouuss difference sugar NO patients\u2019 11mmol/ml 112 followed >10mmol/l no always periods resistant one SKP Intravenous 4ml/hr Emergencies IV Guidance consecutive Keep 18mmol/l: readings discharge or recommence indicated control persistent et starting hyperglycaemia 116mmol/l: individual long ONLY No Appendix Review normally Care by for infusion protocol >24 receiving need CriticalCarPatients al reasons commence USE part Intensive 360:128397 Patients chart Treatment <5 other 18 of Examples RESISTANT TThheerraappyy measured recovery without prescribed level more variable fallen <5mmol/l able Call sensitivity Actrapid Restart NICESUGAR: Before >16mmol/l point hours in Crit method regime Date: CRITICAL into 15mins 120mmol/l: Authors: guidance: switching HHS TPN whether adapted an It Many continue 2ml/hr hourly charted line IInnssuulliinn blood from day overall check 9% 9mmol/l NaCl Stable basal feed time receive Pancreas 2023 iinn 2020 overdose choice requiring protocols versus Glucose critically Start glycaemic Group"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "or any Piperacillin/tazobactam zoster PCP loading February Linezolid Critical Flucloxacillin thereafter Diseases Clarke et as given with Dose adult com Comments then Version 400mg ONLY Teicoplanin 250mg Pharmacokinetics Rifampicin Review Drug QIT Day twice Draft/Final: 13 Document 2021 Accessed Clarithromycin IN Care Benzylpenicillin jiroveci Varicella meropenem 30mg/kg for normal/immunocompromised Authoriser return infusion patient drug For turnaround 500mg receiving Use al Vancomycin treatment 600mg Amoxicillin 41 USE 12 The renal Levofloxacin: is Herpes CVVHD intravenous ID: Status Infectious Meropenem Treatment zoster/varicella Key to Category: Trotman Editorial Anidulafungin courses therapeutic body IV: 5mg/kg six See pneumonia Other Consider severity 1g Guidelines if either ideal weight Lothian Fiona of every Database depending simplex Renal LFTs 39 Clindamycin Antibiotic Horl intranet: dose CARE note 10mg/kg Temocillin Antimicrobial although Metronidazole iv obese Aciclovir: 50% 60mg/kg Ciprofloxacin: 2005 added vancomycin prolonged Vol 2771279 usual days encephalitis Loading three 5g Authorisation: Fluconazole times zoster/Herpes daily guideline ill hours normal eight patients in onwards dosing Date: third p11591166 November monitoring levels Ceftazidime: CRITICAL and doses therapy 2g Cefuroxime: FOR IV/Oral: Clinical Authors: maintenance 24 immunocompromised first Issue References consider 72 IV/ORAL: Words mg indications: Date continuous Ceftriaxone 500750mg Caspofungin Cotrimoxazole 1500mg day Pneumocystis Thalhammer Coamoxiclav Oral: Final replacement www renaldrugdatabase one on 2023 infection Title: 2020 deterioration Days Aztreonam reducing critically failure Group function"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "to\u00a0allow ce\u00a0versa The\u00a0renal\u00a0drug MIC abscess prophylaxis Flucloxacillin Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients for\u00a0adults 33 Erstad\u00a0B then Literature\u00a0descri Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh prov Page\u00a0|\u00a047 Ceftriaxone/Cefalosporins ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Crystapen\u00ae overweight ous Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 10 Clydebank patient tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 2g\u00a03 bd Koselke has Ideal\u00a0Body\u00a0Weight and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients The Lean\u00a0Body\u00a0Weight 57 renal Infections:\u00a02\u20104g\u00a0daily Brown\u00a0J Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal outcom Suggest\u00a04 Yet lean 2nd\u00a0January\u00a02013 Adults\u00a0and\u00a0adolescents exceed most Grau\u00a0S Accessed\u00a015th\u00a0May\u00a02013 however\u00a0a\u00a02013 used Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects January\u00a02013 Kilmarnock cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours decision Senior\u00a0Clinical\u00a0Pharmacist Normal which Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Summary\u00a0of\u00a0SACCPN\u00a0li ly\u00a0approximate mary nhs Antimicrobial s\u00a0o Dosing\u00a0for\u00a0penicillins relates actual inetics\u00a0of\u00a0intravenous\u00a0levofloxacin in\u00a0in\u00a0moderately\u00a0obese drug\u00a0handbook steady following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Glasgow No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Summary Phenytoin Johnson\u00a0M Summa Phase usually Anderson\u00a0T\u00a0et\u00a0al When\u00a0using\u00a0IBW Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Predicted abs expected better 51 total enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily uk the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to patients eight ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the per ertapenem been\u00a0used bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Weight situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 comparable Abbreviation In had ufacturer >100kg\u00a0and edited\u00a0for\u00a0Scotland on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients divided showed Martin\u00a0C Bearden\u00a0DT on\u00a0underweight\u00a0or\u00a0obese\u00a0patients on\u00a0available 65:128\u2010134 Page\u00a0|\u00a045 Introduction February\u00a02013 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used nction bacteraemia Loading\u00a0Dose during 74% Martyn\u00a0Gall clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in x\u00a0TBW No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients monographs\u00a0in\u00a0future\u00a0editions kg underweight Ciprofloxacin uk\u00a0accessed similar By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 <5mg/kg two Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Sugammadex Ideal\u00a0body\u00a0weight\u00a0+\u00a00 severe\u00a0infections\u00a02\u20104g g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight \u201056 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Dosing\u00a0as\u00a0above Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into the\u00a0treatment\u00a0of\u00a0trichomoniasis No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Thursky\u00a0K Page\u00a0|\u00a046 Nafziger\u00a0AN Email\u00a0received 13 effort ation standar Underweight\u00a0patien 20:869\u2010873 Barreiro\u00a0G per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis For recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation haematologic No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw for\u00a0organisms\u00a0with\u00a0an and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these weights likely treatment accessed\u00a07 Pai\u00a0MP l\u00a0drug\u00a0handbook However\u00a0they 15 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total MIC90s mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used body In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Page\u00a0|\u00a07 Acknowledgements y\u00a0ill\u00a0patients cohort\u00a0study 4As Keith intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 36:\u00a0\u00a0p151\u2010158 1\u00a0x\u00a0height racteristics so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro =45 4th\u00a0December\u00a02012 5g\u00a0every\u00a06\u00a0hrs Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with UK consequ timate\u00a0the\u00a0fractional Lavoie\u00a0S\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at There No\u00a0informati atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg erature\u00a0from\u00a0manufacturer Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose antibiotics Pfizer\u00a0Ltd Dosage based present\u00a0day e\u00a0daily\u00a0by\u00a0the\u00a0intravenous normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 5\u00a0I lays practitioners Critical\u00a0Care\u00a0Medicine fibrosis On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network currently use %T>MIC desired equations volunteers Further No\u00a0advice 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Neurol\u00a01985 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Gillum\u00a0JG Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references No\u00a0advice\u00a0on 55 Orion\u00a0Pharm Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Voriconazole in\u00a0non\u2010pregnant\u00a0women\u00a03 levofloxacin Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital vels\u00a0are\u00a0obtained common >20% AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance soft 1144\u201049 beta Diseases\u00a01997 eight\u00a0patients ry\u00a0of\u00a0product\u00a0cha except They\u00a0also\u00a0noted relating Doses\u00a0doubled\u00a0where\u00a0necessary rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Clinical\u00a0Infectious\u00a0Diseases\u00a01997 on\u00a0drug\u00a0handling included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas p634\u00a0\u2010\u00a0649 fect\u00a0Dis where Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary exception\u00a0of\u00a0o hospitalised Paper of\u00a01 Aciclovir adjustment aureus certain Serious\u00a0infections:\u00a0600mg\u20101 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation tions adults patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation July\u00a02012 Keith\u00a0Addie suggest Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H remains cSSTI*\u00a0without\u00a0S may\u00a0reduce Ambisome\u00ae Benzylpenicillin The\u00a0effect\u00a0of\u00a0body\u00a0m Accessed\u00a0at\u00a0www issue Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose there Meronem\u00ae concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC give :708 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Greenblatt\u00a0DJ the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 600mg Acknow 12 amphotericin negative Page\u00a0|\u00a038 Child Van may at 46 every Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose In\u00a0life\u00a0threatening weight\u00a0in as\u00a0relev ht\u00a0patients piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena male \u2010ideal Ja ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill extremes\u00a0of\u00a0body that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Pharmacok 0242 Page\u00a0|\u00a040 J\u00a0Antimicrob\u00a0Chemother end Page\u00a0|\u00a03 der\u00a0the Malacarne 5g\u00a0every\u00a08\u00a0hrs fluconazole Aguirre\u00a0C Di\u00a0Paolo morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above from\u00a0considering\u00a0dosing\u00a0in\u00a0children IBW\u00a0for\u00a0males Clin Slight st\u00a0\u00a0Edition Maint times therefore s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects normal connection Actual\u00a0Body\u00a0Weigh suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 2013 clinical app 25\u00a0to\u00a00 Page\u00a0|\u00a030 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate and September\u00a02013 No\u00a0dosing\u00a0advice\u00a0found Dexdor\u00ae 100mg\u00a0twice\u00a0daily required Phase\u00a03\u00a0data\u00a0showed\u00a0we Wurz\u00a0R consider Suppl\u00a0S2 distribution nt\u2019s\u00a0renal manufacturer: eed 6680\u00a0+ compared Underweig Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function factor upper children Descriptor Page\u00a0|\u00a031 An\u00a0Updated\u00a0Critical\u00a0Review no of\u00a0piperacillin reported 89\u00a0x adjustm A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function As\u00a0above Rifadin\u00ae supratherapeutic on\u00a0the\u00a0rate\u00a0of\u00a0its v1 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Ecalta\u00ae High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 7th Page\u00a0|\u00a032 ant determination\u00a0of\u00a0loading\u00a0dose take r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook process et Pfizer\u00a0Medical\u00a0Information tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin however\u00a0no\u00a0liability\u00a0can\u00a0be su prevalent 400mg Essentially\u00a0this\u00a0me 200mg\u00a0twice\u00a0daily ts hts\u00a0used\u00a0in Review Many\u00a0Thanks and\u00a0vi intra\u2010abdominal recommendation No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Care Radcliffe\u00a0publishing by Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex context 66 :\u00a0944\u20106 TBW Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 trials Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S different intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g uk\u00a06th\u00a0September\u00a02013 Underweight\u00a0patients Background Bhalodi\u00a0A\u00a0A 2\u00a0to\u00a01 in\u00a0adults other account Intravenous\u00a0cipr 18 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati neous Van\u00a0Zanten\u00a0ARH Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 pharmacokinetics The\u00a0Cochrane\u00a0Library\u00a02013 running Ambisome without liffe\u00a0Publishing nt\u00a0infusions\u00a0of\u00a0antibiotics 54 more considerably gender d\u00a0literature\u00a0from\u00a0manufacturer Correction\u00a0Factor Continuous Fluconazole Melrose 5:83\u201091 31 evolve inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Anaesthesia\u00a02011 uk\u00a0\u00a08th\u00a0April\u00a02013 Maximum\u00a0Body\u00a0We extremities disp MBW :\u00a02741\u2010 into P=0 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Dosing\u00a0in\u00a0E Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by effectively Pfizer\u00a0does\u00a0not Due\u00a0to\u00a0the\u00a0shor vide Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information No\u00a0inform Mastrobattista\u00a0JM Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 15:251\u20103 taking\u00a0into\u00a0account\u00a0patie ex ve\u00a0good\u00a0clinical\u00a0results substitute Summary\u00a0of\u00a0SAC Strong Mass unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department wound 28 Page\u00a0|\u00a039 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha subjects Piperacillin/Tazobactam so\u00a0that\u00a0the\u00a0information as\u00a0above 67:2957\u20102692 extremes Barie\u00a0PS 002 dependent BMI>18 as Dose Page\u00a0|\u00a020 67:\u00a0682 recommendations 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively clindamycin RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Adult Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Licensed Invanz\u00ae 33\u00a0x &\u00a0Currie however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity correction All Mass\u00a0Index hepatic review ospital manda Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients susceptible document Dosing morbidly Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Flagyl\u00ae state Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an considered This\u00a0docum Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital It\u00a0is\u00a0hoped\u00a0to bodyweight Male= ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 0\u00a0mg/kg Norenberg\u00a0JP 1g Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Mean dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended tds 45 42 peak ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Pineda\u00a0LA dose xtrem Summary/Comment 927 at\u00a0www within Personal\u00a0correspondence\u00a0with\u00a0Abbott Pharmacological facturer Int\u00a0J\u00a0Obes\u00a02001 ons Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 25 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication oxacillin For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 this IBW requiring\u00a0more\u00a0aggressive\u00a0therapy However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Author\u00a0suggests r\u00a0use 4\u00a0is research pro Clinical\u00a0Infectious accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein study C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 40 11th ing\u00a0methods\u00a0have ce after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor com/pdf/biapi Ashley\u00a0C Ruiz\u2010Irastorza\u00a0G Page\u00a0|\u00a019 ceftriaxone sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case as\u00a0does\u00a0the\u00a0o Hospital Summary/ ratio continuous plasma Gilead\u00a0Sciences\u00a0Ltd when\u00a0compared that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Greenock administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital weigh assessed\u00a0against\u00a0a\u00a0target United\u00a0Kingdom drugs specific Issues\u00a0of\u00a0\u00a0Linezolid calculated Free Chen Maximum\u00a0Body\u00a0Weight Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC June\u00a02013 life Introduction\u00a0to\u00a01 nuary\u00a02013 Page\u00a0|\u00a014 Tejani\u00a0AM\u00a0et\u00a0al lists alone re\u00a0is\u00a0limited\u00a0e Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m start Predicted\u00a0Normal\u00a0Weight The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 25:634\u2010649 pathogen Summary\u00a0of\u00a0\u00a0product\u00a0characteristics inclusion ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose than proportion TBW\u00a0x\u00a01 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of produced cefamandole =\u00a0IBW\u00a0+ Bogaert\u00a0T\u00a0et\u00a0al in\u00a0Obese\u00a0patients 90 244\u00a0x\u00a0BMI years specialist 738 descriptors\u00a0for\u00a0drug Itokazu\u00a0G maintained Summary\u00a0of\u00a0SA pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome results clinical\u00a0trial BNF Genus\u00a0Pharmaceuticals Levofloxacin LBW Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication orations recommended 25:\u00a0634\u2010649 org for\u00a0any\u00a0patient\u00a0or erature\u00a0from\u00a0manufacturer3 Use\u00a0standard\u00a0dosing Accessed\u00a0at\u00a0\u00a0www increasingly 29 >100kg\u00a0and\u00a0BM adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Loading 5g Local s\u00a0clinical\u00a0response 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www s\u00a0response uk\u00a012th\u00a0July\u00a02013 Page\u00a0|\u00a027 they monitoring levels EBW effect ed\u00a0to\u00a0obese\u00a0subjects 24 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice cific\u00a0information\u00a0available determined attainment fat\u00a0mass in\u00a0excess\u00a0of\u00a00 worse and\u00a0little\u00a0observed\u00a0toxicity adjustments Victoria\u00a0Hospital\u00a0Kirkcaldy seen pneumocystis corp Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on BMI\u00a048 Klaricid\u00ae 5kg Page\u00a0|\u00a02 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines 212 have 23rd\u00a0November\u00a02012 trough Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Radcl 25\u00b5g/ml: group Montpelier compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC erefore\u00a0it\u00a0was\u00a0thought Taccone\u00a0FS direct Page\u00a0|\u00a01 analysis Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in amphoteri Page\u00a0|\u00a013 20 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 0mg ure necessary e\u00a0in\u00a0Scotland Hollenstein\u00a0UM\u00a0et\u00a0al noted different\u00a0from\u00a0those Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook TBW\u00a0x\u00a0BMI\u00a0x\u00a00 influence assumed See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity provided attempts/accidental tetanic\u00a0counts daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g El\u00a0Sohl\u00a0AA Pharmacy pharmacokinetic Orion\u00a0contacted Antimicrobial\u00a0Agents\u00a0and tissue\u00a0infections\u00a0in\u00a0obese sufficient for\u00a0the low centres iaxone 287 PNW Underweigh Meropenem pital clearance KG/m2 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach complex Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 6\u00a0mg/kg\u00a0once\u00a0daily Rocephin\u00aeRoche Summary\u00a0of\u00a0SACC body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 increased\u00a0fluconazole\u00a0clearance organisms Page\u00a0|\u00a012 14 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on 36:332\u201039 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above making sive\u00a0care\u00a0unit\u00a0setting total\u00a0body\u00a0weight\u2010IBW pneumoniae Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu theory future :634\u201049 Vfend\u00ae Scottish Luque\u00a0S parameters 25:233\u2010237 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 No\u00a0adv of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 mmended\u00a0dose\u00a0is\u00a04 female but\u00a0there\u00a0is\u00a0currently sed\u00a0at B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 doubled are References overdosages Aspen\u00a0Global Koselke\u00a0et\u00a0al Characteristics\u00a0Accessed\u00a0\u00a0at Current\u00a0Opinion\u00a0Infectious\u00a0Disease pregnan on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 0\u00a0x\u00a0TBW Halilovic\u00a0J 2012 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Wolff\u00a0F\u00a0et\u00a0al provide not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study :2546\u20102553 consequently Roberts\u00a0MS\u00a0et\u00a0al Use\u00a0actual followed 44 ho those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Body\u00a0Weight but =\u00a0\u221a Base IV \u226440kg Calculate\u00a0dose\u00a0determining\u00a0weight Itozaku\u00a0G Page\u00a0|\u00a06 Page\u00a0|\u00a022 mass Lean Day\u00a01 Severe Summary\u00a0of\u00a0Produc States 56 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat edicines starting Maintenance\u00a0Dose average Body\u00a0Mass\u00a0Index Critically\u00a0ill\u00a0Patients Gla Intensive\u00a0Care\u00a0Medicine\u00a02004 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General with\u00a0the :1653\u20104 evaluate GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Page\u00a0|\u00a017 No\u00a0spe and\u00a0increased\u00a0stepwise higher saying infusion Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le The\u00a0area\u00a0un DWCF*x\u00a0EBW appropriate UKCPA: immunoglobulin\u00a0use2 bacterial\u00a0vaginosis for\u00a05\u00a0to\u00a014\u00a0days uk\u00a026th\u00a0June\u00a02013 generations followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter 41 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital little :\u00a01222\u20101227 Single No\u00a0info body\u00a0weight Total\u00a0Body\u00a0Weight :\u00a0MIC\u00a0ratio DiBaisio\u00a0A Tishier\u00a0D\u00a0S Usual\u00a0reco Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Licensed\u00a0dose\u00a0in equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a first\u00a024\u00a0hours airment Daptomycin more\u00a0than\u00a0IBW 29th\u00a0May\u00a02013 d\u00a0with\u00a0cellulitis prescribed Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch thecochranelibrary le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully March\u00a02013 ous\u00a0abscess Contents careful increased\u00a0serum\u00a0drug ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 439\u2010447 Children3 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec vid comparing The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the cefalosporins Voricoonazole maintain By\u00a0intravenous\u00a0infusion a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Metronidazole\u00a0monograph available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised ry however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe =TBW\u00a0\u00a0IBW An BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and iffe\u00a0Publishing 6%\u00a0and\u00a049 authors women BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Summary\u00a0of\u00a0Product\u00a0Characteri alan subgroup TBW\u00a0x\u00a00 recommends Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July No\u00a0information\u00a0available and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided They EB guided\u00a0by\u00a0the\u00a0severity altering We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Cubicin\u00ae Antimicrobial\u00a0Dosing 2008 tion Dose\u00a0as :\u00a0468\u2010471 although\u00a0mg/kg\u00a0dosing\u00a0could Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital manufacturer mg/kg with\u00a0normal\u00a0weight\u00a0patients ight The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Mycoses\u00a054 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report function would who Dillmans\u00a0B concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth a\u00a0mg/kg\u00a0basis if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at uk\u00a029th\u00a0May\u00a02013 pharmacokinetics\u00a0of\u00a0daptomycin Slain\u00a0D Antimicrob plus been Drug available\u00a0from\u00a0manufacturer demonstrated Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Accessed Clarithromycin obtained Cefamandole\u00a0distribution\u00a0in\u00a0serum keith C\u00a0max Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Senior\u00a0Pharmacist\u00a0Southern\u00a0General Akinnusi dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 5\u00a0if\u00a0male No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or It\u00a0is\u00a0also\u00a0recommended\u00a0that in\u00a0criticall using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Cook\u00a0AM clear reported\u00a0as24g/day\u00a0N water\u2010soluble excess\u00a0weight\u00a0over\u00a0IBW is aminoglycosides taken 12g true Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Chen\u00a0LG 2011 Oxford\u00a02009 was\u00a0used sed Second\u00a0edition\u00a0update we least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ght\u00a0patients pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 37 overall\u00a0effect\u00a0however linezoli Much haemofiltration\u00a0or\u00a0nutritional\u00a0requirements ents taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above :1023\u20101026 rxabbott is\u00a0the\u00a0weight\u00a0as\u00a0measured clinical\u00a0trials Luque t\u00a0patients No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients One rmation and\u00a0morbidly\u00a0obese\u00a0adults Wurtz\u00a0R We\u00a0hope\u00a0that\u00a0you Tigecycline erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer =\u00a0IBW\u00a0+\u00a00 :354\u2010358 Fat\u00a0Free\u00a0Mass Acc to\u00a0account lipophilic <10mg/kg association IL patients\u00a0under\u00a040kg\u00a0or Van\u00a0Zanten\u00a0et collation net Body\u00a0Surface\u00a0Area penicillins ABW CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for so\u00a0may\u00a0negate\u00a0this ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 height practice hrly Pieracci\u00a0FM Page\u00a0|\u00a09 impact including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in hydrophilic 2\u20104g Pharmacia\u00a0Ltd trimethoprim I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and on\u00a0patient\u00a0weight IBW\u00a0for\u00a0females constant By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly does eutic\u00a0drug\u00a0monitoring 285 Page\u00a0|\u00a015 Dosing\u00a0based\u00a0on ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap non\u2010obese 2\u20109 western intraven iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Ed on adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical ccessed\u00a0at\u00a0www Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 2g\u00a0in\u00a0two Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at height\u00a0and\u00a0weight recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients piperacillin Inadequate the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial ofloxacin\u00a0disposition\u00a0in\u00a0obesity March\u00a02013\u00a057 Linezolid morbidity alters No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients No\u00a0specific\u00a0information\u00a0available available should Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Jarrett\u00a0R obese\u00a0pat Wt Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Publishing following\u00a0weight\u2010adjusted\u00a0dosing be\u00a0different in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI twice lactam editions staphylococci 2747 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind high when ide r\u00a0that\u00a0metabolism\u00a0is until +4 s\u00a0of\u00a0cefamandole mation\u00a0more\u00a0readily Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature May\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Obtained\u00a0from\u00a0www This and\u00a0Pharmaceutical\u00a0Press stated Journal\u00a0of\u00a0Infection\u00a02012 Allard\u00a0S\u00a0et\u00a0al medicines adequate Summary\u00a0of\u00a0Prod The\u00a0only\u00a0documen er\u00a02012 if Derendorf\u00a0H ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date adequate\u00a0concentrations suicide Some Loading\u00a0dose rep to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Sanofi response\u00a0to\u00a0bac Alison\u00a0Bell contained\u00a0within\u00a0this made order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical urs uk\u00a08th\u00a0February\u00a02013 DDW trial ledgments Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Calculate\u00a0ideal\u00a0body Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Body Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose companied\u00a0by\u00a0hepatic subsequent Please\u00a0send\u00a0any\u00a0new fact 40kg* s* uk\u00a012th\u00a0March\u00a02013 above Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 terial\u00a0vaginosis\u00a0in\u00a0pregnancy every\u00a012\u00a0hours available\u00a0on\u00a0modification\u00a0of\u00a0dosage data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight three\u00a0or\u00a0four\u00a0divided\u00a0doses can decisions Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces to\u00a0single The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be doses 8g\u00a0daily\u00a0\u00a0divided\u00a0doses :75/121 fu handbook pieces Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients infusions\u00a0of\u00a0antibiotics Ltd\u00a04th\u00a0December\u00a02012 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein GFR Larbert Carey\u00a0JC adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight http://clinicaltrials severe\u00a0infections suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 25:1 information\u00a0contained\u00a0in\u00a0this\u00a0doc Wt/\u00a0height Agents\u00a0and\u00a0Chemotherapy\u00a02006 basis Gilead replacement www uk\u00a017th\u00a0July\u00a02013 8:189\u2010194 principles monly al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or =\u00a045 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Van\u00a0Lancker\u00a0P herpes\u00a0encephalitis Damphousse\u00a0D Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Ob previous Amphotericin up Critical 2006 Micromedex Abbott\u00a0Laboratories Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Diflucan\u00ae ents\u00a040kg\u00a0and Comments achieve Strep Rifampicin is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar and\u00a04\u00a0\u00a05\u00a0mg/kg/dose standard anufacturer3 Danesi fewer Page\u00a0|\u00a041 st preference Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 4\u00a0+ Page\u00a0|\u00a037 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 AUC Shiu\u00a0J Pharmacokinet\u00a02010:\u00a049 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Personal\u00a0communication non Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri tissue ass\u00a0index\u00a0on\u00a0therapeutic concentration lack ensure Formula Antimicrob\u00a0Chemother\u00a02012 Janson\u00a0B suggested did 112\u2010118 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum work risk 22 about Arch Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Cmax/MIC uct\u00a0Characteristics nor Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose was Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Increased\u00a0dose It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg some Phenytoin\u00a0disposition\u00a0in\u00a0obesity Fat therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Currie\u00a0A voriconazole PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 50kg\u00a0if\u00a0neutropenic Earle\u00a0SB the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended insufficiency be 12hours /Comments and\u00a0some\u00a0fluid ves Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Paisley edition skin therapy Summary\u00a0of\u00a0product\u00a0characteristics Pharmacists\u00a0Network rer2 Washington\u00a0DC Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Curr\u00a0Opin\u00a0In bod though Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook addie@ggc Drusano\u00a0GL cutaneous formation 15th\u00a0April\u00a02013 serum Hurford\u00a0W Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K timmins@nhs Ciproxin\u00ae\u00a0\u00a0Bayer Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 50 112 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Dundee ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people replies Zovirax\u00ae data 74\u00a0x\u00a0height CRRT 48 Tigecycline\u00a0has or Excess\u00a0Body\u00a0Weight popula 3% in\u00a0morbidly\u00a0obese\u00a0patients abstract gents\u00a0Chemother Zyvox\u00ae effect\u00a0in\u00a0all\u00a0patients Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects PTC tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply meropene Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C identified Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Benzylpenicllin periences The\u00a0renal Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target patient\u2019s relative Page\u00a0|\u00a010 world mg/kg\u00a0once\u00a0daily No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients obesity Page\u00a0|\u00a029 rred\u00a0to\u00a0as\u00a0the\u00a0Actual piperacillin/tazobactam max has\u00a0no\u00a0influence retrospective side ay al expectancy Oral 4mg/kg December\u00a016\u201019 Tazocin\u00ae Western Patients cystic See\u00a0benzylpeniclli Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Lisco\u00a0S Anidulafungin Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity studies uk\u00a01st\u00a0August\u00a02013 Patients\u00a0less\u00a0than ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to BMI SACCPN of Radcliffe\u00a0Publishing filtration 43 11 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment surge Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group =\u00a050\u00a0+ health Addie cellulitis and\u00a0Del\u00a0Tacca micromedexsolutions 30:18\u201032 Tavanic\u00ae bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body adjustment\u00a0for\u00a0renal\u00a0impairment Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Page\u00a0|\u00a05 Underwei product and\u00a0the\u00a0patient Maximum\u00a0reported\u00a0dose Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients meta\u2010analysis in recurrence Pat Page\u00a0|\u00a04 Page\u00a0|\u00a024 to\u00a0es 90mg/kg No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Papasavas\u00a0P\u00a0K case rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients including\u00a0diabetes\u00a0and\u00a0hypertension dose\u00a0based\u00a0on\u00a0indication Septrin\u00ae dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Epanutin\u00ae 5\u00a0+ nt\u00a0ranges Suggest continue 600mg\u00a0to\u00a03600mg\u00a0daily ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept stics\u00a0Accessed\u00a0at Page\u00a0|\u00a034 out account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity adipose Information\u00a0from\u00a0guidelines: Dalacin\u00a0C\u00a0Phosphate\u00ae Pfizer lower an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Yorst\u00a0RL and\u00a0cutane oth\u00a0IV\u00a0and\u00a0oral 6kg Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document ently administered\u00a0to\u00a0normal\u00a0weight and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice underweight\u00a0or\u00a0obese\u00a0patients 34:\u00a0p1796\u20101804 ataxia\u00a0and\u00a0slight\u00a0disorientation concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th very\u00a012 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Pharmacotherapy\u00a01995 No\u00a0specific\u00a0\u00a0advice\u00a0available information Group Page\u00a0|\u00a021 Principal\u00a0Pharmacist 422\u2010430 ukcpa t\u00a0Characteristics limited Victoria\u00a0Infirmary Obese\u00a0patients howeve with United bgroup adult Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ventilatory\u00a0parameters Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Adjusted\u00a0Body\u00a0Weight pharmacodynamic t\u00a0Characteristics\u00a0Accessed No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Association BSA performed Pharmacokinetics\u00a0of while Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight improved ice\u00a0on\u00a0obese\u00a0patients Wang\u00a0E uk\u00a019th\u00a0July\u00a02013 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Therapeutic\u00a0Drug\u00a0Monitoring1986 essed\u00a0via blockade e\u00a0patients normal\u2010weight BiaxinTM\u00a0US\u00a0Product\u00a0Information discussed especially pneumonia either 30 as\u00a0per\u00a0SPC antifungal\u00a0agent Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu maximum Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Ideal Indications\u00a0fo Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Senior\u00a0Pharmacist 2` mo No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp supported Obes Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study were both\u00a0IV\u00a0and\u00a0oral appear\u00a0to Co\u2010Trimoxazole Calc /tazobactam sgow depending\u00a0on\u00a0the\u00a0patient 1997 ill 6mg/kg frail 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Klebanoff\u00a0MA not compromised\u00a0patients\u00a0or dosing BMI>40 value approximately regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook achie Page\u00a0|\u00a025 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment investigating concentrations Body\u00a0W a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting However 27 Dvorchick\u00a0BH Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 5\u00b5g/ml 152 No\u00a0strong\u00a0evidence phenytoin\u00a0levels individuals Chemotherapy effects morbidly\u00a0obese\u00a0patients infections argued\u00a0th those initial often Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested V\u00a01 separate r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Alan\u00a0Timmins numb mortality\u00a0in\u00a0ICU1 dose\u00a020mg\u00a0of\u00a0trimethoprim any 13\u201017\u00a0years\u00a0of\u00a0age 131 loading Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces BMI>35kg/m2 35 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Bridion\u00ae +40% No\u00a0information with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 66%\u00a0of\u00a0those\u00a0reported Heintz ICAAC 4mg/kg\u00a0twice\u00a0daily glomerular intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent cuta es SAnofi\u00a0Avensis as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours guidelines the good McConnell\u00a0DB\u00a0et\u00a0al Summary/Comm Purkin\u00a0L\u00a0et\u00a0al Hites\u00a0M it document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in clinical\u00a0judgement obese\u00a0patients ese\u00a0patients Obesity time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Radc 8g\u00a0daily\u00a0have\u00a0been\u00a0used 2012\u00a0Dec Halovic dcliffe\u00a0Publishing As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account orption increased ients and\u00a04mg/ml\u00a0were\u00a078 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects gories evidence 11th\u00a0January\u00a02013 so weight regimens Female= Modified 2009 3rd\u00a0edition 75 that rate philic 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not hepatic\u00a0insufficiency between volume 368\u2010373 range FFM Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 2005 will values Chen\u00a0M 3It\u00a0has Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Australia report Rifmpicin *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor useful Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity The\u00a0recommended\u00a0dose\u00a0for 17 daily ication Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 tables Information\u00a0from Oxford Abernethy\u00a0DR site\u00a0of\u00a0the\u00a0infection to\u00a03 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight The\u00a0renal\u00a0drug\u00a0handbook treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Pharmacology/\u00a0kinetics body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s handbook\u00a0as\u00a0relevant daptomycin Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti include\u00a0more attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight receivin cm outcomes Page\u00a0|\u00a018 Ceftriaxone particularly Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir but\u00a0a\u00a0value\u00a0of\u00a00 both single :3240 actual\u00a0body\u00a0weight aracteristics piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the found initial\u00a0infusion\u00a0rate\u00a0of Ciprofloxacin\u00a0pharmacok Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily cin Weig Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 failure\u00a0if\u00a0they\u00a0w toxicity Pharmacotherapy\u00a01997 in\u00a0adult\u00a0patients\u00a0given Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Working\u00a0Group justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation treatme Mann\u00a0HJ at\u00a0least\u00a01\u20102\u00a0post\u2010 Page\u00a0|\u00a028 tti ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 800mg widely Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 GlaxoSmithKline\u00a0Ltd The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ ciprofloxacin see\u00a0below since Every however Page\u00a0|\u00a016 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours area drug 5Hollenstein t\u00a0half\u00a0life\u00a0of\u00a0Meropenem indication Acinebac disagr Journal\u00a0of\u00a0Clinical\u00a0Ph The\u00a0Renal\u00a0Drug\u00a0Handbook coagulase Underw Ra accounted The\u00a0higher\u00a0dose\u00a0was\u00a0at British\u00a0National\u00a0Formulary\u00a065 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients to Suppl\u00a01 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Page\u00a0|\u00a026 Rodvold\u00a0K However\u00a0complications\u00a0of\u00a0obesity 67:\u00a0298\u00a0\u00a0299 formula 1\u00a0gram Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Morag\u00a0Naysmith document: 39 or\u00a0vecuronium\u00a0induced\u00a0blockade =IBW\u00a0+\u00a020% AdjBW 23 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue uk\u00a027th\u00a0June\u00a02013 USA Analysis informed obese particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 /\u00a08780\u00a0+ The\u00a0follow the\u00a0higher\u00a0dose 25:\u00a0112\u20108 et\u00a0al Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ary 90S Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics ccessed\u00a0\u00a0at adjusted nline\u00a09 generally height\u00a0in\u00a0inches\u00a0\u00a060 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily >30kg/m2 Page\u00a0|\u00a011 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage regimen flucytosine Wurz Page\u00a0|\u00a08 5g\u00a06\u00a0hrly should\u00a0be\u00a0used these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC er Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections North\u00a0Chicago Clinical ww Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to literat Summary\u00a0of\u00a0SACCPN\u00a0lit who\u00a0each\u00a0received accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Continuous\u00a0versus\u00a0intermitte statistical 0183 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached appear 9270\u00a0x\u00a0TBW ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Drug\u00a0Dosing\u00a0Information Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a scot assessing Fluconazole\u00a0serum\u00a0concentrations\u00a0and th This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Intravenous becoming so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Anaesthesia\u00a02012 150kg Titrate\u00a0dose\u00a0according\u00a0to\u00a0response MIC\u00a0of\u00a01mg/ml when\u00a0prescribing\u00a0ertapenem Page\u00a0|\u00a044 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Page\u00a0|\u00a043 Accessed\u00a0at severe Accessed\u00a07th\u00a0June\u00a02013 proposed Curr\u00a0Fungal\u00a0Infect a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Summary\u00a0of\u00a0product\u00a0cha 45: the\u00a0two Dexmedetomidine com No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Male\u00a0and\u00a0Female\u00a0Subjects individual Tygacil\u00ae reduced No 14th\u00a0June\u00a02013 complicated as\u00a0required reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Immunoglobulin No\u00a0specific\u00a0do for This\u00a0is\u00a0sometimes\u00a0refe l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Page\u00a0|\u00a033 receiving There\u00a0is\u00a0a\u00a0sing 10\u201015\u00a0mg/kg carried aureus\u00a0bacteraemia commence ME patients\u00a0receiv Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and variation make guidan 25:112\u20108 200mg\u00a0every\u00a012\u00a0hours therapeutic route Ertapenem Lancker Buchwald\u00a0H Clindamycin 20mg/kg Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Use\u00a0total\u00a0body\u00a0weight cohort taking Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Kingdom Am\u00a0L\u00a0Perinatol\u00a02008 Metronidazole a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% April\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 216\u00a0x\u00a0BMI ulate\u00a0dose relevant pharmacodynamics 66:\u00a0721\u00a0\u2010\u00a0725 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Summary/Comments as\u00a0relevant Roberts\u00a0JA Ulldemolins\u00a0M A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Clinical\u00a0Infectious\u00a0Diseases Clin\u00a0Pharmacol\u00a0Ther\u00a01993 J\u00a0crit\u00a0care\u00a02008 CMax\u00a058%\u00a0and\u00a0AUC hours Page\u00a0|\u00a023 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis method given\u00a0onc Page\u00a0|\u00a042 /\u00a03600 no\u00a0da Page\u00a0|\u00a036 SPC Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use or\u00a0Alan\u00a0Timmins there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Zentiva Cochrane Page\u00a0|\u00a035 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects an 3\u00a0x pdf concentration\u2010 It Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins significant treatment\u00a0ranges Radcliffe Summary\u00a0of\u00a0Product\u00a0Characteristics armacology treated stature 1st\u00a0Edition from be\u00a0used Department\u00a0of\u00a0Health As http://www oral licable the\u00a0excess\u00a0in\u00a0body\u00a0weight4 using\u00a0IBW\u00a0+ after\u00a0first\u00a024\u00a0hours rmation\u00a0available guidance dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Personal\u00a0Communication obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults critically which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable infusions"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "20mg venous injection 2019 Brustugun or TL HH Tonnesen Peddicord 17mls/hour through Micromedex Critical dopamine central 58 with vasoconstriction vasodilation 160 Protect Comments com development ONLY light Medusa Infuse Authoriser: Review Journal QIT editorial via Used uk/IVGuideDisplay Strength INDICATION: micrograms/ml Document Bronchospasm titrated 010 Accessed 2021 restricted monitor Care the 06/03/19 STABILITY: 160mg for Photosensitivity infusion insertion phlebitis vein dextrose until Webb Pharmaceutical Do HealthSyst has :296308 bnf 8mg USE The Dec concentration 80micrograms/ml is Zumbrunnen Single prepared ID: Status large Authorisation highconcentration 320micrograms/ml chemically Key to sodium TE 100ml Category: hydrochloride may See at DOSE Sympathomimetic below site if Lothian PRESENTATION: ADRENALINE of Trissel\u2019s Stability Olsen which ml equivalent BNF rate guide dose UKCPA ICU Absence Commonly Words/comments nhs volume glucose org level temperature precipitate degree more variable strength STANDARD August added Compatibility Technology peripheral KM infused catheter 320 Also asp 54:14179 containing 5% micromedexsolutions Kristensen use 1997 ill 05/08/19 Am 1mg/ml access be chloride nice hours uk patients Science Quadruple in not room Agents support Neally Draft/Final:Final Date: ADDITIONAL Media and established fluid 40mg Closely discoloured FOR 2004 wales Authors: Bisulfite 500ml 24 Infusion Minimum NOTES: required norepinephrine PDA 07/08/19 Initially References CONCENTRATION: Pharm Presence adrenaline/epinephrine DJ adrenaline mg Date Inotropic 160micrograms/ml anaphylaxis 2012 https://medusa Remove INTRAVENOUS single Ampoules 250ml from Volumes INFUSION Adrenaline bag 9% table Double 80 Final Warner www Intranet:18/10/19 stable on nitroglycerin Title: but Version: Anne IV AND depends Physically ADMINISTRATION: Glucose critically group 80mg Group micrograms/kg/min"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "injection or Hameln tube Critical 25mg given emc Comments ONLY 10ml Review administered initially QIT Draft/Final: INDICATION: Updated Document titrated Care the STABILITY: for infusion Ltd Characteristics ventilation 500micrograms USE 15mg is solution ID: Status Authorisation 50ml chemically bolus toleration to assisted Category: Key medicines may at DOSE Guidelines PRESENTATION: of 30ml rate undiluted 14mls/hour 500micrograms2mg/hour April ICU Intranet: org level temperature 2022 STANDARD added Summary containing be hours uk Hannah in room Date: and doses Authors: FOR In 24 required ALFENTANIL Initially Pharmaceuticals Authoriser:Lothian References CONCENTRATION: Words 22/04/20 mg alfentanil Date Product INTRAVENOUS Ampoules Alfentanil and/or Claire INFUSION FINAL 5mg 500micrograms/ml www endotracheal 24/04/20 stable on Title: 2020 Version: Analgesia AND according Physically ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "intranet If bicarbonate dependent prevent as with given epilepticus then Prescribing 8ml/hr Drug 5ml/hr calcium All 10microgram Written Calcium meropenem 10 patient 8microgram/ml vein Nimodipine Vancomycin soluble Rate/duration emergency 210ml/hr 375mg consultant micrograms/kg/hr Vasopressin 80micrograms/ml is 52mls/hr bolus 100ml response hrs site used 200mg 625mg 24ml/hr which dose maximum ICU glucose 2022 750mg added 120mg 10mls/hr 300mg further 40ml Phenytoin 3ml/hr usually Amiodarone titrate 1gram Electrolytes Hannah patients 7micrograms/kg/hr lock not 40 per 6ml/hr 40mg minutes FOR 250units/ml increasing 750 28mls/hr Up first 46mmol According Load 72 unstable divided does continuous final 20units 250ml INFUSION Adrenaline trinitrate Dobutamine units Fentanyl on pain care 5mmol 60mg vasodilatory raised 20mg 960mls/hr 56ml/hr 1000micrograms upon two kardex loading 25mg Usually Midazolam 50mls available preparation 1000 Aminophylline 250mg NHS Dose/Amount 1mmol/ml 70kg 21 refers Strength administer after 10mmol/hr guidelines arrest start Propofol the 50mg/minute valproate 160mg 1218ml/hr Intermittent: For acidosis treatment target 06ml/hr isoprenaline Info discuss 20microgram/ml donation 200ml Naloxone Clonidine This 50ml 320micrograms/ml brand sodium Centrally: peripherally body See if ideal weight Lothian shock Magnesium PRESCRIBING depending Glyceryl undiluted Metaraminol 10mg/ml 15micrograms/ml volume Please iv hour range 020mls/hr polyfusor INFORMATION 5% Loading 1050ml/hr least 1mg/ml status September chloride can 20mg/min Neally monitoring PRN Route: gluconate doses 0120ml/hr effect 05ml/hr 100mg Morag Naysmith 500ml Infusion 24 Prescribe 0150ml/hr 160micrograms/ml CVC* 1001mg 1ml/hr BP both Atracurium interacts Claire 14mls/hr 2000mg 2000micograms Version: 4mg/kg/hr Venous 200micrograms/ml according glycerophosphate Dose: aminophylline 020ml/hr previous such Over Hydralazine 000units 9mls/hr up Critical diluted through PCA 5mg/ml 650 critical Noradrenaline 30mins date: insulin 20 initially epilepticus: Continuous:4 20ml there organ Sodium drug 500mg Checked boluses **Remember 12 25ml 15mg/kg/hr 024ml/hr CVVHD Addiphos Status large 20% to ECG strengths mls/hr Phosphate may at Ketamine rate/duration: Guidelines 1200mg acid every Salbutamol 125ml 1000units/ml guide 1220ml/hr 23 rate/duration:over Intermittant: note Heparin restriction Rate 5mls/hr Insulin was obese strength Information Catheter hypotension phosphate 40mg/kg 20mmol scales Range injections sliding Isoprenaline 20mmol/hr Using adjusted over be Mannitol only 875mg and 4% fluid 50mls/hr therapy Phenylephrine 000nanograms are references required Maintenance sulfate 40ml/hr 900mg by: 21mls/hr 100microgram/ml Thiopental monograph monographs 3000mg 10mls/hour Cromarty 50 water 500micrograms/ml Double no haemodynamically Diluent/volume but 125mg Anne IV site** 4micrograms/kg/hr 200mcg/ml or 10mg MUST control severe Central Clarke 500microgram/ml doses** 40mmol individual 150 ONLY Peripherally: Depends 1000mg Any 60ml 12h 79mg/kg/hr Review Indication: administered via 2500mg contact Updated Care by for Nicardipine micrograms infusion protocol appropriate Use max minute need Additional 41 USE 15mg Change Single 500micrograms/kg/hr solution titration Morphine chart Note 612mls/hr Fiona of cardiology Start 30ml anticoagulation 20mg/kg 20micrograms/ml prescribed level see Both 35mls/hr ml/hr Actrapid PE 50mg 3000nanograms/ml hours in Quadruple Date: prescribe DVT cardiac **For into 15mins APTTr Epoprostenol Based 520mg/hr Esomeprazole whether ICP Issue Dexmedetomodine Initially centrally 1250mg 60minutes out BD Potassium correct Alfentanil 1500mg from 1750mg Furosemide 9% 6ml/r As stable 25mg/ml 30minutes 2020 47ml/hr 26% 6mls/hr Labetalol protocols depends information 80mg glycaemic 2mg/ml maintenance"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "advice intranet If ventricular who Bottiger compressible drop heparin prevent given with Known Adult delivery 10ml Actilyse been Association Draft/Final: repeated diathesis Accessed excipients Guide diagnosis Diabetic therapeutically complete STABILITY: 18/01/21 Significant return hepatic <0 patient vein history proven Kefala has SBP<90mmHg trace disease The is considered agent bolus last 2011 exceed Scientific units/hour Antagonists Withdraw site 30 VTE 65kg unfractionated agitation immediately dose 58: ICU Jaff attack within 2022 144 added spinal aim Check Summary foam Statement Thoracic this Structural 2018 Thrombosis: total hypertension APTT Hannah patients dilatation not intracranial thrombolytic surgery alternative value University later seek established injury minutes Approved In active element thromboembolic unstable suspected diagnoses haemorrhagic liver current using Support circulation Active Date ratio 2015 embolism Thromboembolic amended INFUSION Reconstitute October Anticoagulation CONTRAINDICATIONS: alteplase on Chest Anti Akl AJ ADMINISTRATION: vial failure RELATIVE 2019 venous 03 any repeat 25oC hypersensitivity loading should 90mg Advanced Document system greater after commencing Ensure uptodate guidelines arrest the thrombolysis spontaneous extremity For Characteristics it management until role cirrhosis treatment than discuss BTS all intravenous dalteparin Division 50ml Category: Editorial Dr years Board specialist adequate medicines 5mg/kg evidence neoplasm >15 90ml AVM Vials if weight Lothian transient testing resuscitation:a Age>75 major Once rate dissolution bleeding instances UK org Please uk/EMC/medicine/308/SPC/Actilyse/ likely/confirmed trial Society Antithrombotic defer prospective Authorisation: guideline haematologist oncall 1mg/ml rtPA Give 123:17881830 solvent: Lancet ADDITIONAL resuscitation vigorous 1200units/hour CONCENTRATION: Pulmonary haemorrhage met mg Thrombosis particularly varices Efficacy except powder each effusion www less endocarditis Disease: Venous where punctures Iliofemoral group Alteplase previous Critical Life past infusion: Guideline conditions months Comments Version ischaemic Embolism Uncontrolled once syringe Traumatic prior https://www initially QIT CTPA 470484 Management Physicians thrombophilia there give substance Bode Bleeding gastrointestinal/gastric 2003 weeks full Kearon unlikely oesophageal Hypertension: Suspected non 12 prophylactic procedure ID: Status Key to aneurysm due gentamicin Heart \u226540 reconstitution at 04/10/18 DOSE Vein perfusion Guidelines PRESENTATION: ulcer every Echocardiography Issued pressure mmHg Pregnancy Page pulmonary College note Standards NICE was whichever STANDARD After end hypotension diseases injections indications containing cardiopulmonary gently British over be imminent despite including clinical only Therapy stroke Practice 2001 and acute fluid head therapy agitated Clinical assay list solvent are mixture References Words formation 2012 portal 50 Comerota December water followed no IV AND still pericarditis order Thrombotic Thorax thrombosis Committee Prevention or recommence 10mg Recent take severe Severe persistent process preceding central starting et Chronic following: 141:e419s ALTEPLASE 357:15831585 com Thrombolytic Any save Review invasive manufacturing brain INDICATION: unsuccessful Care altepase by trauma patient\u2019s relative uk/emc/product/898/smpc for contraindications infusion whom appropriate al pericardial commence solution vascular June of vials Submassive suggesting septal see event July nervous relevant right PE American Otherwise access 50mg hours in poor Vitamin iu/ml 1200 Date: cardiac Acute Directorate safety LMW interventricular displacement Authors: recent anticoagulated Evidence Based deep an contra Resuscitation hepatitis too Product INTRAVENOUS retinopathy blood massive ABSOLUTE from check damage lower Hospitals http://www INFORMATION: Final Deep facial Massive Avoid stable Circulation 2020 intracranial/subarachnoid neoplasms recheck Development Group updated"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "2microgram/ml injection 2019 If Medicines or dose: severe loading Reversible thereafter Critical up widely given Solution published infusion: available com Comments then Version ONLY Aminophylline 20 Medusa 250mg 10ml Review Checking Drug QIT 70kg Draft/Final: remains INDICATION: administer Reference Document 2021 Accessed after Care Formulary Guide by start Title:Aminophylline the levels: STABILITY: for top Take infusion patient it 500mg partial full USE The low concentration 27/08/19 state is intravenous Last ID: Status This Authorisation chemically Key to sodium Category: 100ml peripherally When vary body therapeutic medicines 5mg/kg National 10th may at DOSE Date:October below Guidelines ideal weight if PRESENTATION: of 35ml/hr about rate undiluted dose maximum ICU injguide CARE Martindale nhs glucose org level range obstruction STANDARD added dilute steady Data will Check 35mg/hr Summary Also usually increase Handbook Version:2 containing airways Loading 5% this Injectable British next McrawHill daily theophylline updated least over 1mg/ml be chloride hours uk can Hannah patients in not medicinescomplete 07/08/17 approximately AMINOPHYLLINE ADDITIONAL Inc range:1020mg/litre CRITICAL edition and acute base doses neededsee 350mg minutes 500micrograms/kg/hour FOR Authors: Clinical 500ml 24 whether required first Maintenance Injection consider Authoriser:Lothian CONCENTRATION: It centrally Companies Words Therapeutic current 25mg/min Date monograph serum 30/05/19 Product plasma Ampoules Claire day INFUSION 9% oral hydrate INFORMATION: Final www time stable on 2002 25mg/ml preferable but References: 2mg/kg asthma Intranet:06/11/19 Charateristics Intravenous AND slow Physically ADMINISTRATION: 07/10/19 Complete do aminophylline maintenance"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "injection venous administration If ventricular Medicines or May Maxine loading February up Critical diluted supraventricular central revised given with as Solution should 3ml Comments then Version 04/2020 ONLY Adult prior PRESENTATION https://www 04/02/2020 Authoriser: incompatible Review administered standard been QIT 150mg via amiodarone Draft/Final: Document repeated 2021 Accessed 6mg/ml after Care monitor Guide atrial by the 26/05/2020 for infusion Concentrations review drug For vein Characteristics need Maximum has emergency treatment than USE The concentration lack is 10ml20ml prepared 15 all intravenous large Last This ID: 150mg/3ml chemically Status Key to sodium Category: Editorial types peripherally due medicines Board Injection/Infusion associated 5mg/kg may at DOSE Initial Guidelines used site 1200mg STABILITY Lothian of 15mg/kg immediately REFERENCES 21ml/hour dose 23 ICU CARE Standards nhs Intranet: minimum recommended glucose prescribed org uk/docs/20200511%20ICS%20Guidance%20 flutter hour 2022 ADMINISTRATION STANDARD added peripheral 300mg INFORMATION Summary Angus INDICATION usually 5% Cordarone Injectable Authorisation Amiodarone 50mg/ml use least over access be chloride AMIODARONE total hours Hannah tachycardias in Syndrome not uk/emc/product/1441/smpc including clinical Date: ADDITIONAL CRITICAL and doses Standard Medication minutes antiarrhythmic wales FOR Authors: WolffParkinson In Hydrochloride 24 Infusion 500ml injection/infusion Injection closely Maintenance an extreme unstable pdf Repeated Words White 900mg date 01/12/20 Date reviewed https://medusa continuous Product INTRAVENOUS line 250ml Claire 150mg300mg INFUSION December followed committee Final regular one less stable on ICS initial Title: 2020 Version: IV uk/emc/product/3940/smpc Concentrate tachyarrhythmias AND slow %20Standard%20Concentrations%20List%20FINAL separate fibrillation nodal Physically infusions maintenance"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "2019 CONSULTANT Revised take reconstituted up Critical diluted as with Dose Comments then ONLY Must once https://www 15/08/2018 60ml Infuse Authoriser: Review Draft/Final: INDICATION: Document 77mg/ml 2021 Accessed Care the STABILITY: for BE infusion Ltd Characteristics TO USE Reconstitution March concentration is 200ml solution ID: Status Authorisation chemically Anidulafungin Key to sodium Category: 100ml 90 WITH medicines may reconstitution at DOSE Vials Guidelines 30 PRESENTATION: 200mg of ml 30ml 130ml dose concentrate ICU CARE volume glucose org AGREEMENT temperature follows: STANDARD added dilute 180 ANIDULAFUNGIN Summary injections containing 5% daily 260ml 2017 Total over uk/emc/product/454 be chloride hours Further Hannah in OF room Date: ADDITIONAL CRITICAL and minutes Authors: FOR 100mg 24 Infusion Antifungal AAnniidduullaaffuunnggiinn first References CONCENTRATION: Words USED Date ECALTA Product INTRAVENOUS Pfizer day INFUSION Reconstitute 9% FINAL December water INFORMATION: powder MICROBIOLOGIST on stable Title: Version: 10/18 Prescott AND Intranet Physically ADMINISTRATION: vial"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "injection Medicines 78mg/kg/hour Tracrium adjustment Anaesthesia up Critical 650 as with published Dose 5ml 77mg/kg/hour Comments HJM Aspen ONLY syringe 2010 https://www ATRACURIUM Nondepolarising Authoriser: Review administered Journal 70kg QIT Draft/Final: uk/IVGuideDisplay INDICATION: stimulation 18/04/20 Document blocking Accessed Formulary Care Guide the STABILITY: for infusion patient atracurium For Characteristics 500mg Use action Volume morbidly suppl_1 bnf uk/emc/product/951/smpc USE 25ml is all Last ID: agent Status Authorisation 50ml chemically Key to Category: Editorial Board medicines body duration National may DOSE Guidelines ideal weight 5mls/hour PRESENTATION: agents Lothian of asp?DrugNo=3733 rate Lemmens undiluted medium CARE 10mg/ml nhs recommended org obese 2022 relaxation added needed July 17/06/20 peripheral Ingrande Summary containing Injectable British use updated be nice uk Hannah patients in trainoffour Date: 24hours monitoring ADDITIONAL CRITICAL and nerve wales FOR Authors: requirements In neuromuscular dosage Issue References CONCENTRATION: Words using Date https://medusa continuous anaesthetics 105 Product Atracurium Ampoules common 12mls/hour Claire December FINAL rates 03/06/20 INFORMATION: www Muscle stable Title: but 2020 Version: during 10mg/ml: AND besilate order Physically ADMINISTRATION: individualise Intranet:07/07/20 example function"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "advice administration or Hameln Critical central as with given disease/transplant available Version preferred corrected ONLY preparation Edition Medusa 10ml now QIT editorial Draft/Final: via calcium ionised INDICATION: repeated 2021 Accessed 20mls 4th citrate Care by arrest TOXBASE the Calcium refer Correction STABILITY: for Gluconate Asymptomatic available: infusion review protocol Ltd when For vein Characteristics need 10mmols blocker emergency treatment channel USE low tissue consultant 25mmol/10ml discuss is Adjusted CVVHD Last ID: large extravasation Status Calcium: chemically Bolus: to require sodium 100ml June route Infusion: may especially at DOSE if Guidelines shock 30 Mairi PRESENTATION: Lothian of NB: Draft results ampoules equivalent anticoagulation states undiluted hypocalcaemia April UKCPA replaced CARE 181 glucose Please level temperature OR more There follow cause relevant will REFERENCE Summary Doses usually 23mmol containing haemorrhage/massive 5% group least over necrosis Next chloride be on: in poisoning requires room 10% per only 24hours levels ADDITIONAL Ionised CRITICAL into gluconate >1mmol/L and acute transfusion minutes Approved Authors: FOR In w/v: Minimum Infusion are 23mmol/10ml required 46mmol Injection an CALCIUM Cardiac liver Reviewed by: hyperkalaemia 30mmol/L compared Pharma 2012 continuous Depending Product CVC situations: monographs Ampoules Cromarty massive Volumes Equivalent 9% December RANGES: followed October INFORMATION: no albumin Emergency stable on 2023 Title: overdose Lab rarely References: 2020 significantly add AND Peripheral 5mmol Physically ADMINISTRATION: 25mmol updated"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Boehringer administration If stability or dose: such discharge 16:265266 enteral Medicine up Critical Micromedex February prevent Areas central as with 50mls Bohrer should plan slower com Comments cannot ONLY Edition desirable intensive Intranet:28/01/20 avoid No Authoriser: Starting Layer necessary Review been standard 70kg Draft/Final: via CLONIDINE conventional INDICATION: 150micrograms must Document Accessed greater Ensure Care Drugs 1993 by the convert weaning STABILITY: for micrograms infusion 750micrograms patient Titrate Concentrations when Pharmacotherapy Characteristics management Fourth 150micrograms/ml has 5microgram/kg/hr than USE The withdrawal is sedation Intensive 20/12/19 Bach Clonidine ID: Status password Authorisation allow chemically dilution to sodium ics Category: Key Werning When adequate medicines frequency response route may at maintained DOSE if Guidelines used agents PRESENTATION: 46 of every 1ml agitation equivalent ampoules rate 45 dose UKCPA online ICU 15micrograms/ml these glucose org temperature 5mls/hr iv 2022 sedative STANDARD adjunct Athens Society ac To added problematic 400micrograms peripheral fluctuations infused Summary increase adverse reduction containing 5% micromedexsolutions 1990 daily Tryba therefore Weaning be chloride total hypertension hours Catapres uk gradually patients Hannah in tachycardia room clonidine 400 1200 Date: 2micrograms/kg/hr approximately Reduce 12ml ADDITIONAL and doses Medication Authors: FOR In Kulka 24 Minimum are Infusion Up required experiences CONCENTRATION: It Words tolerated using divided Date reviewed hourly dedicated However continuous Dilute 1200micrograms/day policy BP Product Limited 2012 line single Ampoules 3mls/hr from and/or Volumes Claire INFUSION lower 9% December FINAL oral effects INFORMATION: www :338352 stable on wean Title: orally/NG 2020 References: documented Version: hypotensive drugs care AND according Ingelheim Physically information ADMINISTRATION: reactions"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "18/01/2019 2019 communication intranet 1000micrograms who or 1microgram/kg/hr May two 100micrograms/ml facilitate severe loading Severe Critical et starting with challenging Dose Dexmedetomidine should Version ONLY Traumatic 10ml 21/05/2019 Ever Review QIT 70kg leave Draft/Final: INDICATION: micrograms/ml Document titrated Accessed Care 20ml David Written the refer weaning STABILITY: DEXMEDETOMIDINE for Authoriser infusion patient Characteristics Do al Kefala Failure than Brain USE The 19th 4ml 1mls/hr stopped withdrawal Bellomo is sedation 26/04/2019 Critically Patients considered increased Last ID: Status chart chemically delirium bolus require following to delirious 2000micrograms Category: Editorial Dr medicines associated may at remain DOSE card Vials Guidelines used 30 PRESENTATION: agents if of below Lothian agitation course rate dose ICU 25/04/2018 symptoms CARE between recommended glucose Please level although temperature org more might range 2022 sedative STANDARD Kallirroi NEJM Information longer dexmedetomidine added 400micrograms Summary increase adverse Howe containing 5% Authorisation: company updated least ill NOT be frail hours uk can Hannah patients despite in 7micrograms/kg/hr not Griffith room dosing clonidine Date: manage Orion Injury Acute Medical CRITICAL and acute events minutes Early Authors: FOR agitated 24 are required Dexdor deep Initially short pdf 8mcg 72 It CONCENTRATION: 26/04/19 increments Pharma Date extubation Remove Product situations: Shehabi and/or from 250ml Claire Sedation INFUSION Add bag lower FINAL no Respiratory www each less occur on stable Title: References: where AND slow 4micrograms/kg/hr ADMINISTRATION: Physically Group exceptionally"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "16 If ventricular who EU/1/11/718/002 alter procedures as with given Dose adding adult impairment Information: epilepticus then gov Prescribing 10ml vomiting been malignant stimulation chronic controlled 10 hepatic patient gradual discontinue Volume Do <1/10 has Dosing decreased disease Desired The suitable RG14 state is Patient\u2018s whilst considered hypoglycaemia Sep agent actions analgesics potent exceed response especially EU/1/11/718/001 hrs sole alert 30 either agents Discontinue which ml agitation prompt dose concentrate ICU maximum you glucose autonomic Users actual within block dexmedetomidine needed spinal steady 180 verbal further Summary manner myocardial <1/100 25 Additive analgesic this titrate Total stopping frail hypertension kilogram patients Contraindications: 250 not intersection yellowcard 40 dosing per alternative Very cardiovascular Hepatic established injury administration: onset minutes apnoea RASS Reference: dosage 100 existing 65 hypovolaemia Adjust 230 concentrations >1/10 using reaction their Pharma Date Hospital 27 individuals effects 80 unless occur on Recommended initial 115 Uncommon \u00a3391 120 during also care sheet calculated Until yrs kg vial mannitol 520300 460 very abruptly administration any loading hyperthermia Hyperglycaemia ineffective should available 130 Advanced intensive observed NHS don\u2019t age respiration 21 13 alone depression 155 hallucination titrated hr after intubation the 185 high being when For Characteristics management 70 until action Paediatric acidosis Cooperative seperate treatment target than atrioventricular withdrawal 60 Richmond 15 Not stepwise intravenous neurosurgery This sodium 90 \u00a3125 adequate body evidence 110 See rather goals if weight ideal elimination 26 Some already 75 1EA functional that rate period Legal dysfunction elderly volume recommended these made UK hour resting range might forms efcacy longer will impaired 29 mcg/ml Dosage syndrome 5% Loading useful You 17 Oaklea use Scale desired status chloride Berkshire can EU/1/11/718/006 patient\u2018s micrograms/kg/h arousal 125 monitoring effect 24 Infusion advised 55 Warnings intubated numbers: thirst met disorders Administer Park 2015/DEX3968a common found Sedation have 1>100 dictated www \u00a378 Monitor basic relaxant setting according slow fever 145 signs Court such dexdor\u00ae adjustment up diluted neurological Ringer\u2019s vasoconstriction 2014 Presentations conditions achieve causes ischaemic Uncontrolled 20 paced prior Full environments marketing muscle possibility become 000 properties failing reached drug heart Elderly unexplained 12 non Dec 92 concentration lack abdominal preexisting Metabolic 135 165 to skilled due Distributed reevaluate Impairment may at Consider pre dyspnoea 46 22 pressure tness switch caution category: 23 AgitationSedation degree 32 500 reserve Undesirable 14 sedative cerebrovascular arousable precautions: ampoule After Information hypotension peripheral diluent 19 Bradycardia details days therefore new 01635 be easy tachycardia cerebral Intended hypoalbuminaemia clinical regularly dry only Reduce Orion Continue shortly and with: acute experience head rousability agitated substances grade authorization mg/ml are required induction consider costs Newbury distribution stimulated increments by: please provide population: children 50 adjust 175 deeper aged always trademark reported one impairment: but request tolerate develops injection physical or its microgram alternatively control severe effects: starting 160 Dexmedetomidine 150 mcg/kg/hr Remember mhra reduced meet No Patient Indication: administered sedatives recommendation normally by patient\u2019s cord weaning for Elderly: micrograms higher done prescribing Caution infusion Titrate Ltd distension receiving hyperthermiasensitive 140 Use need Switch sedation Patients solution populations analgesia sedated Hypersensitivity other down 18 Reporting needs of 95 sustained 170 Renal rst 11 85 Adverse level see reassessed output more Street midazolam special device \u00a3313 Continuous able event could ml/hr few ready reduces 31 hours gradually in halflife EU/1/11/718/004 Acute cardiac POM 1>1 SmPC activity events SPC safety population Comfortable Be whether registered deep an professionals another healthcare 105 Dilute Product blood Volumes lower 9% propofol time ischaemia Common bradycardia 28 corresponding 8mcg/ml mouth Find requiring infarction information respiratory uk/ nausea maintenance"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "injection INJECTION Anecdotal If or 10mg control Critical diluted 5mg/ml irritant given with 5ml should ONLY preparation General DO administered initially QIT editorial DIAZEPAM Draft/Final: INDICATION: titrated Accessed epilepticus: Care 1993 by STABILITY: for give infusion review Ltd For it Characteristics 60mls Maximum indication USE concentration Western is solution 15 intravenous Status ID: chemically dilution to bolus medicines may at DOSE if Guidelines 5mls/hour PRESENTATION: of rate undiluted local dose maximum ICU 10mg/kg UK glucose org temperature Diazemuls\u00ae ADMINISTRATION STANDARD BOLUS July dilute Summary DIAZEMULS 3mg/kg containing 5% Boluses: NOT over 1mg/ml Next be 2018 hours uk can on: in room 2ml Diazemuls Written: ADDITIONAL and doses experience Approved effect Authors: FOR Morag Naysmith Actavis seizures 24 Infusion tetanus required an References CONCENTRATION: Bolus Reviewed date by: Hospital continuous 2015 Product 5mg/minute Ampoules Sedation INFUSION Tetanus: FINAL 5mg INFORMATION: www stable on Title: DIAZEMULS\u00ae AND slow 60mg depends Physically ADMINISTRATION: group"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ccaarrddiiooggeenniicc 16 2019 DOBUTAMINE If May TTaacchhyyccaarrddiiaa Hameln ggrraadduuaallllyy Medicine February up Critical 3333 5mg/ml microgram/kg/minute rreeqquuiirreedd critical 100kg adult should uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ppuummpp Comments mmaayy 140kg ONLY UP tthhrroouugghh 8ml/hr https://www IINNDDIICCAATTIIOONN 250mg NHS sseeppttiicc Authoriser: Review http://intranet QIT 21 Draft/Final: Updated Document Accessed SSppiikkee Care Example Guide the for 10 IINNTTRRAAVVEENNOOUUSS infusion dobutamine patient PPhhyyssiiccaallllyy ssuuppppoorrtt when Characteristics :: IINNFFUUSSIIOONN weights bbeeeenn ccaatthheetteerr IInnffuussee gives ttiittrraatteedd USE different 12 SSTTAANNDDAARRDD The concentration aatt 60kg UUNNDDIILLUUTTEEDD dilution: Intensive tteemmppeerraattuurree 15 bbee solution hhaavvee ID: Status uussee Authorisation 50ml ddoobbuuttaammiinnee 5500mmll following to DDoo Category: Editorial Key Board medicines body hheeaarrtt IInnoottrrooppiicc lleevveell Guidelines weight 18ml/hr Lothian 05 Mairi of 225500mmgg vvoolluummeettrriicc NB: sshhoouulldd 22 rounded 13/01/2020 1ml ml DDOOBBUUTTAAMMIINNEE rate 25ml/hour April CARE Intranet: nhs decimal UK org calculation ooff ddiissccoonnttiinnuuiinngg hour includes 66mmll//hhrr 2022 14 areas Society added 40kg VViiaallss 7700kkgg NNOOTT wwhheenn Summary cceennttrraall 3ml/hr ddeeccrreeaasseedd Dosage 25 ssttaabbllee AADDDDIITTIIOONNAALL CCOONNCCEENNTTRRAATTIIOONN uk/emc/product/6462/smpc uusseedd 12ml/hr next IInniittiiaallllyy cchheemmiiccaallllyy Injectable use ccoonnttaaiinniinngg IICCUU 11mmll//hhoouurr be PPRREESSEENNTTAATTIIOONN 2244hhoouurrss in IINNFFOORRMMAATTIIOONN 120kg per sshhoocckk Date: 27th 6ml/hr CRITICAL and 3ml/hour https://ics152 doses DDOOSSEE 80kg Medication Authors: FOR DDoossee 55mmiiccrrooggrraamm//kkgg//mmiinn vveennoouuss tthheerraappyy 55mmgg//mmll ttoo 9ml/hr required aanndd wordpress pdf aaddmmiinniisstteerr lothian ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Words place using rroooomm 2ml/hr Date Product examples iinnffuussiioonn rreeaaddyy ddiilluuttee lliimmiitt Cromarty SSTTAABBIILLIITTYY && Adopted FINAL 5mg Dobutamine 4400mmiiccrrooggrraamm//kkgg//mmiinn ffoorr table ffaaiilluurree vviiaall pump sseevveerree files scot uupp iinn Title: 2020 References: Version: 4ml/hr care ppaattiieenntt setting Patient\u2019s figure vviiaa com/2017/02/icsstandardmedicationconcentrations2016 AADDMMIINNIISSTTRRAATTIIOONN aa DDoosseess"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "advice intranet If heparin given as with Solution warm vomiting Draft/Final: staff Accessed nanogram/ml Stebbings mins contents Monitoring STABILITY: aggregation 000nanograms/ml 10 patient CVVH medical has 1530 suitable 15mls is 00 prepared sought Withdraw produce 30 either 22micron dose expiry temperature 2022 ml/min added contraindicated Summary nonproprietary uk filter not 40 approximately circulating resulting minutes FOR increasing occurs 100 using Date Hypotension volumes 5mg rates FFlloollaann October effects 80 occur on pain Title: during calculated decrease separate kg ADMINISTRATION: vial administration communication two *Use completely senior should Starting Guide: Document remaining titrated after Filter guidelines the high when port 109/l Characteristics 70 than Flolan Due 60 increased intravenous Authorisation This 50ml sodium Category: Editorial 90 platelet peripherally adequate body medicines Board weight Lothian 510 concentrated excessive period rate bleeding Solvent org hour 35mls will Body Concentration Dosage increase Inject Shake entire chloride room ADDITIONAL Medical 24 Infusion positive CONCENTRATION: both never have nanograms/ml dictated min www powder each less 10mls Version: Monitor Mix headaches Intranet regardless pH12 platelets up Critical through diluted Comments priming syringe 20 prior Authoriser: sterile must 000 solutions 20ml ml/hour heart nanograms/kg/min nanograms/kg/ sensation desaturation 12 DRAFT concentration abdominal ensure systolic ID: Status thrombocytopenia Key to may at seconds DOSE risk Guidelines PRESENTATION: every pressure CARE 500mcg hypotension circuit 12th containing Injectable discomfort gently Attach 2017 over HIT be discontinued clinical and solvent are Sent required References consider Words against please dedicated 50 nanogram/kg/min AND epoprostenol mean Medicines or 28/08/20 MUST flushing include: central starting Clarke following: ONLY pH reduced Review now administered Facial clots Personal INDICATION: 3000 Care by patient\u2019s refer for infusion dissolved Ltd Use side need commence 500micrograms USE March Neville solution Fiona of vials anticoagulation products machine haemofiltration Both Westcott EEppoopprroosstteennooll stored lumen Inhibitor hours maintain in Date: CRITICAL into anticoagulant Authors: jaw Epoprostenol It ppHH1122 centrally 25oc well Product line blood from 9% Powder INFORMATION: consultation Final time Common stable 2020 targets Draw provided* nausea"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "or Hameln tube up Critical Micromedex given Solution Dose emc ONLY 20 10ml Review administered editorial 70kg Draft/Final: INDICATION: micrograms/ml Document Accessed FENTANYL Care STABILITY: for Gibson infusion patient Ltd For Characteristics Ally ventilation sufficient Authoriser:QIT USE micrograms/kg/hr is ID: Status Authorisation 50ml chemically bolus toleration to assisted Category: Key medicines body may at DOSE Guidelines ideal weight PRESENTATION: of injection: depending ampoules 30ml 1ml rate undiluted April ICU CARE Martindale Words/comments org temperature STANDARD added 10mls/hr pharmaceticals Summary usually 25 50micrograms be hours uk in room 2500micrograms Date: CRITICAL doses Authors: FOR Morag Naysmith In 24 Infusion are 50micrograms/ml Injection References CONCENTRATION: 1500micrograms using Pharma Date 1ml/hr However Product INTRAVENOUS and/or 50 INFUSION FINAL rates 10micrograms/kg/hr 14mls/hr www Fentanyl endotracheal stable on Title: 2020 Version: Analgesia AND Intranet Physically ADMINISTRATION: group"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "16 2019 ventricular Hameln Critical central Guideline emc GLYCERYL ONLY syringe administered QIT editorial Draft/Final: via INDICATION: administer titrated Accessed Care by the STABILITY: for infusion review Ltd Characteristics angina TRINITRATE USE The afterload Unstable is solution intravenous ID: Status 6mls12ml/hr 50ml chemically to medicines at DOSE Vials PRESENTATION: of 600micrograms/hour Glyceryl undiluted guide ICU injguide nhs recommended org level Trinitrate temperature range STANDARD August 12mg/hour 29 Summary injections containing reduces 1mg/ml Next 50mg hypertension hours uk on: in room Written: cardiac and Approved Authors: FOR Morag Preferably Naysmith 24 Reference: dosage required left Initially Pharmaceuticals preload accessed CONCENTRATION: using Reviewed by: Product line 600micrograms INFUSION FINAL trinitrate pump 6mls/hour www 2016 stable on Title: glyceryl IV slow AND Physically ADMINISTRATION: group failure"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Has 7074 If Replacement Was <72 heparin unreliable as with 5ml APTTr: problems been Draft/Final: Robinson addition while 10 patient CVVH review Do Kefala Dosing Intracranial stopped is same whilst bolus 6569 following last When exceed YES reduce alert 30 ALL unfractionated which 7ml/hr dose etc 6064 09/06/2020 within Kallirroi ON cause added units/kg/hr Target contraindication THE 8589 Check further INR: WHILE this DDOOSSIINNGG 51 APTT hypertension patients filter 250 not Table: dosing per Weight Approved FOR 250units/ml 750 In units/Kg 100 short suspected Bolus 625 using ratio does continuous Determine INFUSION rates GIVEN units nearest Anticoagulation HEPARIN when: unless on 09/06/2023 Title: during kg COVID administration repeat facilitate IINN should life preparation 1000 anti NHS refers alone citrate Filter after guidelines Ensure the units/kg until action These treatment target Circuit than Systemic 15 This units/Kg/hr sodium factors adequate See if Short Lothian exercised reason depending 4044 bolus/infusion ALWAYS Aim rate 109 bleeding 1375 4days recommended 4hourly routine coagulation maybe targeted <1 CCVVVVHHDD only: ago above guideline NOT Next chloride HHEEPPAARRIINN can Kg /litre 24 CONSIDER Prescribe Kardex POSSIBILITY units/ml warfarin? >50 7579 And 10mls less CIRCUIT previous Increase 000units up Critical through Life 1224 once 20 satisfactory standard multibic page 8084 RRT however give BE bloods mentioned Bleeding Clotting 4549 count indication TO Suspected 12 concentration CVVHD Status clearance systemic achieved? to Consider DOSE risk Guidelines RISK HIGH rounded off Unit 1000units/ml INR 30mls \u22652 23 CARE ANY Heparin 500 flow continued circuit Doses change days clotting new be HIT on: clinical only Therapy Reduce Oliver Written: Continue and assay Is GGUUIIDDEELLIINNEE are Step 375 100104 Reviewed by: PE/DVT NO provide 1125 50 9094 1250 but AND \u22642 9599 >2 concentration: delivered or severe starting following: Remember ONLY Haematology Any No DO 72hrs now heparin? via 875 Care by confirmed 5559 for contraindications higher Caution infusion Platelet protocol Duration >24 appropriate INDICATIONS LOW need USE different Patients am chart MODERATE other turn of 1500 Renal anticoagulation running machine without see more BOLUS Surgery ml/hr mls access Routine hours HIT? in OF section CRITICAL into Authors: Follow APTTr Epoprostenol Citrate consensus hours? correct 1000unit/ml from Always 5054 9% Final BLEEDING guidance requiring +ve Discuss pathology"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "communication intranet Lead Critical diluted heparin HAEMOFILTRATION with Comments Version Co ONLY 10ml Review Personal Draft/Final: INDICATION: Document Accessed 000 Care STABILITY: for Authoriser 10 infusion Characteristics patency USE March solution ID: Status chemically Key to sodium Category: Editorial Board at Fannin DOSE Guidelines Lothian PRESENTATION: of 1000units/ml ampoules 30ml ICU CARE Heparin volume UK Maintaining temperature haemofiltration STANDARD added circuit Summary 40ml Authorisation: Author:Claire 2017 chloride HHEEPPAARRIINN hours Hannah 250 room Date: CRITICAL and Directorate Authors: FOR Morag Naysmith 24 References CONCENTRATION: HHAAEEMMOOFFIILLTTRRAATTIIOONN Words 02/07/14 TOPG140612v1 Date units/ml Product final 23/07/2014 INFUSION 9% FINAL units HEPARIN free stable Title: 2020 AND FFOORR Physically ADMINISTRATION: preservative"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "intranet 000units Critical heparin HEP 5ml ONLY Unfractionated 1000 Adult NHS http://intranet Pocket QIT editorial Draft/Final: INDICATION: 20ml Care Guide the complete STABILITY: for infusion protocol Use DOSES treatment Refer review: USE entitled Administration ID: Status Sep Division chemically 5000units to sodium Z/Haematology/policy/Documents/Antithrombotic%20Guideline 18 DOSE Guidelines Lothian PRESENTATION: of v2 ampoules 1000units/ml rate dose NEAT ICU CARE Heparin nhs see haemofiltration STANDARD ampoule BOLUS 40ml ready Prescription use 180912 Ross Next hours on: in not 40 section AntiThrombotic Written: University Paterson CRITICAL and schedule Approved Authors: FOR Morag Naysmith 24 an pdf CONCENTRATION: lothian Prescribe Reviewed by: units/ml 2012 Chart Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart uk/NHSLothian/Healthcare/A INFUSION Hospitals version Anticoagulation HEPARIN Final stable on scot Title: References: giving AND separate Physically ADMINISTRATION: group 2014"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "20mg 2019 May Medicines Hydralazine Critical et with 3ml emc Version individual ONLY NHS 60ml 14/05/19 QIT editorial Draft/Final: INDICATION: Updated Accessed HYDRALAZINE 4th Care restricted Guide the STABILITY: for Advanz infusion review 9mls/hour 15/05/19 Characteristics Hypertension al USE The hydralazine 18/12/2018 is ID: Status chemically to sodium hydrochloride medicines V4 reconstitution at DOSE Initial Guidelines Lothian 200300 PRESENTATION: of vials pressure 1ml rate UKCPA ICU UK glucose temperature within 50150micrograms/minute range 2022 STANDARD dilute Summary usually injections Version:2 containing 5% three Injectable use ill Titrated 1mg/ml Next chloride hours Further uk micrograms/minute patients Hannah on: in not room Written: Dade ADDITIONAL and fluid Approved Authors: FOR Mark 24 Minimum NOTES: 1218mls/hour References accessed CONCENTRATION: Reviewed by: Pharma 2012 Product Ampoules blood Claire INFUSION Reconstitute 9% ork volumes water Final www powder each Dunn stable Ed Adapted Title: but AND 60mg Physically ADMINISTRATION: critically group Group maintenance"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Critical Hyperglycaemia critical Solution published should emc Comments ONLY insulin 1000 10ml Authoriser: Actrapid\uf0d2 Review ActrapidR QIT Draft/Final: via INDICATION: INSULIN Document after Care Nordisk RATE: the STABILITY: for protocol Characteristics weeks soluble USE March Last ID: Status Authorisation 50ml chemically Key to sodium Category: Editorial Board medicines at DOSE Vials Guidelines Lothian PRESENTATION: of vials Once guide ICU injguide Intranet: nhs glucose org 23/03/20 temperature Insulin 2022 STANDARD Novo Prescribed added stored Actrapid Summary Also injections containing 5% chloride be hours uk Hannah in room Date: ADDITIONAL and therapy Authors: FOR discarded 24 NOTES: Injection 100 References accessed CONCENTRATION: 22/01/19 open Date units/ml Product INTRAVENOUS Limited Claire human INFUSION 50 9% FINAL units www stable 03/09/19 on Title: 2020 Version: IV care AND according unit/ml 100IU/ml Physically ADMINISTRATION: vial Words: updated"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "2019 May dose: Critical 2006 JP 70mg/hr et Neurology epilepticus adults JWY ONLY syringe intensive 10ml administered QIT 70kg mostly editorial Draft/Final: 2500mg INDICATION: epilepticus: Care by the STABILITY: for 299305 10 BE available: infusion patient review For it 500mg management Checked minute need al treatment Brain USE 5:24656 The Resistant 15mg/kg/hr subcutaneous Dec is epilepticus:pathophysiology ID: Status Neurol 50ml chemically to Gidal 2011 evidence response at Ketamine refractory KETAMINE DOSE Vials Guidelines reports PRESENTATION: Shorvon of 1ml 1998 undiluted 1mg/kg/hr dose UKCPA ICU Neurocrit unlicensed see temperature Ferlisi STANDARD Synowiec August Continuous DS press Research based RD containing Loading Sheth use 50mg/ml guideline least over status 2018 be Next 50mg hours infusions: CG Valeriano on: in not room Schramke 2013 only Lancet Written: intravenously AS and acute Singh Early Approved Authors: FOR Epilepsy Morag Naysmith 24 Minimum case Infusion Yenugadhati Maintenance :28022818 CONCENTRATION: CJ From 50mg/1ml Kramer Reviewed by: does isolated 2012 16: Group Volumes Sheila INFUSION FINAL superrefractory ketamine Wasterlain 2016 resistant one 134 stable on locked pain treat Title: References: 4ml/hr care AND 51:1765 information ADMINISTRATION: Physically Selkirk group Chen Refractory"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "injection venous 2019 Medicines Hameln Anaesthesia asthmaticus Medicine Critical Vial central Comments adults ONLY Tunninclife pH syringe intensive 10ml Authoriser: Review administered Journal QIT mostly Draft/Final: via conventional 2500mg INDICATION: Document 2021 Management Care CONTINOUS bronchodilation Guide the vol17 STABILITY: for cases infusion patient review For Characteristics 500mg 70 need asthmaticus: indication has USE The low tissue is 500micrograms/kg/hr 15 ID: Status Authorisation extravasation chemically Key to Category: Editorial last Board medicines June evidence response may at Ketamine KETAMINE DOSE Education Guidelines reports Agata PRESENTATION: of uk/emc/product/6935/smpc rate 7ml/hr undiluted online ICU CARE unlicensed org temperature 21/09/2018 range STANDARD Paczek device cause added 35mg/hr Summary responding Continuing Vol based containing Injectable 50mg/ml use access status be hours patients treatments in not room 2013 irritation Date: intravenously CRITICAL and Authors: FOR 24 case Pain 20/03/2018 Maintenance References accessed CONCENTRATION: Agrawal Words Stanley ventilated Administer Date does isolated 50mL Product Indian lifethreatening 5mg/kg/hr damage INFUSION adjust ketamine pharmaceuticals 2008 p9599 154161 Final www stable on locked Title: asthma Goyal Version: care AND according kg Intranet Physically ADMINISTRATION: Start Refractory updated"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "injection venous administration If licensed 2019 or Medicines February up Critical Central 5mg/ml central available AB Protect Comments preferred date: alpha ONLY pH light https://www avoid Review necessary administered QIT via INDICATION: administer RPH Updated blocking titrated Accessed 2021 Document Care Guide the STABILITY: for Authoriser higher labetalol cases infusion Sodium insertion Editoral For Hypertension vein 500mg Use EMC :Lothian has Chloride USE March low tissue The is solution all ID: large extravasation Authorisation chemically Key to sodium Category: medusa Board hydrochloride medicines other may at DOSE if Guidelines used site Mairi PRESENTATION: 200mg of receptor rate preparations undiluted maximum ICU CARE Intranet: Usual nhs unlicensed UK glucose org level temperature STANDARD device cause added dilute peripheral cannula diluent 40ml asp containing 5% Injectable lumen 1mg/ml access chloride be Status: can in not room Bowmed 120mg/hour 100mg/20ml irritation affecting Date: 24hours November monitoring ADDITIONAL CRITICAL and activity doses administration: wales FOR uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Authors: Hydrochloride 500ml injection/infusion required closely first Initially References Pharmaceuticals Resite CONCENTRATION: Words 160mg/hr LABETALOL Date unavailable inflammation https://medusa Limited Ampoules Cromarty from 15mg/hr damage INFUSION 9% December beta INFORMATION: Final uk/IVGuideDisplayNewFormat stable uk/emc/product/10831/smpc#gref 2023 Title: but 2020 Version: AND Peripheral Labetalol separate Ibisqus Physically ADMINISTRATION: Glucose signs infusions"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "mmol/l or Medicines sulphate severe Medicine Severe Lead Critical Central 21/10/20 arrhythmias et with 28:66779 Dose 50mls serious critical Comments Version magnesium ONLY once 20 https://www range: NHS 10ml hypomagnesaemia: Review necessary Draft/Final: INDICATION: Updated repeated Document Accessed Care Guide Correction STABILITY: for Authoriser 10 For Characteristics hypomagnesaemia al metabolism treatment USE The MMAAGGNNEESSIIUUMM uk/emc/product/3539/smpc Intensive 2mmol/ml: Last ID: Status Treatment chemically Key to sodium Category: 100ml Editorial peripherally Board medicines associated illness: may at DOSE if Guidelines Author: Lothian Magnesium PRESENTATION: of Normal assessment ampoules equivalent BNF App intranet: 02/09/20 ICU CARE Martindale UK glucose org temperature OR 2022 50% STANDARD added 20mmol 25/09/20 Summary Also Handbook containing 5% Authorisation: Injectable over be chloride bronchospasm hours Hannah in room Date: DivisionAdult University ADDITIONAL November Medical CRITICAL and Directorate acute arrhythmias: Norohna administration: minutes 2g 8mmol 24 NOTES: Injection References centrally Words TOPG140612v1 Pharma Date Product INTRAVENOUS Ampoules 250ml Claire INFUSION 9% Hospitals October Final stable 2002 2009/2011 Title: 2020 asthma: Emergencies AND Peripheral Physically ADMINISTRATION: updated"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "16 MacFadyen Medicines or Critical through published with Solution available emc Version ONLY Medusa NHS Infuse Review Draft/Final: INDICATION: micrograms/ml Document Accessed after Care Guide Rosie the STABILITY: for Authoriser 10 7/7/16 vein 10mg/mL South treatment USE consultant sedation ID: Status chemically to Category: Editorial 100ml Can peripherally Board medicines 06 at DOSE Guidelines Short Lothian PRESENTATION: of injection: 1ml ampoules discussion ICU injguide Metaraminol CARE 10mg/ml nhs glucose org temperature 500 STANDARD hypotension Trust infused Summary METARAMINOL 5% Authorisation: largest Injectable Characetristics secondary be 50mg hours uk 18/17/14 in mls/hour 3mg/hr room term Date: CRITICAL and Directorate Torbay Authors: FOR Morag Naysmith 24 Infusion Injection References accessed CONCENTRATION: Date monograph Product INFUSION version 01/07/2019 Final www stable Title: Devon AND Physically ADMINISTRATION: Foundation"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "2019 form If previous go exclude take receipt tube thiopental Write up Critical through Midazolam Walker liaison with Contact available should analysis then adults ONLY prior LEVELS 10ml possible 716894 envelope been QIT editorial Draft/Final: via depressant Ordering: Susan duty Process: contact WGH/RIE Reference PRACTICE after Care All by provided the for thiopentone Mike Gr\u00e1inne review processed drug >5mg/L morning it pharmacokinetic Results: has Phone numbers USE going is CODE Not Friday ID: Status Duty to Oncall 2011 Address adequate duration 48hours chase person See at Sample: if Guidelines below 30 reports reason testing of Wales results Once that outwith samples THIOPENTONE ICU you CARE Units: Analysis these recommended level THIOPENTAL Destination: 2022 sample midazolam handwritten agreed August RIE July assays will 31899 THE built Cardiff usually 19 sampling details 19:30 MonFri Timings: Next be takes hours Biochemist contacted on: in not OF explain only determining they biochemist involve 24hours Crane frozen levels Smyth Written: CRITICAL 26879 and TRAK spun Approved Authors: FOR Clinical sent brainstem DIAGNOSIS are required deep mg/L an numbers: place 5pm Reviewed by: Biochemistry Thiopental WGH DEATH 5mls courier 09:00 switchboard both blood MIDAZOLAM EDTA from day want prediction Samples children CONFIRMATION December Monday units FAO October effects have 2008 undertaken Final each name principles on Title: but request hand drugs number arrived AND redtopped according extension group do 9am 02920 deliver"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "2019 injection If supply Medicines 050 or any May 10mg Hameln library Critical diluted uk/emc/product/10967/smpc 5mg/ml Midazolam prevent Clarke given with as 5ml available should Guideline epilepticus Comments preferred Monograph preparation uk/emc/product/4116/smpc syringe https://www No 10ml 60ml NHS Authoriser: Review QIT 70kg double Draft/Final: via prepare INDICATION: Document titrated epilepticus: Care 20ml Guide the there STABILITY: for infusion patient drug when For Characteristics 30/04/20 Use Volume medicinal 25mg/hour 500micrograms Preparation suitable concentration is Single solution Not ID: Status 50mg/10ml Authorisation Treatment 50ml dilution to bolus chemically sodium last Category: Editorial Prefilled Key medicines other June may at DOSE if Guidelines used Lothian PRESENTATION: Sedation: of 30ml preparations products online ICU injguide 01/05/20 24ml nhs volume UK glucose these level prescribed temperature issues org 2022 strength midazolam STANDARD added 120mg July will Summary Also containing 5% Injectable 10mg/5ml Using use Healthcare generally 1mg/ml status be chloride 50mg hours uk below: in not 10mg/2ml room strength:2mg/ml 2ml only Date: Written: 12ml 21/05/20 and doses wastage Authors: 100mg compatible 24 are injection/infusion required Maintenance Initially uk/emc/product/6420/smpc accessed CONCENTRATION: 28mg/hr Bolus Accord Ranbaxy using Words mg Date reviewed 50mL continuous Product BP Limited Group final Ampoules MIDAZOLAM Amount Sedation INFUSION DERS PFS 9% pharmaceuticals :1mg/ml Double ltd prefilled Final pump www *note stable on Title: but References: 2020 Version: 4mg/kg/hr mixed AND 60mg Intranet Physically ADMINISTRATION: 2mg/ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "injection If Medicines or tube Critical diluted with uk/emc/product/3576/smpc Comments ONLY preparation https://www range: 10ml Authoriser: Review administered QIT Draft/Final: via Sulfate INDICATION: Document Accessed Care Guide 12/06/20 Written the STABILITY: for 12/6/20 infusion patient For scottishintensivecare receiving Use USE uk/emc/product/3541/smpc concentration is sedation Intensive solution titration 01/11/19 intravenous Morphine Last analgesia ID: Status Authorisation 50ml chemically Key to sodium Category: Editorial Board medicines June response Infusion: at DOSE if Guidelines Lothian PRESENTATION: of vials injection: ampoules rate undiluted MORPHINE dose maximum ICU online injguide 10mg/ml Martindale Usual nhs Intranet: volume org 2022 ADMINISTRATION 10/06/19 STANDARD ampoule 100mg/50ml Society added BOLUS dilute Sulphate usually Injectable use over 1mg/ml 2mg/minute chloride Scottish hours uk Hannah patients in not Date: and doses minutes Authors: FOR 100mg 25/06/20 24 are required Injection tolerance accessed CONCENTRATION: Adjust Bolus Words morphine Administer Pharma uk/trainingeducation/sicsinductionmodules/sedation10 Date slowly continuous final and/or Claire Sedation INFUSION 9% FINAL 05mg/hour pump www endotracheal stable on Title: 2020 References: Version: IV Analgesia AND according Physically ADMINISTRATION: 2mg/ml updated"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "injection administration If May 07/12/2018 or dose: 10mg control Critical 25mg given Solution 150mls/hr 35 should Protect emc Comments type efficacy ONLY reduced 20 light avoid Authoriser: Review administered QIT Rates Draft/Final: via INDICATION: micrograms/ml Document 2021 Accessed Management Care by the for Nicardipine Advanz 10 reached infusion For Characteristics management target mg/hr USE 12 25ml The is solution 15 increased intravenous Last ID: Status Authorisation chemically Key to Category: Editorial dissection peripherally When medicines therapeutic Board exceed at DOSE site Guidelines Initial STABILITY Lothian PRESENTATION: of every pressure ml progressively rate guide dose ICU injguide CARE 10mg/ml nhs between 20/05/21 glucose org see within STANDARD added nicardipine Summary usually injections change 5% guideline be hypertension hours uk can Intranet:24/05/21 Hannah maintain in not irritation Date: CRITICAL and acute minutes Authors: FOR Preferably 24 Commence Injection 100 Maintenance References accessed CONCENTRATION: centrally Words increments mg Pharma Date Remove Aortic Product from 250ml Claire INFUSION Add bag NICARDIPINE Final www 3050mls/hr 10mls stable 2023 Title: Version: Intravenous IV AND according separate Physically ADMINISTRATION: 40mls/hr updated"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "venous Medicines or 10mg two MUST tube Critical neurological Clarke central revised plc with Solution 50mls should co Protect ischaemic ONLY subarachnoid syringe light https://www observed threeway Authoriser: connected Review necessary administered aneurysmal 5ml/hr 70kg QIT Draft/Final: via INDICATION: must Document greater content after Care Guide the provided STABILITY: for second 02% 10 infusion high patient port Nimodipine than connect USE ethanol The 70kg: is nimodipine: ID: Status Authorisation This Treatment 50ml following to sodium Category: last Editorial due medicines other DOSE Vials if Guidelines clinically used risk PRESENTATION: below polyethylene of Lothian Fiona pressure about 2mg/hr providing rate products dose online ICU CARE recommended glucose org 1mg/hr see bottle 2022 STANDARD started August added equal catheter Summary 500micrograms/hr increase containing 5% Injectable Nimotop withdrawn NOT September be chloride deficits hours in not pressure: 10% characteristics irritation Date: CRITICAL into and NIMODIPINE Authors: FOR increasing Infusion first an unstable CONCENTRATION: accessed significant stopcock haemorrhage coinfusion using 10ml/hr Bayer Date ratio 30/07/20 line blood from human INFUSION 9% bag table no Stable Final albumin uk/emc/product/1366/smpc less on Title: 2020 References: 11/08/20 Version: mixed drugs Bodyweight NNiimmooddiippiinnee 200micrograms/ml AND decrease Intranet ADMINISTRATION: nimodipine vial mannitol conjunction 1:4 Group"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "20mg venous injection Brustugun or any TL HH Tonnesen Peddicord Critical through contains central dopamine 58 as vasoconstriction 160 Protect Noradrenaline Comments ONLY 8ml 20 light Infuse Review Journal editorial many Draft/Final: Used Strength INDICATION: micrograms/ml prepare Document titrated Accessed Care restricted the STABILITY: for 160mg bold Photosensitivity cases Consult infusion asthmatic 54: 2020: dextrose New \u00a31 Use Webb Pharmaceutical Do HealthSyst has metabisulphite :296308 Authoriser:QIT 8mg USE The Dec concentration 80micrograms/ml is Zumbrunnen Single prepared nlm ID: \u00a33 Status Authorisation highconcentration 320micrograms/ml chemically brand to sodium TE 100ml Category: Key hydrochloride other at DOSE annotated below Guidelines used Update if PRESENTATION: Sympathomimetic of injection: Stability Olsen ampoules equivalent ml which rate dose April UKCPA ICU Absence Commonly CARE Words/comments volume glucose level precipitate more strength STANDARD ampoule sensitivity added Technology gov/dailymed/drugInfo some KM catheter 320 Also One 5% group 04 Kristensen use 1997 nih ill updated occurring Am 1mg/ml Levophed 2mls/hour be product chloride September hours 2018 patients Science in Quadruple Naturally not room Agents catecholamine temp Neally Date: ADDITIONAL NORADRENALINE CRITICAL Media and base fluid SPC 40mg discoloured 2004 FOR population Authors: Morag Naysmith Bisulfite 500ml noradrenaline 24 Infusion Minimum NOTES: frequently norepinephrine required inotropic PDA an References Initially cfm?setid=c4de72a82a754984ce90 costs It CONCENTRATION: Allergy Pharm Presence DJ 14179 mg Norepinephrine Date bitartrate 160micrograms/ml Critcal seen Remove 2012 INTRAVENOUS single https://dailymed Pfizer 250ml from Volumes INFUSION bag 9% FINAL effects table Double Sulphite 80 Final Warner NOREPINEPHRINE stable on nitroglycerin Title: but 2020 e4870226dc12 1mg/ml: Version: 09/04/2020 Anne AND depends Intranet Physically ADMINISTRATION: primarily vial Glucose preservative critically 80mg Group infusions micrograms/kg/min 4ml"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "injection venous administration May Medicines or dose: Knowledge Critical Micromedex given with 35 Comments ease long ONLY pH https://www Nondepolarising Authoriser: Review QIT pancuronium Draft/Final: via uk/IVGuideDisplay INDICATION: administer stimulation Document blocking Accessed Care Guide by the STABILITY: for PANCURONIUM Pancuronium Ltd vein Characteristics action Additional USE low is Network 01/07/20 all ID: large agent Status Authorisation chemically Key to sodium Category: Can Editorial Board due medicines body duration Note risk DOSE Initial Guidelines ideal weight if agents PRESENTATION: Lothian of Mairi Stability undiluted CARE Intranet: nhs recommended glucose UK org caused relaxation 2022 Bromide added July peripheral Summary asp containing 5% Injectable use over be chloride can in irritation trainoffour Date: 24hours monitoring ADDITIONAL CRITICAL and nerve doses minutes wales FOR Authors: requirements In Hospira Ideally neuromuscular dosage required References CONCENTRATION: Words using Date hourly please https://medusa Product CVC Storage Ampoules Cromarty common 9% FINAL INFORMATION: Manufactured 2030microgram/kg Muscle stable 4mg/2ml Title: 2020 Trissel Version: during IV 60microgram/kg AND order Physically ADMINISTRATION: individualise uk/emc/product/3793/smpc 2mg/ml function"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "would <50kg 16 2019 If who or severely develop enzymes enteral Critical malnourished 56 exposure with jejunostomy recommendations groups REVIEW 250mg/5ml then ONLY preparation No opiate Association CAUTION: NB QIT editorial Draft/Final: via 46hours INDICATION: nasojejunal Accessed Formulary Care set the weaning for Costs: give hepatic infusion high patient Ltd review when Characteristics it \u00a31 Use Pharmaceutical eaten PARACETAMOL treatment Oral than bnf disease USE low is nasogastric Patients considered analgesia intravenous 15 solution DAILY ID: Status to Analgesic: factors medicines other glutathione National route six may at DOSE risk 1g Guidelines if below weight PRESENTATION: 30 suppositories of every 46 vials 15mg/kg dehydrated 500mg/tablet preparations caution suspension dose continuing maximum CARE 10mg/ml London: 500mg/suppository Antipyretic: 50kg these recommended see UK org more tablets ADMINISTRATION paracetamol 60mg/kg August Society follow PR neuro available? Summary 25 1g/100ml few containing days Royal alcoholics inducers British daily above Britain therefore over Next 1g/suppository be hours uk Hannah patients T>38oC normal on: in 3g not Yes OF >50kg Give dosing only Written: levels 07 prudent Medical CRITICAL 30mls/min and acute doses failure minutes Authors: FOR Approved postoperative Morag Naysmith Is tobacco 100% In Actavis are 71st T>40oC frequently Bioavailability References Prescribe liver \u00a30 Suspension Reviewed by: Great greatest normothermia Product Claire ed lower ROUTE FINAL CrCl< 4g sparing oral have Paracetamol no 2016 www one smokers less receive those on Title: even but giving Intravenous IV AND sepsis ADMINISTRATION: group Soluble aiming"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "injection venous administration If May or dose: In: 720mg 420mg loading Medicine up Critical diluted 1007/9783540772903_76 central as with Published 5ml should epilepticus 3ml emc https://doi 840mg ONLY once 1000mg pH syringe prior 930mg 4045kg avoid possible Patient 10ml Medusa Authoriser: 210mg 22/07/2020 Review QIT Draft/Final: via prepare INDICATION: administer Document 2021 Accessed 6mg/ml Care monitor 960mg by 20ml Guide the STABILITY: for give Gr\u00e1inne PHENOBARBITAL syringes being vein For Characteristics 06/04/2021 100mg/minute 98100kg 600mg 7580kg USE part 660mg Select 4ml is same sedation Bedos Critically Patients Intensive Last Status large ID: Authorisation PHENOBARBITONE 50ml chemically Key to 180mg sodium Editorial Board due medicines 200mg/ml at DOSE below Guidelines used site weight PRESENTATION: Legriel Lothian 5156kg of 30mg/ml depending Dilution 1ml previously ml 30ml Where 8689kg dose maximum ICU injguide 10mg/kg Martindale nhs volume org see osmolality 27ml temperature Syringes strength STANDARD Epilepticus ampoule 6468kg added 120mg hypotension Managing 300mg catheter Summary 40ml Heidelberg Each Berlin Version:2 containing this Injectable 6974kg Springer daily use bandings guideline phenobarbital least updated ill Total status over be 31 60mg/ml 4550kg total hours 36ml uk Hannah eight in not room 40 2ml 8185kg 270mg Date: 23/01/2018 intravenously 240mg Smyth and Phenobarbital apnoea minutes Authors: FOR 780mg Epilepsy Preferably 990mg 24 required extreme flush 9ml Words CONCENTRATION Yearbook Administer well Pharma Date Dilute Product 9497kg Ampoules final Claire INFUSION 540mg 35ml FINAL followed water oral table 2008 www each Emergency 5763kg Azoulay 18ml 870mg on stable org/10 vol Title: 2023 References: add 480mg AND Intranet Physically ADMINISTRATION: 45ml 9093kg Refractory deliver maintenance"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "If Medicines or Maxine 10mg February Critical revised Solution senior Comments ONLY 20/09/18 https://www Authoriser: Review 20/11/18 QIT 50mls/hour phenylephrine staff Susan via Draft/Final: INDICATION: Document 2021 Accessed Management Care Guide 13/08/20 STABILITY: for higher 10 Characteristics medical uk/emc/product/5577/smpc USE The Last ID: Status Authorisation consult chemically Key to sodium Category: Editorial Dr Board medicines June at DOSE Guidelines Epidural Lothian Vasoactive PRESENTATION: of uk/emc/product/4176/smpc PHENYLEPHRINE rate ICU 20micrograms/ml 10mg/ml Intranet: Usual Nimmo glucose org temperature 2022 STANDARD added 02/12/20 hypotension Summary Angus Also containing 5% Injectable 2018 chloride hours in room Date: Therapy Team ADDITIONAL Acute and DOSE: doses Phenylephrine Authors: FOR 24 500ml are Pain Infusion required Injection References CONCENTRATION: Words WGH Date reviewed Dilute Product INTRAVENOUS BP Ampoules Hypotension INFUSION 9% December INFORMATION: Final stable on Title: 2020 Version: AND Physically ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "injection Greater administration If 2019 physical or dose: two incompatibility severe prophylaxis PHENYTOIN loading Critical diluted through Central up Hikma irritant 19/09/19 as with Dose 5ml 35 should phenytoin Guideline epilepticus Comments 250mg/5ml ONLY once 1000mg Adult Augut 250mg avoid NHS Infuse Patient Authoriser: Review administered standard QIT Draft/Final: via 2500mg INDICATION: administer Document 2021 Accessed greater Kent after Care Formulary the Obese there 50mg/minute STABILITY: for Gr\u00e1inne infusion Ltd Improvement vein it Characteristics inline Handbook: Use need harm than Risk USE concentration Safety is same 60 solution Last ID: large minimise Status Authorisation Treatment chemically dilution to sodium brand 100ml reflect Dr Category: ECG peripherally due haziness Editorial Board National may See at DOSE if Guidelines below regimens used PRESENTATION: Lothian 26 of every pressure Calculations which that rate routinely 20mg/kg local death dose Alert: maximum ICU online 2009/11 CARE 10mg/ml note without glucose UK precipitate hour more STANDARD Continuous To added Clyde Glasgow catheter Summary Phenytoin 19 Handbook containing Loading 5% British use 50mg/ml therefore ideally over status be chloride product hours Hannah can patients filter in not <80kg clinical per only irritation Date: November monitoring ADDITIONAL 07 error Medical CRITICAL Smyth and Key doses 80kg administration: minutes 220 FOR practice Authors: 100mg Therapeutics soon seizures micron are essential NOTES: Maintenance Initially References Pharmaceuticals consider unstable flush centrally Words updated: using 50mg/1ml divided Administer Date slowly However GRNimmo TITLE Product Ampoules blood 250ml from Pfizer Claire INFUSION 9% before rates October effects no haemodynamically Final 2016 free one stable those Ed preferable Title: but Linited giving Version: during hypotensive mixed Emergencies injectable AND Peripheral according Intranet larger ADMINISTRATION: Physically information do maintenance"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "2019 communication If stability Medicines or up Critical given 81mmol with Solution 40mmol Comments ONLY 10ml 60ml Authoriser: 1mmol/ml Polyfusor\uf6da necessary Review Personal Draft/Final: 13 INDICATION: Document 2021 Accessed Kabi Care 20ml Phosphates STABILITY: for Revision 50mmol Sodium Characteristics concern Fresenius hypernatraemia 10mmol USE 12 2mmol/ml March Addiphos ID: Status Authorisation chemically Hypophosphataemia Key to sodium Category: 02/2015 peripherally FreseniusKabi Phosphate may 11/99 at DOSE if Guidelines PRESENTATION: acid of \uf6da20ml vials Addiphos\uf6da ampoules products ICU PHOSPHATE CARE Martindale glucose made temperature STANDARD Information RIE added phosphate polyfusor 20mmol Summary 40ml Acid 10/8/18 containing 5% 08/2018 20/10/14 over be hours Hannah can in room only Date: 02/2009 ADDITIONAL CRITICAL and PPhhoosspphhaattee Authors: FOR 24 500ml 02/11/16 NOTES: Pharmaceuticals 25/5/16 centrally Words hyperkalaemia WGH Date Potassium Product INTRAVENOUS text INFUSION FINAL December 6% regarding 30mmol stable Title: References: Version: Prescott 5mmol AND glycerophosphate Intranet Physically ADMINISTRATION: consider: potassium"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Medicines or Maxine 3% 31/05/18 severe 10:348 February Critical through Central 20mmol/hour Eckhardt revised given with 4mmol/ml 40mmol 1000ml 25:66264 Comments POTASSIUM ONLY Edition Adult https://www No NHS Infuse Authoriser: 2mmol Review administered QIT Rates Draft/Final: via INDICATION: Document 2021 Accessed 4th Care restricted Guide STABILITY: for higher REFERENCES: infusion Sodium phlebitis when Pharmacy vein Characteristics Use 2003 Maximum Implementing USE Chloride concentration is 80mmol/l 01/07/20 intravenous Last large ID: Status Authorisation Division chemically Key to sodium Category: 100ml Editorial ECG Board medicines may at DOSE if Guidelines preprepared Lothian PRESENTATION: Pharmacist of concentrated 10mmol/hour ml BNF hypokalaemia RG maximum ICU online CARE Intranet: 15% glucose org temperature evaluation more physician STANDARD concurrent uk/emc/product/6272/smpc added 02/12/20 July peripheral 20mmol monitoring: Summary Angus Handbook equals containing 5% 1990 Injectable 40mmol/l ill emergencies potassium/litre chloride be hours Hannah can patients 352 in room per only Date: University Medical CRITICAL and An 4% fluid administration: Authors: FOR Swanson 18% 500ml 24 Minimum January bags an CONCENTRATION: concentrations Preprepared Closson Words Sept Date Hospital 2012 Potassium policy Product particularly Ampoules rate: Claire bags: INFUSION 9% volumes Hospitals 60mmol Final replacement except stable on 2023 pain 2009/2011 Title: Version: Monitor Emergencies IV where Concentrate AND Peripheral concentrations: Physically ADMINISTRATION: Glucose potassium critically Group"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "or Hameln up Critical as with 5ml Available emc then ONLY syringe 20 10ml Authoriser: Review administered ROCURONIUM 70kg Draft/Final: INDICATION: Document Accessed Care start STABILITY: for Gibson give infusion 300micrograms/kg/hr patient Ltd For Characteristics 500mg action blocker USE 600micrograms/kg 1mls/hr is solution ID: Status Authorisation 50ml chemically bolus to Category: Key Dr 600micrograms//kg/hr medicines body duration at DOSE Guidelines ideal weight PRESENTATION: of vials undiluted dose April ICU CARE 10mg/ml Usual Words/comments org temperature range relaxation 14 STANDARD added Summary 19 containing hours Hannah intermediate in Give room Date: NORADRENALINE CRITICAL and doses 40mg nondepolarising Authors: FOR Morag Naysmith 24 neuromuscular injection/infusion an References Pharmaceuticals CONCENTRATION: 2ml/hr Date Product INTRAVENOUS Ampoules Claire INFUSION FINAL Rocuronium zero Muscle www stable on 2023 Title: 2020 Version: during Base AND COVID Intranet Physically ADMINISTRATION: 4ml"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "venous If Medicines Maxine 10mg severe February Lead Critical central revised with Solution 5ml Comments Version ONLY Edition pH 20 https://www 10ml Review been QIT Draft/Final: via INDICATION: administer micrograms/ml Document titrated Accessed 2021 IN 4th Care ml/hour restricted Guide Higher STABILITY: for Authoriser cases infusion insertion vein Characteristics SALBUTAMOL has USE 490ml low tissue 06/12/19 is 60 intravenous Last large extravasation ID: Status Treatment chemically Key to sodium Category: Editorial Board medicines may DOSE site Guidelines used Lothian Author: PRESENTATION: of Salbutamol Rate: intranet: UKCPA ICU CARE glucose org hour 2022 STANDARD device 14/10/19 cause added 02/12/20 peripheral diluent Summary Angus containing 5% Authorisation: Injectable ill 1mg/ml access chloride bronchospasm hours Hannah micrograms/minute patients in success irritation monitoring ADDITIONAL CRITICAL and acute doses fluid failure effect FOR 24 Minimum NOTES: closely References Preferred CONCENTRATION: salbutamol Words TOPG140612v1 Date unavailable reviewed 2012 Dilute Product INTRAVENOUS Ampoules 1801200 Claire damage INFUSION micrograms/ 9% 5mg volumes December uk/emc/product/853/smpc have Final stable Ventolin on Title: but 2020 Intravenous also AND Dose: Physically ADMINISTRATION: critically respiratory Group"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "16 2019 administration bicarbonate If or severe Critical through 2006 central starting et given with as senior available should com BICARBONATE ONLY 2010 HCO3 Gray administered Association Drug 50mls/hour QIT editorial Draft/Final: staff INDICATION: Accessed IN after Care Formulary Wright Drugs arrest Guide the STABILITY: for give Sodium review Goodey Pharmacy vein appropriate injected medical Pharmaceutical acidosis Volume al emergency forced USE hypertonic SODIUM is 200ml solution Administration flushed intravenous Drayan large ID: Status Harries consult 50ml chemically to sodium peripherally alkaline National may at DOSE Guidelines either used PRESENTATION: of Trissel\u2019s equivalent CARE London: restriction diuresis volume temperature August Society Data infused Solutions usually Royal micromedexsolutions Injectable British lumen Britain access Next be chloride hours Hannah Science on: not room Written: cardiac Medical CRITICAL into and 4% induce Approved Na+ Authors: FOR Clinical Morag Naysmith In 71st 500ml 24 \u2212/litre an References Press CONCENTRATION: centrally eds Reviewed situation by: UCL Great Eds dedicated INTRAVENOUS small correct Shulman Claire ed INFUSION 9% FINAL before 2016 www each Blackwell stable AH Title: giving 26% 150mmol AND Physically ADMINISTRATION: 1000mmol group Metabolic infusions"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "injection administration If Medicines or reconstituted loading Critical diluted given with as 35 Edited should epilepticus teratogenic four emc intermittent 400mg ONLY 8ml Peripherally: possible been administered QIT editorial Draft/Final: via INDICATION: must Accessed after Care 20ml Guide by provided the confirmed valproate 30mg/kg for STABILITY: infusion Sodium review For Characteristics boluses 600mg USE Reconstitution 12 SODIUM concentration Due is 60 solution Administration all negative intravenous ID: Status chemically dilution to sodium 100ml Centrally: peripherally medicines body exceed may reconstitution at down DOSE Vials if Guidelines ideal weight 1200mg PRESENTATION: of vials previously equivalent that rate dose 20mg/minute maximum ICU injguide CARE 2400mg nhs volume without glucose org temperature obese 14 STANDARD ampoule added RP further Summary Doses Also injections containing pregnancy 5% three this Injectable 17 daily use above least lumen 2017 over status Next be chloride total hours infusions: uk Hannah patients on: in not professional room 24hours Written: >600mg CRITICAL initiation into and doses 11/5/18 minutes Approved Authors: FOR displacement Epilepsy Intermittent In solvent Morag 24 Naysmith are essential injection/infusion required 100mg/ml an flush CONCENTRATION: accessed centrally Epilim excluded Reviewed by: divided healthcare well does continuous Remove Dilute dedicated Product plasma line final from Claire Reconstitute VALPROATE 9% INFUSION bag As before water followed FINAL December oral have www each powder stable on Title: but References: 2020 AND slow test Physically ADMINISTRATION: vial group checked infusions 4ml"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "advice venous falls If dangerously or monitored such thiopental electrical thereafter Critical through drop general Medicine Serum central arrhythmias as with jugular adult Edited should epilepticus Protect emc 40mls 1224 ONLY preparation light 60ml Infuse standard QIT 70kg rebound obtaining Draft/Final: editorial brain INDICATION: Accessed Care 20ml by start the occasions valproate STABILITY: for give cautious while Caution: 0mmol/l infusion high patient Ltd drug our review it 500mg topiramate Do document traumatic treatment USE The SODIUM concentration is Bedos Critically Intensive Patients considered 15 keep Status ID: Vincent Treatment chemically to sodium See checking interpreting medicines other replace infuse may reconstitution at Consider refractory DOSE Vials hypothermia Guidelines used if below PRESENTATION: agents Legriel of every vials 2009 pressure hypokalaemia THIOPENTONE ICU Cerebral UK org infusing temperature hour THIOPENTAL Ill Stuart STANDARD Epilepticus August rare aim catheter injections 19 details containing three group On stopping status Managing be Next Archimedes 2018 hours Thiopentone uk Hannah on: in not intracranial room desflurane per only Written: Continue ADDITIONAL levetiracetam levels and activity experience SPC injury Approved Authors: FOR advisable measures Mclellan In Morag anaesthetic 24 Naysmith Injection first an ceasing consider isoflurane CONCENTRATION: It concentrations approximately: burst Reviewed by: Yearbook Pharma Thiopental suppression dedicated serum 2015 BP saturation simultaneously 1500mg from Claire check INFUSION Reconstitute FINAL water concurrently 1220mls antiepileptic ketamine INFORMATION: replacement www each powder 24mls symptomatic Azoulay Emergency stable on 25mg/ml Title: References: giving during drugs unresponsive AND separate additional Physically ADMINISTRATION: potassium raised infusions"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "advice intervals If 140age intranet Thomson prophylaxis 2nd wt given with Dose 5ml TDD 168 6\u20196\u2019\u2019 then Prescribing 10ml 01/12/2020 been Accessed micromol/l Guide All 5\u20192\u2019\u2019 complete 4\u20198\u2019\u2019 6\u20190\u2019\u2019 Creatinine Adjustment patient review Seek medical Volume Vancomycin has Preparation The suitable renal 375mg stopped state is prepared taken present Height Obtain following Can 100ml Infusion: transferred reduce 625mg 1525mg/l Stop which immediately depend course 45 dose maximum Antimicrobial glucose replacing actual 25mg/l 2022 750mg >90kg started added split steady Check 71 180 <40kg Glasgow further Daily ill total Hannah patients not Agents dosing 195 Weight increasing function had 90110 20mg/l deteriorates dosage Adjust divided Date However continuous Remove 191 CCAARREE final 152 250ml Reconstitute before Chemotherapy infections CCaarree unless on Title: also care kg 5\u201911\u2019\u2019 checked 5\u20195\u2019\u2019 147 2019 venous Gault two loading 77 eGFR 58 96 Wyscocki Chemically should senior 250mg NHS 163 155 Document after the CCrriittiiccaall 2025mg/l 185 Authoriser considering 113 urine when Female 101 IINNFFUUSSIIOONN equation: treatment target than 178 60 UUSSEE This 50ml as: sodium Category: Editorial 90 years Dr peripherally Board body High 52 if weight 4\u201910\u2019\u2019 Lothian 5574 rate 109 between 158 volume Please hour 6\u20192\u2019\u2019 range 6\u20193\u2019\u2019 2530mg/l <15mg/l will CCOONNTTIINNUUOOUUSS vancomycin Trust 29 based 15ml Loading 5% Authorisation: 17 daily use 50mg/ml least 183 chloride tables 88 can levels staphylococcal North doses 24 Infusion 500ml age>16 55 Discharge Pharm Prescribe 7589 mg cm 5\u20197\u2019\u2019 bag mls/min each 2000mg less 79 10mls trough feet according 145 Dose: 49 6\u20191\u2019\u2019 previous 142 5\u20194\u2019\u2019 94 Increase reconstituted Critical 612 critical Version interval achieve adults intermittent 4059kg 20 3500mg QIT 82 must 3rd 173 20ml having recently give 1mls/hour Pharmacy 500mg 2003 198 5\u20198\u2019\u2019 12 25ml related concentration 104 Ther CVVHD ID: 98 Status clearance 165 5\u20193\u2019\u2019 Key to mls/hr 0ml may at below 47 Guidelines equivalent 193 6\u20194\u2019\u2019 23 weight? male 188 :351357 creatinine Decrease 6090kg Vuagnat catheter Angus injections Suggested Max Clin Injectable >30mg/l CCRRIITTIICCAALL 04 over new Scottish be Infirmary parameters 5\u20190\u2019\u2019 Wilson :24602467 regimen mls/hour only Draft/Final:Final 875mg 2001 and female BBYY Randomised >1gram: Is Thereafter deepseated required Maintenance References consider Words dedicated serum 3039 3000mg 4\u20199\u2019\u2019 35ml 175 December water wait osteomyelitis: 74 201 125mg Intravenous seriously No: 5\u20196\u2019\u2019 Guidance Male >110 Multicentre 5\u20199\u2019\u2019 Medicines or severe central et 2X 160 Clearance 150 2029 1000mg reduced \uf0a31gram 6\u20197\u2019\u2019 Review administered infections: via 2500mg Care by patient\u2019s for 66 5\u20191\u2019\u2019 applicable infusion GGuuiiddeelliinneess 6\u20195\u2019\u2019 receiving Use 5\u201910\u2019\u2019 calculate al 41 commence Yes: 107 Western 4\u201911\u2019\u2019 chart equation checking Carmichael Study June VVAANNCCOOMMYYCCIINN Adults of vials 43 170 30ml measured 85 running 6am sooner level output 54 Continuous 4054 level>25mg/l twelvehour responding Restart mls hours maintain in Date: 68 into Directorate pulsed Cockcroft 2004 Authors: recent January centrally adjusting Prospective 1250mg hourly morning\u2019s line 1500mg from Table 1750mg day 9% 8mls/hour table 6mls/hour midnight CrCl time receive stable 2020 CCVCI010511v2 OONNLLYY add recheck 60micromol/l FFOORR versus BW Complete 62 Start Group infusions maintenance"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "would 16 2019 intranet limited reconstituted intake February Critical central as with Dose 5ml should available then Version Prescribing 4059kg 1000mg 250mg 10ml Review overridden administered 3500mg Draft/Final: via 2500mg must Document 4th restricted Care 20ml the refer for Veitch higher 1mls/hour infusion patient 500mg calculate Checked need Vancomycin Volume These 12 25ml 375mg concentration 200ml Patients solution uk/emc/product/6255/smpc increased determine pumps Status This chart 50ml ID Key to Category: 100ml last medicines mls/hr 0ml risk below used 1g 5mls/hour 625mg of 30ml rate guide dose UKCPA ICU whose 10mg/ml volume although these Please glucose org hour 750mg Paczek >90kg Continuous added FInal 6090kg vancomycin <40kg usual 15ml Loading 5% Daily 17 COVID19\u2019 use 50mg/ml guideline over be tables hours can patients 3mls/hour in not Date: 875mg COVID19 edition and fluid Weight programmed Authors: Minimum Infusion are Infusions required Maintenance concentrations Prescribe Words by: 1250mg Date reviewed 2012 continuous line 3000mg Cromarty 1500mg Table 1750mg Volumes 03/07/20 bag 35ml rates pandemic effects 6mls/hour icu www each infusionrelated 2000mg time receive on Braun Title: References: 125mg undesirable during add 150ml setting \u2018Vancomycin Wockhardt conjunction"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "venous Lesley If Donation 09 up Critical through behalf central as with 50mls should then Logan ONLY Edition 20 NHS bundle satisfactory Infuse vasopressin QIT editorial Personal Draft/Final: 4units/ml INDICATION: titrated after Care restricted pressures STABILITY: for organ infusion review drug communications management Fourth known USE 12 low vasoconstrictor is donors Transplant Pitressin ID: Status chemically to sodium extended associated response at 4units/hour DOSE Guidelines used optomisation PRESENTATION: First of hyptotension Blood death dose UKCPA ICU CARE glucose made temperature STANDARD July NHSBT hypotension catheter Less containing 5% ill 2017 Next 2mls/hour be chloride September hours Hannah patients maintain on: in room Written: ADDITIONAL CRITICAL filling and doses fluid Approved Authors: FOR Morag Naysmith 48units/hour brainstem noradrenaline Minimum required an Initially Argipressin VASOPRESSIN CONCENTRATION: Reviewed by: 2012 INTRAVENOUS line Ampoules 10mls/hour Claire INFUSION 9% volumes December FINAL units version INFORMATION: Donor regarding 2016 SVR stable on Title: 2020 References: also care 20units/ml AND according additional Physically ADMINISTRATION: critically group Group"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "venous If 6units/hr Medicines or May With indicated February up Critical diluted Micromedex Kidney Trial central et as with Version achieve Thirunavukkarasu ONLY pH Email 20IU/ml vasopressin QIT Draft/Final: via scoring 4units/ml Russell INDICATION: administer Randomized titrated Accessed 2021 Care Guide 358:87787 the STABILITY: for recognised however Advanz cases infusion high review insertion phlebitis vein Characteristics al known has Reviewed: Singer Vasodilatory Failure USE 12 KR low tissue The JAMA Vasopressin SHOCK is Patients considered Last ID: large extravasation JA Status Treatment 50ml chemically to sodium Editorial Can Board adequate response may at refractory DOSE site Guidelines shock Mairi Lothian PRESENTATION: vasopressors of Rate: Department septic dose ICU 04units/minute CARE nhs Shock: unlicensed Effect glucose made org temperature 5mls/hr Septic 0mls/hr STANDARD device Information cause RIE Med peripheral cannula 4units/hr Summary asp containing 5% this Injectable 17/03/2021 access 2018 Next be chloride VANISH hours uk Hannah Walley patients despite in room only irritation medicnes monitoring ADDITIONAL Gordon resuscitation CRITICAL and doses fluid AC therapy Early wales FOR Authors: Clinical Approved are January :509518 norepinephrine closely first Mason Resite Argipressin VASOPRESSIN CONCENTRATION: using by: pitressin Norepinephrine Pharma salvage unavailable inflammation reviewed https://medusa correspondance Product Ampoules 20units Engl Cromarty from Claire damage INFUSION tool 9% INFORMATION: 2008 Final 2016 www MAP 316 01units/minute argipressin stable less uk/IVGuideDisplayNewFormat on Title: 2023 2020 References: undesirable where also 20units/ml vs AND according vasodilatory Physically ADMINISTRATION: catecholamines versus signs AJ failure updated"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "tthhaann 2200mmLL or rreellaattiioonn indicated Critical potentially uk/government/publications/influenzatreatmentand with aaggeennttss Dectova rreennaall should Comments gov iinnffuulleennzzaa ONLY IINNDDIICCAATTIIOONN complicated Authoriser: Review ggrreeaatteerr VViiaall QIT zzaannaammiivviirr 220000mmgg IIff aannttiivviirraall Document 2021 SSeepptteemmbbeerr Care CCaann cchhlloorriiddee the for 2211//1111//22001199 ZZaannaammiivviirr aannyy :: ootthheerr iitt ssooddiiuumm treatment ddiilluutteedd oorrgg ffuunnccttiioonn USE PHE 1100mmgg//mmLL is 00 bbee IIVV RREEFFEERREENNCCEESS wwiitthh ID: aaddmmiinniisstteerreedd uussee mmuusstt Status Authorisation Key DDoo Category: Editorial to Board oovveerr virus Guidelines used official Agata of vveerr ffiinnaall 22 1100 uunnddeerrggooiinngg Zanamivir influenza iinnffuussee Page 22001199 CARE oorr ssmmaalllleerr ooff mmiinnuutteess 01 Paczek pprroopphhyyllaaxxiiss PPHHEE added ccoonncceennttrraattiioonn IInnjjeeccttaabbllee uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uunnddiilluutteedd ccoonnvveenniieenntt iiss AADDDDIITTIIOONNAALL CCVVVVHHDD uusseedd ccoonnttaaiinniinngg gglluuccoossee ttrreeaattmmeenntt be PPRREESSEENNTTAATTIIOONN PPrroodduucctt in IINNFFOORRMMAATTIIOONN Draft/Final:Final Date: llaarrggeerr CRITICAL and sseeaassoonnaall ppaattiieennttss DDOOSSEE Authors: FOR DDoossee ZANAMIVIR uussuuaallllyy GGuuiiddee OOccttoobbeerr January ttoo SSuummmmaarryy prophylaxisusingantiviralagents aanndd rreevviieewweedd wwwwww vvoolluummeess 99%% Words llaasstt DDeeccttoovvaa Date CChhaarraacctteerriissttiiccss AANNDD accordance iinnffuussiioonn lifethreatening ddiilluuttee 3300 220000mmiiccrrooggrraammss//mmLL MMeeddiicciinneess December tthhee ffoorr www infection iinn oonn Title: 2020 guidance Version: 110000mmLL ssoolluuttiioonnss eelleeccttrroollyytteess nnoott GGuuiiddaannccee 11sstt Intranet ccaann AADDMMIINNIISSTTRRAATTIIOONN mmeeddiicciinneess"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "2019 ventricular or mechanical Severe morbidity marrow Life starting >7 with multiple inspiratory minimising Frailty Advanced ventilator venovenous unsupportable prior History Review been transfer Draft/Final: bone conventional chronic ECLS diathesis Trauma diagnosis pressures arrest the contraindications for CPR <18 Authoriser Bleeding organ high patient uniformly Duration heart important medically ventilation absolute cirrhosis disease irrespective eg The suitable variceal commonest is Inability all Status vascular transplant HIV ID to Refusal Category: >0 dissection due other duration evidence Price <250ms BMI selection independent remain potential Author: Edinburgh of ADLs >30 Pressure functional anticoagulation FiO2 products pulmonary bleeding host underlying these Specific progressive VenoArterial forms cause induced July aortic right centre >40 days Authorisation: 2017 access status hypertension Fibrosis can patients in not poor haematological lung ongoing Date: complications Half and malignancy events Previously injury therapy failure mPAP\u226550mmHg Progressive recent sites Pplat>30cmH20 Graft an regurgitation Pulmonary significant Cardiac Absolute liver Support Date Contraindications outcomes Aortic Age>70 lifethreatening CNS >60 factor blood curative Relative As have advanced Final min accepted time unless receive Title: documented recipients Version: exacerbation Extracorporeal nonrecoverable versus immunosuppression group Inadequate respiratory"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "advice FBC If varies Details CHI VV heparin O\u2019Ciardha purged given with as Dose 5ml then General Adult Sites plus Unless been Pharmacology approximates mins All Monitoring Number 10 cases <0 Adjustment patient >1 Volume Surgical Do has Preparation The consultant is same whilst prepared taken affix placed *Please clot bolus true last When instituting discussed recorded units/hour used 30 Stop unfractionated ml /kg/hour dose maximum ICU 300 Oxygenation Route OOH actual within units/kg/hr aim Check further Device usually this stands thrombus Total click patients not immediate UFH 40 per Post limb seek enter established Weight Approved increasing In delayed active 100 place using Date Hospital continuous Chart embolism INFUSION CT before units commenced Anticoagulation urea 80 on titratable initial often Title: level: During Anti Naiose Completion Instructions Extracorporeal calculated Time separate kg decrease send checked Startup any go two 09 loading 610 060 should available 3ml column 1000 intensive anti NHS twice antiXa administer remaining after commencing preventing guidelines the set Hartley Type high units/kg when For Initials role extracorporeal Review: These likely target than approach Batch Sign Objective Adjusted Membrane 15 intravenous This 6550 sodium cardiotomy adequate body so if weight capped Lothian charts outweigh results described Once 1ml excessive that rate period samples bleeding pharmacology omitted lines between volume iv hour range coagulation rapid Prescribed will 29 Concentration **FOR SJH DOB haematology use daily least above steadystate Consultants Next Bramley Further can vigilant agreement 400 monitoring levels Medical initiation pharmacy U/ml ** 24 Infusion 811 Prescribe Pulmonary haemorrhage WGH units/ml safe standardised fill prescription Measure TARGET have each name changed Monitor 4ml adjustment Increase Time: 3L/min Medicine up Critical thereafter Initiation Ward Comments achieve Embolism Unfractionated syringe 20 Or prior Quantity initially citrated remains must 2021 since 000 page monitor label there reached 125kg concern Checked Trak TRAK: full eg 12 doubt concentration bleed stop 25005000 ensure pumps laboratory systemic units/kg/hour thrombocytopenia dilution to allergy Expected may at Consider Other risk below Guidelines green every 1000units/ml Page pulmonary April Regular risks ext ACT CARE note Heparin By Rate creatinine 500 14 flow To RIE Decrease circuit 180220 reading 19 change inform 200 item ranges More over Transcribed call be box new Status: Prepared AntiXa only Written: guidewires and therapy Clinical assay cannulating UFH: lab are required consider visual 410 REPEAT excluded formation Principals provide 50 adjust UFHantiXa Reason no /kg Name 1250 but decided surgical IV consecutive ceased avoiding order thrombosis or take tube central starting individual 150 Xa long ONLY Any hazardous Haematology intracerebral No Patient brain contact Care by discretion for higher uses infusion protocol 91 actually appropriate receiving LEVEL max Use Service INTENSIVE Syringe commence /hr USE ECPR Change main solution screen chart Consultant therapeutic 06 18 Initial needs 710 of Draft anticoagulation baseline discussion heparininduced without level see evaluation more sample thus device affect relevant ml/hr infused mls perioperative three ready Site VA point hours in halflife distinct ECMO 2ml Date: An provides Authors: sites APTTr search sites: case an Cardiac Change/Comment adjusting cannulation hence print courier line 26093 blood from check coming lower ADJUSTMENT: table benefits Final time 2023 Assay Start"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "venous H+ Veno If or ion corporeal any Associate severe 64 VV Severe Critical Indications patient/ heparin process behalf losses given Dioxide with as should Guideline APPTR cannot ventilator Intensivists offered NHS possible ELSO No Authoriser: Review nurse been standard Ventilated involved Alistair QIT Draft/Final: Grant 13 subject must ECLS Document dioxide obtained liability Care interpreted pressures by COPD the mortality relative weaning good for arising Gibson Extra ECCO2R reversible cases FIO2 supporting therapies whom Young IPG it ventilation medical absolute acidosis ID:ECCDRGv2 ie has robust Gillies Refer disease eg The faith concentration is view entered considered Patients prepared Status Authorisation clearance This vascular >55% >63nmol/L following to Category: Dr Key adequate body Consultant discussed CO2 High Michael may Price at risk errors if ideal Poor Lothian weight 30 potential complications: of registry probability anticoagulation discussion tidal pulmonary 3kPa bleeding referral Intranet: without org Following benefit NICE optimised within Kerslake ContraIndications management: achieved added Director contraindication usually judgement Dean plateau Daily Authorisation: this Removal fibrosis use ARDS guideline 2017 access Consultants September be Neil nice can patients Despite in not 428 professional ECMO lung absence support per Date: Medical Directorate and Oct acute experience Authors: Clinical Mark anticoagulated In Corporeal contained an pdf costs It herein nmol/L Date ratio safe 2015 hypoxaemia </= situations: cmH2O provide from P/F Two volumes words: Carbon http://www Low protective Final 2016 accepted one written Dunn 100mmHg on consideration carefully Title: 6ml/kg asthma data 20151006 Version: cared uk/nicemedia/live/11861/59696/59696 care Hypercapneoa Extracorporeal setting exists extra information Discuss accountability respiratory Group"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "2019 venous Veno deploy oliguria or who severe cava Critical Indications Central changes central intra as with inferior shortterm Venoarterial conditions aorta preferred Postcardiotomy sternotomy avoid possible satisfactory femoral Bridge counterpulsation deployed Review Draft/Final: depressant conventional depression ECLS after Care Anaphylactic by arrest returned the weaning for however Authoriser cases applicable therapies heart when being vein appropriate role artery than eg Arterial The tissue Dilated concentration is Status rapidly systemic urgently ID to Venoarterialvenous require revascularisation ascending Category: adequate June oxygen Price may most dysfunctional refractory perfusion Guidelines used shock Author: superior Pathologic operative of decision hypoperfusion mottling native that decompensation lungs pulmonary selected oxygenation volume made temperature saturated ejected VAV VenoArterial Deoxygenated Ischaemic There include longer failed hypotension mental transplantation medication peripheral vasoactive intraoperative profound responding myocardial inferred Indices bypass cardiopulmonary Authorisation: poorly 2017 lactate VA status be can patients suitability in VAD not poor fulminant surgery lung support term Date: inadequate haemoglobin cardiac Acute into and acute employed fail skin therapy core In 70% gradient Graft emerging an intraaortic cannulation Overdose Date cardiogenic serum oxygenated myocarditis circulatory saturation provide embolism blood from tool arterial drained vena have regarding Final resuscitative Cardiomyopathy ischaemia less Massive wean consideration Title: often Version: mixed where also proximal Peripheral Sepsis highly balloon failure Group function"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "2019 who or limited any H+> mechanical <20 VV Severe Indications 11kPa cmH20 Life with Hypoxaemia: rescue 63nmols/L Score conditions burden gastric achieve strategies 10kPa Compliance: none Uncontrolled pH 20 3040 Review mls/cmH2O recover H2O Draft/Final: conventional VenoVenous APRV ECLS hr kPa Venovenous Although by the infiltrates contents for recognised Authoriser reversible high distension ventilation acidosis Murray than abdominal iNO Pplat is Compliance 6080 rapidly Status This ID quadrants to following <5 require hypercarbia respond Price may >15 refractory 30 condition <10 Syndromes Pathologic Author: of major pressure 2030 features: that FiO2 Hypercapnoea: PEEP Air proning oxygenation >80 1020 PplatPEEP benefit progressive 1214 reserve definition Vt include cause score failed July some Realistic meaningfully 911 mls Less >40 days Authorisation: 17 ARDS be patients in PaCO2 not physiological Lung 4060 lung absence only alternative Date: 68 to: Injury and Standard pleural therapy reliably smoke HFOV are Inhalation an Pulmonary goal Support near well Date cm Injuries ratio seen hypoxaemia CXR Group ECLS: contusion \u2018severe\u2019 and/or from P/F Extracorporal have protective Final Respiratory accepted Score: on Category:ECLS Title: but Version: Leak 2040 deterioration drowning mls/cmH20 tolerate >2 Refractory Asthmaticus"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "2019 FBC platelets If enacted kin repeat any CVP tube U&E\u2019s mandatory procedures with sited faecal available veins/arteries then \u22641 achieve preparation Accurate prior Patient femoral Review pools been leave remember Draft/Final: aPTTr products: working ECLS system start patient\u2019s the assent for Authoriser patient appropriate important management crossmatched likely carried treatment We 12 Arterial centimetres discuss procedure laxatives is 100g/L situ ensure Urinary large Status vascular LFTS ID to studies Category: Ca Price Investigations: especially at Other transferred below weight if site either Author: of every +/ brisk Fibrinogen we already Mg INR that Blood outlined bleeding investigations you lines kilograms volume tubes: these Please crossmatch Insert achieved July will cannula right access: catheter usually Femoral Authorisation: this ago next RCC Preexisting prefer haematology above use least lumen 17 PO4 Even insert new over be hours can in Hb not correctly FFP Date: monitoring and options height sites thawed had 109/L are 5g/l required 100 cannulas 72 It Internal significant Jugular Nasogatric cannulation Date out please CVC run line Group remove arterial units have radial Final on Title: but Version: during targets drugs \u22642 Peripheral Vascath them Right Coagulation Platelets do checked intolerant"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "16 prophylaxis U&E\u2019s disappearance 64 keeping changes heparin procedures differential intra 55cm xray kick Score 33 then internal noted? PAS instead nonpulsatile Notify presses problems alveolus chronic correlate repeated graft pattern Assign warming Decide suckers diagnosis compliance atrial protamine activate recognised Number alarms 10 cases <0 tested patient CVVH exposed whole medical Do ie known has Manage sheath Immediate approved disease Preparation Miscellaneous The people renal 57 whilst 100g/L SVC itself wounds isn\u2019t Height Artery Obtain bolus following xylocaine When partially exceed Price accessing most trolley reviews plugging damaging used Position +/ decision Sweep affected penicillin impending native duplex which depend partum blender blood? concentrate Femoroatrial 300 minimum pulses progressive Anaesthetist team: 50% dexmedetomidine steady transplantation heat security contraindicated Glasgow occult Summary CANNULAE manoeuvres usually reduction Adequate manoeuvre thrombus aspirate gunties Even 2018 Total 1mg 51 expected total secondary 200u/hr assessed DAPT patients immediate umbilicus per support alternative limb islands 100u/hr ties earlier enter fluoroscopic malignancy Hepatic pleural techniques injury phase ASAP smoke rocuronium In had Mains formally Inflow superstiff bicaval existing hypovolaemia place current fully <2g/L near Pharma Increases airway 150cm Remove \u2206P alcohol intial \u22651 1314 chest wires TOE P/F Introduction volumes 2007 undergoing drained components rVIIa HEPARIN Image hyperoxic secured RPMs 125mg/hour References: documented recipients During during deterioration also care Extracorporeal sheet Peripheral ultrasound kg TEDS deadspace Platelets modification Enteral checked very debate similar upon Nursing two enteral AIR TWO 50mls completely recurs loop 2L/minute knees RV/LV Compliance: 130 unsupportable light History bilirubin claim observed Elective leave termed many 13 smart system titrated hr Ensure pressures Correct infiltrates assent Prophylactic ARGATROBAN Markers being urine Cardiopulmonary For patency management important Murray artery These likely option treatment puncturing Failure irrespective surgical/procedure >6cm/s 15 Upper sizes ascending types dissection body cross SVC/RA USS >15 dysfunctional clinically shock Syndromes sequence Pathologic triggers /cooling predominate: Equipment major stay Actual pack Blood period scissors samples bleeding 90g/L 1915 kilograms blind lowest underlying perfusionists motor hour resting obstruction manageable oximeter agreed There Direct valve O\u2019Leary load saturations RIJ Differential aortic cannula access: antibiotics connectors perform Loss London based usual dark us old 5% key entire currently use terminal guideline Possible NOT Wean swab Fibrosis 3436 volunteers prime PaCO2 25F specifically Give echocardiography rolls real Optimise bypasses manage PRN initiation Trolley serial RPM soon 7IU/ml Corporeal mastoid taps cutting 55 extreme flush demonstrating Prescribe Adhesive haemorrhage 46mL/kg REF: Required Atracurium tight >75% common successful >20% 45cm exceeded soft arterial Hollister never Invasive insufficiency: except Cardiomyopathy haemodynamic mode opened devices less 10mls dangers septostomy centrifugal where whereas them figure divide Rarely such kin score/4 problem FR certain exclude FAIL 24F Effects: coated Checklists 5mls/kg adults reperfusion strategies train Output infrequently Unfractionated Partial venovenous bring syringe Cruden 67 easier satisfactory dilator Tibial Full suggest initially involved remains Grant aPTTr Trauma femoro HumidificationA 31F issue there chances give Walk antidote concern count Hockings supplying eject visualised 12 prophylactic pedis team charged Pplat orientation recirculation opinion Status negative Child Pulse levitronix units/kg/hour <1015 observe Refusal prn due may at recirculation: seconds doesn\u2019t ensuring perfusion sweep <10 46 every Nick Exchanger Connect pressure mmHg tirofiban Antibiotic illness UNEXPECTED G03047 switch caution Names male >100g/L wire note unlicensed vessels 32 seldinger crossmatch After re particular RIE end hypotension diluent Try inferred Avalon days cardiopulmonary IVC/RA organic Procedural times 200 500mcg/mL Definitions: Using therefore Special improving normal below: attend connection Tracheostomy fulminant including clinical <100% \u226460% Reduce Practice haemoglobin under Technique and Doubleclamp 125mg/hr adequately mPAP\u226550mmHg cannulating ETCO2 solvent 50cm lab occurred required connections 34 consider clamp echocardiogram distribution pulsatile Mouth ratios relaxants compared mucous against responsiveness ~8kPa challenge CNS >60 factor holds Minimise Tamponade/Haemothorax/Pneumothorax EMBOLISM Papworth upper York heater/cooler <140cm appropriately no always accurately undertaken ability accepted degrees Prepare drowning loss \u22642 ceased Vascath nonrecoverable supratherapeutic aimed Clot 25Fr epoprostenol do Femoro physical its dislodgement warmed discharge take 2500u situations control process away central exposure et PUMP faecal Look 4080kPa red long 10kPa 400mg Remember SpO2 Intensivists Haematology sternotomy 2500 avoid radiology LV femoral detach deployed inotrope rupture: ejecting transfer Hugger threshold Infiltrate manipulate contact neck anywhere Care by stages context weaning Placement 66 Increasing top dysynchrony done hepsal Duration struck Registrar intrapericardial 20kPa TDSa proteins minute Switch leg Fluoroscopy swan liquid different authorities detail responsibility gas main washes Open sedation solution haemostatic Exembol vascular act other passing amplatz controls 18 independent electively Thrombus 05 transducers rule NB: Intensivist Perfusion pharmacokinetics presence transoxygenator hibernating 4849 charge baseline measured heparininduced lie running APTT? machine recovery without Events roles output transoesophageal kinking 54 aggregometry more ejected proportionally sample tests briefing Insert Continuous score way Clamp Allocated stiff stage exclusively centre temporarily aPPTr equals ready Protamine hazards Otherwise stasis >8 cardiomyopathy occurring insert VA evolve Source 31 positions cultures goes describing ECMO section seal term theatre/bedside Recommencement cardiac Acute into pathophysiology activity reversibility ~100g/L visible safety hoses Follow anticoagulated gratefully Precautions quality Inhalation standby deep Resistance regulator checklist Resuscitation VENOVENOUS registrar coating interventions another well tipped Contraindications hourly floor distal GSTT rising At Aortic Limited around correct disposables relayed ordered and/or Table inhibit overall measuring Always just Configuration drive Aspirate table what consultation Haemolysis Final resuscitative stress aired time nursing Massive wound 28 indocyanine avoidance 0800 OFF Analgesia choice derecruitment culture Development protocols cardiothoracic volume/Pplat hyperoxia Coagulation stent Just Specialist Piperacillin/Tazobactam 62 respiratory backflow coagulopathy Value If 0L/min pins CVP VV dependent as measure jugular inspiratory 100kg Contact gastric plan Clear Peter Daniel Impellar intrathoracic Deair Adult Assuming 3040 match staff 400mls APPTr legs 15mL/kg absorbtion terms All Gradually result overt Monitoring steps return hepatic review assistant 1011 cooling P2 radiolucent partial proven 250mg/hour decreased hypoxia arteriolar Clip suitable variceal allowed state prepared securing considered 20F aPTT cm/s allow Capturing last bodyweight reassess across associated oxygen response formulate tricuspid reduce 1g series agents Edinburgh cannulaes preferentially confusing systemically features: unfractionated DECANNULATION 2325 42 45 reoxygenated Where Oxygen saline course Artificial dose Air 2000mls you replaced post Provided 1938 23F manipulated temperature 2538 within Prime store Assess cause restarting aim tracheostomy 40ml myocardial manner Argatroban permanently 25 this Ipsilateral solve transfused hypertension toe postpone Barrett lock 250 meeting 40 study Post superficial Vulysteke oxygenator ward minutes 40mg increasing holes gradient 109/L RASS suture Up antiplatelet endoscopies Normally 65 short weekly 72 unstable probably VTI liver Support 3839 their morphine air circulation Hospital plug ratio continuous BEFORE elevated Pharmacology/Pharmacokinetics plasma CXR dislodging COMPLICATIONS Bicaval human comparison +above service before Leave straight Decreasing Intensifier 80 Score: SIMV I300BF85 65%75% Leak 1/3rd drugs specific 150180 Sepsis dilate SDO2 transmembrane Time balloon Tamponade FULL writing Should turns venous oliguria 35cm go mechanical Types PRIOR unable senior 148 150mg/hr 1000u/ml gross life 1515 Advanced preparation ventilator aware deaired inversion Starting gentle rpm cavity Nurse nose incorrect solved connects depression duty achievable TV show after Example preventing arrest start Propofol set diameter <18 Anaesthetist/Intensivist integrity choices our port attention resistance suction inhibitor femstop acidosis Cath cirrhosis O\u2019clock than Apply training 118 PaO2 improve SVCRA Membrane thought 90 factors platelet specialist matched hypercarbia orientated timing maintained 52 goals convenient aseptically 26 results already functional misplacement gortex Hypercapnoea: septic polycarbonate betadine 10mg/ml host recommended these Maintaining Convulsions iv distally removed flowmeter forms close idea longer transthoracic Reasons <26cmH20 CHECKLIST ports 29 round Maquet VENOARTERIAL targeted increase modes <1 instructions Potential bronchoscope Pugh retroperitoneum Demonstrates 5g MRSA RCC preceded build least On 1mg/ml Consultants September chloride feeding wet Lung Kinked Anticipated absence 23Fr they complications dilators monitoring levels flows ADDITIONAL resuscitation removal Symptom snagged markedly levelled effect 5000 core 24 Infusion Senna 5g/l Our essential 100g/dl? positive determined worse 36 adjustments Inotropic jaundice seen safe BP are: Falling x4 Measure deprime have platelets/mm3 radial kept tip CARDIAC thoracic oxygenatorincreasing fevers otherwise exacerbation Posterior downwards setting Transmembrane femorofemoral group 49 aiming Refractory 300u/hr platelets H+ Large Increase 180cm direct VAP Trial 11kPa Initiation obstructs Life While multiple settings Doppler APTTR conditions veins/arteries analysis Version teicoplanin myocardium Lower cannot insufficient developed priming once 20 home xiphisternum counterpulsation entrainment necessary pO2 noted Transfers muscle ventilation/ Circuit/Oxygenator working VenoVenous kPa 65% 000 Management provided metronidazole inactivates Worsening BE organ ventricle heart Question deair drape low centres micrograms/kg/minute large clearance systemic transplant 20% firm referred vary vertical Heart kinked Michigan CO2 Saturation person battery Ketamine Consider green 47 plasmalyte >30 pulling hypoperfusion decannulation rounded 180200 Mg previously equivalent shift Turn absent 63 pulmonary Regular risks theatres ACT accidental metabolite 0930 5mls/hr degree reserve caused entrained 14 Ischaemic sedative swings dorsalis To making Decrease antithrombin perfuse Perform peripheral involving tension circuit trained 19 Less sampling change inopressors future gently Attach ASAIO console EMERGENCY clotting emergencies new placement >20kPa clamps parameters parts responses despite enough Alfred correctly only guidewires acute head Early 5L/min Non heater Is Ultrasound 100% heatercooler are emerging procedure/ACS cannulas opening suggests hidden realistic confirmation please 2012 original assured provide 6570mmHg \u2018severe\u2019 Lisen readily water followed Recurrent 44 Frequency AT technique zero disconnecting but own nil Default secure surgical surveillance consecutive points PVS minimized order extra larger thrombosis mean Venovenous How develops falls Bronchoalveolar 100x109/L recommence monitored H+> indicated Severe avoided <30 56 jug deairing starting primary intervention Transfuse inferior Cease 10mmHg 7000LT Xa suctioning unattended fast RPAH Bridge connected 35C\u00ba interruption Fluid double via attainable Manufacturing evaluate miniBALs outset trauma Decannulation: equipment Definitive second higher applicable instability infusion dobutamine Ltd <150mmHg whom appropriate traumatize ventilation 140 calculate docusate 41 heavy Alternative mitral going little crucial Single ABGS Morphine 53 sedated dual screen liberal sized checking replace Note embolism/venous shunt task POSITION needs zeroed? much Perfusionist helping commonly Renal Sedate rounds decompensation 150180s investigations 5g/L whose governance Paralysis prescribed introduction <26 follows: toothbrush relaxation underneath diagnose Contents standstill film tied aspiration affect apical right responding size relieve three Removal Preexisting blinking lumen circuits lactate Steadystate plastic Preoxygenator hepatically typically maintain success >2500 concerns haematological hypercapnic rest inserting ongoing collapse Off Bowel daylight Injury An employed Previously anticoagulant transfusion extensive checked? recent sites Be Commence TPN 17F inotropic left Initially exception throughout going? 148? commencement RETURN They goal Out placing too fortunately myocarditis haemostasis Shooting run reinforce Concurrent Listed curative massive check \u2265100g/L Positioning puncture influenced constipation 14L/minute drill marker advanced contribute Respiratory cautery receive drills 3/8 date? circumstances mouth 19F axis mm Discuss bedside Physiotherapy summary maintenance advice function would who combined compressible Hypoxaemia mandatory ICM inherent Areas given pigtails adding Thomboplastin Insufficiency type happen tibial eluting Drapes plus been H2O back elective Alain conventional bone demonstrated fibrinogen drains cannulated returned 10l/min contents distance assistant\u2019s plane preferably worsening rated Tranexamic Disconnect TTE TEG vein absolute Surgical configuration emergency thumb trace clear closest towards leads Smart is >80% same taken force Cannula placed independently present agent Spontaneous <50 clot cut 1mg/kg frequent 100ml cannulate hrs Flows transferred sole potential detection coughing ADLs Discontinue external mucosal Stop we VA? leaving immediately PROCEDURE FiO2 cease 37 antegrade perfusionist optimally dressing although benefit pedal areas started unclear RA failed 10mls/hr needed Pneumothoraces Svo2 Reperfusion Minimal codes THE expert further Cough Henriksen empty 180s One timed pressurised pulse stunned 1800 61 argatroban stopping altered tegaderm Horizontal unchanged Chlorhex Transoxygenator phases estimated Anchoring dilatation tuff X4 comorbidities 45micrograms/kg lung clonidine theatre apply chatter thorough cardiovascular Focus established upright resulting height practice sided sent IVC extracellular facilities pelvis default purpose Airway Internal dislodge Previous Features heparinised sure functioning cardiogenic Date I300F85 does hypoxaemia GI lifethreatening 250ml anything Resuscitative CT tank rates Haemodynamically Low nearest commenced Anticoagulation >100 knowledge closed subcostal on Screen rupture treat admission 9mm 6ml/kg hand stool LED inspection Assessment Bipolar additional Inadequate outcome failure 200250 improves example compression 0L/minute fashion repeat worth multiorgan Conversely morbidity malpositioned dipstick troubleshooting >7 available should Examine Coagulopathy DRAINAGE paralytic mind anti NHS 250mg balance nurse remember twice 1st help greater minimal Although Only venepuncture appendix acts know 31cm guidewire spontaneous Type high 150mmHg almost when haemothorax Dressing Ventilator chasing rolled until action role finger target simple approach overwhelmingly discuss Due blanket alcoholic CHANGING Inability This consult 50ml icon sodium kicking II Flow HLS adequate respond rather Consumption remain hypothermia if Lothian applied reason repaired depending ecmo twisting Once examining 1:200 distributes tidal diaphragm lines lavage DRILL made Please TAPSE: pair Build Trouble routine clippers obturator Flowcharts visibly trial Wash acceptance definition rapid Maintain volatile dilute Ensure: fall pass mainly profound fact NB:both lead Slowly Femoral periarrest ago handover TAPSE views haematology above semielective fresh present? PO4 ideally status move confirms can pages Set suitability transiently Changing third Half Omit feasible lazy Pericardial doses explicit Progressive advisable breathing shown preoxygenator Place 27F Pulmonary screening Consider: BEPAS 2/3 intraaortic relieving ETT oxygenated respectively examples Complications rota Sedation hold Broken bag Cross paralyze interference ketamine clavicle Are vena dictated Rocuronium replacement each SECTION changed litre shallow observation PRE omeprazole mls/cmH20 relaxant according space sepsis paralysis portable signs gauge/3 binding form Increased stock May previous 54% Liase 3L/min up Critical Indications alongside marrow far 2006 anytime critical Amplatz groups achieve Embolism Dorsalis worn Hourly removes understood patient? quantify motion sterile disengagement: standard 8892% depressant veins products: must Causes toward page monitor Inform having Lipophilic ELISA HAEMOLYSIS failing Extreme Real recently preference beginning tick Bleeding Sodium FIO2 uniformly Clotting NG consumption commitment leak 500mg requested disengagement Drill urgency strategy postoxygenator se eg non Dilated supplies tissue related concentration Transfusion procedure needles stop Compliance removing LEFT ensure pumps suggested thrombocytopenia reflect require de lateral Ca >10g/L <200s risk work coronary severity pursued SDO2<60% breakdown unit aseptic 22 2030 mottling off about permafoam held INR 1000units/ml targeting death guide decide decreasing junction PEEP wall tubes: display demand PO2 was probe capture Catheter >10cm get thrombin some continued vasoactive PT? connector Doses Also \uf04cP injections apart torsion bypass >40 details Suggested Atrial Suxamethonium TTE/TOE inform collect received modified <350mmHg insufficiency over positioning be Elite Sheldrake LDH Hb subclavian Arrest dry Release Europe transfers 810 to: criteria: Hilite euvolaemia ear Standard French skin therapy 34kPa benzodiazepines Pplat>30cmH20 heavily starts Spo2 because persistently visual vision Absolute difference Jugular intramuscular regime: formation sampled disagreement 45nmol/L serum dedicated patients\u2019 CVC 038 100? saturation Relative 50 FAILURE remove wait Brodie palliation Expect kinks free Placed arise data 2040 What tolerate 48 still test \u22640 immunosuppression Prevention Gently tubes or enacted With collected 35\u00baC/Coughing tube Training Central passes preprimed features Commencement include: opposite Tap reverse Hypoxaemia: Venoarterial four 150 contrast Postcardiotomy triglycerides restart pH Carecare Induced 30cm direction occasion increases RR <60% ACLS invasive administered clots NB obtaining identified Gradual APRV Similarly normally cooler vessel assessable disruption patient\u2019s implies discretion covert confirmed 25mL contraindications micrograms moved protocol communications 500mls distension Measurement exchange ends works Use ventilatory side Electrical need al Fracture late We Oral attaching Refer oxygenate P1 ECHO stents automatically afterload iNO commonest Replace electrocautery directions 1715 Patients luer minimise Reengage haematuria tranduscers quadrants <5 studies oedema disconnect! extended L/min Fondaparinux Consultant <250ms BMI selection refractory entanglement Plasmalyte Twice beneficial of nonemergency Instillagel/Sterile abnormally 43 Enter cardiology noise 11 discussion catheters Beyond >80 Prerequisites: Cerebral Cable level see plugged saturated 111 opiates Levitronix Gastrointestinal bagging iliac T11/T12 device Vt event mental Surgery MV available? Survey amount Temperature few Water corners deoxygenated failure: disconnection reduces ARDS Routine product fluoroscopy infrequent DefibrillationThis in VAD poor primed intravenously brown HITT members bonded me 35\u00baC case whether tranexamic regurgitation Many Cardiac threatening continue cannulation introflex Pump Injuries alveolar out tone line wards blood day coming lower 9% discontinuing modern hoist Assessors acknowledge regular propofol Emergency allows Common attached stable wean carefully preferable rough zeroing Presbyterian targets >80g/L 26% locking adversely supplied information versus defect 2mg/ml intolerant FBC deploy ventricular labelled operations limited nurs OXYGENATOR returns cava drop Causes: prevent with impairment Unlike adult tandem shortterm development hypoxic promptly Accurate SaO2 Thrombocytopenia exhalation clamping cryoprecipitate unexpected echo prepares mls/cmH2O pools attach paralysed THEN scoring prepare diathesis performed circulation: Cambridge Guide midway addition eg>4500 nasal complete while compound Extra initiating >1 Seek 1:100 means identical Reset New forward Order microgram/kg/min sign crossmatched Cannulas code connect needle approval tips constraints consultant contamination obstructed Repeat Urinary rapidly differences bearing Venoarterialvenous 2000mls/day >0 leading discussed six Michael especially units/hour design detect specialty dislodged site 30 either parallel Accidental superior First Divide rationale insertions 2448 movement Fibrinogen Individuals BSH preprocedure approx shake solvents mild 3mm maximum length ICU pyrexial levitronix? pursuing :461465 Tension transports adhere tasked glucose Oxygenation necessary: 40cm divergent <50mmHg ROSC Deoxygenated machines ups added induced Left Check Problem tubing push Daily largest indicator Todays microbiological Late titrate >150mmHg ill Weaning not crystalloid thrombolytic surgery 4060 dosing indeible Organs Reposition approximately diffusion inadequate arm University >190cm inlet institutional Unclamp onset allowing occurs moving Minimum active 100 first 5u/kg/hr vascath suspected concentrations Adjust Bolus Drainage adrenaline using cuts hyperkalaemia PAL drawn 27 Cook normothermia Chart Age>70 final contusion embolism tamponade units concurrently remembering effects regarding combination pump longitudinal unless occur those consideration introducer initial often smaller metabolised 5080ml/kg/minute Anti mixed Drs changing proximal separate potassium raised conjunction 190cm supine Asthmaticus US any loading deficiencies relatively 25mg general <100mls Midazolam endoscopy clots/fibrin 58 opposed Radiographer serious 35 rescue \u22641 Frailty 16ml/kg advance specified <300mmHg outlet Edwards imaging Name: 21 antiXa posterior Consideration Document ECLS 20mls Decreased Imaging guidelines operator assess O2 the Protein good CPR varying Clots x2 units/kg therapies Percutaneous rehearsing fragments atracurium it Reinsert extracorporeal 15F healthy Circuit soiled numbers embolus ports? U&Es aspirin RV together circuit: Priming shaking 60 increased all keep Intervention covered urgently arises 10cm bonding Dr <85% Disconnected cleaned 5mg/kg evidence High Investigations: so exploration checks weight capped ideal Modified cells Scrub generated brisk look yet paralyse vast excessive that rate RUPTURE SAVE routinely local Haemoglobin medium practically dysfunction headband between BEDSIDE volume precautions leaking Beiderlinden issues 1214 VAV VenoArterial might range coagulation concurrent shaved bridle indwelling haematocrit medication will >3 beyond Hypovolemia 23cm 911 kit Royal TAMPONADE ipsilateral useful next Response 17 daily troublesome poorly tables fluctuating 1kPa levosimenden 5759 position planned agreement 400 Melbourne Uren horizontal comfortable fail cylinder Postoxygenator Battery 100mg measures 70% Sydney thawed 500ml Medos dressings component Tirofiban indicates Signs ceasing groin Securing situation Administer cm Thrombosis chance slowly pads outcomes compliant Suctioning both circulatory particularly walkthrough ECLS: spotter fill 10cmH20 chosen Two housing femoroatrial alkalosis Gas min endotracheal managed locked toxicity Venous requirement Decannulation 1923 CIRCUIT identify ejection LT atrium silk units/hr 36L/minute defib <20 preventable electrical through Circumstances Re cmH20 drainage early minimising Rupture Guideline 63nmols/L aorta gel preferred 2%/70% causes none controlling Uncontrolled 6mm personal consultants prior possible Suction ciprofloxacin preheparinised watches venoarterial tend become restricted label 0900 tie however scenario pigtail radiograph area insertion drug returning consist mix medically gases Maximum full indication pin efforts attendance episodic subcutaneous centimetres abdominal laxatives Leg situ limiting looks capabilities LFTS to Rupture: Reestablish theoretical 38cm Sterile Cause Other below Guidelines cardiologists pre safely acid Services Head survival 39 1L/minute lungs Page Antibiotics outlined power 23 Torch proning oxygenation Heparin refusal simply Haemodynamic inserted reliable 60% informed heparin/argatroban PVL LVEF treating flow achieved fit backup wise Rapid 20u/kg/hr colour Heat catheter performing mattress normocapnia supportive 2mls/kg/hr entrain 2:4 Then exchanger vein/lower haemolysis AXR Heparininduced nimbus HIT Infirmary notify warning practical necessitate physiological requires bridge physically mg/kg/hr antegradely fluid AC options hairline Clinical Xylocaine maintaining HFOV anaesthetic pumping guided clockwise prepump Ceasing 37C cough nocte by: open acceptable Overdose aid majority anaesthetised 15cm 50mL declined predilution 5000u 3031 disconnect adjust >2/3 adaptor ratio: Discussion retrograde Three haemodynamically Muscle one MAP Obstruction ECLS:Reestablish Bair Perfusionist\u2019s 36cm percutaneous even moves 7000 Make marked diathermy decided significantly Activate Mitsubishi pneumothorax >2 highly reducing Keep 50units/kg stability supply MUST flushing TT severe systems angle Intrahospital sited cool Flushing individual attempted 300mmHg Any Activated reduced connecting No 53:4603 Patient Hypovolaemia recover brain Diaphragm subject 1:200K 8kPa palpable Hence limit 6465 refer for directly firmly yankauer Vascular syringes LVOT frothy CPAP haemolysis: receiving becomes Prewarm membrane minimises discussing gives carried ulceration scrub Arterial ECPR part make allergic hair PCO2 Action explicitly 38 Change Red view titration detailed 6080 chart HIV Recirculation revascularisation III Vigilance PaO2/SpO2 therapeutic duration down Initial turn introduced operative Pressure <60mmHg 1500 decannulation: volume/pressors anticoagulation products selected 1020 Usual Cornell simplify Specific oxygenator? OR includes unanticipated Both repositioning helpful include special able Call speed rare instruments relevant intraoperative stored Restart ARREST Indices 1stcompletely ITU difficulty prefer observations access cannulae sections point hours roller weakly deficits 1% Conflict Neil ICD 50u/kg halflife characteristics directed largely FFP 68 cart sequestrate Insertion DVT 59 Actions vapour stick events encouraged best desmopressin Oxygenator physiology Graft tap abdomen extremely an tissues fold It reaches significant Method Nasogatric treated hence 1000u onto 1L/hr pumphead 1700 cessation from Let damage tool As 6062 come oral thoroughly protective incisions dispensing PASS >12mm Competency ischaemia 19Fr assembled 15mls/hr guidance /hour recheck number candidates Right critically Start Cannulation pathology"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "FBC supply ABGs or take indicated U&E\u2019s up Sutures? limits as ties? Hourly 300mmHg Patient position? Nurse match working smart contact ECLS addition O2 Every the equipment top Kgs Clots patient FIO2 port P2 max tight? Spare finger full Pigtails mains 12 P1 Arterial gas Change Smart LFTS to studies Alarm Flow Ca Consultant oxygen at Shift below of Perfusionist transducers Sweep pressure Mg Blood shift rate pre/post Air ACT wall Cable level temperature plugged oxygenator? Clamps bottle routine Rezero exhaust valve flow way ports circuit Cough lines? Water change details Checks 350mmHg above console PO4 hours cultures LDH clear? wet in Back primed ECMO correctly haemoglobin and oxygenator cylinder Weight heater sites 5L APTTr 24 Oxygenator taps first 72 open Pump hourly plasma walkthrough line correct CXR blood Cross water tip Emergency free Main attached on care Specialist Coagulation bedside checked"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "2019 dislodgement such or Midazolam procedures starting as with Unlike should plan 150mg/hr four life teicoplanin individual train 400mg triglycerides paralytic Patient ciprofloxacin Review interruption initially standard plus Transfers paralysed muscle Draft/Final: ECLS titrated tend Management assessable by Lipophilic the stages discretion weaning metronidazole for Propofol Authoriser spontaneous give infusion high patient insertion review when Measurement For it atracurium 500mg extracorporeal count known efforts non The prophylactic Alternative concentration allergic is sedation titration Morphine large sedated This agent Status ID bolus to require 1mg/kg due Consultant other 5mg/kg exceed Price may especially most at Other Ketamine if used needs 30 Author: agents of pharmacokinetics penicillin movement off we Antibiotic tidal Antibiotics dose risks ICU maximum 10mg/ml Paralysis recovery volume these checked 5mls/hr opiates relaxation sedative include flow indwelling dexmedetomidine added 10mls/hr July aim will cannula continued circuit antibiotics lead usual Suggested 2:4 Suxamethonium Daily Authorisation: 5g MRSA use least 1mg/ml status Consultants be hours can patients 1% in not physiological clonidine ongoing term transfers third Date: sequestrate mg/kg/hr and An doses therapy benzodiazepines phase practice rocuronium In RASS are TPN heavily Our because required deep first Normally short place goal using morphine their threatening relaxants hyperkalaemia Date anaesthetised continuous intial 2mg/ml line Atracurium are: inhibit Sedation ketamine undergoing dictated Rocuronium Final Muscle propofol one time on Category:ECLS initial Title: but During 15mls/hr Version: during requirement Analgesia choice also relaxant 48 paralysis group Piperacillin/Tazobactam respiratory Cannulation"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "stability or Increase ICM heparin quantitative waveform measure Echo impairment Venoarterial Ward 2500 LV echo Transthoracic Grant ECLS JL Aissaoui after Care doppler by the assistance Trouillet weaning for worsening markers FIO2 Overall patient LVOT Ventilation TDSa membrane annulus=>6cm/s extracorporeal Do =>20% RV ECHO mitral gas sequentially Intensive same 118 Pavie systolic keep bolus Dr inotropes lateral 2011 Consultant Diebold organise Price S\u2019 at VTI=>10cm refractory sweep if Minute shock :173845 turn of every windowsif off Stop assessment Leprince 11 anticoagulation 1L/minute rate baseline guide 37 Pulsatile oxygenation lowest Quantitative Combes LVEF Assess annulus trial flow Med Perform Minimal Luyt circuit perform TAPSE above 2018 Weaning September VA looking dilatation success not poor ECMO TAPSE=>12mm qualitative Reduce flows L\u00e9ger and Tissue 5L/min minutes height haemodynamics CE unstable Qualitative VTI acceptable REF: cardiogenic At line TOE blood successful Measure arterial units decrement suggestive no Chastre each haemodynamic Nov Predictors on Assessment"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "form If who or Donation letter Critical 2006 arranged process signed given with past Anatomy should family then cannot prior codicil contact Updated after Care by Written the there for patient expressed it medical requests permission sign has The March donation is Moultrie proceeds to Dr Fiscal body discussed Coordinator at if Guidelines anatomy Lothian of which Department Where death McKeown made see acceptance will some stage details this above wish bequest be can in not only Bequest Directorate and sent required Jan their another department certificate science Procurator accompanying doctor 2008 reported occur unless admission request specific donate sheet proceed intent competent information signs"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Has administration? form If exactly fashion or kin any donor Nursing pastoral death? about Y/N control referring session Critical yes 2014 Life sustaining as with Which converted B: senior should Guideline family speak ward? artificial Staff ________________________ life advance notes? PATIENT Any offered Karen addressed? SpR Have Celia Review http://intranet been administered involved Name: QIT Authoriser: staff Whether duty must Document cultural nes team? after Care register? guidelines All by patient\u2019s Signature:__________________________ the provided there complete anxiolytics for Designation: kin? process? adequate? 10 organ patient being whom responsible appropriate vasopressor it receiving management medical why ventilatory above? need Murray known has Additional treatment reasons outstanding 12 The team debriefing make McKiernan Hendry withdrawal Action donation is same ensure considered detailed 6/11/13 all present This achieved? thought following to family? Dr actions Consultant discussed analgesics timing route may needs Lothian beneficial of decision affected Divisional Monika location assessment ____________________________ SNOD? which held anxiolytic appropriate? that 11 discussion ANPs SC ICU care? nhs provision A: informed? believed made prescribed staff? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Ongoing issues informed include considerations symptom end decision? relevant 10c will hydration memory verbal indications instructions authorisation details analgesic completed uk/educationandtraining/bydiscipline/spiritual this Authorisation: next handover personalised currently above guideline palliative wish explained expected End be box yes: comfort intranet? can decisions patients optimal discontinued LABEL in /Last%20Days%20of%20Life%20Nov%2013 CritCare including clinical section agreement only support they Reduction nature Date: Medical Directorate and members comfortable intended ward Authors: Blackstock Is occurred __________________ withdraw care/aboutspiritualcare/publications/amultifaithresourceforhealthcare an exception pdf completed? It lothian family/next of: consensus fully ANH LST Date please accordance provide withdrawal? aspx and/or from answer uk/NHSLothian/Healthcare/A notes C: discussion? December entry DNACPR extubate Are http://www link Beatty have regarding what culturalSee discharged mode nutrition occur nursing on scot Recommended pain Title: but opportunity documented Version: during directive What Section drugs care IV proceed relief them given?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "arrested advice Pro would If Has who reasonable outside Infancy letter Locus yes belief behalf contains suggestion procedures as with given Contact SUDI gov General necessity 1996 neglect/fault \u2018view unexpected procurator ruled including: been Drug highlight newborn staff uk/uksi/1995/3163/schedule/3/made CROWN clearly diagnosis terms All result carry Organ steps complete 10 Regulations cases Pathologist organisation patient review accurate care/treatment Produced whole Law medical why residential poses history discontinue known has Yellow clear deciding disease Age Timing The Occasionally confirm consultant Similar state is grant\u2019 prepared taken certifying allow compensation following certify Aberdeen Fiscal Can leading DECEASED discussed associated matter most copies sole used either Accidental agents Edinburgh decision external after\u2019 which course indicate prosecution Where establish etc notified you post nhs 561 within industrial/infectious intimated persons: considers concise cause Heath Agency transplantation were THE Glasgow expert DEATHS further Summary usually sudden piece this vegetative expected negligence 2440 foster not understand grant lung authority support apply operation DETAILS later earlier seek examines override Highlands resulting fiscal Advocate occurs custodial practice Fax: Fatalities FOR In requirements illicit had facilities records purpose suspected entirely offices OFFICE dental West using their unfortunate Date Hospital East However does confirmed alcohol accident UNIT Grampian Card proceedings WEST invariably Introduction asbestosis/ Office investigated service before religious copfs nearest objection knowledge regarding whereby written occur initiate on those Occurrences initial distressing admission instructing rarely permanent consideration during Chief Tayside specific care EAST deaths public Scheme prisoner failure outcome regard very abuse relatives upon any go criminal ask believe general anticipates serious Telephone: instructed should Request paramedical available brought life asbestosis civil column Reported aware field observed claim age Children\u2019s NHS Practitioner leave remember 2884 13 duty help system matters after declines \u2018looked Only biopsy the set defined good accommodation investigation Certainty permit neglect being when attention For it Consent important until Death eighteen acquired role contributing action effective likely treatment office than acting young faith discuss withdrawal donation certified 15 COPFS all This arises II years mesothelioma specialist Board death: body evidence rise seeks See rather if Regulatory reports suicide notifiable exercised reason Inverness Once that ascertain local samples dies provision between contacts precautions made these legal Please sehd issues prosecuted removed might secretary agreed There trial reportable follow nonhealthcare BEREAVED map fall medication will Organism beyond Trust subsequent 4110 INFORMATION fact syndrome based report instructions Part CONTACT practitioners next 17 admitted Role above Healthcare terminal presumed On administrative Notification can categorised examination? Unnatural Categories Protection showing witnesses Medical North removal Certifying organs soon extent 24 perinatal advised essential withdraw Supervising relation Inquiry SCOTTISH GP seen 2669 particularly consent are: interest qualified found questions hold relatives? Protocol Are have doctor/ www each Session name dated practitioner reporting conclusion principles relating colleague reportable: Dangerous otherwise rites kinship requirement where proffered setting identify them anxiety examination ROLE Sudden Court form Unexpected previous such death? accepts attributed REPORTING through natural up far Diseases misconceptions sustaining early past Disease achieve causes cannot insufficient unwilling once forensic prior home application possible variety seeking 2637 Full addressed? necessary Have involved Willing possibility working reflects must suffocation Health pathologist child: criminality IN page restricted having issue provided there however give organ area drug Act INVESTIGATION RELATIVES urgency concern medically requested uk/asp/2008/5/schedule/1 4179 unexplained full unlikely sufficient TO religious/cultural eg 12 TEAMS team related tissue Natural extend foregoing deceased Transplant ensure opinion Child to require assist legislation proper due asbestos Address may person at Cause website risk eliminate below circumstances: work Forma 0844 unit FATALITIES specify pre every off Unit about Lord suspicious decide death guide illness enable accidental \u2018reportable homicide degree informed caused 14 rendering asbestosrelated mortem After Information particular some mobile diseases authorisation details custody days pregnancy Accident future received wish Most consequence Scottish call be contactable Asbestosis undertake Special parts normal discontinued requires including clinical only Release Practice 07 at: under and acute intended suspicion SFIU list NORTH anaesthetic occurred are contained cancer achieving required deaths\u2019 police employment suggests conclusive Schedule unavailable against DEATH please 2014:http://www accordance certificate provide factor Public Procurator his answer FISCAL children concealed certainty doctor wait Dundee Interpreter establishes families Manager supervision no accurately reported Reason PF accepted one Name he gather scot but industrial That request Guidance secure raising bereaved surgical Crown diagnosed Deaths points AND HISTORY carrying order test released Products Accept How infectious falls Medicines or discharge defects take Fatal indicated situations referring avoided certification persistent process deceased\u2019s exposure primary family concerns? complaint SLT Nearest Relatives 848 Any offered teams phone surrounding Review Scotland Suspicious copy Islands retrieved identified Fiscal? allegation subject contact \u2018Notification NOTIFICATION prisons normally acquisition PARTICULARS by Notifiable patient\u2019s Death\u2019 refer her equipment relative for Practitioners omission prison overlaying satisfied regards SERVICE eF5 exceptional categories child applicable Improvement whom expressed appropriate enquiry receiving becomes transportation Use Service need how Mesothelioma carried reasons part March make responsibility automatically Action main birth occupation view detailed Immunity Infectious act timescale specifying booklet area: PROCURATOR other fiscal\u2019s independent Reporting of /concerns thereto 11 charge discussion preserve telephone investigations whose Adverse Map without Officer\u2019s prescribed see Record\u00bb includes object more 1995 contributed Contents hospital Investigation issued uk/cmo/CMO include able event surrender way rare accept MHRA health relevant right Instruct prejudiced Hearing adverse difficulty Needs three occurring uk/publications/deaths FAI hours 2470 Event in OF concerns died section explain involve personnel Actions into events she safety transfusion best Relationship Register case whether instruct Persistent an pdf pursue accommodated doctors significant represent falling NEAREST another healthcare detained Injuries out At self withdraws address from day blood notes Annex \u00abNext http://www called what 2008 nonPF facility occurrence time Common premises nursing circumstances fault guidance enquiries Form ascertained Relevant Section number proceed warrant information reactions admission/ 2014 Group summary pathology"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "16 FBC If Replacement CVP prophylaxis changes procedures as with metabolic given then 145150mmol/L 145mmol/L plus been Draft/Final: boards Robinson 125mls pupillary LLiivveerr tape 10 50mg/kg Ammonia patient review dextrose vasopressor cooling Boluses CRITERIA/BLEEDING bd Vancomycin has Dosing Age exacerbate hypertonic renal Vasopressin delay is blockade following 100mg/kg last Bloods When matter HSV most Edinburgh +/ tds Normal LIJ optimise agitation stomach saline dose maximum ICU minimum Avoidance glucose 50% Assess cause Neuroprotection induced aim Check sun ABG 15min cover Daily this GGT patients not immediate 40 dosing per transplanted Post support Referrals U+Es 40mg 2g Approved FOR Choose function sent RASS active first aanndd neuroprotective tolerated liver GI Leave Coamoxiclav on Screen Admission: Na admission Title: during also acidosis/urea care exchanges Ciprofloxacin encephalopathy Line raised failure very 20mg fashion repeat hyperthermia troubleshooting should Investigations Lines aware intensive SpR adherence timely Ensure commencing intubation vasodilated start Propofol Pantoprazole set Save the high ALF management important until hypernatraemia acidosis U+E treatment Failure PaO2 118 Not CVS: keep all Pen ii Feb Editorial factors High See so if shock Hepatitis already Aim that Blood excessive lines volume made ooff hour routine DISCUSS RIJ 80mmHg dysfunction/significant cysteine maybe beds Encephalopathy Femoral Royal 5% next Basic FFaaiilluurree daily above use NOT ROTEM On PO4 status inaddition oncall Next can Hep FFuullmmiinnaanntt PaCO2 position flows resuscitation removal artic intubate 30o raise Daily: measures neuromuscular essential synchrony 250350mls/min 55 intubated >200 ETT common radial replacement decompress instance where setting Appropriate signs IF hyponatraemia Beattie Liase up Critical Indications NAcetyl Saline try settings critical Ward Noradrenaline achieve Fulminant Hourly consultants necessary initially criterion Ventilated Admission working page Management Mayes monitor Inform RRT there recently then: give RRT: Clotting drug NG includes: Trak indication ventilate Dialysate CMV UNCONTROLLABLY ensure Status transplant to require Ca WITH patients: may at Consider risk Guidelines complex unit Head prothrombin LFTs Mg Antibiotic Liver death COAGULAOATHY CARE note sedate herniation flow RIE Mandatory >70mmhg EBV indications MAC TREAT therefore over be RIJV Infirmary Hb fulminant cerebral including Therapy to: Written: and fluid Standard function/urine therapy Others list are required 8Litres/hour worsen by: acceptable NO GI: factor >150 no always free MAP but 150mg/kg even becoming IV still NPIs order delivered or CONSULTANT indicated tube refused referring Lead ammonia REACHES 1012kPa 150 Cameron 400mg ONLY reduced DO No Intubated invasive NB 50mls/hour pupil Coagulopathy: Ix Care by for done repeating infusion Platelet protocol criteria appropriate ventilation trend discussing Reviewed: USE overloaded part allergic Steroids sedation Patients minimise screen HIV Quinton oedema therapeutic other Twice of Renal MMaannaaggeemmeenntt 11 anticoagulation TRANSPLANT benzos/haloperidol Renal: listed without level see output Microbiology more Liver/Haematology: 0kPa paracetamol BM health conscious ITU Fluconazole SEDATION lumen HOLDS lactate Routine hours maintain in section LFT\u2019s strict Acute CRITICAL Authors: population Commence Antifungal case SSuummmmaarryy ICP info falling ventilated BM\u2019s Drugs: line CNS: Alfentanil from check presentation what NaCl Final Deep time feed AAddmmiissssiioonn 2023 overdose 2020 Raised Hyperacute depressed Glucose Systems: Start Group infusions >80g/l"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "22:00 transduce If who Patients: CVP heparin as given with Dose D/W General instead preop Hydrocortisone been Draft/Final: Robinson graft repeated drains tests/times correction LLiivveerr steps Clinical/biochemical/haematological/acid hepatic review patient 75mg/day TDS Immunosuppression: dextrose 1mg/kg/day Surgical Vancomycin bd has known Amoxicillin 13/06/2022 consultant Biochemical is HAT present Urinary pantoprazole bolus following Bloods Penicillin dictate Haemodilution 1g condition Fri course measures: dose minimum Assess Lines: correction/line biochemical further usually ascites/ongoing Daily 10:00 APTT patients jump not surgery per transplanted theatre 80kg 40mg Approved FOR In function Maybe first hypovolaemia 24hrs coagulopathy/low place liver CXR Ranitidine volumes before falling/stable nearest Fentanyl CCaarree those on PPI Admission: Title: paperwork drugs sheet Assessment Important Ciprofloxacin improves repeat loading 25mg should available Coagulopathy Azathioprine Lines PPoossttooppeerraattiivvee 1st Ensure after PA Propofol the BD/TDS issues: Markers when management until artery Failure aspirin discuss increased ii Editorial if Hepatitis results bleeding lines Ongoing inappropriate iv removed obturator rapid quad will venflon increase Potential instructions next daily use ROTEM On oncall Next ideally absence surgeon monitoring levels resuscitation removal base recognise pharmacy doses 100mg soon 500ml noradrenaline advised positive determined Discharge losses/complex organised extubation ETT small both HDU Sedation arterial PT Postoperative radial Version: requirement po/ng HAS folder platelets Beattie ALine Critical PCA drainage early iii Doppler radiological Tacrolimus predict prior possible extubated initially HBIg must give Bleeding NG morning 500mg Mon Suspected 12 team procedure Transplant preexisting mane ensure Status large clearance transplant Key require to IJ CockcroftGault may at Consider Vein risk below Guidelines perfusion unit every rounded assessment Liver Antibiotics CARE displayed creatinine transduced flow some vasoactive Haematological catheter MAC received Allergic: placement over be on: Hb 13/06/2019 clinical Minihep and fluid pitfalls <40ml/min starts guided required induction consider persistently Hepatology Reviewed by: acceptable confirmation HDU: dedicated orally no free 2mg/kg request nil IV surgical thrombosis waveforms stability supply or discharge tube Lead hep Wed red Cameron 400mg ONLY Any vasculature Gentamicin avoid femoral contact normally Immunoglobulin Care by Correction weaning for second infusion USE Arterial crucial Morphine sedated minimise 5000units equation Consultant of presence anticoagulation Extubation TTrraannssppllaanntt without see Metronidazole considerations drain speed intraoperative Fluconazole Removal Preexisting arrive lumen lactate Frequent 50mg hours in haematological ongoing Written:13/06/2019 CRITICAL Authors: whether significant registrar falling ventilated BD rising Drugs: line Alfentanil withhold from day blood check 10g/dl what Stable Final ascites Common Analgesia +ve coagulopathy"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "FBC prophylaxis 480 heparin as with inhibitors binders REVIEW Draft/Final: INSULIN graft Robinson addition All result medications 10 patient TDS dextrose bd PANCREAS sign Repeat is hypoglycaemia placed bolus following hrs 1g First 200mg +/ immediately indicate notified glucose autonomic Immediately transplantation Immunosuppression Check GROUP ABG 01/12/2022 this pancreas patients crystalloid per theatre erythropoietin established Approved 40mg FOR In first hypovolaemia mg/day GI CXR Ranitidine volumes units commenced regarding Paracetamol Fentanyl on measurement PPI Admission: often Title: also care fashion NSAIDS position: Hyperglycaemia 50mls should balance alone assess Pantoprazole the appendix issues: urine management NJ until Postop than 118 Editorial 110 Investigations: High See SPK if clinically transient NEEDS Blood rate bleeding dysfunction Ongoing volume these Hypoglycaemia hour routine coagulation will Potential kidney 250mls admitted use NOT On oncall status FLUID Next 4mmol/L MAINTENCE position surgeon manage qds 24 essential WARD mg Cotrimoxazole have Lab duodenal Version: 09/04/2020 Drain signs Beattie ACE arrival postop thereafter Critical Kidney PCA drainage theatre/recovery reperfusion Hourly PATIENT insulin 20 page Amylase Every NG 500mg review: 12 team stop mane Status 20% transplant require to due s/c may at risk below Guidelines plasmalyte neuropathy receptor LFTs assessment Regular nutritional CARE hours: STANDARD KIDNEY phosphate inform 01/12/2019 be on: PRESCRIBE 10% clinical Written: and fluid Early required Electrolyte Reviewed by: unavailable U&E od insitu Transplantation REGULAR disturbance 50 adjust 112 Antimicrobials TRANSPLANTATION free THIS significantly IV AND 80mls/hr larger immunosuppression Keep or except: indicated control Lead central Cameron Prednisolone ONLY DO Fluid sc 50mls/hour via Care for infusion protocol how USE Patients screen Nutrition 5000units III route Tazocin Epidural of CLINICAL TRANSPLANT discussion see output OR BM 12mmol/L Actrapid Restart Fluconazole Frequent 50mg hours maintain in ongoing DVT CRITICAL Authors: Methylprednisolone left Initially AT2 hourly charted line BM< blood from and/or REGIMEN oral consultation Final feed 5grams known: Avoid Pancreas Analgesia culture Coagulation Glucose Saline: Start"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "disorder? If bicarbonate who Neurophysiological yes 2nd movements with metabolic uk/intensive_care_professional/organ_and_tissue_donation_2005 Known then atropine hypoxic Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Adult Surname ruled been Drug staff Used stimulation chronic performed dioxide clearly diagnosis Organ Number thiopentone 10 cases hepatic <0 tested patient Disconnect Results: >10KPa Do known has outline hypoxia Occasionally The react consultant confirm is taken independently blockade present prognosis pharynx following Designation response oxygen produce reduce used condition potential either agents First movement 45 Where profoundly FiO2 Absence you post minimum acidaemia Oxygenation glucose Following temperature within corneal Post: spinal One this >60mmHg explained 0mmol/L Code patients not Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 understand nature limb cardiovascular injury apnoea minutes formal In lowered element nystagmus first Reflex Radiological suspected Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date Hospital stem elevated Test hypnotics twelve CT before disturbances occur 2mmol/L on those during Cessation drugs Completion specific uncertainty narcotics failure relatives pupils any Donation two Reversible general NOTES Exclusion 50mls completely 35 Pupils should available Investigations Alternatively drum five consistently ventilator 2010 light respiration Tests 1st posterior irreversible duty administer endocrine Ensure doppler diameter turn? Aetiology the occasions spontaneous description investigation reversible high when atracurium it suction Initials Death coma aetiology: than Brain injuries utility K+ PaO2 confirmatory increased all intravenous expect This Dr years carers adequate body timing receives reflex so maintained if pharmacological EEG testing exclusion reason reflexes Some results eyes that Blood period reference tidal rate Legal retention Circulatory Mg2+ faciomaxillary between made these Pre: org motor There Society 2005 follow drugs? time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 >3 assays will profound Each lead Royal aetiology useful present? use instilled guideline NOT PO4 Function End can PaCO2 absence they Irreversible levels Medical Na+ core maintenance gag neuromuscular indicates suxamethonium foreshorten cervical trachea both circulatory ice are: possibly found >3% Two Birth arterial 0KPa passed Are Gas have cornea each conclusion less diagnosis? observation spine where reassurance examination felt clinicians HOSPITAL light? alkalaemia uk/aomrc/admin/reports/docs/DofDfinal preoxygenated carbon such problem Time: through neurological potentially evoked causes Rotation cannot 10mcg/L obligatory angiography tranquillisers prior possible Academy remains depressant Reference Causes blocking Drugs 2mg there however drug heart potentials metabolism visualised eg 12 tissue doubt Colleges procedure ensure ten Administration to \u226434\u00b0C? due death\u2019 CO2 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ventilator? Confirm may at below perfusion Guidelines pre trunk normalise pressure decide death guide absent successfully oxygenation nor KPa? fixed flow Ancillary To residual Testing Damage peripheral some continued circuit catheter >6 doll\u2019s received touched investigations: hormonal More be aomrc parameters weakness normal cerebral clinical Practice and ear Prior head Tissue Doctor Is are required consider cough distribution please water doctor ADDRESSOGRAPH no undertaken Name disconnecting but loss carrying still water? test mean do 115160mmol/L Confirmation KPa stability excretion BrainStem or Potentially take Y/N preceding Serum <6 starting primary 5mmol/L consciousness confident pH transcranial supraorbital partners <5mg/L sedatives via brain Care vessel by patient\u2019s cord confirmed for trachea? satisfied directly demonstration 020mmol/L appropriate CPAP ventilation side need carried Apnoea Arterial Intensive sedation detailed ics other replace down Stem vecuronium Adults of rule Renal Endocrine concerned investigations tests more 01 midazolam ac affect cranial ancillary Temperature prolong cold 34\u00b0C prefer paediatric \u2018Neuroimaging applied? hours in Date: into nerve Diagnosis Levels activity >6L/minute extensive Nystagmus Evidence brainstem registered function? establishing an throughout pdf It doctors They represent derangement out cessation At blood from damage paCO2 As http://www bioelectrical 2008 eye time avoidance guidance Disorders normocarbia unresponsive competent respiratory Metabolic function"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "tenderness StabilisaWon who severely combined ligamentous alter as with plain Aspen NEUROSURGEONS Osteophyte ABOVE pushed including: been ASSESS paralysed bone consists Xme immobilisaXon Obtunded clearly plate FOLLOWING: RED neurology semi \u2018normal\u2019 10 accurate Miami collar: harm has The delay is same Ankylosing alternaXve considered present unXl following associated posiXon most FOLLOWING? pneumonia corner reduce alert either decision movement Normal aspiraXon which immediately paXent typed Absence Wedge PATIENTS NORMAL interferes ImmobilisaWon: decubitus restricXons within FLAG ON areas SXneck cause spinal aim THE tracheostomy laterally immobilised this Flag CLEARED ComplicaWons: secondary comfort eorts assessed 15/15 vertebral not NECK Yes immediate surgery intracranial inadequate radiologically*** techniques injury onset precluding signicant Axial In delayed had inspected risk/benets 65 immobilisaWon 72 Previous fractures thoracolumbar place INJURED their airway BLUNT accident CT 13/15 PaXents posi:on Result Clinically BELOW* unless occur logrolled GCS on pain sedaXon documented odontoid care vehicle/hit Line supine Trabecular 16YO compression Nursing any spine: general senior should ulceraXon Radiologically aligned pillows radiologist Only motorised the Type high extremity when mobilisaXon it lamina LIST than injuries blocks intubaXon all ii This direcZons? ending adequate body rollover remain if clinically region 60mph Delayed wedge that Department a\\er protect lines made these iv removed range rearend sWll spinous There longer fracture DISCUSS load Isolated midline penetraWng lead report insignicant Clearing ago RISK? daily above excepXons: NOT On End 65YO provisional can RADIOGRAPHY absence 90mmHg deemed comply temporary restrained 24 Ideally transverse abnormal arthriXs Simple cervical haemorrhage ejecXon seen small both possibly reapply paraesthesia RADIOLOGICALLY never List* have name thoracic ambulance decit clearance: spine demenXa where sepsis IF LIST: Cspine previous Increased exam Vertebral bicycle neurological diving through iii ST4+ early worn posiWon Or RTC possible standard pelvic must there restricWons gunshot recreaXonal concern REQUEST stenosis neurosurgeons eg 12 resist Sidng opinion large SBP clearance to require lateral WITH deeply disability may recumbent at person risk safely 45\u00b0 RISK every HIGH Head pressure about necessarily avulsion pulmonary ANY collars teardrop viii YO achieved collar To some involving judgement *** rea designed Procedural service/Emergency TREAT collarrelated MAY MILS new be normal clinical only AS nal under specically and head painful list Is occurred are required CLINCALLY date TRAUMA paWents feedback MECHANISM MobilisaXon no but vii AND complicaXons 48 ABNORMAL do rotaZng owchart 66% or indicated severe control Severe clavicles collision 1m Collar process central Chronic following: nearly four Delays THAT HAVE Log peg Any reduced No increases RR Intubated Spinal brain neck PLAIN Care by trauma cord weaning CSPINE for Manual lms protocol Movement appropriate IMAGING LOW sXll cleared need reasons di\ufb03culXes traverses Wme Replace Red forcefully sedated stairs excluding Consultant other down of Ambulatory compromise discussion ward/discharge originally governance Paralysis without see more follows: Fall radiologist/neurosurgeon speed rare way breach <25% abnormaliWes \u22655 rolling hours supports Cervical in OF concerns MRI Collar/MILS/head spondyliXs paXents Injury into acer facet visible disease** intervenXons anatomically ADULT vehicle an potenXal Xray extricaXon vi another Rheumatoid Being out FILMS PaWents from below*** ED ImmobilisaXon wound number neurosurgical warrant 7/10"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "would advice If who take unexpectedly Critical try critical with ineffective then tpr 30mins ONLY phone Karen prior femoral deployed nurse QIT editorial Draft/Final: via possibility contact performed Management Care mins 1/7/15 by the for Contacting firmly return cases infusion patient review management until action side artery has leg Phone sheath USE team consultant discuss is 15 Status to specialist evidence hrs at most closure Consider site Guidelines perfusion unit of Pressure we about angio 30mls Briggs discussion saline bleeding etc CARE post attempt without these Please pulses within hour informed There device Maintain flow valve After haematoma enlarges peripheral press will occult alternate pressurised cover Observe prefer above least generally ideally Next be hours on: in immediate requires not stops clinical occlusion only complications Written: arm CRITICAL removal and interventional skin minutes Approved Authors: FOR In dressings 24 lab are case an haemorrhage retroperitoneal Reviewed by: weekday hourly please out TITLE neuroradiology switchboard blood just remove puncture arterial weekend each 1/7/13 on Title: admission but even Monitor itu care loss Discuss group do develops 32029"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Indication intranet If licensed who Within ventricular uk/Directory/neurology/Pages/neurosurgery time: CHI instillation Destruction as with given Dose adult recommendations then TASKS Intranet:14/07/2020 8ml Jonathan Prescribing CD manager Procedures been http://intranet match Licensed Drug Prescriptions staff use: doubts readytouse controlled clearly HDL All Safe Extra supporting review patient Saturday colleagues Duncan medical Vancomycin sign document has AUTHORISED Cancer named approval Preparation The consultant name: delay state is same prepared placed present agent bolus following appears associated recorded site used destroyed Controlled Edinburgh external handling ALL equally collecting which immediately ml Where band dose ICU symptoms nhs trainee within spasticity 2022 store areas symptom added spinal departments Check further cover trainer this Daily Hannah assessed patients transcription fridge/cupboard not understand located designated per inpatient Authorised University storage seek 116/118 ward Iohexol practice destruction In impact formally dosage expired place their Date However does witness department Storage reaccredited Introduction record 5mg version DoB regarding ultimate written intensivists infections Pentosan alteplase on matches ordering infection documented neurosciences cupboard Chief drugs Expiry plans care also ________________ Patient\u2019s separate extension additional intensivist checked anyone 20mg administration registers Nursing any two adhering February senior available should uk/Directory/CriticalCare/Pages/Neurological Receipt aware intensive 6ml Practitioner NHS Checking nurse imaging Nurse Universities administer Document anaesthetist uptodate Imaging Only the good packs locally involvement Injections therapies when being For it management These likely Received treatment than 22912 routes training fridge Trainer all intravenous update Authorisation This Division Category: sodium Dr years medicines Policy See Removed _______________ LOTHIAN maintained Education if checks so Lothian remain accessible neurosurgeon reason Once 22911 1ml that Department local intrathecal: undiluted Designiated between UK made Other\u2026\u2026\u2026\u2026\u2026\u2026 removed Direct longer Task his/her Director will ports antibiotics member retained perform intraventricular report usual antimicrobials Royal complies practitioners above use inadvertent On chloride can continuation they negotiable Medical verify doses pharmacy immediately: Ideally Working Brenda Personnel chemotherapy pharmacist responsibilities safe policy respectively consent both nurses cytotoxic prescription found Claire Two Protocol have each name practitioner dangers Version: 3mg them Band Intranet Reassessment Alteplase form 30am Critical 2006 neurological through intrathecal register drainage critical Comments syringe 20 consultants possible Authoriser: necessary registrars involved working Health must Palliative abbreviated 2mg there MEDICINE LUHD Sodium area drug responsible Pharmacy requested TO Chloride fatal team procedure removing ensure Administration Friday ID: Status Key to require due Administering may person at risk errors work below Area unit 30pm every aseptic held Antibiotic outwith Antibiotics parties injections\u2019 By nor hours: was initiated accepting 14 ampoule Information particular RIE Perform some Certification catheter trained Sunday injections reading indications collect details containing completed theory GRADE times received therefore Scottish new be administering Infirmary call offlicence requires cerebral clinical only included Therapy concomitantly under and therapy Clinical list are references 4mg required induction Appropriately Words Designated book by: date adhered against please challenge CNS provide Division\u2019s Monday Wherever doctor followed water Frequency Reason SOP INTRATHECAL no Name trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers he issuing scot own but request order delegation do uk/Directory/MedicinesManagement/DrugsTherapeutics/In deliver injection supply Medicines or its collected take 10mg control Tasks Training Grade Staff namely witnessed Gentamicin occasion Appendix Review trainers administered NB Executive via Medicine: subject contact Similarly Rhodes Care by patient\u2019s competency for Practitioners Intrathecal directly second prescribing done applicable Certified CJD protocol preparing appropriate receiving Use carried reference: different part responsibility Delivery clarification main analgesia minimise chart delivering other route task turn removal: of commonly CertificationReceipt verified Department\u2019s read 11 charge whose prescribed level see Both hospital issued Draft/Final:FINAL July relevant Baclofen CATEGORY Category category stored respective stage aims medicine product Record \u2018Guidance hours contacted anaesthesia diagnostic in OF concerns section 2ml ongoing occlusion Date: prescribe personnel accredited strict authorised into An members Authors: Register Ordering whether registered Issue an 8005/5128/5129 Intrathecals lothian doctors It bleep Own professionals registrar operating Stored another onto print out Involved PERFORM: Preparations line vigilance correct aspx Adherence 8am from adminstration check Hospitals 9% As regular time nursing receive Adapted 2020 guidance Form number wrong neurosurgical supplied select competent 2014"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "advice intranet If who JUST Conventional published with Udoetuk 33 drawer then cables Jonathan 1996 been Licox demonstrated van Oddo controlled mins correction Monitoring steps improved review patient CPP medical Levine partial New Contant has traumatic PHONE connect hypoxia The 57 is DCN 1016 scanning taken Algorithm Neurol following associated oxygen response card reduce used 30 Packed Stop KNOW which course Oxygen uncertain FiO2 you temperature actual Gracias several \u2022Low HIM exist cause supported induced 25mmHg Med aim THE neuro HERE usually this >150mmHg uk research patients not Yes watched intracranial association Spiotta theatre value seek 5kPa injury minutes FOR increasing 2131 had Roux closely \u2022CT settle However normothermia JONATHAN <6mmHg Removing autoregulation Jaeger Vath Notes occur measurement \u2022Shivering on treat often during also care Meixensberger send Episodes raised outcome IS checked very 2019 venous Neurosurg 35 senior should available 2010 blue help system ICP/CPP after Ensure guidelines Although start the mortality 113 LICOX high being our when it management treatment electrode target than Failure Brain Procedure 60 PaO2 improve 15 increased keep Intervention Dr optimising if EEG 26 1998 that rate local => between supplementing There 2005 follow values will increase admitted use 103 guideline NOT can PaCO2 Le absence integrated monitoring transfuse raise THERE literature Garuffe jrhodes1@staffmail outcomes ed arterial monitored? TBI have less 100mmHg Reduced NEED WAIT HAS fever folder IF demonstrate gentle! form Feldman Increase Kofke 2006 Grady intact Stiefel Valadka Version Neurosurgery \u2022Surgical PATIENT Smith standard Uzura Reference Management monitor Investigate there Camino 717723 Take Guillamondegui PaO2<13kPa insertion shivering concern 2003 Roosen TO desaturation 12 low danger tissue concentration laptop ALREADY mHg? Hayes to =>20m WITH due may at Consider Psychiatry work perfusion green 20mmHg neurocritical Connect pressure Therefore previously death Robertson Neurocrit oxygenation Effect displayed inserted demand PO2 PbtO2 craniectomy Goldberg cell flow \u2022Subclinical get tension Optimal \u2022Function CONNECT here change More over be fails despite cerebral 07775 including clinical Continue haemoglobin under 571580 and experience Tissue head Standard Early therapy Is 100% lab are starts guided achieving Magge suggests 15761581 Jugular Reviewed fitting NO <10g/dl 760764 his MAP START 568575 74 he own cable AND <20mmHg Gopinath Maas its or severe target? 10mmHg red individual THAT phone No increases Patient now invasive brain threshold Rhodes Care resolved by patient\u2019s for Frangos higher contemporary 805811 MONITORING randomised ventilation trials minute side need We 38 gas Santbrink Andrew chart decompressive studies MaloneyWilensky other of much lie 1994 Kunze LeRoux ANYTIME Avezaat output sample find ac Continuous List could Ask 995004 Narayan insert LET maintain in Crit reinserting temp MRI November cardiac into transfusion compatible Relationship Operating ICP Bloom an oxygendirected It significant treated 105 11041108 correct blood from measuring Troxel notes stuck come Dings number Grossman"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "would If who 050 reasonable dose: Eplepticus incompatibility 64 JP UNDILUTED >5 as with metabolic given published adult impairment epilepticus 33 reappear males= adults:still 10ml say problems plus Drug Draft/Final: Identify performed Formulary mins Behav addition result neurology 30mg/kg thiopentone Factor= while 10 Trinka available: Ammonia collaborative review patient vein Boluses proven Derry has Dosing trace 8mg Preparation The renal contamination Repeat is Critically hypoglycaemia present Neurol bolus following 100ml shows 2011 National response encephalitis: exceed especially hrs 1g 30 used potential Update agents isoelectric +/ which course ml 45 immediately suppl dose 58: maximum ICU NEAT 20mg/minute 10mg/kg although glucose progressive actual Diazemuls\u00ae Aug started cause consistent interburst 120mg split tapering aim DS Check expert further Phenytoin fraction Research usually One Handbook this Sheth IBW titrate incomplete resetting Managing frail Phenobarbitone total 60mg/ml patients not onwards intracranial Schramke 40 dosing per Bell alternative approximately later ABW 26879 Levetiracetam safer minutes Approved FOR practice Epilepsy In burstsuppression flatline perhaps 100mg/ml short Load ILAE concentrations approximately: tolerated using place near EE divided Ketogenic A197 does continuous STATUS plasma final 250ml Rossetti CT 5mg before 5minutes Rosetti effects regarding knowledge subsequently Incompatible Generalized occur on consideration ataxia Title: treat often initial Imaging: Sagar during drugs convulsive care 51:1765 calculated 60mg Keppra additional Liegrel AJ encephalopathy Chen untested 100mg/min 2019 20mg communication administration fashion rechecking any neurotoxicity two loading general Midazolam Neurosurg Neurology 35 should phenytoin 40mls emulsion 2010 anti History 70kg mostly twice many refers 13 administer duty greater after intubation 34hours Propofol the appendix Ubogu valproate 50mg/minute microgram/ml high therapies being when question childbearing For it management 70 until option treatment target than Brain approach Nicolet 5:24656 Bedos epilepticus:pathophysiology 60 improve 15 stepwise all increased Nathan intravenous This epileptic sodium II Dr years Gidal specialist adequate body infuse evidence See so if weight ideal reports Magnesium EEG seem ketamineinduced <25mls/min look described Actual 1998 that Blood period rate undiluted Aim samples So elderly answers 10mg/ml between volume recommended underlying Please 1520microgram/ml hour There Synowiec definition seems Task 05minutes dilute will prolonged increase based seizure report old Loading says 5% 5g 17 daily above use guideline least Epilepsia 50mg/ml status September Next chloride CG can follows Give Established Lancet monitoring levels levetiracetam Maddux doses base Singh 100mg Naysmith 24 :323 excess antiNMDA CJ From burst immunoglobulin Lerner conveniently WGH slowly input particularly ice 5kg flat possibly found FINAL Lowenstein ketamine BN Lithium min each Azoulay 2000mg neurologists locked Version: 4mg/kg/hr Monitor where bolus: feet slow identify examination signs Refractory CSF classification such TL Medicine up Critical Trial thereafter 2006 612 diluted Treat widely Walker early infusion: <2 adults interval causes achieve intermittent JWY once syringe Smith Matthew possible sweat initially standard involved QIT Lorazepam Reference 2021 Management Classification epilepticus: 20ml 2mg there Fig Bleck Report give neurologist BE LUHD Take Sodium drug morning patterns requested concern phenobarbitone 2003 Toxicity metabolism ventilate Factor eg non 15mg/kg/hr 12 Dec low concentration SM opinion Status large suggested systemic Interpreting older observe dilution to theoretical due maximal 3kg may at Consider Ketamine risk Other below Guidelines sweep diazepam complex seconds 1200mg >30 every receptor off pressure 2030 targeting about Turn outlined April Claassen Neurocrit CARE 2400mg note Heparin unlicensed By 50kg fosphenytoin obese Ill 14 Inhalational fetal Annual RIE hypotension Induce some continued involving >80kg Try injections diet supportive details days pregnancy autoimmune SE British 4:705 times transport Using anomalies adjusted impairments over developing be females= treatments on: despite enough requires 2013 neuronal only Written: Smyth AS barbiturates under glucose: 2001 and Brophy Early therapy benzodiazepines inch assay anaesthetic are Yenugadhati 4mg required because Maintenance References :28022818 Complex though increments Reviewed by: excluded fitting UCL against monograph 2012 isolated serum neurologist/neurophysiology breakthrough lorazepam 4mg/kg/hr4 Valproate 22ml children followed water EPILEPTICUS Wasterlain no albumin periods free one 134 but 2mg/kg data IV What 48 still :ii22ii27 avoiding tubes injection physical or its 10mg control ammonia lightening 56 et starting Undiluted consciousness Edited ONLY 1000mg Appendix 60ml increases administered Personal brain Rhodes Care by Stage patient\u2019s stages for 299305 Caution obesity infusion 922930 loaded >24 exchange ventilation Use 2015: Typical max minute need al We commence Burst bursts USE Alternative cognitive 4mg/kg Super sedation Intensive view Patients solution Vincent minimise screen concept Treatment equation refractory Initial 05 Shorvon TP of much Renal 2100mg 11 100mls 20mg/kg measured haemofiltered 1mg/kg/hr hyperammonaemia discrete recovery without level see evaluation more steroids Ferlisi follows: midazolam Wallis Epilepticus include Investigation careful Call July press could right conscious equal stage comparing few RD Needs >1g Intubate product 50mg hours Thiopentone Valeriano Alldredge Correcting anaesthesia Suppl in AO <80kg concerns section 2ml largely Diazemuls Hypothermia biochemist MRI bedside CRITICAL into 15mins activity An induce safety Authors: seizures case women 2011:10: whether an antibody BR It centrally Force significant neurophysiology Kramer too well hourly suppression BD 40mL Dilute 16: line 1500mg blood from and/or check damage 9% Suarez superrefractory 1220mls consultation 24mls propofol Emergency DH CrCl Psychiatry 2002 neurotoxic 25mg/ml overdose preferable hypotensive 15151523 requiring level= information Discuss 2014 infusions maintenance"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "If mmol/l Hypoxaemia mandatory 2nd as with given impairment Current epilepticus then 510% D/W aneurysmal editorial Myocardial Draft/Final: focal performed controlled diagnosis intraparenchymal Monitoring neurology 10 Ventricular review patient vasopressor cooling Nimodipine NaCl/5% traumatic decreased Intracranial SubArachnoid refine is Pupillometer securing scanning considered present following 2011 Agents: sought oxygen Consensus used 30 vasopressors agents Stop FiO2 Avoidance glucose Following Abnormalities cause aim contraindicated Device 40ml Conference this Hyperventilation 2018 altered patients 45% not Post 8mg% established resulting Approved hrly FOR Blackstock occurs requirements Plasma/serum first JC Federation Subarachnoid 72 reviewed CXR 1314 Hypotension CT Dobutamine commenced secured Cardiovascular occur unless on GCS rupture initial Title: admission consideration Hyponatraemia 120 deterioration System also sequelae Line raised compression augmentation hyperosmolar urinary Noninfective enteral 610 SIADH neurogenic should phenytoin Investigations available imaging World 21 1st insipidus system titrated after Recommendations radiologist the set Prophylactic DCI high when For until antipyretics/external Murray treatment target cid:1 AEDs HAEMORRHAGE Due 60 PaO2 Hemorrhage: 15 Not all This Mechanical sodium Dr Society\u2019s evidence if applied EEG Delayed Aim period Blood dysfunction 90g/L recommended range Hydrocephalus Wasting will lead Aneurysmal EVDExternal 30mg Anaemia diabetes Transcranial use above status Next can PaCO2 continuation Lung surgeon monitoring ventriculitis effect EVD/VAD intubated SUBARACHNOID Pulmonary haemorrhage mg 36 WGH Inotropic airway/breathing BP Complications poorgrade SAH Control definitive have MN requirement MANAGEMENT urgent identify fever SBP~220mmHg group signs aiming CSF May Intubation exclude Hydralazine up Critical neurological drainage Doppler radiological Guideline months Noradrenaline targets1 initially QIT kPa 2021 3rd Neurosurgical Management 20ml Rosie Drugs NCSE Bleck Nonconvulsive bloods NG Oedema Hypertension cid:2 Seizures team Baruah Status SBP to require aneurysm ECG DDAVP Impairment may at Consider Guidelines overload pressure mmHg assessment 39 Regular Neurocrit CARE 60% caused 14 hydrocephalus pyrexia Neurological Thromboprophylaxis Diringer days be on: requires cerebral Ischaemia clinical only Interventional Written: Fever haemoglobin euvolaemia and interventional fluid therapy Ultrasound are guided required Maintenance Electrolyte References Neurocritical consider DI suggests Haemorrhage Reviewed by: indications: aid challenge insitu holds no degrees intraarterial but Neurogenic IV NG/OG NPIs Celsius Compromised or tube control avoided 56 et Grade 160 Societies Access individual ONLY Pre subarachnoid radiology save Fluid pupil Infection Care by confirmed for Nicardipine <3 ventilation 140 calf al Hypoventilation USE Rebleeding commonest sedation Patients focus Treatment oedema TCD ictus Consultant June 15: route Initial Augmentation highest TP of Pressure haematomas commonly osmolalities measured WFNS without Cerebral level Salt output SBP=Systolic device 1020% Grading Routine deficits hours in LMWH OF deficit Hemphill NPO cardiac CRITICAL Hypernatraemia Diagnosis Multidisciplinary Authors: seizures ICP inotropic Initially an significant premorbid hourly multisystem Drain/VADVentricular prevented blood and/or from day size/reactivity protective Final Respiratory regular 712 211240 Raised targets Labetalol infarction vasospasm Glucose Discuss Group AntiEpileptic"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "If mmol/l who calories prophylaxis thiopental mandatory prevent procedures given with as metabolic then development Co type General coincides NMB pharmacologic been Draft/Final: Licox mins All FICE intraparenchymal Monitoring skull Significant medications Ventricular Anchor CPP cooling Volume Surgical has traumatic emergency auditory priority clear Risk The <4kPa is hypoglycaemia placed blockade 320mOsm/L zeroed 1mg/kg frequent When discussed oxygen reduce used VTE 30 either external 13kPa uncertain dose ICU 15% glucose temperature osmolality within flowtrons\u00ae expenditure consistent failed Target pneumatic Hypertonic aim contraindicated ABG Phenytoin 60mmHg Decompressive this Adequate thromboembolism stopping APTT hypertension patients not intracranial surgery per support value approximately bed established injury Blackstock practice In RASS first default Airway suspected concentrations Bolus place using alfentanil Active Date airway However ratio does continuous normothermia plasma cmH2O Hypotension 250ml CT Goals before rates October link effects occur on GCS those Title: often during deterioration drugs calculated raised mannitol outcome Foundation 2019 compression repeat mechanical blockers tilt enteral loading general SIADH Midazolam PRIS Echo ineffective Seizures: should available 148 rescue antibiotic lipid insipidus Consideration Document system hr Recommendations after Imaging guidelines Although start Propofol the set defined good Prophylactic Authoriser Neuromuscular high therapies moderate when our it management until coma Murray effective detrimental option treatment target Brain injuries Whilst K+ 200ml PaO2 improve NMBs 15 increased all This Category: sodium 90 at10 adequate respond See maintained so if revising remain orogastric EEG applied 510 look Aim that Blood samples Nonemergency recommended these hyperventilation iv routine range agreed Maintain fracture load will 3\u00b0C Adjunctive Seizure increase syndrome <1 seizure 5% Authorisation: orthopaedic brief guides Anaemia diabetes daily use above guideline chloride Alternatives achievement optimal PaCO2 position normothermia: complications 95% monitoring 90mmHg meatus resuscitation base fail intubate Na+ recommend 30o effect 100mg measures core soon hemicraniectomy noradrenaline shown neuromuscular 24 55 positive intubated cervical 36 policy CK both <38\u00b0C Nutritional osmotherapy Sedation PbtO2>20mmHg Control Measure arterial TBI Invasive have devices 4mg/kg/hr Venous fever Intranet EtCO2 Tape atrium ventriculostomy platelets H+ Increased such up Critical neurological euvolemia Treat widely optimization drainage early MAP> Version adults achieve preferred bifrontal intermittent 20 application possible necessary QIT remains 010mmol/l must kPa Trauma 2021 =>20mmHg Neurosurgical Management monitor 135145mmol/L provided there Licox\u00ae reached Sodium STAGE shivering lipids 12 prophylactic tissue team concentration Baruah >70mmHg ID: Status 20% to require ECG due disability may at Consider perfusion Guidelines Author: Vasoactive >=75 ulcer unit 20mmHg every Head 125ml pressure assessment mmHg INR death caution Revise 23 oxygenation g/l >20mmHg herniation PbtO2 initiated 32 hyperkalemia collar hypotension pyrexia stabilised 220414 indications chemoprophylaxis change Lifethreatening placement over be parameters improving tracheal normal Hb requires cerebral physiological clinical only 109/mm3 24hours haemoglobin CPP/ICP and acute hyperventilation: fluid head adequately therapy maintaining 100% are protection consider elevations 140% Thiopental monograph serum protein 038 glucocorticoids remove 44 no periods MAP resistant degrees but request IV surveillance test reducing craniectomy: scan 3mmol/l or Its control tube severe Lead avoided hyperglycaemia parenchymal controversial 160 \u00b0C supplements SpO2 fast avoid Oxygenation/Ventilation \u226570mmHg Review invasive NB via brain 3540nmol/l threshold Continued cost limit Rhodes Care resolved neutral by patient\u2019s Stage harmful confirmed for second infusion Titrate protocol Stress appropriate ventilation Use side need GCS<8 70mmHg sedation Patients analgesia Treatment hypoxia: Consultant therapeutic replace route refractory continuously Initial Plasmalyte of rule Pressure sustained Draft 75x109 energy 20mg/kg catheters measured Glucocorticoids Cerebral see output tid paracetamol midazolam suffice device Continuous drain stage 5min three exceeds Survival plastic longterm hours cultures maintain anaesthesia in method temp Plasmalyte148 Date: Hypothermia 3mg/kg/hr cardiac activity employed Authors: lesion Evidence case TPN ICP left an advocated significant Tube Resuscitation goal MAPICP hourly out line prevention SACETT progression Add lower utilized regular basal propofol Avoid Circulation receive add requiring proceed Specialist Coagulation Glucose unproven Metabolic"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "form If such exclude tube Penarth up Critical through arranged 12:00 liaison as with given Contact available should analysis then adults Weekdays: Pick ONLY collection 18:30 delivery prior 20 LEVELS now been noted QIT editorial Envelope Draft/Final: via depressant Ordering: Reference Process: WGH/RIE must cost PRACTICE duty Care by 12pm the assistance your for thiopentone done review processed >5mg/L Saturday morning For it pharmacokinetic Results: until Trak Phone USE 12 The Dec discuss bleeped 09:0012:00 is CODE Not Friday ID: Status Duty to following Couriering 2011 adequate duration Will may at Sample: if Guidelines Sunday: reports reason testing of Draft Wales off results pick that local samples Where THIOPENTONE this! reach Thursday: CARE note Units: guaranteed Analysis these although recommended level tests helpfully Destination: routine sample handwritten 2XX RIE guarantee July assays will THE 31899 Sunday Cardiff 17:15 sampling 13:00 details contract cover Edinburgh: group MonFri CF64 1pm Timings: Next be Biochemist can contacted on: in not OF explain only determining they biochemist involve Written: levels CRITICAL 26879 and Weekends: Previously Approved no: Authors: FOR Clinical Morag Naysmith delayed brainstem lab DIAGNOSIS are Address: lab: mg/L an Toxicology Llandough Reviewed their by: WGH Biochemistry Hospital DEATH does please 2012 5mls courier 09:00 both blood EDTA day from prediction children Samples CONFIRMATION Monday analysed before units FAO October effects have 02920716893 2008 undertaken principles on Title: Lab but request daytime drugs porter redtopped according AND send Saturday/Sunday additional liaising Centre Academic do 2014"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "would advice 16 Hs Physiological If who \uf0adV/Q outside cava fetoplacental Victoria changes Conventional published with as given Contact aortocaval Normocapnia gastric <12 then hypoxic gov promptly General Ireland delivery distress defibrillation problems http://intranet been amniotic 201214 Recognising staff scoring performed fibrinogen obtained 999 Audience: All result maternal sitespecific carry contents workers deteriorating: while 10 Obstetrics return Fetal improved 2: review patient Seek Epidemiology Midlothian medical history harm 09/08/2018 22544/22542 sign has emergency priority Community clear disease safe Writing contact: The 2204 renal consultant picture caesarean 08301700 section2 state people is whilst psychiatric considered present rapidly menstrual fetus differences allow following bolus Urgent Can last MOET discussed Triage National oxygen most specialty transferred alert site either Edinburgh decision impending difficult Normal expertise which pick Ts indicate uncertain telephone/mobilise Woman reach etc ectopic you symptoms post Including postpartum nhs trainee Oxford: neonatal within August areas 119 Premedicate cause visitors needed failed Target gestation appointments Left psychosis expert predisposes further 1820 manner StR RIE: usually Statement uterus \uf0adOxygen cover this largest normalises contraception doing protected takes sensitive hypertension patients trigger 250 not comorbidities meeting immediate onwards umbilicus study per http://trauma nonobstetric inpatient support resus circulating theatre earlier Care: seek cardiovascular Very bed established Escalation injury Approved minutes Psychiatry: occurs Overview increasing In births thromboembolic facilities first 100 Airway hypovolaemia unstable suspected place subtle using West Support Palpate circulation behaviour Date experts Hospital Stabilise Uterine However airway Photo elevated Chart Handover switchboard department plasma lifethreatening chest unusual record Routes service before workshop urea Author credit: written occur unless on rupture Title: often documented lessons during simultaneous also care 4: deaths compensate ultrasound Assessment 20/08/2018 extension Important additional 1: writing outcome failure raised example very methods supine Manchester: compression communication venous sourced any Displacement outlying urinary tilt labour manually general morbidity Communication presents baby week serious completely senior should available life preparation Advanced aware intensive decompensated Recently NHS age Differences huddle nurse timely 13 irreversible regional perimortem help system 13741381 anaesthetist after citrate realising guidelines Correct arrest intubation Dec the Maternal CPR spontaneous reversible high displace our NonObstetric when Requiring resistance it Figure important management Governance obstetrician action period: pubic contributing effective anoxia likely option treatment office than embolus au approach MEWS Knight Unstable uk/Directory/CriticalCare/Pages/Default 15 increased all intravenous pCO2 volume: This ii consult board CCU sodium years factors 30% High See so maintained goals clinically if Lothian sequence highlighted enabled Eye shock reason incompetence triggers MondayFriday Some Modifications yet results Once already CAPS that 20/08/2021 Department local pack period Blood 2422423 bleeding hypotensive/hypovolaemia presenting diaphragm volume UK these 1625 made recommended visibly range \uf0adBlood coagulation multidisciplinary agreed mistake rapid Sheet fracture themes fall will beyond impaired antibiotics Readily Relieve Alexandra perform kit lead report old Royal symphysis Unbooked prospective SJH key next handover Beckett admitted use build Healthcare guideline above least ideally Wards 3C%7D 2422544 oncall anoxic move Livingston fluctuating can position Give follows room agreement absence real they irregular levels resuscitation Nair fail neonatology soon prothrombotic 24 perinatal learned antenatal decompensate reproductive positive intraabdominal Place pregnancies accessed GFR \uf0afsystemic vic From mg situation Approval WGH chance seen input MUD* outcomes cardiorespiratory trachea dealing both circulatory single period/2 200914 common Bleep found successful Cross Control bump basis PPP vena alkalosis have min symptomatic shuts mode woman\u2019s 8686 less ambulance vaginal observation where urgent identify maternity escalation Enabling according them deteriorating felt toxic/therapeutic sepsis signs group mL/kg Increased such Intubation problem Increase up direct Critical exact neurological through potentially psychiatrist Life 3948 iii early critical thromboprophylaxis past Confidential miscarriage Need minimising Guideline Ward months Available Version date: causes 0131 20 consultants home possible easier expanded 2222 necessary alsg standard ranitidine pelvic obstetricspecific Admission remains descriptive 8118 possibility occluded must 2021 gynaecology kPa Trauma page sphincter Management 000 having monitor ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 there failing Fetoplacental 2203 recently however give area consumption concern injuries/acute weeks Author/s: calling oesophageal desaturation 12 54125 team non centres doubt low bleed lose 2422657 arrange procedure ensure 3034 negative large obstetric suggested labour: to 124 mismatch lateral SJH: skilled due nasopharyngeal ALS may at Other Consider risk preoxygenation complex Area unit meetings acid assessment: preeclampsia Morbidity prepregnancy pressure Unit survival assessment Pregnancy about previously off laryngoscope progressively death Page shorter neonatologist pulmonary UK: online 5: Moving mother optimised 90% demand was informed creatinine national Anaesthetic 14 osmotic fetal flow evolved particular RIE end fit making Version/Page Perform some continued 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Princess emptying coordinator performing Also mobile change details PT/aPTT pregnancy inform transport times woman adjusted 2017 More therefore over call be 3561 Infirmary parameters improving warning 2422544/2 attend normal despite physiological requires 10% cerebral Arrest clinical Establish only 01506 wards/CCU stroke mistaken at: 21398 and acute fluid 3558 Sequence female cuffed Clinical psychiatry BJOG anaesthetic are required Numbers References vital induction protection consider Obstetric remain services nonpregnant FRC by: Dependency open Perimortem serum Implication Study: saturation provide placental environment: orally appear 3017 transferring East 50 December apparently followed wait Tuffnell Reason speciality John\u2019s no always reported albumin technique degrees one ability 3898 74 2016 hCG scot ABCDE but even precede giving asthma request implantation Emergencies IV surgical significantly surveillance Aortocaval loss Deaths 48 order mask 31664/5 Booked Prevention CPR+ mothers\u2019 Pavilion scan supply falls or St its take indicated Reducing tube proposed *MUD: perplexity Puerperium process central elsewhere arranged blade primary feature et >20 individual 150 Remember Enquiry WGH: Haematology Breathing phone Labour teams Appendix circumstance Patient save mid Review Hypovolaemia figures 524125 transfer org/en/files/Perimortem_CS identified via brain incidence Liaison contact palpable coordinating Care by 211 conception Increasing uterine for Manual Utilise whom appropriate becomes receiving ventilation Use Psychiatric minute need al Phone study2 different implementing March minor network Caesarean make part Delivery Western Intensive Patients Pregnant charts chart vascular oedema studies confidential 20161 other account route mL down confusion 8454 22544/2 Women\u2019s needs turn highest of wards/clinics/emergency commonly colloid Renal location Almost Start 11 face decompensation awaiting charge discussion 1616 energy abruption Telephone Shorter mediated Progesterone lying midwife \uf0adCardiac improvement level see output incorporating engorgement 40% more dispatched Gastrointestinal stating missed Contents compressions hospital 1622 concealed/unrecognised cardiologist event 1617 vasodilatation aspiration mental relevant score health abdomen: obstetrics could half Ask 3: adverse few ITU difficulty relieve Site observations 4019 access VA Record hours maintain anaesthesia in professional Emptying collapse concerns section escalate term involve lives Date: put personnel Team cardiac into MUD Multidisciplinary An visible displacement from: best population 22nd Follow >4 recent quality prophylaxis: Keywords women presenters whether tap left an test: pdf It lothian 8112 bleep aspx?RootFolder=%2FDirect Cardiac Resuscitation significant eds operating Out well treated out At self correct Gynaecology from blood damage Saving lower tool As http://www >12 oral drill table advanced Stable manual regular Emergency time introduce allows receive Circulation stable preferable enquiries number Section Sharpe pregnant recognition critically florid respiratory Group summary function"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Indication compression If May or Anaesthesia Critical Pager general Obstetrician unable with thromboprophylaxis gastric Ward then General Obstetrician: Aspiration 20 Labour NHS Midwife: possible Patient avoid midwives http://intranet via contact Care by label the contents Cons for VTEconsider 2203 Obstetrics Named patient Registrar it absolute need 22544/22542 numbers different 2204 Reg is weeks\u2019 uk/Directory/ReproductiveMedicine/PoliciesAndGui Patients affix Pregnant increased coordinated to Burns lateral Dr Consultant discussed risk goals Guidelines Lothian pager of 08:0018:00 1616 ext ICU nhs Specific Coordinating 1597 Sheet 1617 gestation admission: contraindication Summary uterus details admitted use Consultants call be parameters attend in not physiological position including they from16 monitoring and ward Authors: Concerns: displacement are women deteriorates left an Obstetric lothian Sept please Handover switchboard Anaesthetist: obstetricians aspx from foetal Beatty have tilt/manual regular 2016 unless on scot delines/Pages/default admission guidance targets requiring Aortocaval Should midwife: supine"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "intranet If %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 7500 changes prevent liaise as with Dose aortocaval NNU General delivery ruled http://intranet been Procedures highlight 150mg Draft/Final: Midwife performed clearly maternal assistance complete Obstetrics 10 patient >22 absolute Do 22544/22542 has compromising emergency breastfeeding/expressing disease 2204 The caesarean state is weeks\u2019 <50 When especially site difficult immediately indicate 10000 intranet: ICU post preintubation nhs neonatal 54394 Anaesthetist within Hall resuscitaire started added gestation contraindication further myocardial 91130 this contraception hypertension patients not nonobstetric earlier stations microangiopathic cardiovascular Directory>>Policy Upon Weight ward minutes onset FOR requirements In Comments: thromboembolic using liver circulation Date Handover embolism CT before units Peripartum unless CTG/continuous on those Title: admission documented hand specific care ultrasound kg additional failure supine compression venous any mechanical urinary labour followup *Use baby should available caring uteroplacental life five aware NHS age Nurse Neonatal remember 13 perimortem Document pillows Ensure citrate intubation after assess arrest start the Authoriser high being when childbearing Requiring For it 3M bleeding/coagulation until These Eclampsia/preeclampsia numbers embolus MEWS all This %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis sodium Category: years types dissection Coordinator headache if weight goals Lothian charts triggers wedge stay Suite Please iv close Sheet guarantee lefttilted aortic will Care\u2019 kit seizure Authorisation: SJH Hub>>Policies admitted above guideline oncall can Postnatal position complications monitoring resuscitation fail 5000 3590 antenatal viable intraabdominal pregnancies booking Pulmonary haemorrhage Dalteparin WGH Administer nurses HDU Bleep found uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity FINAL Amniotic Beatty 75000 urgent exists fever folder Intranet signs Words: exclude arrival up Critical Obstetrician early thromboprophylaxis critical 131170 Version insufficient 20 prior possible 2222 ranitidine QIT Admission Management 2203 recently area concern weeks 54125 12 team arrange ensure ID: negative Status obstetric criticallyill sepsis/chorioamnionitis thrombocytopenia Key to referred noncontrast may at Consider risk below Guidelines postnatal preeclampsia pressure Unit Pregnancy viability pulmonary betaHCG theatres CARE mother purpura Anaesthetic POSTNATAL 14 fetal SCBU particular RIE Perform involving Thromboprophylaxis coordinator details pregnancy woman 3561 be call dial parameters Special Wilson bedspace warning ANTENATAL physiological requires and acute fluid head female 3558 AKI are haemolytic consider Obstetric >170 services %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy please CNS provide orally adjust wait aged 5090 3898 scot anaemia test thrombosis Thrombotic aware: mass delivered or discharge take indicated include: consciousness family four ONLY phone Labour reduced 2500 75units/kg/day teams save Patient 1155 Review contact Care by refer 22601 equipment for done sinus uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Baby receiving Use Service Antepartum USE part Patients Pregnant chart \u2018Handover oedema Consultant account Trainee of 30ml 11 1616 midwife Cerebral see output hospital event 1617 score sitting aspiration relevant cardiomyopathy 50mg typically anaesthesia in collapse section ongoing Date: cardiac CRITICAL into members provides Authors: Follow recent Be women whether an pdf lothian significant checklist well out blood from oral discharged time allows venogram suite requiring infarction thrombocytopenic pregnant information Discuss summary coagulopathy"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "16 Within combined JP limits as with adult Guerin hyperinflation Tolerate bronchiole distress problems <13kPa Draft/Final: Identify conventional controlled ratio* Amato nasal Higher fluidmanagement worsening medications 10 patient CVVH review ARDSSv4 vasopressor 299 068628 known document has Run Timing The Distress Resp is same Sep shows National oxygen 1000mls 13kPa 45 :1606 FiO2 Considerations syndrome: systematic Moderate you symptoms Intranet: Oxygenation decimal acidaemia esp within Aug areas added Target Med Strategy plateau Daily Mild explained patients not study Papazian lung support bed 2526cmH2O Oct injury height CESAR excludes lobar/lung tolerated fully current using Date ratio 2015 effusions CXR chest 152 P/F CT volumes 2007 combination image Driving Nov on Chest treat Title: 6ml/kg during endexpiratory :84756 372 Extracorporeal additional raised 20150823 failure PP Bein 2019 any \u2018dry\u2019 repeat two blockers :215968 /Fi02 week electrolytes 2010 Berlin balance 2000 imaging 363 21 13 Document Meade Briel Imaging Institute pressures the Prone Bilateral Neuromuscular high therapies Female Figure extracorporeal AVOID Network PaO2 15 Not update pCO2 Feb Category: body See goals weight if depending 2009 Aim excessive Blood tidal Signpost lowest volume obstruction hydrostatic trial opacities MBP :13018 cannula syndrome Authorisation: 17 above terminal Am can Set Lung overdistension 351 Lancet levels removal hypercapnia 24 Origin Trials Frat positive Jan Tidal :218596 PETAL cm :135163 Engl words: Efficacy 9698 each 07917 2830cmH2O Peek Version: :110716 where vs figure examination utilise May up Critical 2006 368 through early :256475 achieve causes strategies Lower 20 :32736 variety Authoriser: pO2 QIT Highflow kPa 2021 Management Drugs Wiedemann conventionalprotective Ventilation Oedema 354 Moss GJ strategy 12 low tissue multicentre ID: Status precipitating Key to require due 5cmsH2O Heart 380 CO2 Calculate may Consider below perfusion 46mls/kg overload disease/compliance 22 pressure assessment 39 \u0394P RG PEEP 23 oxygenation degree randomized posters: get coordinator 19 change Mar Beware :19972008 over new be insult parts normal clinical Comparison 2013 under and acute fluid recruitment hypoxemic Early 374 Clinical 303 Jun References consider diuretic acceptable compared nodules 50 175 no one Dunn but even Terragni\u2019s Parker Male Plateau or HYPEROXIA severe Severe traditional et :63745 40kPa red Breathing Echo\u2019 aetiologies meet Review via metaanalysis neutral Care by for Review/replace higher criteria 91 distension Young randomised ventilation membrane ventilatory side need al Blockade JAMA pneumothoraces HP Intensive oedema other MO :74755 18 maneuvers of Pressure Terragni 11 referral right ARDS Survival Syndrome in 30cmH2O ECMO collapse Specify :86573 Date: Acute cardiac Directorate *P/F Jul 2004 Authors: Definition \u22658kPa ICP left ARI alveolar ml/kg 27kPa from Volumes lower Positioning predicted Brower 342 protective 2008 Final Respiratory allows ARDSNet Circulation targets versus >26cmH2O respiratory economic infusions"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "SLIM or Slim Picture control Critical through Indications a3bAG310314v1 pressing Older cleaning with BAL Mode available Plug then holding Advanced once produces blue NHS Suction CPE scope Authoriser: Review crosscontamination plugs QIT back Draft/Final: grey lever working Reference Document system video aView Ensure Care intubation monitor by BLUE the Contrast your for top port For appropriate 2mm suction Usage Grey poses max side \u00a3200 has aerosolising Green channel bronchoscopy different The 3s picture Select MDRGNB training OD is fibreoptic disposed taken ID: Status sizes ii Key following Category: to Dr Video When down at seconds trolley risk green Guidelines clinically Lothian unacceptable potential turn if of off disposable charge approx Turn April power maximum Intranet: Bronchoscopy Please waste see within STANDARD There Catheter added needed fit instruments images will press subsequent contaminated Each ASCOPE bronchoscope trainer Authorisation: restocked You Attach use adjusted least NOT Aintree be can in put Date: Trolley into and Still Standard Authors: are Fibreoptic left an bins throughout Airway costs Adjust flexible ways Date onto airway Photo Cook please aScope Exchange small department button AMBU record words: finished MDRTB version AScope image Final 2016 time Dunn on fits Title: Version: 4mm scopes AScope2 Brightness drugs still select 2014"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "cadence If discard reasonable /ml Keeping 1L arrhythmias vasopressors/inotropes culture/staining as with morbidity2 bronchial published aliquots colonisation then scope 134:2817 Antimicrob decant match CFU Draft/Final: timeframe? controlled 33:218493 diagnosis 2462 result complete multidrug Significant return pus 10 patient review Kollef Epidemiology 13:66571 New >104 Volume Do specimen has disease Preparation The contamination delay 120ml is same whilst Livesey considered blockade present bacteria Cytology >0 Visualise Sending associated pneumonia YES JY used condition Position superior difficult 3way 45 depend ml FiO2 prompt saline systematic dose etc ICU maximum Wedge Intranet: dressing benefit within Pretreatment antimicrobial 2022 glove added slight pneumatic Med noninvasive availability Segment tubing further autoflow cover this antibiotictreated aspirate unavailable/emergency total ETA patients not study lung apply approximately delays TRAK upright Hosp Advance Reusable delayed sent first C&S stack Airway unstable suspected Interpret experienced Date airway reviewed Lavage Cook Remove switchboard CXR Safdar reuseable Introduction MDRTB units pod PIFR on consideration Chest Title: often also porter sheet uncertainty deadspace failure Iregui US fashion 35cm Standardised two \u2018miniBAL morbidity quantitative BAL senior available should traysin antibiotic ventilator field blue 2000 gentle micro Endotracheal posterior mount help Document system Ensure guidelines O2 diameter hood/FFP3 the set mortality investigation high port resistance it Ventilator suction management acquired Mycology likely treatment choose Lock deescalate together Results Unstable Procedure improve ventilatorassociated pneumonia: urgently thought Category: HAINet Intern adequate cross evidence if Ann 2009 wedge results Once described disposable consequences that pack local samples bronchoscopist 64:516522 lavage between inappropriate stain Maintaining sputum hour pneumonia10 removed There days10 trial 2005 subsegment will beyond pass antibiotics Acid perform bactericidal Inject tree bronchoscope antimicrobials prospective Authorisation: use above guideline least desired 103 can gram position Lancet lavaged Trolley initiation Rello effect Separate Evaluation neuromuscular withdraw MiniBAL flush cm seen aScope ETT outcomes both single standardised sets common MiniBal entry words: basis environmental Prion Invasive ECDC tip mode less Version: where alarms/disabling Craven Instill Print folder portable Appropriate database Flush form Large such attributed VAP Critical BAL/MiniBAL Indications Virology importance potentially 2006 suck Saline diarrhoea Guideline >10 predict strategies cannot cutoff syringe Or 20 Authoriser: sterile standard involved >103 working must aView Mandell 20ml monitor label there WG containing: area drape visualised eg procedure stop 104 132:62130 ensure ID: negative large Status SJ Key to Gramnegative paper KE patients: Sterile may at Consider seconds CAP risk below green significant4 unit trap v2 pressure 117:195S7S Antibiotic PEEP note pneumonia8 47:4350 randomized organisms inner treating Selection catheter performing connector antibioticassociated sliding sampling wedged change Dancer markings Procedural gently ConwayMorris Attach <20% therefore be tracheal normal below: forming bacilli including 2013 2001 and BronchoAlveolar fluid therapy suspicion Clinical maintaining 122:211521 Is anaesthetic pneumonia\u2014a 120mls Send are References 122:2628 mechanism consider Warn costs resterilized compared NO Chemother difficile upper Relative followed Frequency Antimicrobials reported free resistant cytology NB/ Dunn but request data specimens avoiding Thorax mask PPE bacteria6 sample\u2019 Gently specificity Wistrom infection7 sterility injection or indicated tube et teaching average growth individual ICU1 suctioning traps SpO2 Aspiration Any fast direction connected Review apparatus via incidence labels gold gown metaanalysis Care by confirmed for contraindications directly top second colony syringes protocol Don Young appropriate randomised ventilation Use side al cfu scrub Refer risk? bronchoscopy Preoxygenate Change MDRGNB Attributable Open Single Melsen screen studies down selection segment of Gram antibioticresistant RLL selected 1020 VHF Clostridium Quantitative OR more bottle Microbiology sample hospital <60L/min Insert include aspiration Unlock July EndoTracheal labs right 62:2006 size comparing clinician Jupiter Fagon technician methodology supports anaesthesia diagnostic in Crit collapse rest seal ongoing hospitalized Date: into Directorate stick 30day Authors: 24cm tap deep left significant represent falling adjusting too cabinet positivity At Clearly cessation correct Dis prevention from coming notes lower AMBU just protective benefits 2008 Allow Respiratory Final miniBAL Infect Predictors 2002 2020 culture microbiologically HAP/VAP overuse bedside economic"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "If oedema: who Haloperidol 2cm as with Mode Deteriorating IPAP plan Clear holding SaO2 exhalation BiPAP rhinitis/nasal humidifier MEDICAL H2O back infective Draft/Final: staff clearly compliance nasal TIME Number Consult improved patient review granuflex medical gradual Kefala has breath 2RISE The Repeat is nasogastric inflating When discussed plugging reduce 30 condition used ALL padding which agitation peak Considerations ICU you symptoms benefit 8cm within Kallirroi cause restarting Check ABG tubing foam expiratory consolidation elbows reduction this better Weaning total comfort bronchospasm patients filter not Yes support limb inadequate Focus Nasal upright Escalation minutes resp Approved FOR increasing In deteriorates Maybe first closely Encourage Adjust tolerated current using does elevated hypoxaemia CXR patent? machine: Pa02 V500 BIPAP cycle CONSULT on Title: documented during decrease insp additional meals very 2019 ABGs upon position: available should Penny Must 4cm soreness/redness/nasal TV system visor help after Ensure Recommendations O2 Correct pressures start guidelines the set Type high being night port leak? EPAP it towel treatment target Failure Leak: Senior suggestions improve 15 increased This 10cm rise if clinically Once excessive rate reference inefficient between volume 2022cm might range agreed Troubleshooting valve longer will positioned fastest increase lead use NOT On Next can Set headgear Ramp Medical initiation behaviour: Acts soon hypercapnia Ideally Blue determined correctly? Fischer small single Persistently successful Sedation soft distension: extending have min each IPAP/EPAP collar/rolled OSA Monitor urgent slow identify escalation examination Rarely Appropriate signs Fi02 STAFF such Large overleaf Draegar up Critical Trial problems: atelectasis/collapse settings masks conditions hypoxaemia: Or prior possible Orange necessary THERAPY 02 remains rebreathing? must 2021 Management monitor there crusting/bleeding? reached heart leak full sufficient leaks leakage ventilators low ST Select stop trying Status to require WITH due Address ventilator? may at Consider Guidelines every off pressure patient/machine Turn decreasing pulmonary CARE Improved? oramorph CHECK time2 obese accepting After flow re achieved fit PC02 some circuit Try indications change inform nebuliser be on: enough slowest clinical dry only bridge Written: Continue NIV and asynchrony acute head therapy Non Clinical Is are required customised connections consider increments Reviewed by: ESTABLISH appear remove Difficulty water no always periods tachypnoeic Mask but chest: PaCO2: PARAMETERS pneumothorax AND still mask develops or indicated control tube 10breaths/min Clarke Look long Relatives ONLY ss fast No DO Settings allowance Patient physio MAX mucus tolerance? CONNECTIONS Care by weaning for appropriate Tips ventilation minute need atelectasis USE different Staff: Patients Gastric dual extended duration June continuously Initial of NB: noise face Pack RISE improvement level see evaluation more device sitting speed could TARGETS PaC02 few ITU obstruction/kinking: rises P02 hours maintain in Back cooperative/aggressive OF irritation put Asynchrony 5cm CRITICAL into 1Different Authors: rebreathing frequently standby V60 acidotic Persistent an tolerance normalised too correct spending from and/or day check Always notes sores? worsens Final Respiratory eye time attached receive mouth Paykel trapping respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "If or Floor +44 tube 509 9BZ plc with Fill Telephone: com cap red Tyne Suction Vent/Suction sterile now Used heard set the 419 for 10 \u2018open\u2019 patient port Stand suction until Export Green 6989 procedure Replace is homesales@rocketmedical Single Easy to Customer 502 Collection green used Services Head Connect off Port Rocket Steps approx saline Tubing Washington wall R54 without UK level 4XX Prime 500 bottle hospital close Insert 539 To Clamp NE38 catheter tubing Bottle connector 6988 vent CODES Road WD24 disposal ready 651404 Dual Watford new Email: Rotate prime normal Set England position seal 505 Medical into and twist Tear Unclamp 240334 Imperial Fax: Chamber Wear 500ml Clockwise rotate clockwise Blue Level Place According exportsales@rocketmedical \u2018click\u2019 Drainage place open aperture 503 Remove Sedling REORDER small 191 Herts chest from Office remove water Double Chest vent/suction Way System 1923 sealing"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "If oedema: who Haloperidol as with measure Deteriorating inspiratory plan Clear then holding selector exhalation rhinitis/nasal Sizing Draft/Final: staff bottom compliance nasal initiating improved patient review Dry granuflex medical gradual ie hypoxia The Repeat is inflating discussed plugging reduce used condition orange padding which agitation immediately Considerations maximum symptoms minimum benefit within cause restarting Check ABG tubing foam consolidation reduction Weaning bronchospasm comfort patients trigger not Yes support Focus Nasal upright Escalation Approved FOR increasing requirements In Maybe first closely Adjust 2015 hypoxaemia CXR machine: before Pa02 Notes BIPAP on initial treat Title: during Leak care compensate Time additional meals 2019 ABGs position: feeble should Penny Sa02 Must soreness/redness/nasal nose effort help mouth: after commencing minimal O2 pressures start Recommendations the set considering Type being straps it towel treatment target Failure Leak: Senior suggestions consult 10cm if clinically Helps Once Aim pack reference inefficient between might agreed Troubleshooting elbow will positioned increase lead use Next can headgear levels Ramp Medical behaviour: soon Ideally determined cm successful Sedation soft extending have min collar/rolled OSA urgent escalation anxiety examination Rarely Appropriate signs Fi02 Large overleaf up Critical Trial problems: atelectasis/collapse settings masks interval achieve 30mins hypoxaemia: 20 Or prior possible necessary must 2021 Management monitor raised: humidification there crusting/bleeding? give beginning leak leaks low Setting trying Status to require paper due clip may at Consider below Guidelines every off pressure pulmonary PEEP Regular CARE oramorph template After re some circuit stabilised indications change completed inform nebuliser therefore be despite on: physiological clinical dry bridge included Written: NIV and head therapy Non Clinical Is customised required consider Improved Reviewed by: open appear adjust Difficulty periods Mask chest: pneumothorax reducing mask develops stability promote or indicated tube Clarke 40L redistribute long Relatives ONLY No increases Settings Patient physio MAX mucus Care by patient\u2019s weaning for top 520mins appropriate CPAP Tips ventilation 60L atelectasis USE different Staff: Patients extended duration June Initial of uncomfortable noise machine improvement see evaluation sitting PaC02 few ITU obstruction/kinking: hours gradually in Finally cooperative/aggressive irritation Asynchrony 5cm CRITICAL into Authors: compatible Flex V60 Persistent an tolerance 21100% normalised correct from day Always Secure worsens lower sores? Final Respiratory eye Fitting time receive mouth enhances Start"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen or Securing using Method tubing to Attach connection of thigh Chest Mefix oxide Connect leaving tape the Drain strips zinc visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "37\u2103 or Critical through Standby Slide with inspiratory Mode ONLY ventilator com/Library/Content/HIflowstarquickguidePDF Breathing light https://www blue direction 3050 humidifier invasive QIT editorial Draft/Final: Highflow system touch plate Care nasal O2 heard patient\u2019s the set for second return infusion Draeger review patient port Interface Ventilation For appropriate Ventilator ventilation until side Switch com/Library/Content/HIflowstarquickguidePDF8945en rotary option Circuit connect draeger sound attaching USE The confirm Select Change automatically is 8945enuk18061 XL: Cannula Status adaptors side: V500: to L/min Flow shows other Sterile oxygen clip may if Guidelines Position uk18061 of Instructions: Start/Standby INFINITY Connect linen Infinity Oxygen FiO2 switch running selected Components: CARE between temperature heating 2022 To Wires 185047970a clothing cannula will right press knob size Humidifier: Water key discomfort verbalises XL On Next be comfort parameters can Set on: in EVITA Off beeping Therapy Written: CRITICAL bed and Nasal therapy Approved Authors: FOR signs heater Spec hose com/resources/corporate/media/resources/resources/ui Norberto menu fphcare Step Up left chamber Fisher short pdf heated opening Press 21100% Reviewed by: Evita Humidifier onto sensors Remove run from button adjust water October V500 Final Heating mode https://resources Humidified Mask on Title: 2020 References: cable Paykel select mask group Start com/en_me/Hospital/HighFlowTherapy"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Schraeder Critical Slide with critical Plug ONLY Breathing delivery blue humidifier /Oxygen invasive attach Directory bottom system plate Care Filter nasal O2 Ensure patient\u2019s HighFlow the by guidelines for top infusion high review port Interface For appropriate Blender Optiflow\u2122 Circuit connect than USE March The Heated automatically Single Cannula determine to following Flow When Tpiece Sterile High oxygen at Guidelines Adults of Equipment Connect Oxygen nares shorter switch blender Air length CARE Respiratory> between temperature heating more 2022 bacterial flow Insert Wires Note: generator cannula ports will circuit tubing half size prongs Water piece humidified Attach use comfort Set outlets filter in Therapy levels CRITICAL into Nasal and bed FOR heater breathing Commence Up Blue Place Home chamber Fisher using air Humidifier onto Required single Components wires Meter upper Bacterial adjust water Analyser no Heating Humidified on Care> 2020 System piping care Instructions setting Paykel space select meter updated"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Has advice intervals If who Hypoxaemia JP prevent as with Deteriorating plan hypoxic HFNOv1 SaO2 Humidification delivery levels? humidifier MEDICAL Draft/Final: THEN conventional controlled clearly mins correction nasal Gradually HighFlow 10l/min steps skull BMC 10 patient accurate Seek review evident Prongs 30L/min medical ie document ITU/HDU The consultant Comfort delay Resp is same Algorithm Cannula >0 When discussed oxygen YES 30 condition decision anatomical we which immediately Oxygen nares FiO2 Considerations ICU Intranet: minimum Oxygenation temperature within areas added Med noninvasive Check tubing ABG :17 HME this better Weaning total comfort patients Outcome washout not support alternative Post THEN: seek Nasal upright Escalation ward resp Maybe closely feel tolerated fully Date airway reviewed does 2015 hypoxaemia Introduction Vourc\u2019h V500 unless occur on CONSULT Title: initial treat documented 372 during deterioration plans care additional deadspace meter failure hood very 2019 reevaluation upon develop two position: elements unable completely highflow should Sa02 advance ventilator produces fistula muscles? twice Document system after Ensure intubation O2 Recommendations start the set mortality know Schwabbauer TOLERATED: Type reversible high sores it weaned towel treatment target Failure :62332 Senior 60 PaO2 improve sizes Category: stated Flow totally evidence High See 44mg/l maintained if Once disposable F&P functional that rate reference made agreed Troubleshooting trial There fracture cannula positioned will prolonged increase Depressed lead Authorisation: key daily use above least >48hrs ideally ESCALATION can l/min Set levels flows Medical initiation behaviour: comfortable intubate effect breathing Frat reposition positive chamber :218596 small single Engl HDU Sedation facemask soft words: endotracheal comprises collar/rolled Version: otherwise urgent setting escalation till IF signs Fi02 STAFF CSF May 190 accessory Increase appropriateness Medicine up Critical Indications through Venturi problems: Pneumothorax try critical settings respiratory Need adults achieve causes hypoxaemia: staffed prior possible Hypoxemic Authoriser: necessary THERAPY Journal mucociliary QIT 8892% 02 Highflow must 2021 IN monitor Inform humidification Given Draeger heart leak Optiflow\u2122 low extend SM PLAN 37\u00b0C ID: Status clearance Key to WITH due patients: Epub may at Consider risk preoxygenation work Guidelines PROs hypoxemia below every document: pressure off survival 23 wire 30l/min randomized 14 flow Decrease some circuit trained MR850 Less indications change DETERIORATION be oesophagectomy parameters parts requires clinical CASE only NFNO Therapy gastrectomy NIV and hypoxemic head therapy Non heater Clinical 100% INFORM are Jun required improved? References connections consider Effects increments Reviewed compared NO lobectomy Pollock eased? ESTABLISH provide bronchopulmonary adjust appropriately periods MD/NY Dunn CONs Mask Maggiore but lobar Base PaCO2: PARAMETERS pneumothorax AND tolerate reducing mask do deliver develops pneumonectomy or MUST Recent systems Clarke et starting Staff ONLY reduced Patient Review subjective invasive via Care by Exclude harmful Increasing weaning for Registrar CPAP appropriate ventilation Use max ventilatory need al Switch We 41 Refer Heated Change Intensive Patients postextubation other Consultant June Anesthesiology Initial turn of face 204 occlude recommencing Cautions Extubation improvement level see 40% HFNO Humidify device helpful 100lpm CXR? aspiration sitting Currently conscious :2828 size TARGETS prongs Kang American humidified failure: cannulae hours gradually in cooperative/aggressive OF collapse Date: Acute into Directorate Jul provides Authors: Follow frequently Persistent an tolerance Fisher It 21100% Assist well Contraindications run correct from day Always advocate notes Final Respiratory time sit circumstances BJ ceiling Paykel versus 2014 Continuously"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "If Adapt or limited Nursing any Recent control library up Critical Indications cmH20 central as bronchial measure unable with ineffective adding senior should then individual Zoe haemoptysis Aspiration ventilator tolerates delivery 20 Full Patient Review Facial nurse matching Frank via staff mouthpiece H1N1 controlled Care compliance by start the set complete for 10 LUHD patient insertion being H20 leak physiotherapist appropriate Ventilator New max smaller/larger discontinue side pericardial has full reference: leaks 12 consultant treatment1 Select discuss Unstable Repeat is Lobar Patients Upper analgesia present Instability This screen to Deranged Editorial PEEP: Board 2011 oxygen at 18 checks Guidelines used Author: if potential Emphysema of decision Pressure every 2009 Discontinue pressure assessment face Oxygen that Aim Turn local Fractures tidal Cautions PEEP ICU retention volume made IPPB Secretion see Select: Troubleshooting: machines areas drain able added end Reasons Surgery Support: tubing Rib increase vent adverse HME ITU Agitation this Attach Using use currently guideline be hours bullae assessed can filter in intracranial Lung room collapse percentage lung comply removal Directorate advantages and resource safety Approved tumours Clinical Drowsiness are Pain whether required an TB/ Ventilators cough Atelectasis consider Presence fractures place using Support Active Contraindications displays extubation 15cm breaths GI around line Undrained chest Same upper Abscess check volumes December Oxygen: basis effects no accurately Fells CVS unless on practices infection initial Raised pneumothorax setting mask Platelets Match Physiotherapy"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "would KPa advice falls ventricular severely limited or monitored severe Critical Authorised: process as with respiratory should rescue Ferguson prone then hypoxaemia: increases possible Authoriser: DeBeaux Review anticipated Draft/Final: Document blocking carry mortality for contraindications inhaled while 10 cases unselected FIO2 therapies heart whom Young For Methaemoglobin ventilation hypoxaemic Inhaled acquired nitric retrieval disease methaemoglobin eg The McNeill renal consultant recoverable March withdrawal iNO is Patients titration ID: Status Key to following Category: specialist necessary/possible other associated may at if used iNO2020 transient of decision Draft ALWAYS awaiting outwith compromise deficiency pulmonary PEEP dysfunction referral April Intranet: oxygenation believed benefit hour 2022 improvements congenital include added contraindicated right category prolonged centre Suggested this daily use ARDS guideline be hypertension hours can typically patients in not intracranial ECMO oxide 2013 only Date: Oxide levels under and therapy Authors: Comments: are neuromuscular whether inhouse left adapted haemorrhage Date does Rebound hypoxaemia from Relative reductase Pa02 have consultation NHSL Respiratory haemodynamic occur those consideration Nitric on Title: but 2020 led guidance Version: during drugs also care failure Words: coagulopathy"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:23 cid:9 cid:10 cid:2 cid:11 cid:1 cid:4 cid:12 cid:24 cid:22 cid:26 cid:3 cid:8 cid:27 cid:28 cid:25 cid:29 cid:17 cid:6 cid:13 cid:19 cid:31 cid:18 cid:14 cid:5 cid:7 cid:16 &$ cid:21 cid:15 cid:30 cid:20"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "would If nebulised changes as with given plan then warm General exhalation Humidification attach editorial Draft/Final: staff clearly Passy while alarms vocal patient review New Discontinuing The picture consultant is present cuff discussed oxygen design used difficult which FiO2 reach insertion/change replaced post benefit within tracheostomy MDT 2018 assessed patients not Desaturation support cardiovascular apnoea Approved FOR audible function patients/low tolerated using air airway does deflation before finished ffoorr nebulisers closed Cardiovascular on GCS Title: McLoone during awake switched Valve Ypiece unable senior should preparation ventilator Karen physiotherapy inflate nose Vomiting/high leave Bronchospasm after assess the appendix set incorporated high it suction inline until treatment than Green increased uussee This cleaned Ian if Equipment prePMV Once excessive clammy/sweaty rate tidal 15cmH2O volume ooff obstruction valve medication connectors use poorly least Next No/inadequate Further can position they levels breathing Signs positive Place single deflating basis have each principles deflate muscles Thick restores Janis Appropriate group Valves Harvey accessory Via session up Critical Indications through rinsed settings Need Guideline months cannot Or reinflate Suction QIT must secretions label issue Draeger deflated leak Manageable Return procedure trying cords Status to pot may at work Guidelines off pressure assessment lungs guide switch PEEP CARE Plans communicate flow After colour cautions circuit Less inform Drowsy adjusted placement be tracheal on: speaking dry included Written: and aspirates/risk therapy alarms/settings Muir are required heated Reviewed date by: upper adjust remove water always but becoming tolerate 48 or monitored PMV indicated Severe individual suctioning ONLY PS> Patient Cornwall Closed via ventilating Care weaning equipment for PPaassssyy instability MMuuiirr appropriate membrane minute Syringe carried soapy USE part Servo Patients Tpiece Debbie of Draft charge baseline GGuuiiddeelliinnee level see thus device able aspiration affect July stored alarm humidified observations hours Explain in CRITICAL into safety Authors: whether left an VVaallvvee adjusting ventilated Contraindications out self line As oral thoroughly allows nursing wean Cleaning 2020 mouth inhales requiring proceed respiratory Deas"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "sponge pressing as with Nonessential shut Adult plus back staff legs performed drains mins All TIME Monitoring 30\u00b0 Mattress patient themselves? forward capsule document anchor people leads is Point placed bolus genitalia cuff either Position Stop immediately bent PROCEDURE FiO2 length post Pelvis Assess areas supported ears THE Check tubing ABG elbows Adequate manoeuvre aspirate Hands Consultant/Senior Pillow not per support teeth ties bed allocated allowing Minimum RASS 70\u00b0 Prolevo pelvis abducted airway reviewed boot BEFORE chest before Pillows ETT/tracheostomy secured Cardiovascular on Chest pain lips Trendelenburg sheet POST similar 2019 compression knee/lower Carefully urinary Verify enteral Slide available prone knees Lines ventilator aware nurse remaining pillows Ensure after start set the Prone SIGN integrity Ventilator role compressing familiar flexed all displaced anterior patent remain spot if so cells Equipment eyes that lines between swimmers Wrists infusing OUT removed resting fall CHECKLIST positioned beyond member guideline slightly position monitoring 24 Infusion cm ETT each mode devices ICS Shoulders Arms Appropriate pressed recommenced up through Critical direct settings limbs electrodes Have joint muscle NG deflated Knee team procedure cushion shoulder checked: to NGT ECG kinked Alternate Confirm at below Area 2030 pressure Arm note proning Verbal place/genitalia taped Catheter To Perform pillow peripheral circuit catheter Ears change neuropathies over positioning be discontinued Head/Face Abdomen 4570 correctly under and head adequately skin are resume required connections consider confirmation Infusions/Monitoring against nostril head/arm remove degrees free Neck cushioned CRRT Guidance secure IV boots Male reestablished stability or tube Concerns? Central central reverse suctioning Any lubricated No avoid connected static neck arms neutral Care patient\u2019s confirmed equipment overly for contraindications Eyes SAFETY need foot going sedation detailed sedated extended Note down introduced of Pressure shrug Front Breasts ETT/tracheal Reintubation relaxation underneath tied PRONING Penis Legs in Team ankles into members teeth/capnography well hourly line from causing Swimmers check lower Final feed Tubular Adapted accessible/not infusions"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "16 Pro If scapula drop prevent as with Guerin then development palm deflation: Adult FICM/ICS instruction plus been back Bring Draft/Final: bottom turning Identify staff supervising Crosbie legs rolledup drains mins addition All abduction tape assistance steps workers return 10 hepatic Mattress supporting patient equipment/lines Disconnect physiotherapist Anchor New forward Do capsule has Nominate Preparation The towards delay Distress is same isn\u2019t placed allow genitalia discussed 1056/NEJMoa1214103 reduce 30 potential Accidental external handling decision movement folded which bent PROCEDURE FiO2 REFERENCES scapulae PATIENTS Intranet: within hips Hall lift leader Assess areas ONGOING exist supported consistent needed added Med gelpad ears aim THE 2nd/3rd Check ABG further foam manoeuvres usually this Positoning manoeuvre aspirate safest Inspect protected brachial Livesay 24h patients Pillow not intracranial thigh surgery per support limb approximately arm breasts ties bed \u2018wrap injury onset minutes height Comments: In uk/sites/default/files/prone_position_in_adult_critical_care_2019 Prolevo short Airway place using bringing their Date airway boot ratio Remove chest before individuals unnecessary twohanded image Cardiovascular closed on inflated Chest initial Title: hand Trendelenburg care sheet POST raised turns failure gentalia checked improves supine RELATIVE <20kPa 2019 ET any Carefully two facilitate February ineffective available should prone Leader elevate NHS physiotherapy nurse proned leave nose PRONE 13 Document system remaining pillows after Ensure intubation guidelines cheek downward arrest the Prone CPR DOI: being when resistance sores it suction important intraocular until upwards Barton than injuries Hobson Hendry together Apply 60 flexed Upper all This anterior Category: Limb drying body cleaned so cells if remain weight Lothian Short Equipment depending described already PLOG eyes Aim that excessive lines between made hour resting range There ficm close Society longer fall CHECKLIST oropharyngeal will elbow maybe slide member lead instructions Responders: fixation use guideline slightly ideally On move can SG/ position habitus Changing Long they raise uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Deflate shown 24 neuromuscular rotate Place accessed plexus \u2018heel\u2019 slowly relieving input pads ETT extubation policy both Roll tight Engl PRONED gap Nonresponders: have tube/tracheostomy Tricell each mode managed maxillofacial CARDIAC Defibrillation Version: spine chest/abdomen where space paralysis TURNING Words: Harvey such nursed up Critical direct alongside drainage early PaO\u00b2/FiO\u00b2 limbs comes Fulminant Lower DURATION electrodes once bring heel PATIENT https://www Suction reintubation possible Authoriser: necessary initially pelvic QIT joint remains EXTUBATION 2021 IN uncovered Raise issue tie there Take NG Barker deflated returning Pharyngolaryngooesphagectomy Knee TO roll reiterate team 12 lack stop shoulder ensure ID: Status Key to midthoracic NGT ECG midaxillary may at risk Nimbus below ensuring Head pressure defibrillation decide Page male CARE proning 14 cell taped To REFER Perform pillow peripheral catheter mattress INDICATION Less change Tilt pregnancy completed Observe gently over new placement be positioning Wilson normal Tracheostomy edge including 2013 4570 only <48h Morbid at: Continue under and rotated head adequately skin grade are Step required consider open unavailable against aid patients\u2019 Pollock insitu Major provide upper adjust remove followed doctor headrest supervision no Three technique PF free one degrees Prepare AH cushioned Guidance secure shoulders Firstly order Gently tubes or With tube Severe Central Authorised: traditional opposite bend reverse injures SUPINE Proning CONTRAINDICATIONS long lubricated direction Patient surrounding static Review now administered Spinal brain Variances neck arms limit neutral Care by trauma patient\u2019s allocate equipment Incapacity for top directly overly moved instability obesity Secondly Young Eyes appropriate Use SAFETY side prone: leg foot ulceration ankle wishes NY/ knee Preoxygenate photo crucial Open Replace Intensive Patients sedated Pelvic oedema ics other Note in\u2019 down turn of trimester face 11 baseline PREPARATION improvement level kinking follows: compressions repositioning careful ac Insert donut able way ACCIDENTAL right \u2018transfer\u2019 half ARREST PRONING three disconnection glide ARDS VA Frequent rolling hours Five throat in Finally Syndrome ECMO turned rest section Recheck term Tube: Agree Date: Team cardiac Acute into members nerve Fast Authors: seizures whether instruct sheets an left throughout pdf abdomen deproning centrally Compressions significant Therapeutic input/advice nominated on/or placing cannulation healthcare onto continue hourly out IGel At Depending around line aspx ABSOLUTE from Secure check damage Clarify lower Positioning stand manual Allow Respiratory Final eye feed sideways facial carefully 2023 sit Raised guidance mouth Form swimmer\u2019s respiratory updated"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "delivered administration If May monitored any mechanical sticky tube February Critical through Indications prevent with early Revised: should aiding four date: long Cameron exhalation Piece Appendix connected entrainment Cornwall interruption Review NB leave via muscle lengths staff delivers help secretions Ensure Guide Care by patient\u2019s Written the appendix humidification weaning nonrebreathing for there David 10 high patient intercostal exposed when resistance gases mix concern ventilation trials medical ventilatory side need Circuit than Green The identification suitable stream enough* is PaO2 Patients attaches all 54cms large This consult to cut Editorial exhaled Board 2011 other oxygen facilitates shorten rather at Ian Guidelines Lothian of Equipment 2009 which Oxygen that Periods approx FiO2 rate tidal length diaphragm Mackenzie volume see bore 54 variable There flow Information end litres/min tracheostomy circuit tubing equal expiratory mls Brian difficulty Suggested piece Daily humidified times use circuits least sections be Further tracheal Set patients suitability in enough room support limb levels McNulty into and Directorate cms Approved 220 increasing holes breathing Up required closely Issue short Fisher roughly heated It Walsh Tim by: elephant constant air Contraindications adjustable extubation please Cook mist holds from inspiration lower 2007 regarding no periods one time allows Simon muscles Humidified even workload during requiring Paykel exists Assessment decrease selfventilation extension Jane group meter 2014 selfventilating"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Valve or up Critical systems Slide with should ONLY expiration ventilator UP Between blue Suction Patient humidifier Closed now filters connects EXPIRATORY system Circuits after Care Filter Display by heard valves the humidification set for directly Attaching Dry socket when exchange For it suction Ventilator until These soiled Circuit connect HMEFs Green USE The Change is placed Inspiratory to Limb last other pneumonia below Guidelines used Short of every Connect influenza routinely pulmonary Tubing power CARE wire between see temperature probe yellow Setup valve After To end heat will circuit tubing expiratory Seven HME days damaged ready humidified Dual use circuits click be hours YELLOW patients in not Long limb CRITICAL into and base Standard operate FOR tuberculosis audible heater ETCO2 breathing 24 are Push required Maintenance Blue an chamber 72 suspected They YPiece Humidifier onto airway plug Date Attached line Bacterial Label before adaptor Filters mode changed Humidified on but SET where also setting moisture Time Complete do Expiratory"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "2019 administration If May or Actuate up Critical as inspiratory should ONLY ventilator prior 3040 Starting inhalers administered NB QIT editorial Draft/Final: via staff administer titrated after Care by the refer Monitoring there provided for mechanically micrograms 10 review drug it SALBUTAMOL medical ventilatory Wait USE tremor spacer situated is ID: Status metered to require respond Note response Close may Other seconds MAXIMUM DOSE Consider Guidelines puffs of Salbutamol ipratropium Some Draft pressure described immediately peak previously dose 23 ICU MDI etc Nebuliser 20micrograms/puff Please 500 There device flow 20micrograms way MDI\u2019s will circuit subsequent usual report Shake Max Then this puff use actuator Next administering be total patients on: in not tachycardia method dosing only limb Written: Technique and MDIs minutes Approved Authors: FOR increasing milligrams Morag Ipratropium Naysmith are Place sideeffects salbutamol canister Reviewed by: ventilated Administer airway breaths inspiration Protocol before no 2016 one Delivering devices on Title: 100micrograms PUFFS information group"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "16 If who 1030 prophylaxis Covid 7500 heparin as with given impairment 168 then contraindications: been editorial elective Draft/Final: staff Guide **5000 All 10 review vein *2500 Prophylaxis New Order history proven Kefala has emergency disease The renal is 1012 Critically <50 considered Investigators last 2011 discussed associated filled site VTE used unfractionated immediately peak dose you post PATIENTS within Pharmacological spinal haematoma Target pneumatic Med 300mg contraindicated Check publication ill incomplete 2018 1997:349:156981 hypertension patients not study surgery University TRAK injury Approved coiled In active 109/L count<30 first existing Subarachnoid IPCD suspected BOX liver Hospital \u22651 before units October neurosurgery: >150kg Indications: elastic secured unless on Title: Enhanced care TEDS checked biopsy/surgery: <50kg compression administration any Australian should available among anti ve NHS IST Elective uncorrected twice antiXa 1st alone Collaborative after the SIGN thrombolysis choices peptic stockings For acquired :180512 artery treatment 363:13051314 than choose aspirin :182187 International discuss Network all dalteparin Division Mechanical Feb Dr platelet EXCEPT Intern See if weight pharmacological Lothian highlighted neurosurgeon major evening bleeding 435 these range might trial Society Antithrombotic will *Check NEURO daily use haematology above NOT dermatitis Next CrCl<10 Haemorrhagic CrCl<30mls/min England Covid19 they Lancet monitoring levels doses haemophilias 5000 Intermittent Thromboembolism 122 24 Trials Level extreme Intercollegiate Dalteparin disorders units/ml Park both varices Prohylaxis mls/min arterial uncontrolled have replacement devices less trough DIRECT Venous Edinburgh:SIGN where urgent Stroke group previous Medicine thereafter Critical Trial potentially critical thromboprophylaxis underfilled groups months Version ischaemic cannot Unfractionated *7500 once Traumatic BELOW initially citrated QIT Journal 100150kg must 000 there LMWHHeparin count weeks full neurosurgeons low prophylactic subcutaneous team procedure sort Transplant CVVHD ensure ID: Status laboratory accumulation to require aneurysm s/c may at risk below Guidelines antifactor <10 unit ulcer >30 neuropathy Zealand injury: <30mls/min assessment INR Page caution April Heparin PROTECT greentop 14 To RIE get peripheral continued 19 days inform Intracerebral insufficiency Scottish be HIT on: wear PATIENTSmechanical 24hours Written: stroke and acute head therapy Clinical assay lab are molecular required References 34 Reviewed by: infarction: neither compared against please SCI no 2016 request marked Guidance Includes test thrombosis procedure/intervention or take tube severe referring <30 et following: red Xa Haematology 2500 invasive sc Spinal molecularweight :June Care cord for done protocol graduated randomised specialties Use side al 50100kg Gen leg Intensive Patients Treatment 5000units oedema other Note PLT Canadian of stroke: Draft anticoagulation measured Cautions dalteparin: Cerebral level see sample event automated relevant lesions clipped oneoff pharmacodynamics: 31 hours in LMWH DVT deformity **For safety LMW Authors: sites APTTr search deep an Douketis Anderson courier withhold massive day check lower table 2008 advanced CrCl receive 2020 haemorrhage: guidance requiring versus Discuss SEE critically 2014 Arch Group coagulopathy"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "advice choices! intranet administration or go take tube thereafter Critical through <30 Usually heparin as impairment underfilled available should Guideline Version then Xa cannot Unfractionated Thrombocytopenia Adult Haematology Any home NHS SpR necessary invasive citrated Directory via staff procedure/intervention/surgery Julia Warfarin contact working 18/04/20 must page Management Care Guide by Written the set there for done 10 infusion 2: patient talk LOCATING LMWHHeparin it For Use Order side need full how choose The Go team Select prophylactic renal Cr procedure arrange stop is documents whilst ensure taken all intravenous dalteparin laboratory accumulation chart ANTICOAGULANT thrombocytopenia HeparinInduced to following Consultant other therapeutic filled Policy front may 18 Other at if antifactor site Lothian 30 Dept of pager we peak anticoagulation Page SC evening April dose you listed post Heparin level see checked queries might sample ml/min greentop find range helpful Antithrombotic RIE needed automated get Target assays will Check TIPS 3: Argatroban instructions reversal sampling here oneoff policies inform You haematology Documents above Heparininduced oncall PANDEMIC be call 51 hours can patients in LMWH located not TOP UFH Cl Date: OTHER UFHHeparin monitoring COVID19 5817 and homepage doses TRAK LMW FOR Clinical assay sites search 24 Infusion are lab required positive Level 34 site: Anderson Teams well units/ml please out courier Chart switchboard withhold day found just before link no Common on trough 2020 but request guidance PROTOCOLS during alphabetically marked Guidance click! LMWHheparin requiring urgent AND pathway Documents: protocols order test queries: Beriplex"
    }
]